JP2006273847A - Cinnamoyl compound and its application - Google Patents
Cinnamoyl compound and its application Download PDFInfo
- Publication number
- JP2006273847A JP2006273847A JP2006054781A JP2006054781A JP2006273847A JP 2006273847 A JP2006273847 A JP 2006273847A JP 2006054781 A JP2006054781 A JP 2006054781A JP 2006054781 A JP2006054781 A JP 2006054781A JP 2006273847 A JP2006273847 A JP 2006273847A
- Authority
- JP
- Japan
- Prior art keywords
- group
- same meaning
- represent
- same
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 Cinnamoyl compound Chemical class 0.000 title claims abstract description 148
- 150000001875 compounds Chemical class 0.000 claims abstract description 313
- 125000001424 substituent group Chemical group 0.000 claims abstract description 149
- 239000000203 mixture Substances 0.000 claims abstract description 105
- 125000003118 aryl group Chemical group 0.000 claims abstract description 71
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 51
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims abstract description 46
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims abstract description 46
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims abstract description 46
- 206010016654 Fibrosis Diseases 0.000 claims abstract description 40
- 230000004761 fibrosis Effects 0.000 claims abstract description 37
- 210000001519 tissue Anatomy 0.000 claims abstract description 37
- 238000013518 transcription Methods 0.000 claims abstract description 35
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 34
- 230000035897 transcription Effects 0.000 claims abstract description 31
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 27
- 210000002744 extracellular matrix Anatomy 0.000 claims abstract description 26
- 238000009825 accumulation Methods 0.000 claims abstract description 18
- 206010019280 Heart failures Diseases 0.000 claims abstract description 17
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 15
- 230000014509 gene expression Effects 0.000 claims abstract description 14
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 12
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 220
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 181
- 125000005843 halogen group Chemical group 0.000 claims description 155
- 125000004149 thio group Chemical group *S* 0.000 claims description 122
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 121
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 109
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 82
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 79
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 77
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 76
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 64
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 64
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 57
- 239000004480 active ingredient Substances 0.000 claims description 54
- 125000000304 alkynyl group Chemical group 0.000 claims description 54
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 51
- 125000003342 alkenyl group Chemical group 0.000 claims description 46
- 125000002947 alkylene group Chemical group 0.000 claims description 45
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims description 43
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 42
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims description 40
- 125000004450 alkenylene group Chemical group 0.000 claims description 40
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 35
- 125000000623 heterocyclic group Chemical group 0.000 claims description 33
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 29
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 22
- 229910052757 nitrogen Inorganic materials 0.000 claims description 22
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 20
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 19
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 16
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 16
- 125000001188 haloalkyl group Chemical group 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 13
- 229920006395 saturated elastomer Polymers 0.000 claims description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 12
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 12
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 10
- 125000004429 atom Chemical group 0.000 claims description 10
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims description 9
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims description 9
- 208000020832 chronic kidney disease Diseases 0.000 claims description 9
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims description 9
- 125000004076 pyridyl group Chemical group 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 6
- 125000004414 alkyl thio group Chemical group 0.000 claims description 6
- 125000004419 alkynylene group Chemical group 0.000 claims description 6
- 230000000754 repressing effect Effects 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 230000003778 catagen phase Effects 0.000 claims description 5
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 5
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000002541 furyl group Chemical group 0.000 claims description 4
- 125000000232 haloalkynyl group Chemical group 0.000 claims description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 230000007704 transition Effects 0.000 claims description 4
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 claims description 3
- 230000003779 hair growth Effects 0.000 claims description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 3
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- CBKDCOKSXCTDAA-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1-benzothiophene Chemical group C1CCCC2=C1C=CS2 CBKDCOKSXCTDAA-UHFFFAOYSA-N 0.000 claims description 2
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 claims description 2
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical group C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 22
- 241000189705 Dunedin group Species 0.000 claims 6
- 238000003763 carbonization Methods 0.000 claims 4
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 210000002257 embryonic structure Anatomy 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 abstract description 7
- 230000003247 decreasing effect Effects 0.000 abstract description 5
- 230000001256 tonic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 54
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 51
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 47
- 230000015572 biosynthetic process Effects 0.000 description 47
- 238000003786 synthesis reaction Methods 0.000 description 46
- 238000005160 1H NMR spectroscopy Methods 0.000 description 42
- 239000000243 solution Substances 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 239000013078 crystal Substances 0.000 description 33
- 150000002430 hydrocarbons Chemical group 0.000 description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
- 150000001299 aldehydes Chemical class 0.000 description 29
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 108010067306 Fibronectins Proteins 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 17
- 230000002829 reductive effect Effects 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 0 CC1=C(C)N(*)C(O)=CC1=O Chemical compound CC1=C(C)N(*)C(O)=CC1=O 0.000 description 13
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 108010022452 Collagen Type I Proteins 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- GYHDUKUKBGMCAY-UHFFFAOYSA-N 5-(2-hydroxyethoxymethyl)thiophene-2-carbaldehyde Chemical compound OCCOCC1=CC=C(C=O)S1 GYHDUKUKBGMCAY-UHFFFAOYSA-N 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 108010035532 Collagen Proteins 0.000 description 10
- 102000016359 Fibronectins Human genes 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- VFEAMMGYJFFXKV-UHFFFAOYSA-N 5-formylthiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(C=O)S1 VFEAMMGYJFFXKV-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 239000000546 pharmaceutical excipient Substances 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- JUWKRJDTXQGWBT-UHFFFAOYSA-N 5-formyl-n-(2-hydroxyethyl)thiophene-2-carboxamide Chemical compound OCCNC(=O)C1=CC=C(C=O)S1 JUWKRJDTXQGWBT-UHFFFAOYSA-N 0.000 description 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- KOHBEDRJXKOYHL-UHFFFAOYSA-N 2-methoxy-n-methylethanamine Chemical compound CNCCOC KOHBEDRJXKOYHL-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 238000010898 silica gel chromatography Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001721 carbon Chemical group 0.000 description 6
- 229910002091 carbon monoxide Inorganic materials 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 5
- QAQJKDRAJZWQCM-UHFFFAOYSA-N 2-methoxyethyl carbamate Chemical compound COCCOC(N)=O QAQJKDRAJZWQCM-UHFFFAOYSA-N 0.000 description 5
- GYZSRVOSYGPHQP-UHFFFAOYSA-N 5-formyl-n-(2-methoxyethyl)thiophene-2-carboxamide Chemical compound COCCNC(=O)C1=CC=C(C=O)S1 GYZSRVOSYGPHQP-UHFFFAOYSA-N 0.000 description 5
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 5
- 208000033679 diabetic kidney disease Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 5
- KHGZYQVHWKGKPD-UHFFFAOYSA-N n-(5-formylthiophen-3-yl)-2-methoxyacetamide Chemical compound COCC(=O)NC1=CSC(C=O)=C1 KHGZYQVHWKGKPD-UHFFFAOYSA-N 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- MTEZLAATISORQK-UHFFFAOYSA-N 2-methoxyacetamide Chemical compound COCC(N)=O MTEZLAATISORQK-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 4
- 208000010159 IgA glomerulonephritis Diseases 0.000 description 4
- 206010021263 IgA nephropathy Diseases 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 150000003935 benzaldehydes Chemical class 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000000490 cosmetic additive Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 4
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 210000001626 skin fibroblast Anatomy 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- PDONIKHDXYHTLS-UHFFFAOYSA-N 4-bromothiophene-2-carbaldehyde Chemical compound BrC1=CSC(C=O)=C1 PDONIKHDXYHTLS-UHFFFAOYSA-N 0.000 description 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000029523 Interstitial Lung disease Diseases 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 206010039710 Scleroderma Diseases 0.000 description 3
- AVRWEULSKHQETA-UHFFFAOYSA-N Thiophene-2 Chemical compound S1C=2CCCCCC=2C(C(=O)OC)=C1NC(=O)C1=C(F)C(F)=C(F)C(F)=C1F AVRWEULSKHQETA-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000007882 cirrhosis Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000012024 dehydrating agents Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000003176 fibrotic effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- MKIJJIMOAABWGF-UHFFFAOYSA-N methyl 2-sulfanylacetate Chemical compound COC(=O)CS MKIJJIMOAABWGF-UHFFFAOYSA-N 0.000 description 3
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 201000009925 nephrosclerosis Diseases 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 201000002793 renal fibrosis Diseases 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 150000003464 sulfur compounds Chemical class 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 230000005758 transcription activity Effects 0.000 description 3
- 125000006017 1-propenyl group Chemical group 0.000 description 2
- JJKWHOSQTYYFAE-UHFFFAOYSA-N 2-methoxyacetyl chloride Chemical compound COCC(Cl)=O JJKWHOSQTYYFAE-UHFFFAOYSA-N 0.000 description 2
- WPHHQFQYBDEXFF-UHFFFAOYSA-N 2-methoxyethyl n-(5-formylthiophen-2-yl)carbamate Chemical compound COCCOC(=O)NC1=CC=C(C=O)S1 WPHHQFQYBDEXFF-UHFFFAOYSA-N 0.000 description 2
- QUYIISZLCVRHGN-UHFFFAOYSA-N 3-acetyl-4-hydroxy-1,6-dimethylpyridin-2-one Chemical compound CC(=O)C1=C(O)C=C(C)N(C)C1=O QUYIISZLCVRHGN-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 2
- GJSJNCNHQQTXDX-UHFFFAOYSA-N 5-(bromomethyl)thiophene-2-carbaldehyde Chemical compound BrCC1=CC=C(C=O)S1 GJSJNCNHQQTXDX-UHFFFAOYSA-N 0.000 description 2
- GFBVUFQNHLUCPX-UHFFFAOYSA-N 5-bromothiophene-2-carbaldehyde Chemical compound BrC1=CC=C(C=O)S1 GFBVUFQNHLUCPX-UHFFFAOYSA-N 0.000 description 2
- SHNRXUWGUKDPMA-UHFFFAOYSA-N 5-formyl-2-furoic acid Chemical compound OC(=O)C1=CC=C(C=O)O1 SHNRXUWGUKDPMA-UHFFFAOYSA-N 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 208000000668 Chronic Pancreatitis Diseases 0.000 description 2
- 102000001187 Collagen Type III Human genes 0.000 description 2
- 108010069502 Collagen Type III Proteins 0.000 description 2
- 102000004266 Collagen Type IV Human genes 0.000 description 2
- 108010042086 Collagen Type IV Proteins 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- 206010018364 Glomerulonephritis Diseases 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000005777 Lupus Nephritis Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028594 Myocardial fibrosis Diseases 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- 206010033649 Pancreatitis chronic Diseases 0.000 description 2
- 208000031848 Peritonitis sclerosing Diseases 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 206010039580 Scar Diseases 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 206010046798 Uterine leiomyoma Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 201000006334 interstitial nephritis Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LVQLQYLIKYDXHL-UHFFFAOYSA-N methyl 2-[(5-formylthiophen-2-yl)methylsulfanyl]acetate Chemical compound COC(=O)CSCC1=CC=C(C=O)S1 LVQLQYLIKYDXHL-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical group 0.000 description 2
- 206010028537 myelofibrosis Diseases 0.000 description 2
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000036573 scar formation Effects 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000003419 tautomerization reaction Methods 0.000 description 2
- 239000003860 topical agent Substances 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical group C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- UDGKZGLPXCRRAM-UHFFFAOYSA-N 1,2,5-thiadiazole Chemical group C=1C=NSN=1 UDGKZGLPXCRRAM-UHFFFAOYSA-N 0.000 description 1
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- PBRUALJXPXRDHW-UHFFFAOYSA-N 1-(4-hydroxy-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-3-yl)ethanone Chemical compound C1=CC=C2S(=O)(=O)N(C)C(C(C)=O)=C(O)C2=C1 PBRUALJXPXRDHW-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- NIBFJPXGNVPNHK-UHFFFAOYSA-N 2,2-difluoro-1,3-benzodioxole-4-carbaldehyde Chemical group C1=CC(C=O)=C2OC(F)(F)OC2=C1 NIBFJPXGNVPNHK-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- HZKMBJCDAXLMDN-UHFFFAOYSA-N 2-amino-1,3-thiazole-5-carbaldehyde Chemical compound NC1=NC=C(C=O)S1 HZKMBJCDAXLMDN-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- XTPRSWPAZJPVMR-UHFFFAOYSA-N 2-hydroxyethylazanide Chemical compound [NH-]CCO XTPRSWPAZJPVMR-UHFFFAOYSA-N 0.000 description 1
- NDYYWMXJZWHRLZ-UHFFFAOYSA-N 2-methoxyethyl carbonochloridate Chemical compound COCCOC(Cl)=O NDYYWMXJZWHRLZ-UHFFFAOYSA-N 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- GWHQXPRMCYBFDA-UHFFFAOYSA-N 3-acetyl-4-hydroxy-1-methyl-1,8-naphthyridin-2-one Chemical compound C1=CN=C2N(C)C(=O)C(C(=O)C)=C(O)C2=C1 GWHQXPRMCYBFDA-UHFFFAOYSA-N 0.000 description 1
- UNENKAJBDVFWSE-UHFFFAOYSA-N 4-formyl-1-methylpyrrole-2-carboxylic acid Chemical compound CN1C=C(C=O)C=C1C(O)=O UNENKAJBDVFWSE-UHFFFAOYSA-N 0.000 description 1
- GVNULOJEHQKWGI-UHFFFAOYSA-N 4-formyl-n-(2-methoxyethyl)-1-methylpyrrole-2-carboxamide Chemical compound COCCNC(=O)C1=CC(C=O)=CN1C GVNULOJEHQKWGI-UHFFFAOYSA-N 0.000 description 1
- NUIXLPFZDJBSRX-UHFFFAOYSA-N 4-formylthiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC(C=O)=CS1 NUIXLPFZDJBSRX-UHFFFAOYSA-N 0.000 description 1
- OFLOHKOTBNOKSN-UHFFFAOYSA-N 5-[2-(dimethylamino)ethyl-methylamino]thiophene-2-carbaldehyde Chemical compound CN(C)CCN(C)C1=CC=C(C=O)S1 OFLOHKOTBNOKSN-UHFFFAOYSA-N 0.000 description 1
- SAQPSESWKBAQIW-UHFFFAOYSA-N 5-[3-(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)-3-oxoprop-1-enyl]-N-(2-methoxyethyl)furan-2-carboxamide Chemical compound O1C(C(=O)NCCOC)=CC=C1C=CC(=O)C1=C(O)C=C(C)N(C)C1=O SAQPSESWKBAQIW-UHFFFAOYSA-N 0.000 description 1
- FWOBGCSEUVKGMN-UHFFFAOYSA-N 5-[3-(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)-3-oxoprop-1-enyl]-N-(2-methoxyethyl)thiophene-2-carboxamide Chemical compound S1C(C(=O)NCCOC)=CC=C1C=CC(=O)C1=C(O)C=C(C)N(C)C1=O FWOBGCSEUVKGMN-UHFFFAOYSA-N 0.000 description 1
- IRZBYIDEBJVXLK-UHFFFAOYSA-N 5-formyl-1-methylpyrrole-2-carboxylic acid Chemical compound CN1C(C=O)=CC=C1C(O)=O IRZBYIDEBJVXLK-UHFFFAOYSA-N 0.000 description 1
- VEKYYBHIJVEVAB-UHFFFAOYSA-N 5-formyl-n-(2-methoxyethyl)-1-methylpyrrole-2-carboxamide Chemical compound COCCNC(=O)C1=CC=C(C=O)N1C VEKYYBHIJVEVAB-UHFFFAOYSA-N 0.000 description 1
- UYKINVUGKDPTQI-UHFFFAOYSA-N 5-formyl-n-(2-methoxyethyl)furan-2-carboxamide Chemical compound COCCNC(=O)C1=CC=C(C=O)O1 UYKINVUGKDPTQI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- TZOMWNXJPOHSCY-HWKANZROSA-N CC(N1C=[IH])=CC(O)=C(C(/C=C/c2ccc(C(NCCOC)=O)[s]2)=O)C1=O Chemical compound CC(N1C=[IH])=CC(O)=C(C(/C=C/c2ccc(C(NCCOC)=O)[s]2)=O)C1=O TZOMWNXJPOHSCY-HWKANZROSA-N 0.000 description 1
- 101100297347 Caenorhabditis elegans pgl-3 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 101001066129 Homo sapiens Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102100031775 Leptin receptor Human genes 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229920002274 Nalgene Polymers 0.000 description 1
- 241000287463 Phalacrocorax Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010050207 Skin fibrosis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 108091005735 TGF-beta receptors Proteins 0.000 description 1
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 229960001931 ampicillin sodium Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 102000047486 human GAPDH Human genes 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 108010019813 leptin receptors Proteins 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- KQSSATDQUYCRGS-UHFFFAOYSA-N methyl glycinate Chemical compound COC(=O)CN KQSSATDQUYCRGS-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- DYJWKTWUMIXHES-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-5-formylthiophene-2-carboxamide Chemical compound NC(=O)CNC(=O)C1=CC=C(C=O)S1 DYJWKTWUMIXHES-UHFFFAOYSA-N 0.000 description 1
- OWNHWCOUKGTTSA-UHFFFAOYSA-N n-(2-hydroxyethyl)-5-[3-(4-hydroxy-1-methyl-2-oxo-1,8-naphthyridin-3-yl)-3-oxoprop-1-enyl]thiophene-2-carboxamide Chemical compound O=C1N(C)C2=NC=CC=C2C(O)=C1C(=O)C=CC1=CC=C(C(=O)NCCO)S1 OWNHWCOUKGTTSA-UHFFFAOYSA-N 0.000 description 1
- ZKGOIFDAWVJOTC-UHFFFAOYSA-N n-(2-hydroxyethyl)-5-[3-(4-hydroxy-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-3-yl)-3-oxoprop-1-enyl]thiophene-2-carboxamide Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)C=CC1=CC=C(C(=O)NCCO)S1 ZKGOIFDAWVJOTC-UHFFFAOYSA-N 0.000 description 1
- PAFNNSFZSJSSEY-UHFFFAOYSA-N n-(2-hydroxyethyl)thiophene-2-carboxamide Chemical compound OCCNC(=O)C1=CC=CS1 PAFNNSFZSJSSEY-UHFFFAOYSA-N 0.000 description 1
- DMOBYIVSAUJQJR-UHFFFAOYSA-N n-(5-formyl-1,3-thiazol-2-yl)-2-methoxyacetamide Chemical compound COCC(=O)NC1=NC=C(C=O)S1 DMOBYIVSAUJQJR-UHFFFAOYSA-N 0.000 description 1
- ZGPZAUFWRUMRLR-UHFFFAOYSA-N n-(5-formylthiophen-2-yl)-2-methoxyacetamide Chemical compound COCC(=O)NC1=CC=C(C=O)S1 ZGPZAUFWRUMRLR-UHFFFAOYSA-N 0.000 description 1
- CMFITBGFKWPJEG-UHFFFAOYSA-N n-[5-[3-(4-hydroxy-1-methyl-2-oxo-1,8-naphthyridin-3-yl)-3-oxoprop-1-enyl]thiophen-3-yl]-2-methoxyacetamide Chemical compound COCC(=O)NC1=CSC(C=CC(=O)C=2C(N(C)C3=NC=CC=C3C=2O)=O)=C1 CMFITBGFKWPJEG-UHFFFAOYSA-N 0.000 description 1
- YTBHRIDCWHBXMB-UHFFFAOYSA-N n-[5-[3-(4-hydroxy-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-3-yl)-3-oxoprop-1-enyl]thiophen-3-yl]-2-methoxyacetamide Chemical compound COCC(=O)NC1=CSC(C=CC(=O)C=2N(S(=O)(=O)C3=CC=CC=C3C=2O)C)=C1 YTBHRIDCWHBXMB-UHFFFAOYSA-N 0.000 description 1
- SFMJNHNUOVADRW-UHFFFAOYSA-N n-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide Chemical compound C1=C(NC(=O)C=C)C(C)=CC=C1N1C(=O)C=CC2=C1C1=CC(C=3C=CC(NS(C)(=O)=O)=CC=3)=CC=C1N=C2 SFMJNHNUOVADRW-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003799 water insoluble solvent Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Abstract
Description
本発明は、シンナモイル化合物及びその用途等に関する。 The present invention relates to cinnamoyl compounds and uses thereof.
肝硬変、慢性膵炎、スキルス胃癌、間質性肺疾患、喘息、慢性閉塞性肺疾患、糸球体腎炎、ループス腎炎、尿細管間質性腎炎、IgA腎症、腎硬化症、糖尿病性腎症、遺伝性腎疾患、心筋線維症、心不全、PTCA後の再狭窄、動脈硬化、骨髄線維症、関節リウマチ、炎症後の過形成痕跡、術後の瘢痕や熱傷性瘢痕、アトピー性皮膚炎、肥厚性瘢痕、子宮筋腫、前立腺肥大症、強皮症、アルツハイマー病、硬化性腹膜炎、糖尿病性網膜症、I型糖尿病においては、コラーゲン及びフィブロネクチンに代表されるような細胞外マトリックスの過度の集積により組織が線維化して硬化し、その結果、臓器・組織の機能低下や瘢痕形成等に至る。このような細胞外マトリックスの過度の集積は、細胞外マトリックスの生合成と分解とのバランスの破綻に基づく細胞外マトリックスの産生亢進によって導かれる。実際、線維化した組織においては、コラーゲン遺伝子(特にI型コラーゲン、III型コラーゲン、IV型コラーゲン)や、フィブロネクチン遺伝子、ラミニン遺伝子、プロテオグリカン遺伝子等といった細胞外マトリックス遺伝子の発現量が増加していることが観察されている(例えば、非特許文献1〜6参照)。
また、線維化した組織においては、サイトカインの1種であるTGF−βの量が上昇していることも観察されている(例えば、非特許文献1、2参照)。TGF−βは、細胞外マトリックス遺伝子の発現量を増加させ、細胞外マトリックスタンパクの産生亢進、ひいては、組織の線維化に関与していることが示唆されている(例えば、非特許文献1、7参照)。さらに、組織線維化のモデル動物に対し、抗TGF−β抗体や可溶性TGF−β受容体を投与することにより、組織の線維化が改善され、それに伴い組織機能が改善されることが明らかにされており(例えば、非特許文献8〜10参照)、またTGF−βの細胞内シグナル伝達に対し、抑制的に働く化合物を投与することにより、組織の線維化が改善され、それに伴い組織機能が改善されることも知られている(例えば、非特許文献11〜13参照)。
一方、左室拡張不全等の心不全や糖尿病性腎症や腎硬化症等の腎不全の病因は、高血圧状態の心臓線維化がその1つとされている。
Cirrhosis, chronic pancreatitis, Skills gastric cancer, interstitial lung disease, asthma, chronic obstructive pulmonary disease, glomerulonephritis, lupus nephritis, tubulointerstitial nephritis, IgA nephropathy, nephrosclerosis, diabetic nephropathy, heredity Renal disease, myocardial fibrosis, heart failure, restenosis after PTCA, arteriosclerosis, myelofibrosis, rheumatoid arthritis, post-inflammation hyperplasia, postoperative scar or burn scar, atopic dermatitis, hypertrophic scar In uterine fibroids, benign prostatic hyperplasia, scleroderma, Alzheimer's disease, sclerosing peritonitis, diabetic retinopathy, type I diabetes, the tissue is fibrotic due to excessive accumulation of extracellular matrix such as collagen and fibronectin. As a result, the function of organs / tissues decreases and scar formation occurs. Such excessive accumulation of the extracellular matrix is induced by increased production of the extracellular matrix based on the breakdown of the balance between biosynthesis and degradation of the extracellular matrix. In fact, in fibrotic tissues, the expression level of extracellular matrix genes such as collagen genes (particularly type I collagen, type III collagen, type IV collagen), fibronectin gene, laminin gene, proteoglycan gene, etc. has increased. Has been observed (for example, see Non-Patent Documents 1 to 6).
In fibrotic tissues, it has also been observed that the amount of TGF-β, which is a kind of cytokine, is increased (for example, see Non-Patent Documents 1 and 2). It has been suggested that TGF-β increases the expression level of extracellular matrix genes and is involved in the enhancement of extracellular matrix protein production and, consequently, tissue fibrosis (for example, Non-Patent Documents 1 and 7). reference). Furthermore, it has been clarified that administration of anti-TGF-β antibody and soluble TGF-β receptor to tissue fibrosis model animals improves tissue fibrosis and accompanyingly improves tissue function. (For example, see Non-Patent Documents 8 to 10), and by administering a compound that acts to suppress the intracellular signal transduction of TGF-β, tissue fibrosis is improved. It is also known to be improved (for example, see Non-Patent Documents 11 to 13).
On the other hand, heart fibrosis in a hypertensive state is one of the causes of heart failure such as left ventricular diastolic failure and renal failure such as diabetic nephropathy and nephrosclerosis.
そこで、組織における細胞外マトリックス遺伝子の発現量を減少させ、細胞外マトリックス蓄積量を低下させることにより、組織の線維化を改善させる薬剤(即ち、細胞外マトリックス蓄積抑制剤や、線維症治療剤又は心不全治療剤)の開発・提供が切望されている。 Therefore, an agent that improves tissue fibrosis by decreasing the amount of extracellular matrix gene expression in the tissue and reducing the amount of extracellular matrix accumulation (ie, an agent for inhibiting extracellular matrix accumulation, a therapeutic agent for fibrosis, or The development and provision of therapeutic agents for heart failure) are eagerly desired.
本発明者らは、かかる状況の下、鋭意検討した結果、下記の式(I)〜(VI)(I')、(II')及び(V')で示される化合物が細胞外マトリックス遺伝子の転写を抑制する能力を有することを見出し、本発明に至った。
即ち、本発明は、
1.式(I)
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.βは、
式(I-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(I-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(I-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(I-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(I-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(I-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(I-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(I-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(I-9)
[式中、U及びWαは、前記と同一の意味を表す。]
で示される基を表す。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物と不活性担体とを含有することを特徴とする細胞外マトリックス遺伝子転写抑制組成物。
2.式(II)
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.βは、
式(II-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(II-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(II-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(II-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(II-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(II-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(II-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(II-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(II-9)
[式中、U及びWαは、前記と同一の意味を表す。]
で示される基を表す。
但し、αがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
3.式(III)
[式中、
I.A0は、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表す。
II.(XA0)pにおいて、XA0は、下記のA0群からN0群までのいずれかの群に含まれる基を表し、pは、0、1、2又は3を表し、pが2以上のとき、XA0は、同一又は相異なる。
(1)A0群:D1−R4−基[D1は、(R1−(O)k−)A1N−(O)k’−基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表し、kは、0又は1を表し、A1は、R3−(CHR0)m−(B2−B3)m’−基{R3は、水素原子、又は、ハロゲン原子若しくはR2−B1−基(R2及びB1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基を表し、R0は、水素原子、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、mは、0又は1を表し、B2は、単結合、オキシ基、チオ基又は−N((O)nR1’)−基(R1’は、R1と同一又は相異なり、R1と同一の意味を表し、nは、0又は1を表す。)を表し、B3は、カルボニル基、チオカルボニル基又はスルホニル基を表し、m’は、0又は1を表し、B3がスルホニル基のとき、mは0となりかつR3が水素原子となることはない。}を表し、k’は、0又は1を表す。}を表し、R4は、C1-C10アルキレン基を表す。但し、R0’R0 ’’N−R4−基(R0’及びR0’’は、R0と同一又は相異なり、R0と同一の意味を表し、R4は、前記と同一の意味を表す。)を除く。]、D2−R4−基[D2は、シアノ基、R1R1’NC(=N−(O)n−A1)−基(R1、R1’、n、及びA1は、前記と同一の意味を表す。)、A1N=C(−OR2)−基(A1及びR2は、前記と同一の意味を表す。)又はNH2−CS−基を表し、R4は前記と同一の意味を表す。]、D3−R4−基{D3は、ニトロ基又はR1OSO2−基(R1は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}又はR1OSO2−基(R1は、前記と同一の意味を表す。)である。
(2)B0群:
(a0)−基
((a0)において、E0は、置換基を有してもよい、飽和又は不飽和の、芳香族又は非芳香族の、5〜14員の炭化水素環又は複素環をなし、R1は、前記と同一の意味を表す。)である。
(3)C0群:ハロゲン原子 、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D4−R4−基[D4は、水酸基又はA1−O−基(A1は、前記と同一の意味を表す。)を表し、R4は前記と同一の意味を表す。]、D5−基[D5は、O=C(R3)−基(R3は、前記と同一の意味を表す。)、A1−(O)n−N=C(R3)−基(A1、n及びR3は、前記と同一の意味を表す。)、R1−B0−CO−R4−(O)n−N=C(R3)−基{R1、R4、n及びR3は、前記と同一の意味を表し、B0は、オキシ基、チオ基又は−N((O)mR1’)−基(R1’及びmは、前記と同一の意味を表す。)を表す。}、D2−R4−(O)n−N=C(R3)−基(D2、R4、n及びR3は、前記と同一の意味を表す。)又はR1A1N−N=C(R3)−基(R1、A1及びR3は、前記と同一の意味を表す。)を表す。]、R1A1N−O−R4−基(R1、A1及びR4は、前記と同一の意味を表す。)、R1(A1−(O)n−)N−基(R1、A1及びnは、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−基(D3は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(4)D0群:
(b0) −R4−基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−R4−基
((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなし、R4は、前記と同一の意味を表す。)、ハロゲン原子、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−R4−基(D3及びR4は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基
である。
(5)E0群:A2−CO−R5−基
である。但し、A2が水酸基のとき、R5がビニレン基ではない。
[A2は、
(i)A3−B4−基
{A3は、水素原子、又は、C1-C10アルキル基、又は、C2-C10ハロアルキル基、又は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、又は、ハロゲン原子で置換されてもよいC3-C10アルキニル基、又は、Ra0−(R4)m−基(Ra0は、置換されてもよい5−7員環のアリール基又はヘテロアリール基を表し、R4及びmは前記と同一の意味を表す。)、又は、(b0)−R4−基((b0)及びR4は、前記と同一の意味を表す。)、(c0)−R4−基((c0)及びR4は、前記と同一の意味を表す。)、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)若しくはA4−SO2−R4−基{A4は、(b0)−基((b0)は、前記と同一の意味を表す。)、(c0)−基((c0)は、前記と同一の意味を表す。)又はR1R1’N−基(R1及びR1’は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}で置換されたC1-C10アルキル基を表し、
B4は、オキシ基、チオ基又は−N((O)mR1)−基(R1及びmは、前記と同一の意味を表す。)を表す。但し、B4がチオ基のとき、A3が水素原子ではない。}、
(ii)R1−B4−CO−R4−B4’−基(R1、B4及びR4は、前記と同一の意味を表し、B4’は、B4と同一又は相異なり、B4と同一の意味を表す。但し、B4がチオ基のとき、R2が水素原子ではない。)又はD2−R4−B4−基(D2、R4及びB4は、前記と同一の意味を表す。)、
(iii)R2−SO2−NR1−基(R2は、前記と同一の意味を表す。但し、水素原子を除く。R1は、前記と同一の意味を表す。)、
(iv)(b0)−基((b0)は、前記と同一の意味を表す。)、
(v)(c0)−基((c0)は、前記と同一の意味を表す。)又は
(vi)R1A1N−NR1’−基(R1、A1及びR1’は、前記と同一の意味を表す。)を表し、R5は、ハロゲン原子で置換されてもよいC2-C10アルケニレン基、又は、C2-C10アルキニレン基を表す。]
(6)F0群:A5−B5−R6−基[A5は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)、D3−基(D3は、前記と同一の意味を表す。)若しくはA4−SO2−基(A4は、前記と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC1-C10アルキル基を表し、B5は、B1−基(B1は、前記と同一の意味を表す。)又は−NA1−基(A1は、前記と同一の意味を表す。)を表し、R6は、単結合又はC1-C10アルキレン基を表す。]
である。
(7)G0群:A6−B5−R6−基
[A6は、(a0)−R4−基((a0)及びR4は、前記と同一の意味を表す。)、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基、又は、(b0)−基((b0)は、前記と同一の意味を表す。)、(c0)−基((c0)は、前記と同一の意味を表す。)、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルケニル基、又は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルキニル基を表し、B5及びR6は、前記と同一の意味を表す。]
である。
(8)H0群:
D2−N(−(O)n−A1)−R6−基(D2、n、A1及びR6は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。但し、シアノ基を除く。)、R1(R1’(O)n)N−CR1’’=N−R6−基(R1、R1’、n及びR6は、前記と同一の意味を表し、R1’’は、R1と同一又は相異なり、R1と同一の意味を表す。)、R1−(O)n−N=CR1’−NR2−R6−基(R1、n、R1’、R2及びR6は、前記と同一の意味を表す。)、R2−B3−NR1−CO−NR1’−R6−基(R2、B3、R1、R1’及びR6は、前記と同一の意味を表す。)、D2−CO−NR1−R6−基(D2、R1及びR6は、前記と同一の意味を表す。)又はA2−COCO−NR1−R6−基(A2、R1及びR6は、前記と同一の意味を表す。)
である。
(9)I0群:
A7−B6−N((O)nR1)−R6−基[A7は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、C2-C10アルキニル基、C3-C10ハロアルキニル基、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、(b0)−R4−基((b0)及びR4は、前記と同一の意味を表す。)、(c0)−R4−基((c0)及びR4は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)、A4−SO2−R4−基(A4及びR4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B6は、カルボニル基又はチオカルボニル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8−CS−N((O)nR1)−R6−基[A8は、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、
A7’−B2’−B3−N((O)nR1)−R6−基[A7’は、ハロゲン原子で置換されてもよいC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2及びB1は、前記と同一の意味を表し、R4’は、C2-C10アルキレン基を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b0)−R4’−基((b0)及びR4’は、前記と同一の意味を表す。)、(c0)−R4’−基((c0)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4’−基(D3及びR4’は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B2’は、オキシ基、チオ基又は−N((O)n’R1’)−基(n’は、nと同一又は相異なり、nと同一の意味を表し、R1’は、前記と同一の意味を表す。)を表し、B3、n、R1及びR6は、前記と同一の意味を表す。]、A8’−B2’−CS−N((O)nR1)−R6−基[A8’は、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、B2’は、前記と同一の意味を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8’−S−B3’−N((O)nR1)−R6−基[A8’、n、R1及びR6は、前記と同一の意味を表し、B3’は、カルボニル基又はスルホニル基を表す。]又はA7’’−SO2−N((O)nR1)−R6−基[A7’’は、C2-C10アルケニル基、ハロゲン原子で置換されたC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2、B1及びR4’は、前記と同一の意味を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b0)−R4’−基((b0)及びR4’は、前記と同一の意味を表す。)、(c0)−R4’−基((c0)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、NO2−R4−基(R4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(10)J0群:A7−CO−基(A7は、前記と同一の意味を表す。)、又は、A9−CS−基(A9は、A7又はA8を表す。)、又は、A9’(O)mN=C(A9)−基(A9’は、A7’又はA8’を表し、m及びA9は、前記と同一の意味を表す。)、又は、D2−CO−基(D2は、前記と同一の意味を表す。)、又は、A2−COCO−基(A2は、前記と同一の意味を表す。)、又は、A9−CO−B1’−R6−基(A9及びR6は、前記と同一の意味を表し、B1’は、オキシ基又はチオ基を表す。但し、B1’がオキシ基のとき、A9は、A8ではない。)、又は、A9−CS−B1’−R6−基(A9、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A7’’−SO2−B1’−R6−基(A7’’、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A8−SO2−B1’−R6−基(A8、B1’及びR6は、は、前記と同一の意味を表す。但し、A8は、水素原子となることはない。)、又は、A9’−B2’−B3−B1’−R6−基(A9’、B2’、B3、B1’及びR6は、は、前記と同一の意味を表す。)、又は、(b0)−基((b0)は、前記と同一の意味を表す。)若しくは(c0)−基((c0)は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(11)K0群:A10−N((O)nR1)−CO−R6−基[A10は、水素原子(但し、nは0ではない。)、A7’’−SO2−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−基(A8は、前記と同一の意味を表す。但し、A8は、水素原子とはならない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2OCH2−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(12)L0群:A10’−N((O)nR1)−SO2−R6−基[A10’は、水素原子(但し、nは0ではない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2−CO−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]、A9’’R1N−SO2−N((O)nR1’)−R6−基[A9’’は、水素原子又はA9’−基(A9’は、前記と同一の意味を表す。)を表し、R1、n、R1’及びR6は、前記と同一の意味を表す。]又は(b0)−SO2−N((O)nR1’)−R6−基[(b0)、n、R1’及びR6は、前記と同一の意味を表す。]
である。
(13)M0群:R1(R2S)C=N−R6−基(R1、R2及びR6は、前記と同一の意味を表す。)、R2B(R2’B’)C=N−R6−基(R2及びR6は、前記と同一の意味を表し、R2’は、R2と同一又は相異なり、R2と、同一の意味を表し、B及びB’は、同一又は相異なり、オキシ基又はチオ基を表す。)、R1R1’N−(R2S)C=N−R6−基(R1、R1’、R2及びR6は、前記と同一の意味を表す。)、R1N=C(SR2)−NR2’−R6−基(R1、R2、R2’及びR6は、前記と同一の意味を表す。)又はR1(R1’O)N−R6−基(R1、R1’及びR6は、前記と同一の意味を表す。)
である。
(14)N0群:A11−P(=O)(OR1’)−R4−基[A11は、R1−基(R1は、前記と同一の意味を表す。)、R1O−R6−基(R1及びR6は、前記と同一の意味を表す。)又はR1OCO−CHR0−基(R1及びR0は、前記と同一の意味を表す。)を表し、R1’及びR4は、前記と同一の意味を表す。]
である。
III.(YA0)qにおいて、YA0は、下記のX0群及びY0群の基を表し、qは、0、1、2又は3を表し、p(pは、前記と同一の意味を表す。)とqとの和は3以下であり、qが2以上のとき、YA0は同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYA0は、Z0群の基をなして、A0環と縮環してもよい。
(1)X0群:
Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:
Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)は、前記と同一の意味を表す。)、
(c0)−基((c0)は、前記と同一の意味を表す。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、A0環と縮環する基である。
IV.B0は、
式(III-1)
[式中、
(1)QA0は、水酸基、(b0)−基((b0)は、前記と同一の意味を表す。)、A9−B6−Bc−基[A9及びB6は、前記と同一の意味を表し、Bcは、オキシ基又は−N((O)mR1)−基(m及びR1は、前記と同一の意味を表す。)を表す。但し、A9が水素原子のとき、Bcは、スルホニル基ではない。]、A7’’−SO2−Bc−基(A7’’及びBcは、前記と同一の意味を表す。)、A8−SO2−Bc−基(A8及びBcは、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−Bc−基(R1、R1’及びBcは、前記と同一の意味を表す。)、(b0)−SO2−Bc−基((b0)及びBcは、前記と同一の意味を表す。)、A9’−Bc−基(A9’及びBcは、前記と同一の意味を表す。)、D5−R4−Bc−基(D5、R4及びBcは、前記と同一の意味を表す。)、Mc0−B3−Bc−基(Mc0、B3及びBcは、前記と同一の意味を表す。)又はMc0−Bc−基(Mc0及びBcは、前記と同一の意味を表す。)を表す。
(2)WA0は、酸素原子又は−NTA0−基[TA0は、水素原子、A9’−基(A9’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)又はMc0−基(Mc0は、前記と同一の意味を表す。)を表す。]を表す。
(3)KA0は、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、LA0は、水素原子、C1-C10アルキル基又はMb0−基(Mb0は、前記と同一の意味を表す。)を表し、KA0とLA0とは、C3-C10アルキレン基、又は、単数又は同一又は相異なる複数のMa−基(Maは、前記と同一の意味を表す。)で置換されてもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(III-2)
[式中、TA0は、前記と同一の意味を表し、LB0は水酸基又はメチル基を表す。]
で示される基、
式(III-3)
[式中、TA0は、前記と同一の意味を表し、LC0は、C1-C10アルキル基を表す。]
で示される基、
式(III-4)
[式中、TA0は、前記と同一の意味を表す。]
で示される基、
式(III-5)
[式中、TA0は、前記と同一の意味を表し、KB0は、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(III-6)
[式中、WA0は、前記と同一の意味を表し、KC0とLD0とは、C3-C10アルキレン基又は単数又は同一又は相異なる複数のMa−基(Maは、前記と同一の意味を表す。)で置換されてもよいC4-C10アルケニレン基をなす。]
で示される基、
式(III-7)
[式中、QA0及びWA0は、前記と同一の意味を表し、KD0とLE0とは、−VA0=VA0’−VA0’’=VA0’’’−基{VA0、VA0’、VA0’’及びVA0’’’は、同一又は相異なり、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいメチン基、又は、−N=基を表し、VA0、VA0’、VA0’’及びVA0’’’のうち少なくとも一つは−N=基を表す。}をなす。]
で示される基、
式(III-8)
[式中、TA0は、前記と同一の意味を表し、QB0は、水酸基、A9−B6−O−基[A9及びB6は、前記と同一の意味を表す。]、A7’’−SO2−O−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−O−基(A8は、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−O−基(R1及びR1’は、前記と同一の意味を表す。)、(b0)−SO2−O−基((b0)は、前記と同一の意味を表す。)、A9’−O−基(A9’は、前記と同一の意味を表す。)、D5−R4−O−基(D5及びR4は、前記と同一の意味を表す。)、Mc0−B3−O−基(Mc0及びB3は、前記と同一の意味を表す。)又はMc0−O−基(Mc0は、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(III-9)
[式中、U及びWA0は、前記と同一の意味を表す。]
で示される基を表す。
但し、A0がフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
4.式(IV)
[式中、
I.Aは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表す。
II.(XA)pにおいて、XAは、下記のA群からN群までのいずれかの群に含まれる基を表し、pは、0、1、2又は3を表し、pが2以上のとき、XAは、同一又は相異なる。
(1)A群:D1−R4−基[D1は、(R1−(O)k−)A1N−(O)k’−基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表し、kは、0又は1を表し、A1は、R3−(CHR0)m−(B2−B3)m’−基{R3は、水素原子、又は、ハロゲン原子若しくはR2−B1−基(R2及びB1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基を表し、R0は、水素原子、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、mは、0又は1を表し、B2は、単結合、オキシ基、チオ基又は−N((O)nR1’)−基(R1’は、R1と同一又は相異なり、R1と同一の意味を表し、nは、0又は1を表す。)を表し、B3は、カルボニル基、チオカルボニル基又はスルホニル基を表し、m’は、0又は1を表し、B3がスルホニル基のとき、mは0となりかつR3が水素原子となることはない。}を表し、k’は、0又は1を表す。}を表し、R4は、C1-C10アルキレン基を表す。但し、R0’R0 ’’N−R4−基(R0’及びR0’’は、R0と同一又は相異なり、R0と同一の意味を表し、R4は、前記と同一の意味を表す。)を除く。]、D2−R4−基[D2は、シアノ基、R1R1’NC(=N−(O)n−A1)−基(R1、R1’、n、及びA1は、前記と同一の意味を表す。)、A1N=C(−OR2)−基(A1及びR2は、前記と同一の意味を表す。)又はNH2−CS−基を表し、R4は前記と同一の意味を表す。]、D3−R4−基{D3は、ニトロ基又はR1OSO2−基(R1は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}又はR1OSO2−基(R1は、前記と同一の意味を表す。)である。
(2)B群:
(a)−基
[(a)において、E1及びE1’は、C1-C10アルキル基若しくはC1-C10アルコキシ基で置換されてもよいメチレン基、又は、カルボニル基を表す。但し、E1及びE1’は、同時にカルボニル基となることはない。E2は、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)で置換されてもよいC2-C10アルキレン基、又は、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)で置換されてもよいC3-C10アルケニレン基を表し、R1は、前記と同一の意味を表す。]
である。
(3)C群:ハロゲン原子 、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D4−R4−基[D4は、水酸基又はA1−O−基(A1は、前記と同一の意味を表す。)を表し、R4は前記と同一の意味を表す。]、D5−基[D5は、O=C(R3)−基(R3は、前記と同一の意味を表す。)、A1−(O)n−N=C(R3)−基(A1、n及びR3は、前記と同一の意味を表す。)、R1−B0−CO−R4−(O)n−N=C(R3)−基{R1、R4、n及びR3は、前記と同一の意味を表し、B0は、オキシ基、チオ基又は−N((O)mR1’)−基(R1’及びmは、前記と同一の意味を表す。)を表す。}、D2−R4−(O)n−N=C(R3)−基(D2、R4、n及びR3は、前記と同一の意味を表す。)又はR1A1N−N=C(R3)−基(R1、A1及びR3は、前記と同一の意味を表す。)を表す。]、R1A1N−O−R4−基(R1、A1及びR4は、前記と同一の意味を表す。)、R1(A1−(O)n−)N−基(R1、A1及びnは、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−基(D3は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(4)D群:
(b) −R4−基[(b)において、G1、G2、G4及びG5は、隣接原子と単結合で結ばれた、メチル基で置換されてもよいメチレン基、又は、隣接原子と二重結合で結ばれた、メチル基で置換されてもよいメチン基を表し、G3は、単結合、又は、二重結合、又は、メチル基、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキレン基、又は、メチル基、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)で置換されてもよいC2-C10アルケニレン基を表し、R4は、前記と同一の意味を表す。]、
(c)−R4−基
((c)において、J1、J2及びJ3は、同一又は相異なり、メチル基で置換されてもよいメチン基、又は、窒素原子を表し、R4は、前記と同一の意味を表す。)、ハロゲン原子、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−R4−基(D3及びR4は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基
である。
(5)E群:A2−CO−R5−基
である。但し、A2が水酸基のとき、R5がビニレン基ではない。
[A2は、
(i)A3−B4−基
{A3は、水素原子、又は、C1-C10アルキル基、又は、C2-C10ハロアルキル基、又は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、又は、ハロゲン原子で置換されてもよいC3-C10アルキニル基、又は、Ra−(R4)m−基(Raは、ハロゲン原子、C1-C10アルキル基、C1-C10アルコキシ基若しくはニトロ基で置換されてもよい、フェニル基、ピリジル基、フリル基若しくはチエニル基を表し、R4及びmは前記と同一の意味を表す。)、又は、(b)−R4−基((b)及びR4は、前記と同一の意味を表す。)、(c)−R4−基((c)及びR4は、前記と同一の意味を表す。)、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)若しくはA4−SO2−R4−基{A4は、(b)−基((b)は、前記と同一の意味を表す。)、(c)−基((c)は、前記と同一の意味を表す。)又はR1R1’N−基(R1及びR1’は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}で置換されたC1-C10アルキル基を表し、
B4は、オキシ基、チオ基又は−N((O)mR1)−基(R1及びmは、前記と同一の意味を表す。)を表す。但し、B4がチオ基のとき、A3が水素原子ではない。}、
(ii)R1−B4−CO−R4−B4’−基(R1、B4及びR4は、前記と同一の意味を表し、B4’は、B4と同一又は相異なり、B4と同一の意味を表す。但し、B4がチオ基のとき、R2が水素原子ではない。)又はD2−R4−B4−基(D2、R4及びB4は、前記と同一の意味を表す。)、
(iii)R2−SO2−NR1−基(R2は、前記と同一の意味を表す。但し、水素原子を除く。R1は、前記と同一の意味を表す。)、
(iv)(b)−基((b)は、前記と同一の意味を表す。)、
(v)(c)−基((c)は、前記と同一の意味を表す。)又は
(vi)R1A1N−NR1’−基(R1、A1及びR1’は、前記と同一の意味を表す。)を表し、R5は、ハロゲン原子で置換されてもよいC2-C10アルケニレン基、又は、C2-C10アルキニレン基を表す。]
(6)F群:A5−B5−R6−基[A5は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)、D3−基(D3は、前記と同一の意味を表す。)若しくはA4−SO2−基(A4は、前記と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC1-C10アルキル基を表し、B5は、B1−基(B1は、前記と同一の意味を表す。)又は−NA1−基(A1は、前記と同一の意味を表す。)を表し、R6は、単結合又はC1-C10アルキレン基を表す。]
である。
(7)G群:A6−B5−R6−基
[A6は、(a)−R4−基((a)及びR4は、前記と同一の意味を表す。)、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基、又は、(b)−基((b)は、前記と同一の意味を表す。)、(c)−基((c)は、前記と同一の意味を表す。)、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルケニル基、又は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルキニル基を表し、B5及びR6は、前記と同一の意味を表す。]
である。
(8)H群:
D2−N(−(O)n−A1)−R6−基(D2、n、A1及びR6は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。但し、シアノ基を除く。)、R1(R1’(O)n)N−CR1’’=N−R6−基(R1、R1’、n及びR6は、前記と同一の意味を表し、R1’’は、R1と同一又は相異なり、R1と同一の意味を表す。)、R1−(O)n−N=CR1’−NR2−R6−基(R1、n、R1’、R2及びR6は、前記と同一の意味を表す。)、R2−B3−NR1−CO−NR1’−R6−基(R2、B3、R1、R1’及びR6は、前記と同一の意味を表す。)、D2−CO−NR1−R6−基(D2、R1及びR6は、前記と同一の意味を表す。)又はA2−COCO−NR1−R6−基(A2、R1及びR6は、前記と同一の意味を表す。)
である。
(9)I群:
A7−B6−N((O)nR1)−R6−基[A7は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、C2-C10アルキニル基、C3-C10ハロアルキニル基、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、(b)−R4−基((b)及びR4は、前記と同一の意味を表す。)、(c)−R4−基((c)及びR4は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)、A4−SO2−R4−基(A4及びR4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B6は、カルボニル基又はチオカルボニル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8−CS−N((O)nR1)−R6−基[A8は、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、
A7’−B2’−B3−N((O)nR1)−R6−基[A7’は、ハロゲン原子で置換されてもよいC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2及びB1は、前記と同一の意味を表し、R4’は、C2-C10アルキレン基を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b)−R4’−基((b)及びR4’は、前記と同一の意味を表す。)、(c)−R4’−基((c)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4’−基(D3及びR4’は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B2’は、オキシ基、チオ基又は−N((O)n’R1’)−基(n’は、nと同一又は相異なり、nと同一の意味を表し、R1’は、前記と同一の意味を表す。)を表し、B3、n、R1及びR6は、前記と同一の意味を表す。]、A8’−B2’−CS−N((O)nR1)−R6−基[A8’は、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、B2’は、前記と同一の意味を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8’−S−B3’−N((O)nR1)−R6−基[A8’、n、R1及びR6は、前記と同一の意味を表し、B3’は、カルボニル基又はスルホニル基を表す。]又はA7’’−SO2−N((O)nR1)−R6−基[A7’’は、C2-C10アルケニル基、ハロゲン原子で置換されたC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2、B1及びR4’は、前記と同一の意味を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b)−R4’−基((b)及びR4’は、前記と同一の意味を表す。)、(c)−R4’−基((c)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、NO2−R4−基(R4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(10)J群:A7−CO−基(A7は、前記と同一の意味を表す。)、又は、A9−CS−基(A9は、A7又はA8を表す。)、又は、A9’(O)mN=C(A9)−基(A9’は、A7’又はA8’を表し、m及びA9は、前記と同一の意味を表す。)、又は、D2−CO−基(D2は、前記と同一の意味を表す。)、又は、A2−COCO−基(A2は、前記と同一の意味を表す。)、又は、A9−CO−B1’−R6−基(A9及びR6は、前記と同一の意味を表し、B1’は、オキシ基又はチオ基を表す。但し、B1’がオキシ基のとき、A9は、A8ではない。)、又は、A9−CS−B1’−R6−基(A9、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A7’’−SO2−B1’−R6−基(A7’’、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A8−SO2−B1’−R6−基(A8、B1’及びR6は、は、前記と同一の意味を表す。但し、A8は、水素原子となることはない。)、又は、A9’−B2’−B3−B1’−R6−基(A9’、B2’、B3、B1’及びR6は、は、前記と同一の意味を表す。)、又は、(b)−基((b)は、前記と同一の意味を表す。)若しくは(c)−基((c)は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(11)K群:A10−N((O)nR1)−CO−R6−基[A10は、水素原子(但し、nは0ではない。)、A7’’−SO2−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−基(A8は、前記と同一の意味を表す。但し、A8は、水素原子とはならない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2OCH2−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(12)L群:A10’−N((O)nR1)−SO2−R6−基[A10’は、水素原子(但し、nは0ではない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2−CO−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]、A9’’R1N−SO2−N((O)nR1’)−R6−基[A9’’は、水素原子又はA9’−基(A9’は、前記と同一の意味を表す。)を表し、R1、n、R1’及びR6は、前記と同一の意味を表す。]又は(b)−SO2−N((O)nR1’)−R6−基[(b)、n、R1’及びR6は、前記と同一の意味を表す。]
である。
(13)M群:R1(R2S)C=N−R6−基(R1、R2及びR6は、前記と同一の意味を表す。)、R2B(R2’B’)C=N−R6−基(R2及びR6は、前記と同一の意味を表し、R2’は、R2と同一又は相異なり、R2と、同一の意味を表し、B及びB’は、同一又は相異なり、オキシ基又はチオ基を表す。)、R1R1’N−(R2S)C=N−R6−基(R1、R1’、R2及びR6は、前記と同一の意味を表す。)、R1N=C(SR2)−NR2’−R6−基(R1、R2、R2’及びR6は、前記と同一の意味を表す。)又はR1(R1’O)N−R6−基(R1、R1’及びR6は、前記と同一の意味を表す。)
である。
(14)N群:A11−P(=O)(OR1’)−R4−基[A11は、R1−基(R1は、前記と同一の意味を表す。)、R1O−R6−基(R1及びR6は、前記と同一の意味を表す。)又はR1OCO−CHR0−基(R1及びR0は、前記と同一の意味を表す。)を表し、R1’及びR4は、前記と同一の意味を表す。]
である。
III.(YA)qにおいて、YAは、下記のX群又はY群の基を表し、qは、0、1、2又は3を表し、p(pは、前記と同一の意味を表す。)とqとの和は3以下であり、qが2以上のとき、YAは、同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYAは、Z群の基をなして、A環と縮環してもよい。
(1)X群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HO−Rd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y群:Mb−Rd−基[Mbは、Mc−基{Mcは、Md−Rd’−基{Mdは、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいフェニル基、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいピリジル基、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいナフチル基、(b)−基((b)は、前記と同一の意味を表す。)、(c)−基((c)は、前記と同一の意味を表す。)、
(d)−基(lは、2、3又は4であり、Bbは、オキシ基又はチオ基を表す。)又は
(e)−基(l及びBbは、前記と同一の意味を表す。)を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc−Ba−基(Mc及びBaは、前記と同一の意味を表す。)、Mc−CO−基(Mcは、前記と同一の意味を表す。)、Mc−CO−O−基(Mcは、前記と同一の意味を表す。)、McO−CO−基(Mcは、前記と同一の意味を表す。)、McReN−基(Mc及びReは、前記と同一の意味を表す。)、Mc−CO−NRe−基(Mc及びReは、前記と同一の意味を表す。)、McO−CO−NRe−基(Mc及びReは、前記と同一の意味を表す。)、McReN−CO−基(Mc及びReは、前記と同一の意味を表す。)、McReN−CO−NRe’−基(Mc、Re及びRe’は、前記と同一の意味を表す。)、McReN−C(=NRe’)−NRe’’−基(Mc、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc−SO2−NRe−基(Mc及びReは、前記と同一の意味を表す。)又はMcReN−SO2−基(Mc及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z群:−Ya’’=C(Ya)−Ya’−基(Yaは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基、又は、C1-C10アルコキシ基を表し、Ya’は、オキシ基、又は、チオ基、又は、C1-C10アルキル基で置換されてもよいイミノ基を表し、Ya’’は、−N=基又はメチン基を表す。)、C3-C10アルキレン基又は−Yb=Yb’−Yb’’=Yb’’’−基[Yb、Yb’、Yb’’及びYb’’’は、同一又は相異なり、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいメチン基、又は、−N=基を表す。]である。
IV.Bは、
式(IV-1)
[式中、
(1)QAは、水酸基、(b)−基((b)は、前記と同一の意味を表す。)、A9−B6−Bc−基[A9及びB6は、前記と同一の意味を表し、Bcは、オキシ基又は−N((O)mR1)−基(m及びR1は、前記と同一の意味を表す。)を表す。但し、A9が水素原子のとき、Bcは、スルホニル基ではない。]、A7’’−SO2−Bc−基(A7’’及びBcは、前記と同一の意味を表す。)、A8−SO2−Bc−基(A8及びBcは、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−Bc−基(R1、R1’及びBcは、前記と同一の意味を表す。)、(b)−SO2−Bc−基((b)及びBcは、前記と同一の意味を表す。)、A9’−Bc−基(A9’及びBcは、前記と同一の意味を表す。)、D5−R4−Bc−基(D5、R4及びBcは、前記と同一の意味を表す。)、Mc−B3−Bc−基(Mc、B3及びBcは、前記と同一の意味を表す。)又はMc−Bc−基(Mc及びBcは、前記と同一の意味を表す。)を表す。
(2)WAは、酸素原子又は−NTA−基[TAは、水素原子、A9’−基(A9’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)又はMc−基(Mcは、前記と同一の意味を表す。)を表す。]を表す。TAは、水素原子、A9’−基(A9’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)又はMc−基(Mcは、前記と同一の意味を表す。)を表す。
(3)KAは、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、LAは、水素原子、C1-C10アルキル基又はMb−基(Mbは、前記と同一の意味を表す。)を表し、KAとLAとは、C3-C10アルキレン基又は−C(Ma’)=C(Ma’’)−C(Ma’’’)=C(Ma’’’’)−基(Ma’、Ma’’、Ma’’’及びMa’’’’は、同一又は相異なり、Maと同一又は相異なり、水素原子又はMaを表す。)をなすことがある。]
で示される基、
式(IV-2)
[式中、TAは、前記と同一の意味を表し、LBは水酸基又はメチル基を表す。]
で示される基、
式(IV-3)
[式中、TAは、前記と同一の意味を表し、LCは、C1-C10アルキル基を表す。]
で示される基、
式(IV-4)
[式中、TAは、前記と同一の意味を表す。]
で示される基、
式(IV-5)
[式中、TAは、前記と同一の意味を表し、KBは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(IV-6)
[式中、WAは、前記と同一の意味を表し、KCとLDとは、C3-C10アルキレン基又は単数又は同一又は相異なる複数のMa−基(Maは、前記と同一の意味を表す。)で置換されてもよいC4-C10アルケニレン基をなす。]
で示される基、
式(IV-7)
[式中、QA及びWAは、前記と同一の意味を表し、KDとLEとは、−VA=VA’−VA’’=VA’’’−基{VA、VA’、VA’’及びVA’’’は、同一又は相異なり、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいメチン基、又は、−N=基を表し、VA、VA’、VA’’及びVA’’’のうち少なくとも一つは−N=基を表す。}をなす。]
で示される基、
式(IV-8)
[式中、TAは、前記と同一の意味を表し、QBは、水酸基、A9−B6−O−基[A9及びB6は、前記と同一の意味を表す。]、A7’’−SO2−O−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−O−基(A8は、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−O−基(R1及びR1’は、前記と同一の意味を表す。)、(b)−SO2−O−基((b)は、前記と同一の意味を表す。)、A9’−O−基(A9’は、前記と同一の意味を表す。)、D5−R4−O−基(D5及びR4は、前記と同一の意味を表す。)、Mc−B3−O−基(Mc及びB3は、前記と同一の意味を表す。)又はMc−O−基(Mcは、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(IV-9)
[式中、U及びWAは、前記と同一の意味を表す。]
で示される基を表す。
但し、Aがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
5.式(V)
[式中、
I.aは、チオフェン環、フラン環、ピロール環、ピラゾール環、1,2,3−トリアゾール環、テトラゾール環、イソオキサゾール環、チアゾール環、ピリダジン環又はピリミジン環を表し、Xaは、シアノ基で置換されたC1-C10アルキル基、又は、テトラヒドロピラン−4−イリデン基で置換されたC1-C10アルキル基、又は、ハロゲン原子若しくはシアノ基で置換されたC2-C10アルケニル基、又は、C1-C10アルコキシカルボニル基で置換されたC2-C10アルケニル基、又は、ヒドロキシ基で置換されたC3-C10アルキニル基、又は、a0−r1−b−r1’−基{a0は、C1-C10アルキルチオ基で置換されたメチル基、C1-C10アルキルスルフィニル基で置換されたメチル基、C1-C10アルキルスルホニル基で置換されたメチル基、C2-C10アルケニル基、C2-C10アルキニル基、r2O−CO−基(r2は、C1-C10アルキル基又は水酸基で置換されたC2-C10アルキル基を表す。)、カルボキシ基、rr’N−CO−基(r及びr’は、同一又は相異なり、水素原子又はC1-C10アルキル基を表す。)、a1−NH−CO−基(a1は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、a1’−CO−基(a1’は、モルホリノ基を表す。)、rr’N−CH2−基(r及びr’は、前記と同一の意味を表す。)、r0−(O)l−CONH−CH2−基(r0は、C1-C10アルキル基を表し、lは0又は1を表す。)、r−OCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、シアノ基又はスルホメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、bは、オキシ基、チオ基、スルフィニル基、スルホニル基又はメチル基で置換されてもよいイミノ基を表す。}、又は、a2−y−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表し、yは、オキシ基又はイミノ基を表す。)、又は、rO−COCO−NH−基(rは、前記と同一の意味を表す。)、又は、a3−z−NH−基(a3は、C2-C10アルケニル基、又は、C1-C10アルコキシ基、C1-C10アルコキシカルボニル基、カルボキシ基若しくはシアノ基で置換されたC1-C10アルキル基を表し、zは、カルボニル基又はスルホニル基を表す。)、又は、a4−Nr’CO−基{a4は、C1-C10アルコキシ基、又は、C3-C10アルケニルオキシ基、又は、r0−SO2−基(r0は、前記と同一の意味を表す。)、又は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、r0r0’N−基(r0は、前記と同一の意味を表し、r0’は、r0と同一又は相異なり、r0と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、シアノ基若しくはアミノカルボニル基で置換されたC1-C10アルキル基、又は、rO−CO−(rO−COCH2)CH−基(rは、前記と同一の意味を表す。)を表し、r’は、前記と同一の意味を表す。}、又は、a5−NHSO2−基(a5は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、r0ON=CH−基(r0は、前記と同一の意味を表す。)、又は、r0NHCSNH−基(r0は、前記と同一の意味を表す。)、又は、r0NHC(−Sr0’)=N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、(rO)2P(=O)CH2−基(rは、前記と同一の意味を表す。)を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xaは、同一又は相異なり、
Yaは、ハロゲン原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基、又は、C1-C10アルコキシ基で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、2−オキソ−オキサゾリジン−3−イル基、又は、[1,3]ジオキソラン−2−イル基、又は、モルホリノ基で置換されたC1-C10アルコキシ基、又は、a0’−b’−基(a0’は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、b’は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)、又は、ニトロ基、又は、シアノ基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、又は、r0r0’N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、r0CO−NH−基(r0は、前記と同一の意味を表す。)、又は、r0r0’NCONH−基(r0及びr0’は、前記と同一の意味を表す。)、又は、rr’NCO−基(r及びr’は、前記と同一の意味を表す。)、又は、水酸基を表し、qは、0、1、2又は3を表し、qが2以上のとき、Yaは、同一又は相異なり、qが2以上のとき、隣接しているYaは、a環と縮環して4,5,6,7−テトラヒドロベンゾ[b]チオフェン環をなしてもよい。
II.bは、
式(V-1)
[式中、Qaは、ra−O−基{raは、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、r0r0’N−CH2−基(r0及びr0’は、前記と同一の意味を表す。)、rOCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、C1-C10アルコキシカルボニル基、カルボキシ基、アミノカルボニル基若しくはシアノ基で置換されたC1-C10アルキル基、又は、r3−r1−基(r3は、フェニル基又はピリジル基を表し、r1は、前記と同一の意味を表す。)を表す。}、又は、ピペリジノ基、又は、モルホリノ基、又は、r4r4’N−基(r4及びr4’は、同一又は相異なり、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。但し、同時に水素原子となることはない。)を表し、Waは、酸素原子又は−NTa−基[Taは、rb−基(rbは、raと同一又は相異なり、raと同一の意味を表す。)又はr3’−基(r3’は、r3と同一又は相異なり、r3と同一の意味を表す。)を表す。]を表し、Kaは、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、Laは、水素原子又はC1-C10アルキル基を表し、KaとLaとは、C3-C10アルキレン基又は1,3−ブタジエニレン基をなすことがある。]
で示される基、
式(V-2)
[式中、Taは、前記と同一の意味を表し、Lbは水酸基又はメチル基を表す。]
で示される基、
式(V-3)
[式中、Taは、前記と同一の意味を表し、Lcは、C1-C10アルキル基を表す。]
で示される基、
式(V-4)
[式中、Taは、前記と同一の意味を表す。]
で示される基、
式(V-5)
[式中、Taは、前記と同一の意味を表し、Kbは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(V-6)
[式中、Waは、前記と同一の意味を表し、KcとLdとは、C3-C10アルキレン基又はC4-C10アルケニレン基をなす。]
で示される基、
式(V-7)
[式中、Qa及びWaは、前記と同一の意味を表し、KdとLeとは、−Va=Va’−Va’’=Va’’’−基(Va、Va’、Va’’及びVa’’’は、同一又は相異なり、メチン基、又は、−N=基を表し、Va、Va’、Va’’及びVa’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(V-8)
[式中、Taは、前記と同一の意味を表し、Qbは、ra−O−基(raは、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(V-9)
[式中、U及びWaは、前記と同一の意味を表す。]
で示される基を表す。
但し、aがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
6.式(VI)
[式中、a1は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa1は、a0’−r1−b0−r1’−基{a0’は、rO−CO−基(rは、水素原子又はC1-C10アルキル基を表す。)、r0r0’N−CH2−基(r0及びr0’は、同一又は相異なり、C1-C10アルキル基を表す。)、又は、ヒドロキシメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、b0は、オキシ基、チオ基、スルフィニル基、スルホニル基又は1個のメチル基で置換されたイミノ基を表す。}、又は、a2−O−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、a3’−CO−NH−基(a3’は、C1-C10アルコキシ基で置換されたC1-C10アルキル基を表す。)、又は、a4’−NrCO−基
(a4’は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、
アミノカルボニル基で置換されたC1-C10アルキル基を表し、rは、前記と同一の意味を表す。)を表し、b1は、
式(VI-1)
(式中、rb1は、水素原子又はC1-C10アルキル基を表し、Ka1は、水素原子を表し、La1は、C1-C10アルキル基を表し、Ka1とLa1とは、1,3−ブタジエニレン基をなすことがある。)
で示される基、
式(VI-7)
(式中、rb1は、前記と同一の意味を表す。)
で示される基、又は、
式(VI-8)
(式中、rb1は、前記と同一の意味を表す。)
で示される基を表す。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
7.式(VII)
[式中、a1は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa1は、a0’−r1−b0−r1’−基{a0’は、r0O−CO−基(r0は、C1-C10アルキル基を表す。)、r0r0’N−CH2−基(r0及びr0’は、同一又は相異なり、r0’は、r0と同一の意味を表す。)、又は、ヒドロキシメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、b0は、オキシ基、チオ基、スルフィニル基、スルホニル基又は1個のメチル基で置換されたイミノ基を表す。}、又は、a2−O−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、a3’−CO−NH−基(a3’は、C1-C10アルコキシ基で置換されたC1-C10アルキル基を表す。)、又は、a4’−NrCO−基
(a4’は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、
アミノカルボニル基で置換されたC1-C10アルキル基を表し、rは、水素原子又はC1-C10アルキル基を表す。)を表す。但し、a1がチオフェン環のとき、同時に、a0’がジメチルアミノメチル基又はヒドロキシメチル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、オキシ基、チオ基又は1個のメチル基で置換されたイミノ基であることはなく、また、a1がチオフェン環のとき、a0’がメトキシカルボニル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、チオ基であることはない。]
で示されるアルデヒド誘導体。
8.式(VIII)
[式中、a1は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa1は、a0’−r1−b0−r1’−基{a0’は、r0O−CO−基(r0は、C1-C10アルキル基を表す。)、r0r0’N−CH2−基(r0及びr0’は、同一又は相異なり、r0’は、r0と同一の意味を表す。)、又は、ヒドロキシメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、b0は、オキシ基、チオ基、スルフィニル基、スルホニル基又は1個のメチル基で置換されたイミノ基を表す。}、又は、a2−O−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、a3’−CO−NH−基(a3’は、C1-C10アルコキシ基で置換されたC1-C10アルキル基を表す。)、又は、a4’−NrCO−基
(a4’は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、
アミノカルボニル基で置換されたC1-C10アルキル基を表し、rは、水素原子又はC1-C10アルキル基を表す。)を表す。但し、a1がチオフェン環のとき、同時に、a0’がジメチルアミノメチル基又はヒドロキシメチル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、オキシ基、チオ基又は1個のメチル基で置換されたイミノ基であることはなく、また、a1がチオフェン環のとき、a0’がメトキシカルボニル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、チオ基であることはない。]
で示されるアルデヒド誘導体と、式(VIII’)
[式中、b1は、
式(VIII-1)
(式中、rb1は、水素原子又はC1-C10アルキル基を表し、Ka1は、水素原子を表し、La1は、C1-C10アルキル基を表し、Ka1とLa1とは、1,3−ブタジエニレン基をなすことがある。)
で示される基、
式(VIII-7)
(式中、rb1は、前記と同一の意味を表す。)
で示される基、又は、
式(VIII-8)
(式中、rb1は、前記と同一の意味を表す。)
で示される基を表す。]
で示される化合物とを反応させることを特徴とする、式(VIII’’)
[式中、a1、Xa1及びb1は、前記と同一の意味を表す。]
で示されるシンナモイル化合物の製造法。
9.式(I')
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.β'は、
式(I'-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(I'-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(I'-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(I'-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(I'-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(I'-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(I'-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(I'-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(I'-9)
[式中、Wαは、前記と同一の意味を表す。]
で示される基を表す。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物と不活性担体とを含有することを特徴とする細胞外マトリックス遺伝子転写抑制組成物。
10.式(II')
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.β'は、
式(II'-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(II'-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(II'-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(II-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(II'-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(II'-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(II'-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(II'-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(II'-9)
[式中、Wαは、前記と同一の意味を表す。]
で示される基を表す。
但し、αがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
11.式(V')
[式中、
I.aは、チオフェン環、フラン環、ピロール環又はテトラゾール環を表し、Xaは、シアノ基で置換されたC1-C10アルキル基、又は、テトラヒドロピラン−4−イリデン基で置換されたC1-C10アルキル基、又は、ハロゲン原子若しくはシアノ基で置換されたC2-C10アルケニル基、又は、C1-C10アルコキシカルボニル基で置換されたC2-C10アルケニル基、又は、ヒドロキシ基で置換されたC3-C10アルキニル基、又は、a0−r1−b−r1’−基{a0は、C1-C10アルキルチオ基で置換されたメチル基、C1-C10アルキルスルフィニル基で置換されたメチル基、C1-C10アルキルスルホニル基で置換されたメチル基、C2-C10アルケニル基、C2-C10アルキニル基、r2O−CO−基(r2は、C1-C10アルキル基又は水酸基で置換されたC2-C10アルキル基を表す。)、カルボキシ基、rr’N−CO−基(r及びr’は、同一又は相異なり、水素原子又はC1-C10アルキル基を表す。)、a1−NH−CO−基(a1は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、a1’−CO−基(a1’は、モルホリノ基を表す。)、rr’N−CH2−基(r及びr’は、前記と同一の意味を表す。)、r0−(O)l−CONH−CH2−基(r0は、C1-C10アルキル基を表し、lは0又は1を表す。)、r−OCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、シアノ基又はスルホメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、bは、オキシ基、チオ基、スルフィニル基、スルホニル基又はイミノ基を表す。}、又は、a2−y−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表し、yは、オキシ基又はイミノ基を表す。)、又は、rO−COCO−NH−基(rは、前記と同一の意味を表す。)、又は、a3−z−NH−基(a3は、C2-C10アルケニル基、又は、C1-C10アルコキシ基、C1-C10アルコキシカルボニル基、カルボキシ基若しくはシアノ基で置換されたC1-C10アルキル基を表し、zは、カルボニル基又はスルホニル基を表す。)、又は、a4−Nr’CO−基{a4は、C1-C10アルコキシ基、又は、C3-C10アルケニルオキシ基、又は、r0−SO2−基(r0は、前記と同一の意味を表す。)、又は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、r0r0’N−基(r0は、前記と同一の意味を表し、r0’は、r0と同一又は相異なり、r0と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、シアノ基若しくはアミノカルボニル基で置換されたC1-C10アルキル基、又は、rO−CO−(rO−COCH2)CH−基(rは、前記と同一の意味を表す。)を表し、r’は、前記と同一の意味を表す。}、又は、a5−NHSO2−基(a5は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、r0ON=CH−基(r0は、前記と同一の意味を表す。)、又は、r0NHCSNH−基(r0は、前記と同一の意味を表す。)、又は、r0NHC(−Sr0’)=N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、(rO)2P(=O)CH2−基(rは、前記と同一の意味を表す。)を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xaは、同一又は相異なり、
Yaは、ハロゲン原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基、又は、C1-C10アルコキシ基で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、2−オキソ−オキサゾリジン−3−イル基、又は、[1,3]ジオキソラン−2−イル基、又は、モルホリノ基で置換されたC1-C10アルコキシ基、又は、a0’−b’−基(a0’は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、b’は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)、又は、ニトロ基、又は、シアノ基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、又は、r0r0’N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、r0CO−NH−基(r0は、前記と同一の意味を表す。)、又は、r0r0’NCONH−基(r0及びr0’は、前記と同一の意味を表す。)、又は、rr’NCO−基(r及びr’は、前記と同一の意味を表す。)、又は、水酸基を表し、qは、0、1、2又は3を表し、qが2以上のとき、Yaは、同一又は相異なり、qが2以上のとき、隣接しているYaは、a環と縮環して2,3−ジヒドロ−ベンゾ[1,4]ジオキシン環をなしてもよい。
II.b'は、
式(V'-1)
[式中、Qaは、ra−O−基{raは、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、r0r0’N−CH2−基(r0及びr0’は、前記と同一の意味を表す。)、rOCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、C1-C10アルコキシカルボニル基、カルボキシ基、アミノカルボニル基若しくはシアノ基で置換されたC1-C10アルキル基、又は、r3−r1−基(r3は、フェニル基又はピリジル基を表し、r1は、前記と同一の意味を表す。)を表す。}、又は、ピペリジノ基、又は、モルホリノ基、又は、r4r4’N−基(r4及びr4’は、同一又は相異なり、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。但し、同時に水素原子となることはない。)を表し、Waは、酸素原子又は−NTa−基[Taは、rb−基(rbは、raと同一又は相異なり、raと同一の意味を表す。)又はr3’−基(r3’は、r3と同一又は相異なり、r3と同一の意味を表す。)を表す。]を表し、Kaは、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、Laは、水素原子又はC1-C10アルキル基を表し、KaとLaとは、C3-C10アルキレン基又は1,3−ブタジエニレン基をなすことがある。]
で示される基、
式(V'-2)
[式中、Taは、前記と同一の意味を表し、Lbは水酸基又はメチル基を表す。]
で示される基、
式(V'-3)
[式中、Taは、前記と同一の意味を表し、Lcは、C1-C10アルキル基を表す。]
で示される基、
式(V'-4)
[式中、Taは、前記と同一の意味を表す。]
で示される基、
式(V'-5)
[式中、Taは、前記と同一の意味を表し、Kbは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(V'-6)
[式中、Waは、前記と同一の意味を表し、KcとLdとは、C3-C10アルキレン基又はC4-C10アルケニレン基をなす。]
で示される基、
式(V'-7)
[式中、Qa及びWaは、前記と同一の意味を表し、KdとLeとは、−Va=Va’−Va’’=Va’’’−基(Va、Va’、Va’’及びVa’’’は、同一又は相異なり、メチン基、又は、−N=基を表し、Va、Va’、Va’’及びVa’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(V'-8)
[式中、Taは、前記と同一の意味を表し、Qbは、ra−O−基(raは、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(V-9')
[式中、Waは、前記と同一の意味を表す。]
で示される基を表す。
但し、aがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。
12.前項2〜6、10及び11記載の化合物と不活性担体とを含有することを特徴とする細胞外マトリックス遺伝子転写抑制組成物。
13.前項5及び11記載の化合物と不活性担体とを含有することを特徴とする細胞外マトリックス遺伝子転写抑制組成物。
14.細胞外マトリックス遺伝子の転写を抑制するための有効成分としての、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物の使用。
15.細胞外マトリックス遺伝子の転写を抑制するための有効成分としての、前項2〜6、10及び11記載の化合物の使用。
16.細胞外マトリックス遺伝子の転写を抑制するための有効成分としての、前項5及び11記載の化合物の使用。
17.細胞外マトリックス遺伝子の発現量を減少させて細胞外マトリックス蓄積量の低下を導くことにより組織の線維化を改善するための有効成分としての、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物の使用。
18.細胞外マトリックス遺伝子の発現量を減少させて細胞外マトリックス蓄積量の低下を導くことにより組織の線維化を改善するための有効成分としての、前項2〜6、10及び11記載の化合物の使用。
19.有効量の、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物を、組織の線維化を改善させる処置を必要とする哺乳動物患者に投与することを特徴とする組織線維化改善方法。
20.有効量の前項2〜6、10及び11記載の化合物を、組織の線維化を改善させる処置を必要とする哺乳動物患者に投与することを特徴とする組織線維化改善方法。
21.前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物と、不活性担体とを含有することを特徴とする慢性腎不全治療剤。
22.慢性腎不全を治療するための有効成分としての、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物の使用。
23.有効量の、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物を、慢性腎不全治療処置を必要とする哺乳動物患者に投与することを特徴とする慢性腎不全治療方法。
24.前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物と、不活性担体とを含有することを特徴とする心不全治療剤。
25.心不全を治療するための有効成分としての、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物の使用。
26.有効量の、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物を、心不全治療処置を必要とする哺乳動物患者に投与することを特徴とする心不全治療方法。
27.前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物と不活性担体とを含有することを特徴とするTGF−β作用抑制組成物。
28.前項2〜6、10及び11記載の化合物と不活性担体とを含有することを特徴とするTGF−β作用抑制組成物。
29.TGF−βの作用を抑制するための有効成分としての、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物の使用。
30.TGF−βの作用を抑制するための有効成分としての、前項2〜6、10及び11記載の化合物の使用。
31.前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物と、不活性担体とを含有することを特徴とする養毛組成物。
32.TGF−βによる毛髪退行期への移行促進を阻害して毛髪成長期の延長を導くことにより養毛効果を得るための有効成分としての、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物の使用。
33.有効量の、前項1及び9記載の組成物に有効成分として含有されるシンナモイル化合物、又は、前項2〜6、10及び11記載の化合物を、養毛処置を必要とする哺乳動物患者に投与することを特徴とする養毛方法;
等を提供するものである。
As a result of intensive studies under these circumstances, the present inventors have found that compounds represented by the following formulas (I) to (VI) (I ′), (II ′) and (V ′) are extracellular matrix genes. It has been found that it has the ability to suppress transcription, and has led to the present invention.
That is, the present invention
1. Formula (I)
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms, and (Y α ) q Y α Is the following X 0 Group or Y 0 Represents a group of groups, q represents 0, 1, 2 or 3, and when q is 2 or more, Y α Are the same or different, and when q is 2 or more, two adjacent Y same or different Y α Is Z 0 It may be condensed with an α ring as a group, and (X α ) p X α Is the following X 0 Group, Y 0 Group and Z 0 Represents a substituent not belonging to the group, p represents 0, 1, 2 or 3, and when p is 2 or more, X α Are the same or different, and the sum of p and q is 3 or less.
(1) X 0 Group: M a -Group [M a Is R b -Group (R b Represents a C1-C10 alkyl group which may be substituted with a halogen atom. ), Halogen atom, nitro group, cyano group, hydroxyl group, R c -B a -R d -Group (R c Represents a C1-C10 alkyl group which may be substituted with a halogen atom; a Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group, and R d Represents a single bond or a C1-C10 alkylene group. ), HOR d -Group (R d Represents the same meaning as described above. ), R e -CO-R d -Group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom; d Represents the same meaning as described above. ), R e -CO-O-R d -Group (R e And R d Represents the same meaning as described above. ), R e O-CO-R d -Group (R e And R d Represents the same meaning as described above. ), HO—CO—CH═CH— group, R e R e 'N-R d -Group (R e And R e 'Is the same or different, R e Represents the same meaning as above, R e 'R e Represents the same meaning as R d Represents the same meaning as described above. ), R e -CO-NR e '-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R b O-CO-N (R e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-CO-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R e R e 'N-CO-NR e '' -R d -Group (R e , R e 'And R e '' Is the same or different, R e And R e 'Represents the same meaning as described above, and R e '' Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R e R e 'N-C (= NR e '') -NR e '''-R d -Group (R e , R e ', R e '' And R e '''Is the same or different, R e , R e 'And R e '' Represents the same meaning as above, R e '''Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R b -SO 2 -NR e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-SO 2 -R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 Group: M b0 -R d -Group [M b0 Is M c0 -Group {M c0 Is M d0 -R d '-Group {M d0 Is M a -Group (M a Represents the same meaning as described above. 6-10 membered aryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 5-10 membered heteroaryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 3-10-membered hydrocarbon ring or heterocyclic group which may contain an unsaturated bond which may be substituted, or
(b 0 ) -Group ((b 0 ) G 0 Forms a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
(C 0 ) -Group ((c 0 ) 0 May contain a nitrogen atom and form an aromatic 5- to 7-membered ring. ),
(D 0 ) -Group {d 0 Is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, —NR 1 -Group {R 1 Is a hydrogen atom, a C1-C10 alkyl group, a halogen atom or R 2 -B 1 -Group (R 2 Represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group; 1 Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ) Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -Group {e 0 Is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, -NR 1 -Group (R 1 Represents the same meaning as described above. ), A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. }, R d 'R d Same or different from R d Represents the same meaning as }. }, M c0 -B a -Group (M c0 And B a Represents the same meaning as described above. ), M c0 —CO— group (M c0 Represents the same meaning as described above. ), M c0 -CO-O- group (M c0 Represents the same meaning as described above. ), M c0 O-CO- group (M c0 Represents the same meaning as described above. ), M c0 R e N-group (M c0 And R e Represents the same meaning as described above. ), M c0 -CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 O-CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO- group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO-NR e '-Group (M c0 , R e And R e 'Represents the same meaning as described above. ), M c0 R e N-C (= NR e ') -NR e '' -Group (M c0 , R e , R e 'And R e '' Represents the same meaning as described above. ), M c0 -SO 2 -NR e -Group (M c0 And R e Represents the same meaning as described above. ) Or M c0 R e N-SO 2 -Group (M c0 And R e Represents the same meaning as described above. ) And R d Represents the same meaning as described above. ].
(3) Z 0 Group: may have a halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group, A 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β is
Formula (I-1)
[Where:
(1) Q α Represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α Is an oxygen atom or -NT α -Group (T α Represents a hydrogen atom or a substituent on a nitrogen atom. ).
(3) K α And L α Are the same or different and each represents a hydrogen atom or a substituent on a carbon atom; α And L α And may be a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (I-2)
[Where T α Represents the same meaning as described above, and L β Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (I-3)
[Where T α Represents the same meaning as described above, and L γ Represents a C1-C10 alkyl group. ]
A group represented by
Formula (I-4)
[Where T α Represents the same meaning as described above. ]
A group represented by
Formula (I-5)
[Where T α Represents the same meaning as described above, and K β Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (I-6)
[Where W α Represents the same meaning as described above, and K γ And L δ Is a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (I-7)
[Where Q α And W α Represents the same meaning as described above, and K δ And L ε Is -V α = V α '-V α '' = V α '''-Group (V α , V α ', V α '' And V α '''Represents the same or different methine group which may be substituted, or -N = group, and V α , V α ', V α '' And V α At least one of '''represents a -N = group. ). ]
A group represented by
Formula (I-8)
[Where T α Represents the same meaning as above, Q β Represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (I-9)
[Where U and W α Represents the same meaning as described above. ]
Represents a group represented by
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A composition for inhibiting transcription of an extracellular matrix gene, comprising a cinnamoyl compound represented by the formula (1) and an inert carrier.
2. Formula (II)
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms, and (Y α ) q Y α Is the following X 0 Group or Y 0 Represents a group of groups, q represents 0, 1, 2 or 3, and when q is 2 or more, Y α Are the same or different, and when q is 2 or more, two adjacent Y same or different Y α Is Z 0 It may be condensed with an α ring as a group, and (X α ) p X α Is the following X 0 Group, Y 0 Group and Z 0 Represents a substituent not belonging to the group, p represents 0, 1, 2 or 3, and when p is 2 or more, X α Are the same or different, and the sum of p and q is 3 or less.
(1) X 0 Group: M a -Group [M a Is R b -Group (R b Represents a C1-C10 alkyl group which may be substituted with a halogen atom. ), Halogen atom, nitro group, cyano group, hydroxyl group, R c -B a -R d -Group (R c Represents a C1-C10 alkyl group which may be substituted with a halogen atom; a Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group, and R d Represents a single bond or a C1-C10 alkylene group. ), HOR d -Group (R d Represents the same meaning as described above. ), R e -CO-R d -Group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom; d Represents the same meaning as described above. ), R e -CO-O-R d -Group (R e And R d Represents the same meaning as described above. ), R e O-CO-R d -Group (R e And R d Represents the same meaning as described above. ), HO—CO—CH═CH— group, R e R e 'N-R d -Group (R e And R e 'Is the same or different, R e Represents the same meaning as above, R e 'R e Represents the same meaning as R d Represents the same meaning as described above. ), R e -CO-NR e '-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R b O-CO-N (R e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-CO-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R e R e 'N-CO-NR e '' -R d -Group (R e , R e 'And R e '' Is the same or different, R e And R e 'Represents the same meaning as described above, and R e '' Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R e R e 'N-C (= NR e '') -NR e '''-R d -Group (R e , R e ', R e '' And R e '''Is the same or different, R e , R e 'And R e '' Represents the same meaning as above, R e '''Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R b -SO 2 -NR e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-SO 2 -R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 Group: M b0 -R d -Group [M b0 Is M c0 -Group {M c0 Is M d0 -R d '-Group {M d0 Is M a -Group (M a Represents the same meaning as described above. 6-10 membered aryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 5-10 membered heteroaryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 3-10-membered hydrocarbon ring or heterocyclic group which may contain an unsaturated bond which may be substituted, or
(b 0 ) -Group ((b 0 ) G 0 Forms a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
(C 0 ) -Group ((c 0 ) 0 May contain a nitrogen atom and form an aromatic 5- to 7-membered ring. ),
(D 0 ) -Group {d 0 Is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, —NR 1 -Group {R 1 Is a hydrogen atom, a C1-C10 alkyl group, a halogen atom or R 2 -B 1 -Group (R 2 Represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group; 1 Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ) Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -Group {e 0 Is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, -NR 1 -Group (R 1 Represents the same meaning as described above. ), A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. }, R d 'R d Same or different from R d Represents the same meaning as }. }, M c0 -B a -Group (M c0 And B a Represents the same meaning as described above. ), M c0 —CO— group (M c0 Represents the same meaning as described above. ), M c0 -CO-O- group (M c0 Represents the same meaning as described above. ), M c0 O-CO- group (M c0 Represents the same meaning as described above. ), M c0 R e N-group (M c0 And R e Represents the same meaning as described above. ), M c0 -CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 O-CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO- group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO-NR e '-Group (M c0 , R e And R e 'Represents the same meaning as described above. ), M c0 R e N-C (= NR e ') -NR e '' -Group (M c0 , R e , R e 'And R e '' Represents the same meaning as described above. ), M c0 -SO 2 -NR e -Group (M c0 And R e Represents the same meaning as described above. ) Or M c0 R e N-SO 2 -Group (M c0 And R e Represents the same meaning as described above. ) And R d Represents the same meaning as described above. ].
(3) Z 0 Group: may have a halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group, A 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β is
Formula (II-1)
[Where:
(1) Q α Represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α Is an oxygen atom or -NT α -Group (T α Represents a hydrogen atom or a substituent on a nitrogen atom. ).
(3) K α And L α Are the same or different and each represents a hydrogen atom or a substituent on a carbon atom; α And L α And may be a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (II-2)
[Where T α Represents the same meaning as described above, and L β Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (II-3)
[Where T α Represents the same meaning as described above, and L γ Represents a C1-C10 alkyl group. ]
A group represented by
Formula (II-4)
[Where T α Represents the same meaning as described above. ]
A group represented by
Formula (II-5)
[Where T α Represents the same meaning as described above, and K β Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (II-6)
[Where W α Represents the same meaning as described above, and K γ And L δ Is a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (II-7)
[Where Q α And W α Represents the same meaning as described above, and K δ And L ε Is -V α = V α '-V α '' = V α '''-Group (V α , V α ', V α '' And V α '''Represents the same or different methine group which may be substituted, or -N = group, and V α , V α ', V α '' And V α At least one of '''represents a -N = group. ). ]
A group represented by
Formula (II-8)
[Where T α Represents the same meaning as above, Q β Represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (II-9)
[Where U and W α Represents the same meaning as described above. ]
Represents a group represented by
However, when α is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
3. Formula (III)
[Where:
I. A0 represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms.
II. (X A0 ) p X A0 Is the following A 0 N from the group 0 Represents a group included in any group up to the group, p represents 0, 1, 2 or 3, and when p is 2 or more, X A0 Are the same or different.
(1) A 0 Group: D 1 -R 4 -Group [D 1 (R 1 -(O) k -) A 1 N- (O) k ' -Group {R 1 Is a hydrogen atom, a C1-C10 alkyl group, a halogen atom or R 2 -B 1 -Group (R 2 Represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group; 1 Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ) Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group, and k represents 0 or 1; 1 Is R 3 -(CHR 0 ) m -(B 2 -B 3 ) m ' -Group {R 3 Is a hydrogen atom, a halogen atom or R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ) Represents a C1-C10 alkyl group, a C2-C10 alkenyl group, or a C2-C10 alkynyl group optionally substituted by R) 0 Represents a hydrogen atom, a C1-C10 alkyl group or a C2-C10 haloalkyl group, m represents 0 or 1, B 2 Is a single bond, an oxy group, a thio group or —N ((O) n R 1 ') -Group (R 1 'R 1 Same or different from R 1 And n represents 0 or 1. ) And B 3 Represents a carbonyl group, a thiocarbonyl group or a sulfonyl group, m ′ represents 0 or 1, and B 3 When is a sulfonyl group, m is 0 and R 3 Does not become a hydrogen atom. }, And k ′ represents 0 or 1. }, R 4 Represents a C1-C10 alkylene group. However, R 0 'R 0 '' N-R 4 -Group (R 0 'And R 0 '' Is R 0 Same or different from R 0 Represents the same meaning as R 4 Represents the same meaning as described above. )except for. ], D 2 -R 4 -Group [D 2 Is a cyano group, R 1 R 1 'NC (= N- (O) n -A 1 ) -Group (R 1 , R 1 ', N, and A 1 Represents the same meaning as described above. ), A 1 N = C (-OR 2 ) -Group (A 1 And R 2 Represents the same meaning as described above. Or NH 2 Represents -CS- group, R 4 Represents the same meaning as described above. ], D 3 -R 4 -Group {D 3 Is a nitro group or R 1 OSO 2 -Group (R 1 Represents the same meaning as described above. ) And R 4 Represents the same meaning as described above. } Or R 1 OSO 2 -Group (R 1 Represents the same meaning as described above. ).
(2) B 0 group:
(A 0 ) -Group
((A 0 ) In E 0 Is a saturated or unsaturated, aromatic or non-aromatic 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent, R 1 Represents the same meaning as described above. ).
(3) C 0 Group: Halogen atom, R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 4 -R 4 -Group [D 4 Is a hydroxyl group or A 1 —O— group (A 1 Represents the same meaning as described above. ) And R 4 Represents the same meaning as described above. ], D 5 -Group [D 5 Is O = C (R 3 ) -Group (R 3 Represents the same meaning as described above. ), A 1 -(O) n -N = C (R 3 ) -Group (A 1 , N and R 3 Represents the same meaning as described above. ), R 1 -B 0 -CO-R 4 -(O) n -N = C (R 3 ) -Group {R 1 , R 4 , N and R 3 Represents the same meaning as above, B 0 Is an oxy group, a thio group or -N ((O) m R 1 ') -Group (R 1 'And m represent the same meaning as described above. ). }, D 2 -R 4 -(O) n -N = C (R 3 ) -Group (D 2 , R 4 , N and R 3 Represents the same meaning as described above. Or R 1 A 1 N−N = C (R 3 ) -Group (R 1 , A 1 And R 3 Represents the same meaning as described above. ). ], R 1 A 1 N-O-R 4 -Group (R 1 , A 1 And R 4 Represents the same meaning as described above. ), R 1 (A 1 -(O) n -) N-group (R 1 , A 1 And n represent the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or D 3 -Group (D 3 Represents the same meaning as described above. C2-C10 alkenyl group substituted with
It is.
(4) D 0 group:
(b 0 -R 4 -Group ((b 0 ) G 0 Forms a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
(C 0 -R 4 -Group
((C 0 ) 0 May contain a nitrogen atom, form an aromatic 5-7 membered ring, R 4 Represents the same meaning as described above. ), Halogen atom, R 2 -B 1 -R 4 -Group (R 2 , B 1 And R 4 Represents the same meaning as described above. ), D 4 -R 4 -Group (D 4 And R 4 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 1 -R 4 -Group (D 1 And R 4 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or D 3 -R 4 -Group (D 3 And R 4 Represents the same meaning as described above. C2-C10 alkynyl group substituted with
It is.
(5) E 0 Group: A 2 -CO-R 5 -Group
It is. However, A 2 When R is a hydroxyl group, R 5 Is not a vinylene group.
[A 2 Is
(i) A 3 -B 4 -Group
{A 3 Is a hydrogen atom, a C1-C10 alkyl group, a C2-C10 haloalkyl group, a C2-C10 alkenyl group optionally substituted with a halogen atom, or a C3-C10 optionally substituted with a halogen atom. Alkynyl group or R a0 -(R 4 ) m -Group (R a0 Represents an optionally substituted 5-7 membered aryl or heteroaryl group, R 4 And m represent the same meaning as described above. ) Or (b 0 -R 4 -Group ((b 0 ) And R 4 Represents the same meaning as described above. ), (C 0 -R 4 -Group ((c 0 ) And R 4 Represents the same meaning as described above. ), R 2 -B 1 -R 4 -Group (R 2 , B 1 And R 4 Represents the same meaning as described above. ), D 4 -R 4 -Group (D 4 And R 4 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 1 -R 4 -Group (D 1 And R 4 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. ), D 3 -R 4 -Group (D 3 And R 4 Represents the same meaning as described above. Or A 4 -SO 2 -R 4 -Group {A 4 (B 0 ) -Group ((b 0 ) Represents the same meaning as described above. ), (C 0 ) -Group ((c 0 ) Represents the same meaning as described above. Or R 1 R 1 'N-group (R 1 And R 1 'Represents the same meaning as described above. ) And R 4 Represents the same meaning as described above. } Represents a C1-C10 alkyl group substituted with
B 4 Is an oxy group, a thio group or -N ((O) m R 1 ) -Group (R 1 And m represent the same meaning as described above. ). However, B 4 When is a thio group, A 3 Is not a hydrogen atom. },
(ii) R 1 -B 4 -CO-R 4 -B 4 '-Group (R 1 , B 4 And R 4 Represents the same meaning as above, B 4 'B 4 Same or different from B 4 Represents the same meaning as However, B 4 When is a thio group, R 2 Is not a hydrogen atom. Or D 2 -R 4 -B 4 -Group (D 2 , R 4 And B 4 Represents the same meaning as described above. ),
(iii) R 2 -SO 2 -NR 1 -Group (R 2 Represents the same meaning as described above. However, a hydrogen atom is excluded. R 1 Represents the same meaning as described above. ),
(iv) (b 0 ) -Group ((b 0 ) Represents the same meaning as described above. ),
(v) (c 0 ) -Group ((c 0 ) Represents the same meaning as described above. Or
(vi) R 1 A 1 N-NR 1 '-Group (R 1 , A 1 And R 1 'Represents the same meaning as described above. ) And R 5 Represents a C2-C10 alkenylene group or a C2-C10 alkynylene group which may be substituted with a halogen atom. ]
(6) F 0 Group: A 5 -B 5 -R 6 -Group [A 5 D 4 -Group (D 4 Represents the same meaning as described above. ), D 1 -Group (D 1 Represents the same meaning as described above. ), D 3 -Group (D 3 Represents the same meaning as described above. Or A 4 -SO 2 -Group (A 4 Represents the same meaning as described above. Or a C2-C10 alkyl group substituted with R) or R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. Or A 2 -CO- group (A 2 Represents the same meaning as described above. ) Represents a C1-C10 alkyl group substituted with 5 Is B 1 -Group (B 1 Represents the same meaning as described above. ) Or -NA 1 -Group (A 1 Represents the same meaning as described above. ) And R 6 Represents a single bond or a C1-C10 alkylene group. ]
It is.
(7) G 0 Group: A 6 -B 5 -R 6 -Group
[A 6 (A 0 -R 4 -Group ((a 0 ) And R 4 Represents the same meaning as described above. ), A C2-C10 alkenyl group, a C2-C10 alkynyl group, a halogen atom, R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or A 2 -CO- group (A 2 Represents the same meaning as described above. ) Substituted C2-C10 alkenyl group, or halogen atom, R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or A 2 -CO- group (A 2 Represents the same meaning as described above. ) Substituted C2-C10 alkynyl group, or (b 0 ) -Group ((b 0 ) Represents the same meaning as described above. ), (C 0 ) -Group ((c 0 ) Represents the same meaning as described above. ), D 4 -Group (D 4 Represents the same meaning as described above. ), D 1 -Group (D 1 Represents the same meaning as described above. Or D 3 -Group (D 3 Represents the same meaning as described above. C3-C10 alkenyl group substituted with) or D 4 -Group (D 4 Represents the same meaning as described above. ), D 1 -Group (D 1 Represents the same meaning as described above. Or D 3 -Group (D 3 Represents the same meaning as described above. ) Represents a C3-C10 alkynyl group substituted with 5 And R 6 Represents the same meaning as described above. ]
It is.
(8) H 0 group:
D 2 -N (-(O) n -A 1 -R 6 -Group (D 2 , N, A 1 And R 6 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. However, the cyano group is excluded. ), R 1 (R 1 '(O) n ) N-CR 1 '' = N-R 6 -Group (R 1 , R 1 ', N and R 6 Represents the same meaning as above, R 1 '' Is R 1 Same or different from R 1 Represents the same meaning as ), R 1 -(O) n -N = CR 1 '-NR 2 -R 6 -Group (R 1 , N, R 1 ', R 2 And R 6 Represents the same meaning as described above. ), R 2 -B 3 -NR 1 -CO-NR 1 '-R 6 -Group (R 2 , B 3 , R 1 , R 1 'And R 6 Represents the same meaning as described above. ), D 2 -CO-NR 1 -R 6 -Group (D 2 , R 1 And R 6 Represents the same meaning as described above. ) Or A 2 -COCO-NR 1 -R 6 -Group (A 2 , R 1 And R 6 Represents the same meaning as described above. )
It is.
(9) I 0 group:
A 7 -B 6 -N ((O) n R 1 -R 6 -Group [A 7 Is a C2-C10 alkenyl group, C2-C10 alkynyl group, C3-C10 haloalkynyl group, R which may be substituted with a halogen atom, 2 -B 1 -R 4 -Group (R 2 , B 1 And R 4 Represents the same meaning as described above. ), D 4 -R 4 -Group (D 4 And R 4 Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ), D 1 -R 4 -Group (D 1 And R 4 Represents the same meaning as described above. ), (B 0 -R 4 -Group ((b 0 ) And R 4 Represents the same meaning as described above. ), (C 0 -R 4 -Group ((c 0 ) And R 4 Represents the same meaning as described above. ), D 2 -R 4 -Group (D 2 And R 4 Represents the same meaning as described above. ), D 3 -R 4 -Group (D 3 And R 4 Represents the same meaning as described above. ), A 4 -SO 2 -R 4 -Group (A 4 And R 4 Represents the same meaning as described above. ) Or A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) And B 6 Represents a carbonyl group or a thiocarbonyl group, and n, R 1 And R 6 Represents the same meaning as described above. ], A 8 -CS-N ((O) n R 1 -R 6 -Group [A 8 Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and n, R 1 And R 6 Represents the same meaning as described above. ],
A 7 '-B 2 '-B 3 -N ((O) n R 1 -R 6 -Group [A 7 'Is a C3-C10 alkenyl group which may be substituted with a halogen atom, a C3-C10 alkynyl group which may be substituted with a halogen atom, R 2 -B 1 -R 4 '-Group (R 2 And B 1 Represents the same meaning as above, R 4 'Represents a C2-C10 alkylene group. ), D 4 -R 4 '-Group (D 4 And R 4 'Represents the same meaning as described above. ), D 1 -R 4 '-Group (D 1 And R 4 'Represents the same meaning as described above. ), (B 0 -R 4 '-Group ((b 0 ) And R 4 'Represents the same meaning as described above. ), (C 0 -R 4 '-Group ((c 0 ) And R 4 'Represents the same meaning as described above. ), D 2 -R 4 -Group (D 2 And R 4 Represents the same meaning as described above. ), D 3 -R 4 '-Group (D 3 And R 4 'Represents the same meaning as described above. ) Or A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) And B 2 'Represents an oxy group, a thio group, or -N ((O) n ' R 1 ') -Group (n' is the same as or different from n and represents the same meaning as n, R 1 'Represents the same meaning as described above. ) And B 3 , N, R 1 And R 6 Represents the same meaning as described above. ], A 8 '-B 2 '-CS-N ((O) n R 1 -R 6 -Group [A 8 'Represents a C1-C10 alkyl group or a C2-C10 haloalkyl group, and B 2 'Represents the same meaning as described above, and n, R 1 And R 6 Represents the same meaning as described above. ], A 8 '-SB 3 '-N ((O) n R 1 -R 6 -Group [A 8 ', N, R 1 And R 6 Represents the same meaning as above, B 3 'Represents a carbonyl group or a sulfonyl group. ] Or A 7 '' -SO 2 -N ((O) n R 1 -R 6 -Group [A 7 '' Is a C2-C10 alkenyl group, a C3-C10 alkenyl group substituted with a halogen atom, a C3-C10 alkynyl group optionally substituted with a halogen atom, R 2 -B 1 -R 4 '-Group (R 2 , B 1 And R 4 'Represents the same meaning as described above. ), D 4 -R 4 '-Group (D 4 And R 4 'Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ), D 1 -R 4 '-Group (D 1 And R 4 'Represents the same meaning as described above. ), (B 0 -R 4 '-Group ((b 0 ) And R 4 'Represents the same meaning as described above. ), (C 0 -R 4 '-Group ((c 0 ) And R 4 'Represents the same meaning as described above. ), D 2 -R 4 -Group (D 2 And R 4 Represents the same meaning as described above. ), NO 2 -R 4 -Group (R 4 Represents the same meaning as described above. ) Or A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ), N, R 1 And R 6 Represents the same meaning as described above. ]
It is.
(10) J 0 Group: A 7 -CO- group (A 7 Represents the same meaning as described above. ) Or A 9 -CS- group (A 9 A 7 Or A 8 Represents. ) Or A 9 '(O) m N = C (A 9 ) -Group (A 9 'A 7 'Or A 8 'And m and A 9 Represents the same meaning as described above. ) Or D 2 —CO— group (D 2 Represents the same meaning as described above. ) Or A 2 -COCO- group (A 2 Represents the same meaning as described above. ) Or A 9 -CO-B 1 '-R 6 -Group (A 9 And R 6 Represents the same meaning as above, B 1 'Represents an oxy group or a thio group. However, B 1 When 'is an oxy group, A 9 A 8 is not. ) Or A 9 -CS-B 1 '-R 6 -Group (A 9 , B 1 'And R 6 Represents the same meaning as described above. ) Or A 7 '' -SO 2 -B 1 '-R 6 -Group (A 7 '' 、 B 1 'And R 6 Represents the same meaning as described above. ) Or A 8 -SO 2 -B 1 '-R 6 -Group (A 8 , B 1 'And R 6 Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ) Or A 9 '-B 2 '-B 3 -B 1 '-R 6 -Group (A 9 ', B 2 ', B 3 , B 1 'And R 6 Represents the same meaning as described above. ) Or (b 0 ) -Group ((b 0 ) Represents the same meaning as described above. ) Or (c 0 ) -Group ((c 0 ) Represents the same meaning as described above. C2-C10 alkenyl group substituted with
It is.
(11) K 0 Group: A 10 -N ((O) n R 1 ) -CO-R 6 -Group [A 10 Is a hydrogen atom (where n is not 0), A 7 '' -SO 2 -Group (A 7 '' Represents the same meaning as described above. ), A 8 -SO 2 -Group (A 8 Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ), A 9 'O-group (A 9 'Represents the same meaning as described above. However, n is not 1. ), A 9 '-Group (A 9 'Represents the same meaning as described above. However, when n is 0, A 8 'except for. ), R 2 OCH 2 -Group (R 2 Represents the same meaning as described above. ), A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) Or A 2 -CO-CH (CH 2 CO-A 2 ) -Group (A 2 Represents the same meaning as described above. ), N, R 1 And R 6 Represents the same meaning as described above. ]
It is.
(12) L 0 Group: A 10 '-N ((O) n R 1 -SO 2 -R 6 -Group [A 10 'Is a hydrogen atom (where n is not 0), A 9 'O-group (A 9 'Represents the same meaning as described above. However, n is not 1. ), A 9 '-Group (A 9 'Represents the same meaning as described above. However, when n is 0, A 8 'except for. ), R 2 —CO— group (R 2 Represents the same meaning as described above. ), A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) Or A 2 -CO-CH (CH 2 CO-A 2 ) -Group (A 2 Represents the same meaning as described above. ), N, R 1 And R 6 Represents the same meaning as described above. ], A 9 '' R 1 N-SO 2 -N ((O) n R 1 ') -R 6 -Group [A 9 '' Is a hydrogen atom or A 9 '-Group (A 9 'Represents the same meaning as described above. ) And R 1 , N, R 1 'And R 6 Represents the same meaning as described above. ] Or (b 0 -SO 2 -N ((O) n R 1 ') -R 6 -Group [(b 0 ), N, R 1 'And R 6 Represents the same meaning as described above. ]
It is.
(13) M 0 Group: R 1 (R 2 S) C = N-R 6 -Group (R 1 , R 2 And R 6 Represents the same meaning as described above. ), R 2 B (R 2 'B') C = N-R 6 -Group (R 2 And R 6 Represents the same meaning as above, R 2 'R 2 Same or different from R 2 And B and B ′ are the same or different and represent an oxy group or a thio group. ), R 1 R 1 'N- (R 2 S) C = N-R 6 -Group (R 1 , R 1 ', R 2 And R 6 Represents the same meaning as described above. ), R 1 N = C (SR 2 -NR 2 '-R 6 -Group (R 1 , R 2 , R 2 'And R 6 Represents the same meaning as described above. Or R 1 (R 1 'O) N-R 6 -Group (R 1 , R 1 'And R 6 Represents the same meaning as described above. )
It is.
(14) N 0 Group: A 11 -P (= O) (OR 1 ') -R 4 -Group [A 11 Is R 1 -Group (R 1 Represents the same meaning as described above. ), R 1 O-R 6 -Group (R 1 And R 6 Represents the same meaning as described above. Or R 1 OCO-CHR 0 -Group (R 1 And R 0 Represents the same meaning as described above. ) And R 1 'And R 4 Represents the same meaning as described above. ]
It is.
III. (Y A0 ) q Y A0 Is the following X 0 Group and Y 0 Represents a group of groups, q represents 0, 1, 2 or 3, the sum of p (p represents the same meaning as described above) and q is 3 or less, and q is 2 or more , Y A0 Are the same or different, and when q is 2 or more, two adjacent Y same or different Y A0 Is Z 0 A group may be formed to be condensed with the A0 ring.
(1) X 0 group:
M a -Group [M a Is R b -Group (R b Represents a C1-C10 alkyl group which may be substituted with a halogen atom. ), Halogen atom, nitro group, cyano group, hydroxyl group, R c -B a -R d -Group (R c Represents a C1-C10 alkyl group which may be substituted with a halogen atom; a Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group, and R d Represents a single bond or a C1-C10 alkylene group. ), HOR d -Group (R d Represents the same meaning as described above. ), R e -CO-R d -Group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom; d Represents the same meaning as described above. ), R e -CO-O-R d -Group (R e And R d Represents the same meaning as described above. ), R e O-CO-R d -Group (R e And R d Represents the same meaning as described above. ), HO—CO—CH═CH— group, R e R e 'N-R d -Group (R e And R e 'Is the same or different, R e Represents the same meaning as above, R e 'R e Represents the same meaning as R d Represents the same meaning as described above. ), R e -CO-NR e '-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R b O-CO-N (R e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-CO-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R e R e 'N-CO-NR e '' -R d -Group (R e , R e 'And R e '' Is the same or different, R e And R e 'Represents the same meaning as described above, and R e '' Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R e R e 'NC (= NR e '') -NR e '''-R d -Group (R e , R e ', R e '' And R e '''Is the same or different, R e , R e 'And R e '' Represents the same meaning as above, R e '''Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R b -SO 2 -NR e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-SO 2 -R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 group:
M b0 -R d -Group [M b0 Is M c0 -Group {M c0 Is M d0 -R d '-Group {M d0 Is M a -Group (M a Represents the same meaning as described above. 6-10 membered aryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 5-10 membered heteroaryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 3-10-membered hydrocarbon ring or heterocyclic group which may contain an unsaturated bond which may be substituted, or
(b 0 ) -Group ((b 0 ) Represents the same meaning as described above. ),
(C 0 ) -Group ((c 0 ) Represents the same meaning as described above. ),
(D 0 ) -Group {d 0 Is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, —NR 1 -Group (R 1 Represents the same meaning as described above. ), A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -Group {e 0 Is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, -NR 1 -Group (R 1 Represents the same meaning as described above. ), A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. }, R d 'R d Same or different from R d Represents the same meaning as }. }, M c0 -B a -Group (M c0 And B a Represents the same meaning as described above. ), M c0 —CO— group (M c0 Represents the same meaning as described above. ), M c0 -CO-O- group (M c0 Represents the same meaning as described above. ), M c0 O-CO- group (M c0 Represents the same meaning as described above. ), M c0 R e N-group (M c0 And R e Represents the same meaning as described above. ), M c0 -CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 O-CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO- group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO-NR e '-Group (M c0 , R e And R e 'Represents the same meaning as described above. ), M c0 R e N-C (= NR e ') -NR e '' -Group (M c0 , R e , R e 'And R e '' Represents the same meaning as described above. ), M c0 -SO 2 -NR e -Group (M c0 And R e Represents the same meaning as described above. ) Or M c0 R e N-SO 2 -Group (M c0 And R e Represents the same meaning as described above. ) And R d Represents the same meaning as described above. ].
(3) Z 0 Group: may have a halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group, A 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring, and a group condensed with the A0 ring.
IV. B0 is
Formula (III-1)
[Where:
(1) Q A0 Is a hydroxyl group (b 0 ) -Group ((b 0 ) Represents the same meaning as described above. ), A 9 -B 6 -B c -Group [A 9 And B 6 Represents the same meaning as above, B c Is an oxy group or -N ((O) m R 1 ) -Group (m and R 1 Represents the same meaning as described above. ). However, A 9 When is a hydrogen atom, B c Is not a sulfonyl group. ], A 7 '' -SO 2 -B c -Group (A 7 '' And B c Represents the same meaning as described above. ), A 8 -SO 2 -B c -Group (A 8 And B c Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ), R 1 R 1 'N-SO 2 -B c -Group (R 1 , R 1 'And B c Represents the same meaning as described above. ), (B 0 -SO 2 -B c -Group ((b 0 ) And B c Represents the same meaning as described above. ), A 9 '-B c -Group (A 9 'And B c Represents the same meaning as described above. ), D 5 -R 4 -B c -Group (D 5 , R 4 And B c Represents the same meaning as described above. ), M c0 -B 3 -B c -Group (M c0 , B 3 And B c Represents the same meaning as described above. ) Or M c0 -B c -Group (M c0 And B c Represents the same meaning as described above. ).
(2) W A0 Is an oxygen atom or -NT A0 -Group [T A0 Is a hydrogen atom, A 9 '-Group (A 9 'Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ) Or M c0 -Group (M c0 Represents the same meaning as described above. ). ].
(3) K A0 Represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group; A0 Is a hydrogen atom, a C1-C10 alkyl group or M b0 -Group (M b0 Represents the same meaning as described above. ) And K A0 And L A0 Is a C3-C10 alkylene group, or a C4-C10 alkenylene group which may be substituted with one or a plurality of Ma-groups (Ma represents the same meaning as described above). is there. ]
A group represented by
Formula (III-2)
[Where T A0 Represents the same meaning as described above, and L B0 Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (III-3)
[Where T A0 Represents the same meaning as described above, and L C0 Represents a C1-C10 alkyl group. ]
A group represented by
Formula (III-4)
[Where T A0 Represents the same meaning as described above. ]
A group represented by
Formula (III-5)
[Where T A0 Represents the same meaning as described above, and K B0 Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (III-6)
[Where W A0 Represents the same meaning as described above, and K C0 And L D0 Is a C3-C10 alkylene group or a C4-C10 alkenylene group which may be substituted with one or a plurality of Ma-groups (Ma represents the same meaning as described above). ]
A group represented by
Formula (III-7)
[Where Q A0 And W A0 Represents the same meaning as described above, and K D0 And L E0 Is -V A0 = V A0 '-V A0 '' = V A0 '''-Group {V A0 , V A0 ', V A0 '' And V A0 '''Is the same or different, M a -Group (M a Represents the same meaning as described above. ) Represents a methine group which may be substituted, or -N = group, and V A0 , V A0 ', V A0 '' And V A0 At least one of '''represents a -N = group. }. ]
A group represented by
Formula (III-8)
[Where T A0 Represents the same meaning as above, Q B0 Is a hydroxyl group, A 9 -B 6 —O— group [A 9 And B 6 Represents the same meaning as described above. ], A 7 '' -SO 2 —O— group (A 7 '' Represents the same meaning as described above. ), A 8 -SO 2 —O— group (A 8 Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ), R 1 R 1 'N-SO 2 —O— group (R 1 And R 1 'Represents the same meaning as described above. ), (B 0 -SO 2 —O— group ((b 0 ) Represents the same meaning as described above. ), A 9 '-O- group (A 9 'Represents the same meaning as described above. ), D 5 -R 4 —O— group (D 5 And R 4 Represents the same meaning as described above. ), M c0 -B 3 —O— group (M c0 And B 3 Represents the same meaning as described above. ) Or M c0 —O— group (M c0 Represents the same meaning as described above. ). ]
Or a group represented by
Formula (III-9)
[Where U and W A0 Represents the same meaning as described above. ]
Represents a group represented by
However, when A0 is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
4). Formula (IV)
[Where:
I. A represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms.
II. (X A ) p X A Represents a group included in any of the following groups A to N, p represents 0, 1, 2 or 3, and when p is 2 or more, X represents A Are the same or different.
(1) Group A: D 1 -R 4 -Group [D 1 (R 1 -(O) k -) A 1 N- (O) k ' -Group {R 1 Is a hydrogen atom, a C1-C10 alkyl group, a halogen atom or R 2 -B 1 -Group (R 2 Represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group; 1 Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ) Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group, and k represents 0 or 1; 1 Is R 3 -(CHR 0 ) m -(B 2 -B 3 ) m ' -Group {R 3 Is a hydrogen atom, a halogen atom or R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ) Represents a C1-C10 alkyl group, a C2-C10 alkenyl group, or a C2-C10 alkynyl group optionally substituted by R) 0 Represents a hydrogen atom, a C1-C10 alkyl group or a C2-C10 haloalkyl group, m represents 0 or 1, B 2 Is a single bond, an oxy group, a thio group or —N ((O) n R 1 ') -Group (R 1 'R 1 Same or different from R 1 And n represents 0 or 1. ) And B 3 Represents a carbonyl group, a thiocarbonyl group or a sulfonyl group, m ′ represents 0 or 1, and B 3 When is a sulfonyl group, m is 0 and R 3 Does not become a hydrogen atom. }, And k ′ represents 0 or 1. }, R 4 Represents a C1-C10 alkylene group. However, R 0 'R 0 '' N-R 4 -Group (R 0 'And R 0 '' Is R 0 Same or different from R 0 Represents the same meaning as R 4 Represents the same meaning as described above. )except for. ], D 2 -R 4 -Group [D 2 Is a cyano group, R 1 R 1 'NC (= N- (O) n -A 1 ) -Group (R 1 , R 1 ', N, and A 1 Represents the same meaning as described above. ), A 1 N = C (-OR 2 ) -Group (A 1 And R 2 Represents the same meaning as described above. Or NH 2 Represents -CS- group, R 4 Represents the same meaning as described above. ], D 3 -R 4 -Group {D 3 Is a nitro group or R 1 OSO 2 -Group (R 1 Represents the same meaning as described above. ) And R 4 Represents the same meaning as described above. } Or R 1 OSO 2 -Group (R 1 Represents the same meaning as described above. ).
(2) Group B:
(A) -group
[In (a), E 1 And E 1 'Represents a methylene group which may be substituted with a C1-C10 alkyl group or a C1-C10 alkoxy group, or a carbonyl group. However, E 1 And E 1 'Is not a carbonyl group at the same time. E 2 Is an oxy group, thio group, sulfinyl group, sulfonyl group or -NR 1 '-Group (R 1 'Represents the same meaning as described above. C2-C10 alkylene group which may be substituted with 1 '-Group (R 1 'Represents the same meaning as described above. ) Represents a C3-C10 alkenylene group optionally substituted by 1 Represents the same meaning as described above. ]
It is.
(3) Group C: halogen atom, R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 4 -R 4 -Group [D 4 Is a hydroxyl group or A 1 —O— group (A 1 Represents the same meaning as described above. ) And R 4 Represents the same meaning as described above. ], D 5 -Group [D 5 Is O = C (R 3 ) -Group (R 3 Represents the same meaning as described above. ), A 1 -(O) n -N = C (R 3 ) -Group (A 1 , N and R 3 Represents the same meaning as described above. ), R 1 -B 0 -CO-R 4 -(O) n -N = C (R 3 ) -Group {R 1 , R 4 , N and R 3 Represents the same meaning as above, B 0 Is an oxy group, a thio group or -N ((O) m R 1 ') -Group (R 1 'And m represent the same meaning as described above. ). }, D 2 -R 4 -(O) n -N = C (R 3 ) -Group (D 2 , R 4 , N and R 3 Represents the same meaning as described above. Or R 1 A 1 N−N = C (R 3 ) -Group (R 1 , A 1 And R 3 Represents the same meaning as described above. ). ], R 1 A 1 N-O-R 4 -Group (R 1 , A 1 And R 4 Represents the same meaning as described above. ), R 1 (A 1 -(O) n -) N-group (R 1 , A 1 And n represent the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or D 3 -Group (D 3 Represents the same meaning as described above. C2-C10 alkenyl group substituted with
It is.
(4) Group D:
(b) -R 4 -In the group [(b) G 1 , G 2 , G 4 And G 5 Represents a methylene group which may be substituted with a methyl group which is bonded to an adjacent atom with a single bond, or a methine group which is bonded to an adjacent atom with a double bond and which may be substituted with a methyl group; 3 Is a single bond, a double bond, a methyl group, an oxy group, a thio group, a sulfinyl group, a sulfonyl group or —NR 1 -Group (R 1 Represents the same meaning as described above. C1-C10 alkylene group optionally substituted with a methyl group, oxy group, thio group, sulfinyl group, sulfonyl group or —NR 1 -Group (R 1 Represents the same meaning as described above. ) Represents a C2-C10 alkenylene group which may be substituted with R) 4 Represents the same meaning as described above. ],
(C) -R 4 -Group
(In (c), J 1 , J 2 And J 3 Are the same or different and each represents a methine group which may be substituted with a methyl group or a nitrogen atom; 4 Represents the same meaning as described above. ), Halogen atom, R 2 -B 1 -R 4 -Group (R 2 , B 1 And R 4 Represents the same meaning as described above. ), D 4 -R 4 -Group (D 4 And R 4 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 1 -R 4 -Group (D 1 And R 4 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or D 3 -R 4 -Group (D 3 And R 4 Represents the same meaning as described above. C2-C10 alkynyl group substituted with
It is.
(5) Group E: A 2 -CO-R 5 -Group
It is. However, A 2 When R is a hydroxyl group, R 5 Is not a vinylene group.
[A 2 Is
(i) A 3 -B 4 -Group
{A 3 Is a hydrogen atom, a C1-C10 alkyl group, a C2-C10 haloalkyl group, a C2-C10 alkenyl group optionally substituted with a halogen atom, or a C3-C10 optionally substituted with a halogen atom. Alkynyl group or R a -(R 4 ) m -Group (R a Represents a phenyl group, a pyridyl group, a furyl group or a thienyl group, which may be substituted with a halogen atom, a C1-C10 alkyl group, a C1-C10 alkoxy group or a nitro group, and R 4 And m represent the same meaning as described above. ) Or (b) -R 4 -Groups ((b) and R 4 Represents the same meaning as described above. ), (C) -R 4 -Groups ((c) and R 4 Represents the same meaning as described above. ), R 2 -B 1 -R 4 -Group (R 2 , B 1 And R 4 Represents the same meaning as described above. ), D 4 -R 4 -Group (D 4 And R 4 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 1 -R 4 -Group (D 1 And R 4 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. ), D 3 -R 4 -Group (D 3 And R 4 Represents the same meaning as described above. Or A 4 -SO 2 -R 4 -Group {A 4 Is a (b) -group ((b) is as defined above), (c) -group ((c) is as defined above) or R 1 R 1 'N-group (R 1 And R 1 'Represents the same meaning as described above. ) And R 4 Represents the same meaning as described above. } Represents a C1-C10 alkyl group substituted with
B 4 Is an oxy group, a thio group or -N ((O) m R 1 ) -Group (R 1 And m represent the same meaning as described above. ). However, B 4 When is a thio group, A 3 Is not a hydrogen atom. },
(ii) R 1 -B 4 -CO-R 4 -B 4 '-Group (R 1 , B 4 And R 4 Represents the same meaning as above, B 4 'B 4 Same or different from B 4 Represents the same meaning as However, B 4 When is a thio group, R 2 Is not a hydrogen atom. Or D 2 -R 4 -B 4 -Group (D 2 , R 4 And B 4 Represents the same meaning as described above. ),
(iii) R 2 -SO 2 -NR 1 -Group (R 2 Represents the same meaning as described above. However, a hydrogen atom is excluded. R 1 Represents the same meaning as described above. ),
(iv) (b) -group ((b) represents the same meaning as described above),
(v) (c) -group ((c) represents the same meaning as described above) or
(vi) R 1 A 1 N-NR 1 '-Group (R 1 , A 1 And R 1 'Represents the same meaning as described above. ) And R 5 Represents a C2-C10 alkenylene group or a C2-C10 alkynylene group which may be substituted with a halogen atom. ]
(6) Group F: A 5 -B 5 -R 6 -Group [A 5 D 4 -Group (D 4 Represents the same meaning as described above. ), D 1 -Group (D 1 Represents the same meaning as described above. ), D 3 -Group (D 3 Represents the same meaning as described above. Or A 4 -SO 2 -Group (A 4 Represents the same meaning as described above. Or a C2-C10 alkyl group substituted with R) or R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. Or A 2 -CO- group (A 2 Represents the same meaning as described above. ) Represents a C1-C10 alkyl group substituted with 5 Is B 1 -Group (B 1 Represents the same meaning as described above. ) Or -NA 1 -Group (A 1 Represents the same meaning as described above. ) And R 6 Represents a single bond or a C1-C10 alkylene group. ]
It is.
(7) Group G: A 6 -B 5 -R 6 -Group
[A 6 (A) -R 4 -Groups ((a) and R 4 Represents the same meaning as described above. ), A C2-C10 alkenyl group, a C2-C10 alkynyl group, a halogen atom, R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or A 2 -CO- group (A 2 Represents the same meaning as described above. ) Substituted C2-C10 alkenyl group or halogen atom, R 2 -B 1 -Group (R 2 And B 1 Represents the same meaning as described above. ), D 5 -Group (D 5 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. Or A 2 -CO- group (A 2 Represents the same meaning as described above. ) -Substituted C2-C10 alkynyl group or (b) -group ((b) represents the same meaning as described above), (c) -group ((c) represents the same meaning as described above) D) 4 -Group (D 4 Represents the same meaning as described above. ), D 1 -Group (D 1 Represents the same meaning as described above. Or D 3 -Group (D 3 Represents the same meaning as described above. C3-C10 alkenyl group substituted with) or D 4 -Group (D 4 Represents the same meaning as described above. ), D 1 -Group (D 1 Represents the same meaning as described above. Or D 3 -Group (D 3 Represents the same meaning as described above. ) Represents a C3-C10 alkynyl group substituted with 5 And R 6 Represents the same meaning as described above. ]
It is.
(8) Group H:
D 2 -N (-(O) n -A 1 -R 6 -Group (D 2 , N, A 1 And R 6 Represents the same meaning as described above. ), D 2 -Group (D 2 Represents the same meaning as described above. However, the cyano group is excluded. ), R 1 (R 1 '(O) n ) N-CR 1 '' = N-R 6 -Group (R 1 , R 1 ', N and R 6 Represents the same meaning as above, R 1 '' Is R 1 Same or different from R 1 Represents the same meaning as ), R 1 -(O) n -N = CR 1 '-NR 2 -R 6 -Group (R 1 , N, R 1 ', R 2 And R 6 Represents the same meaning as described above. ), R 2 -B 3 -NR 1 -CO-NR 1 '-R 6 -Group (R 2 , B 3 , R 1 , R 1 'And R 6 Represents the same meaning as described above. ), D 2 -CO-NR 1 -R 6 -Group (D 2 , R 1 And R 6 Represents the same meaning as described above. ) Or A 2 -COCO-NR 1 -R 6 -Group (A 2 , R 1 And R 6 Represents the same meaning as described above. )
It is.
(9) Group I:
A 7 -B 6 -N ((O) n R 1 -R 6 -Group [A 7 Is a C2-C10 alkenyl group, C2-C10 alkynyl group, C3-C10 haloalkynyl group, R which may be substituted with a halogen atom, 2 -B 1 -R 4 -Group (R 2 , B 1 And R 4 Represents the same meaning as described above. ), D 4 -R 4 -Group (D 4 And R 4 Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ), D 1 -R 4 -Group (D 1 And R 4 Represents the same meaning as described above. ), (B) -R 4 -Groups ((b) and R 4 Represents the same meaning as described above. ), (C) -R 4 -Groups ((c) and R 4 Represents the same meaning as described above. ), D 2 -R 4 -Group (D 2 And R 4 Represents the same meaning as described above. ), D 3 -R 4 -Group (D 3 And R 4 Represents the same meaning as described above. ), A 4 -SO 2 -R 4 -Group (A 4 And R 4 Represents the same meaning as described above. ) Or A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) And B 6 Represents a carbonyl group or a thiocarbonyl group, and n, R 1 And R 6 Represents the same meaning as described above. ], A 8 -CS-N ((O) n R 1 -R 6 -Group [A 8 Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and n, R 1 And R 6 Represents the same meaning as described above. ],
A 7 '-B 2 '-B 3 -N ((O) n R 1 -R 6 -Group [A 7 'Is a C3-C10 alkenyl group which may be substituted with a halogen atom, a C3-C10 alkynyl group which may be substituted with a halogen atom, R 2 -B 1 -R 4 '-Group (R 2 And B 1 Represents the same meaning as above, R 4 'Represents a C2-C10 alkylene group. ), D 4 -R 4 '-Group (D 4 And R 4 'Represents the same meaning as described above. ), D 1 -R 4 '-Group (D 1 And R 4 'Represents the same meaning as described above. ), (B) -R 4 '-Group ((b) and R 4 'Represents the same meaning as described above. ), (C) -R 4 '-Group ((c) and R 4 'Represents the same meaning as described above. ), D 2 -R 4 -Group (D 2 And R 4 Represents the same meaning as described above. ), D 3 -R 4 '-Group (D 3 And R 4 'Represents the same meaning as described above. ) Or A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) And B 2 'Represents an oxy group, a thio group, or -N ((O) n ' R 1 ') -Group (n' is the same as or different from n and represents the same meaning as n, R 1 'Represents the same meaning as described above. ) And B 3 , N, R 1 And R 6 Represents the same meaning as described above. ], A 8 '-B 2 '-CS-N ((O) n R 1 -R 6 -Group [A 8 'Represents a C1-C10 alkyl group or a C2-C10 haloalkyl group, and B 2 'Represents the same meaning as described above, and n, R 1 And R 6 Represents the same meaning as described above. ], A 8 '-SB 3 '-N ((O) n R 1 -R 6 -Group [A 8 ', N, R 1 And R 6 Represents the same meaning as above, B 3 'Represents a carbonyl group or a sulfonyl group. ] Or A 7 '' -SO 2 -N ((O) n R 1 -R 6 -Group [A 7 '' Is a C2-C10 alkenyl group, a C3-C10 alkenyl group substituted with a halogen atom, a C3-C10 alkynyl group optionally substituted with a halogen atom, R 2 -B 1 -R 4 '-Group (R 2 , B 1 And R 4 'Represents the same meaning as described above. ), D 4 -R 4 '-Group (D 4 And R 4 'Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ), D 1 -R 4 '-Group (D 1 And R 4 'Represents the same meaning as described above. ), (B) -R 4 '-Group ((b) and R 4 'Represents the same meaning as described above. ), (C) -R 4 '-Group ((c) and R 4 'Represents the same meaning as described above. ), D 2 -R 4 -Group (D 2 And R 4 Represents the same meaning as described above. ), NO 2 -R 4 -Group (R 4 Represents the same meaning as described above. ) Or A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ), N, R 1 And R 6 Represents the same meaning as described above. ]
It is.
(10) Group J: A 7 -CO- group (A 7 Represents the same meaning as described above. ) Or A 9 -CS- group (A 9 A 7 Or A 8 Represents. ) Or A 9 '(O) m N = C (A 9 ) -Group (A 9 'A 7 'Or A 8 'And m and A 9 Represents the same meaning as described above. ) Or D 2 —CO— group (D 2 Represents the same meaning as described above. ) Or A 2 -COCO- group (A 2 Represents the same meaning as described above. ) Or A 9 -CO-B 1 '-R 6 -Group (A 9 And R 6 Represents the same meaning as above, B 1 'Represents an oxy group or a thio group. However, B 1 When 'is an oxy group, A 9 A 8 is not. ) Or A 9 -CS-B 1 '-R 6 -Group (A 9 , B 1 'And R 6 Represents the same meaning as described above. ) Or A 7 '' -SO 2 -B 1 '-R 6 -Group (A 7 '' 、 B 1 'And R 6 Represents the same meaning as described above. ) Or A 8 -SO 2 -B 1 '-R 6 -Group (A 8 , B 1 'And R 6 Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ) Or A 9 '-B 2 '-B 3 -B 1 '-R 6 -Group (A 9 ', B 2 ', B 3 , B 1 'And R 6 Represents the same meaning as described above. ) Or (b) -group ((b) represents the same meaning as described above) or (c) -group ((c) represents the same meaning as described above) substituted C2 -C10 alkenyl group
It is.
(11) Group K: A 10 -N ((O) n R 1 ) -CO-R 6 -Group [A 10 Is a hydrogen atom (where n is not 0), A 7 '' -SO 2 -Group (A 7 '' Represents the same meaning as described above. ), A 8 -SO 2 -Group (A 8 Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ), A 9 'O-group (A 9 'Represents the same meaning as described above. However, n is not 1. ), A 9 '-Group (A 9 'Represents the same meaning as described above. However, when n is 0, A 8 'except for. ), R 2 OCH 2 -Group (R 2 Represents the same meaning as described above. ), A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) Or A 2 -CO-CH (CH 2 CO-A 2 ) -Group (A 2 Represents the same meaning as described above. ), N, R 1 And R 6 Represents the same meaning as described above. ]
It is.
(12) L group: A 10 '-N ((O) n R 1 -SO 2 -R 6 -Group [A 10 'Is a hydrogen atom (where n is not 0), A 9 'O-group (A 9 'Represents the same meaning as described above. However, n is not 1. ), A 9 '-Group (A 9 'Represents the same meaning as described above. However, when n is 0, A 8 'except for. ), R 2 —CO— group (R 2 Represents the same meaning as described above. ), A 2 -CO-R 4 -Group (A 2 And R 4 Represents the same meaning as described above. ) Or A 2 -CO-CH (CH 2 CO-A 2 ) -Group (A 2 Represents the same meaning as described above. ), N, R 1 And R 6 Represents the same meaning as described above. ], A 9 '' R 1 N-SO 2 -N ((O) n R 1 ') -R 6 -Group [A 9 '' Is a hydrogen atom or A 9 '-Group (A 9 'Represents the same meaning as described above. ) And R 1 , N, R 1 'And R 6 Represents the same meaning as described above. Or (b) -SO 2 -N ((O) n R 1 ') -R 6 -Group [(b), n, R 1 'And R 6 Represents the same meaning as described above. ]
It is.
(13) M group: R 1 (R 2 S) C = N-R 6 -Group (R 1 , R 2 And R 6 Represents the same meaning as described above. ), R 2 B (R 2 'B') C = N-R 6 -Group (R 2 And R 6 Represents the same meaning as above, R 2 'R 2 Same or different from R 2 And B and B ′ are the same or different and represent an oxy group or a thio group. ), R 1 R 1 'N- (R 2 S) C = N-R 6 -Group (R 1 , R 1 ', R 2 And R 6 Represents the same meaning as described above. ), R 1 N = C (SR 2 -NR 2 '-R 6 -Group (R 1 , R 2 , R 2 'And R 6 Represents the same meaning as described above. Or R 1 (R 1 'O) N-R 6 -Group (R 1 , R 1 'And R 6 Represents the same meaning as described above. )
It is.
(14) Group N: A 11 -P (= O) (OR 1 ') -R 4 -Group [A 11 Is R 1 -Group (R 1 Represents the same meaning as described above. ), R 1 O-R 6 -Group (R 1 And R 6 Represents the same meaning as described above. Or R 1 OCO-CHR 0 -Group (R 1 And R 0 Represents the same meaning as described above. ) And R 1 'And R 4 Represents the same meaning as described above. ]
It is.
III. (Y A ) q Y A Represents a group of the following X group or Y group, q represents 0, 1, 2 or 3, and the sum of p (p represents the same meaning as described above) and q is 3 or less. Yes, when q is 2 or more, Y A Are the same or different, and when q is 2 or more, two adjacent Ys that are the same or different A May form a group Z and may be condensed with the A ring.
(1) Group X: M a -Group [M a Is R b -Group (R b Represents a C1-C10 alkyl group which may be substituted with a halogen atom. ), Halogen atom, nitro group, cyano group, R c -B a -R d -Group (R c Represents a C1-C10 alkyl group which may be substituted with a halogen atom; a Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group, and R d Represents a single bond or a C1-C10 alkylene group. ), HO-R d -Group (R d Represents the same meaning as described above. ), R e -CO-R d -Group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom; d Represents the same meaning as described above. ), R e -CO-O-R d -Group (R e And R d Represents the same meaning as described above. ), R e O-CO-R d -Group (R e And R d Represents the same meaning as described above. ), HO—CO—CH═CH— group, R e R e 'N-R d -Group (R e And R e 'Is the same or different, R e Represents the same meaning as above, R e 'R e Represents the same meaning as R d Represents the same meaning as described above. ), R e -CO-NR e '-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R b O-CO-N (R e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-CO-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R e R e 'N-CO-NR e '' -R d -Group (R e , R e 'And R e '' Is the same or different, R e And R e 'Represents the same meaning as described above, and R e '' Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R e R e 'NC (= NR e '') -NR e '''-R d -Group (R e , R e ', R e '' And R e '''Is the same or different, R e , R e 'And R e '' Represents the same meaning as above, R e '''Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R b -SO 2 -NR e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-SO 2 -R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y group: M b -R d -Group [M b Is M c -Group {M c Is M d -R d '-Group {M d Is M a -Group (M a Represents the same meaning as described above. A phenyl group optionally substituted with M) a -Group (M a Represents the same meaning as described above. Pyridyl group optionally substituted with M) a -Group (M a Represents the same meaning as described above. ) May be substituted with a naphthyl group, (b) -group ((b) represents the same meaning as described above), (c) -group ((c) represents the same meaning as described above. ),
(D) -group (l is 2, 3 or 4; B b Represents an oxy group or a thio group. Or
(E) -group (l and B b Represents the same meaning as described above. ) And R d 'R d Same or different from R d Represents the same meaning as }. }, M c -B a -Group (M c And B a Represents the same meaning as described above. ), M c —CO— group (M c Represents the same meaning as described above. ), M c -CO-O- group (M c Represents the same meaning as described above. ), M c O-CO- group (M c Represents the same meaning as described above. ), M c R e N-group (M c And R e Represents the same meaning as described above. ), M c -CO-NR e -Group (M c And R e Represents the same meaning as described above. ), M c O-CO-NR e -Group (M c And R e Represents the same meaning as described above. ), M c R e N-CO- group (M c And R e Represents the same meaning as described above. ), M c R e N-CO-NR e '-Group (M c , R e And R e 'Represents the same meaning as described above. ), M c R e N-C (= NR e ') -NR e '' -Group (M c , R e , R e 'And R e '' Represents the same meaning as described above. ), M c -SO 2 -NR e -Group (M c And R e Represents the same meaning as described above. ) Or M c R e N-SO 2 -Group (M c And R e Represents the same meaning as described above. ) And R d Represents the same meaning as described above. ].
(3) Z group: -Y a '' = C (Y a -Y a '-Group (Y a Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom or a C1-C10 alkoxy group; a 'Represents an imino group that may be substituted with an oxy group, a thio group, or a C1-C10 alkyl group; a '' Represents a -N = group or a methine group. ), C3-C10 alkylene group or -Y b = Y b '-Y b '' = Y b '''-Group [Y b , Y b ', Y b '' And Y b '''Is the same or different, and Ma-group (M a Represents the same meaning as described above. ) Represents a methine group which may be substituted or -N = group. ].
IV. B is
Formula (IV-1)
[Where:
(1) Q A Is a hydroxyl group, (b) -group ((b) represents the same meaning as described above), A 9 -B 6 -B c -Group [A 9 And B 6 Represents the same meaning as above, B c Is an oxy group or -N ((O) m R 1 ) -Group (m and R 1 Represents the same meaning as described above. ). However, A 9 When is a hydrogen atom, B c Is not a sulfonyl group. ], A 7 '' -SO 2 -B c -Group (A 7 '' And B c Represents the same meaning as described above. ), A 8 -SO 2 -B c -Group (A 8 And B c Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ), R 1 R 1 'N-SO 2 -B c -Group (R 1 , R 1 'And B c Represents the same meaning as described above. ), (B) -SO 2 -B c -Groups ((b) and B c Represents the same meaning as described above. ), A 9 '-B c -Group (A 9 'And B c Represents the same meaning as described above. ), D 5 -R 4 -B c -Group (D 5 , R 4 And B c Represents the same meaning as described above. ), M c -B 3 -B c -Group (M c , B 3 And B c Represents the same meaning as described above. ) Or M c -B c -Group (M c And B c Represents the same meaning as described above. ).
(2) W A Is an oxygen atom or -NT A -Group [T A Is a hydrogen atom, A 9 '-Group (A 9 'Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ) Or M c -Group (M c Represents the same meaning as described above. ). ]. T A Is a hydrogen atom, A 9 '-Group (A 9 'Represents the same meaning as described above. ), D 5 -R 4 -Group (D 5 And R 4 Represents the same meaning as described above. ) Or M c -Group (M c Represents the same meaning as described above. ).
(3) K A Represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group; A Is a hydrogen atom, a C1-C10 alkyl group or M b -Group (M b Represents the same meaning as described above. ) And K A And L A Is a C3-C10 alkylene group or -C (M a ') = C (M a '') -C (M a ''') = C (M a '''') -Group (M a ', M a '', M a '''And M a '''' Is the same or different, M a Same as or different from, hydrogen atom or M a Represents. ). ]
A group represented by
Formula (IV-2)
[Where T A Represents the same meaning as described above, and L B Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (IV-3)
[Where T A Represents the same meaning as described above, and L C Represents a C1-C10 alkyl group. ]
A group represented by
Formula (IV-4)
[Where T A Represents the same meaning as described above. ]
A group represented by
Formula (IV-5)
[Where T A Represents the same meaning as described above, and K B Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (IV-6)
[Where W A Represents the same meaning as described above, and K C And L D Is a C3-C10 alkylene group or a C4-C10 alkenylene group which may be substituted with one or a plurality of Ma-groups (Ma represents the same meaning as described above). ]
A group represented by
Formula (IV-7)
[Where Q A And W A Represents the same meaning as described above, and K D And L E Is -V A = V A '-V A '' = V A '''-Group {V A , V A ', V A '' And V A '''Is the same or different, M a -Group (M a Represents the same meaning as described above. ) Represents a methine group which may be substituted, or -N = group, and V A , V A ', V A '' And V A At least one of '''represents a -N = group. }. ]
A group represented by
Formula (IV-8)
[Where T A Represents the same meaning as above, Q B Is a hydroxyl group, A 9 -B 6 —O— group [A 9 And B 6 Represents the same meaning as described above. ], A 7 '' -SO 2 —O— group (A 7 '' Represents the same meaning as described above. ), A 8 -SO 2 —O— group (A 8 Represents the same meaning as described above. However, A 8 Does not become a hydrogen atom. ), R 1 R 1 'N-SO 2 —O— group (R 1 And R 1 'Represents the same meaning as described above. ), (B) -SO 2 -O- group ((b) represents the same meaning as described above), A 9 '-O- group (A 9 'Represents the same meaning as described above. ), D 5 -R 4 —O— group (D 5 And R 4 Represents the same meaning as described above. ), M c -B 3 —O— group (M c And B 3 Represents the same meaning as described above. ) Or M c —O— group (M c Represents the same meaning as described above. ). ]
Or a group represented by
Formula (IV-9)
[Where U and W A Represents the same meaning as described above. ]
Represents a group represented by
However, when A is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
5. Formula (V)
[Where:
I. a represents a thiophene ring, furan ring, pyrrole ring, pyrazole ring, 1,2,3-triazole ring, tetrazole ring, isoxazole ring, thiazole ring, pyridazine ring or pyrimidine ring; a Is a C1-C10 alkyl group substituted with a cyano group, a C1-C10 alkyl group substituted with a tetrahydropyran-4-ylidene group, or a C2-C10 alkenyl group substituted with a halogen atom or a cyano group, Or a C2-C10 alkenyl group substituted with a C1-C10 alkoxycarbonyl group, a C3-C10 alkynyl group substituted with a hydroxy group, or a 0 -R 1 -B-r 1 '-Group {a 0 Is a methyl group substituted with a C1-C10 alkylthio group, a methyl group substituted with a C1-C10 alkylsulfinyl group, a methyl group substituted with a C1-C10 alkylsulfonyl group, a C2-C10 alkenyl group, a C2-C10 alkynyl group Group, r 2 O—CO— group (r 2 Represents a C1-C10 alkyl group or a C2-C10 alkyl group substituted with a hydroxyl group. ), A carboxy group, an rr′N—CO— group (r and r ′ are the same or different and each represents a hydrogen atom or a C1-C10 alkyl group), a 1 -NH-CO- group (a 1 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ), A 1 '-CO- group (a 1 'Represents a morpholino group. ), Rr'N-CH 2 -Group (r and r 'are as defined above), r 0 -(O) l -CONH-CH 2 -Group (r 0 Represents a C1-C10 alkyl group, and l represents 0 or 1. ), R-OCH 2 -Group (r represents the same meaning as described above), r 0 —CO— group (r 0 Represents the same meaning as described above. ), A cyano group or a sulfomethyl group, r 1 Represents a C1-C10 alkylene group, r 1 'Represents a single bond or a C1-C10 alkylene group, and b represents an imino group which may be substituted with an oxy group, a thio group, a sulfinyl group, a sulfonyl group or a methyl group. } Or a 2 -Y-CO-NH- group (a 2 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group, and y represents an oxy group or an imino group. ) Or rO—COCO—NH— group (where r represents the same meaning as described above), or a 3 -Z-NH- group (a 3 Represents a C2-C10 alkenyl group, or a C1-C10 alkoxy group substituted with a C1-C10 alkoxy group, a C1-C10 alkoxycarbonyl group, a carboxy group or a cyano group, and z represents a carbonyl group or a sulfonyl group. . ) Or a 4 -Nr'CO- group {a 4 Is a C1-C10 alkoxy group, a C3-C10 alkenyloxy group, or r 0 -SO 2 -Group (r 0 Represents the same meaning as described above. ), Or a C2-C10 alkyl group substituted with a hydroxyl group or a C1-C10 alkoxy group, or r 0 r 0 'N-group (r 0 Represents the same meaning as described above, and r 0 'R 0 Same as or different from r 0 Represents the same meaning as ) -Substituted C2-C10 alkyl group, or rO-CO- group (where r represents the same meaning as described above), a C1-C10 alkyl group substituted with a cyano group or an aminocarbonyl group, or rO-CO- (rO-COCH 2 ) CH— group (wherein r represents the same meaning as described above), and r ′ represents the same meaning as described above. } Or a 5 -NHSO 2 -Group (a 5 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or r 0 ON = CH-group (r 0 Represents the same meaning as described above. ) Or r 0 NHCSNH-group (r 0 Represents the same meaning as described above. ) Or r 0 NHC (-Sr 0 ') = N-group (r 0 And r 0 'Represents the same meaning as described above. ) Or (rO) 2 P (= O) CH 2 -Represents a group (r represents the same meaning as described above), p represents 0, 1, 2, or 3, and when p is 2 or more, X a Are the same or different,
Y a Is a halogen atom, a C1-C10 alkyl group that may be substituted with a halogen atom, a C1-C10 alkyl group that may be substituted with a C1-C10 alkoxy group, or a C2-C10 alkenyl group, or A C2-C10 alkynyl group, a 2-oxo-oxazolidin-3-yl group, a [1,3] dioxolan-2-yl group, or a C1-C10 alkoxy group substituted with a morpholino group, or a 0 '-B'-group (a 0 'Represents a C1-C10 alkyl group which may be substituted with a halogen atom, and b' represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ), A nitro group, a cyano group, or an rO—CO— group (where r represents the same meaning as described above), or r 0 r 0 'N-group (r 0 And r 0 'Represents the same meaning as described above. ) Or r 0 CO—NH— group (r 0 Represents the same meaning as described above. ) Or r 0 r 0 'NCONH-group (r 0 And r 0 'Represents the same meaning as described above. ) Or rr′NCO— group (r and r ′ represent the same meaning as described above) or a hydroxyl group, q represents 0, 1, 2 or 3, and q is 2 or more. When Y a Are the same or different, and when q is 2 or more, adjacent Y a May be condensed with a ring to form a 4,5,6,7-tetrahydrobenzo [b] thiophene ring.
II. b is
Formula (V-1)
[Where Q a R a —O— group {r a Is a hydrogen atom, a C1-C10 alkyl group, a C3-C10 alkenyl group, a C3-C10 alkynyl group, or r 0 r 0 'N-CH 2 -Group (r 0 And r 0 'Represents the same meaning as described above. ), ROCH 2 -Group (r represents the same meaning as described above), r 0 —CO— group (r 0 Represents the same meaning as described above. ), A C1-C10 alkoxycarbonyl group, a carboxy group, an aminocarbonyl group, a C1-C10 alkyl group substituted with a cyano group, or r 3 -R 1 -Group (r 3 Represents a phenyl group or a pyridyl group, and r 1 Represents the same meaning as described above. ). }, Or a piperidino group, or a morpholino group, or r 4 r 4 'N-group (r 4 And r 4 'Is the same or different and is a C2-C10 alkyl substituted with a hydrogen atom, a C1-C10 alkyl group, a C3-C10 alkenyl group, a C3-C10 alkynyl group, or a C1-C10 alkoxy group. Represents a group. However, it does not become a hydrogen atom at the same time. ) And W a Is an oxygen atom or -NT a -Group [T a R b -Group (r b R a Same as or different from r a Represents the same meaning as Or r 3 '-Group (r 3 'R 3 Same as or different from r 3 Represents the same meaning as ). ] And K a Represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group; a Represents a hydrogen atom or a C1-C10 alkyl group, and K a And L a And may form a C3-C10 alkylene group or a 1,3-butadienylene group. ]
A group represented by
Formula (V-2)
[Where T a Represents the same meaning as described above, and L b Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (V-3)
[Where T a Represents the same meaning as described above, and L c Represents a C1-C10 alkyl group. ]
A group represented by
Formula (V-4)
[Where T a Represents the same meaning as described above. ]
A group represented by
Formula (V-5)
[Where T a Represents the same meaning as described above, and K b Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (V-6)
[Where W a Represents the same meaning as described above, and K c And L d And C3-C10 alkylene group or C4-C10 alkenylene group. ]
A group represented by
Formula (V-7)
[Where Q a And W a Represents the same meaning as described above, and K d And L e Is -V a = V a '-V a '' = V a '''-Group (V a , V a ', V a '' And V a '''Is the same or different and represents a methine group or -N = group; a , V a ', V a '' And V a At least one of '''represents a -N = group. ). ]
A group represented by
Formula (V-8)
[Where T a Represents the same meaning as above, Q b R a —O— group (r a Represents the same meaning as described above. ). ]
Or a group represented by
Formula (V-9)
[Where U and W a Represents the same meaning as described above. ]
Represents a group represented by
However, when a is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
6). Formula (VI)
[Wherein, a1 represents a thiophene ring, a furan ring, a pyrrole ring or a thiazole ring; a1 Is a 0 '-R 1 -B 0 -R 1 '-Group {a 0 'Represents an rO-CO- group (r represents a hydrogen atom or a C1-C10 alkyl group), r 0 r 0 'N-CH 2 -Group (r 0 And r 0 'Is the same or different and represents a C1-C10 alkyl group. ) Or a hydroxymethyl group, r 1 Represents a C1-C10 alkylene group, r 1 'Represents a single bond or a C1-C10 alkylene group, b 0 Represents an imino group substituted with an oxy group, a thio group, a sulfinyl group, a sulfonyl group or one methyl group. } Or a 2 -O-CO-NH- group (a 2 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or a 3 '-CO-NH- group (a 3 'Represents a C1-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or a 4 '-NrCO- group
(A 4 Is a C2-C10 alkyl group substituted with a hydroxyl group or a C1-C10 alkoxy group, or
Represents a C1-C10 alkyl group substituted with an aminocarbonyl group, and r represents the same meaning as described above. ) And b1 is
Formula (VI-1)
(Where r b1 Represents a hydrogen atom or a C1-C10 alkyl group, and K a1 Represents a hydrogen atom and L a1 Represents a C1-C10 alkyl group and K a1 And L a1 May form a 1,3-butadienylene group. )
A group represented by
Formula (VI-7)
(Where r b1 Represents the same meaning as described above. )
Or a group represented by
Formula (VI-8)
(Where r b1 Represents the same meaning as described above. )
Represents a group represented by
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
7). Formula (VII)
[Wherein, a1 represents a thiophene ring, a furan ring, a pyrrole ring or a thiazole ring; a1 Is a 0 '-R 1 -B 0 -R 1 '-Group {a 0 'R 0 O—CO— group (r 0 Represents a C1-C10 alkyl group. ), R 0 r 0 'N-CH 2 -Group (r 0 And r 0 'Is the same or different, r 0 'R 0 Represents the same meaning as ) Or a hydroxymethyl group, r 1 Represents a C1-C10 alkylene group, r 1 'Represents a single bond or a C1-C10 alkylene group, b 0 Represents an imino group substituted with an oxy group, a thio group, a sulfinyl group, a sulfonyl group or one methyl group. } Or a 2 -O-CO-NH- group (a 2 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or a 3 '-CO-NH- group (a 3 'Represents a C1-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or a 4 '-NrCO- group
(A 4 Is a C2-C10 alkyl group substituted with a hydroxyl group or a C1-C10 alkoxy group, or
Represents a C1-C10 alkyl group substituted with an aminocarbonyl group, and r represents a hydrogen atom or a C1-C10 alkyl group. ). However, when a1 is a thiophene ring, 0 Is a dimethylaminomethyl group or a hydroxymethyl group, and at the same time, r 1 Is a methylene group and at the same time r 1 'Is a single bond and at the same time b 0 Is not an oxy group, a thio group or an imino group substituted with one methyl group, and when a1 is a thiophene ring, 0 'Is a methoxycarbonyl group and at the same time r 1 Is a methylene group and at the same time r 1 'Is a single bond and at the same time b 0 Is not a thio group. ]
An aldehyde derivative represented by
8). Formula (VIII)
[Wherein, a1 represents a thiophene ring, a furan ring, a pyrrole ring or a thiazole ring; a1 Is a 0 '-R 1 -B 0 -R 1 '-Group {a 0 'R 0 O—CO— group (r 0 Represents a C1-C10 alkyl group. ), R 0 r 0 'N-CH 2 -Group (r 0 And r 0 'Is the same or different, r 0 'R 0 Represents the same meaning as ) Or a hydroxymethyl group, r 1 Represents a C1-C10 alkylene group, r 1 'Represents a single bond or a C1-C10 alkylene group, b 0 Represents an imino group substituted with an oxy group, a thio group, a sulfinyl group, a sulfonyl group or one methyl group. } Or a 2 -O-CO-NH- group (a 2 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or a 3 '-CO-NH- group (a 3 'Represents a C1-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or a 4 '-NrCO- group
(A 4 Is a C2-C10 alkyl group substituted with a hydroxyl group or a C1-C10 alkoxy group, or
Represents a C1-C10 alkyl group substituted with an aminocarbonyl group, and r represents a hydrogen atom or a C1-C10 alkyl group. ). However, when a1 is a thiophene ring, 0 Is a dimethylaminomethyl group or a hydroxymethyl group, and at the same time, r 1 Is a methylene group and at the same time r 1 'Is a single bond and at the same time b 0 Is not an oxy group, a thio group or an imino group substituted with one methyl group, and when a1 is a thiophene ring, 0 'Is a methoxycarbonyl group and at the same time r 1 Is a methylene group and at the same time r 1 'Is a single bond and at the same time b 0 Is not a thio group. ]
An aldehyde derivative represented by formula (VIII ′)
[Wherein b1 is
Formula (VIII-1)
(Where r b1 Represents a hydrogen atom or a C1-C10 alkyl group, and K a1 Represents a hydrogen atom and L a1 Represents a C1-C10 alkyl group and K a1 And L a1 May form a 1,3-butadienylene group. )
A group represented by
Formula (VIII-7)
(Where r b1 Represents the same meaning as described above. )
Or a group represented by
Formula (VIII-8)
(Where r b1 Represents the same meaning as described above. )
Represents a group represented by ]
Characterized by reacting with a compound of formula (VIII ″)
[Wherein a1, X a1 And b1 represent the same meaning as described above. ]
The manufacturing method of the cinnamoyl compound shown by these.
9. Formula (I ')
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms, and (Y α ) q Y α Is the following X 0 Group or Y 0 Represents a group of groups, q represents 0, 1, 2 or 3, and when q is 2 or more, Y α Are the same or different, and when q is 2 or more, two adjacent Y same or different Y α Is Z 0 It may be condensed with an α ring as a group, and (X α ) p X α Is the following X 0 Group, Y 0 Group and Z 0 Represents a substituent not belonging to the group, p represents 0, 1, 2 or 3, and when p is 2 or more, X α Are the same or different, and the sum of p and q is 3 or less.
(1) X 0 Group: M a -Group [M a Is R b -Group (R b Represents a C1-C10 alkyl group which may be substituted with a halogen atom. ), Halogen atom, nitro group, cyano group, hydroxyl group, R c -B a -R d -Group (R c Represents a C1-C10 alkyl group which may be substituted with a halogen atom; a Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group, and R d Represents a single bond or a C1-C10 alkylene group. ), HOR d -Group (R d Represents the same meaning as described above. ), R e -CO-R d -Group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom; d Represents the same meaning as described above. ), R e -CO-O-R d -Group (R e And R d Represents the same meaning as described above. ), R e O-CO-R d -Group (R e And R d Represents the same meaning as described above. ), HO—CO—CH═CH— group, R e R e 'N-R d -Group (R e And R e 'Is the same or different, R e Represents the same meaning as above, R e 'R e Represents the same meaning as R d Represents the same meaning as described above. ), R e -CO-NR e '-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R b O-CO-N (R e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-CO-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R e R e 'N-CO-NR e '' -R d -Group (R e , R e 'And R e '' Is the same or different, R e And R e 'Represents the same meaning as described above, and R e '' Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R e R e 'NC (= NR e '') -NR e '''-R d -Group (R e , R e ', R e '' And R e '''Is the same or different, R e , R e 'And R e '' Represents the same meaning as above, R e '''Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R b -SO 2 -NR e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-SO 2 -R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 Group: M b0 -R d -Group [M b0 Is M c0 -Group {M c0 Is M d0 -R d '-Group {M d0 Is M a -Group (M a Represents the same meaning as described above. 6-10 membered aryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 5-10 membered heteroaryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 3-10-membered hydrocarbon ring or heterocyclic group which may contain an unsaturated bond which may be substituted, or
(b 0 ) -Group ((b 0 ) G 0 Forms a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
(C 0 ) -Group ((c 0 ) 0 May contain a nitrogen atom and form an aromatic 5- to 7-membered ring. ),
(D 0 ) -Group {d 0 Is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, —NR 1 -Group {R 1 Is a hydrogen atom, a C1-C10 alkyl group, a halogen atom or R 2 -B 1 -Group (R 2 Represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group; 1 Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ) Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -Group {e 0 Is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, -NR 1 -Group (R 1 Represents the same meaning as described above. ), A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. }, R d 'R d Same or different from R d Represents the same meaning as }. }, M c0 -B a -Group (M c0 And B a Represents the same meaning as described above. ), M c0 —CO— group (M c0 Represents the same meaning as described above. ), M c0 -CO-O- group (M c0 Represents the same meaning as described above. ), M c0 O-CO- group (M c0 Represents the same meaning as described above. ), M c0 R e N-group (M c0 And R e Represents the same meaning as described above. ), M c0 -CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 O-CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO- group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO-NR e '-Group (M c0 , R e And R e 'Represents the same meaning as described above. ), M c0 R e N-C (= NR e ') -NR e '' -Group (M c0 , R e , R e 'And R e '' Represents the same meaning as described above. ), M c0 -SO 2 -NR e -Group (M c0 And R e Represents the same meaning as described above. ) Or M c0 R e N-SO 2 -Group (M c0 And R e Represents the same meaning as described above. ) And R d Represents the same meaning as described above. ].
(3) Z 0 Group: may have a halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group, A 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β 'is
Formula (I'-1)
[Where:
(1) Q α Represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α Is an oxygen atom or -NT α -Group (T α Represents a hydrogen atom or a substituent on a nitrogen atom. ).
(3) K α And L α Are the same or different and each represents a hydrogen atom or a substituent on a carbon atom; α And L α And may be a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (I'-2)
[Where T α Represents the same meaning as described above, and L β Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (I'-3)
[Where T α Represents the same meaning as described above, and L γ Represents a C1-C10 alkyl group. ]
A group represented by
Formula (I'-4)
[Where T α Represents the same meaning as described above. ]
A group represented by
Formula (I'-5)
[Where T α Represents the same meaning as described above, and K β Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (I'-6)
[Where W α Represents the same meaning as described above, and K γ And L δ Is a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (I'-7)
[Where Q α And W α Represents the same meaning as described above, and K δ And L ε Is -V α = V α '-V α '' = V α '''-Group (V α , V α ', V α '' And V α '''Represents the same or different methine group which may be substituted, or -N = group, and V α , V α ', V α '' And V α At least one of '''represents a -N = group. ). ]
A group represented by
Formula (I'-8)
[Where T α Represents the same meaning as above, Q β Represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (I'-9)
[Where W α Represents the same meaning as described above. ]
Represents a group represented by
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A composition for inhibiting transcription of an extracellular matrix gene, comprising a cinnamoyl compound represented by the formula (1) and an inert carrier.
10. Formula (II ')
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms, and (Y α ) q Y α Is the following X 0 Group or Y 0 Represents a group of groups, q represents 0, 1, 2 or 3, and when q is 2 or more, Y α Are the same or different, and when q is 2 or more, two adjacent Y same or different Y α Is Z 0 It may be condensed with an α ring as a group, and (X α ) p X α Is the following X 0 Group, Y 0 Group and Z 0 Represents a substituent not belonging to the group, p represents 0, 1, 2 or 3, and when p is 2 or more, X α Are the same or different, and the sum of p and q is 3 or less.
(1) X 0 Group: M a -Group [M a Is R b -Group (R b Represents a C1-C10 alkyl group which may be substituted with a halogen atom. ), Halogen atom, nitro group, cyano group, hydroxyl group, R c -B a -R d -Group (R c Represents a C1-C10 alkyl group which may be substituted with a halogen atom; a Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group, and R d Represents a single bond or a C1-C10 alkylene group. ), HOR d -Group (R d Represents the same meaning as described above. ), R e -CO-R d -Group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom; d Represents the same meaning as described above. ), R e -CO-O-R d -Group (R e And R d Represents the same meaning as described above. ), R e O-CO-R d -Group (R e And R d Represents the same meaning as described above. ), HO—CO—CH═CH— group, R e R e 'N-R d -Group (R e And R e 'Is the same or different, R e Represents the same meaning as above, R e 'R e Represents the same meaning as R d Represents the same meaning as described above. ), R e -CO-NR e '-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R b O-CO-N (R e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-CO-R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), R e R e 'N-CO-NR e '' -R d -Group (R e , R e 'And R e '' Is the same or different, R e And R e 'Represents the same meaning as described above, and R e '' Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R e R e 'NC (= NR e '') -NR e '''-R d -Group (R e , R e ', R e '' And R e '''Is the same or different, R e , R e 'And R e '' Represents the same meaning as above, R e '''Is R e Represents the same meaning as R d Represents the same meaning as described above. ), R b -SO 2 -NR e -R d -Group (R b , R e And R d Represents the same meaning as described above. ), R e R e 'N-SO 2 -R d -Group (R e , R e 'And R d Represents the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 Group: M b0 -R d -Group [M b0 Is M c0 -Group {M c0 Is M d0 -R d '-Group {M d0 Is M a -Group (M a Represents the same meaning as described above. 6-10 membered aryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 5-10 membered heteroaryl group optionally substituted with M), or M a -Group (M a Represents the same meaning as described above. 3-10-membered hydrocarbon ring or heterocyclic group which may contain an unsaturated bond which may be substituted, or
(b 0 ) -Group ((b 0 ) G 0 Forms a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
(C 0 ) -Group ((c 0 ) 0 May contain a nitrogen atom and form an aromatic 5- to 7-membered ring. ),
(D 0 ) -Group {d 0 Is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, —NR 1 -Group {R 1 Is a hydrogen atom, a C1-C10 alkyl group, a halogen atom or R 2 -B 1 -Group (R 2 Represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group; 1 Represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ) Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -Group {e 0 Is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, -NR 1 -Group (R 1 Represents the same meaning as described above. ), A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. }, R d 'R d Same or different from R d Represents the same meaning as }. }, M c0 -B a -Group (M c0 And B a Represents the same meaning as described above. ), M c0 —CO— group (M c0 Represents the same meaning as described above. ), M c0 -CO-O- group (M c0 Represents the same meaning as described above. ), M c0 O-CO- group (M c0 Represents the same meaning as described above. ), M c0 R e N-group (M c0 And R e Represents the same meaning as described above. ), M c0 -CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 O-CO-NR e -Group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO- group (M c0 And R e Represents the same meaning as described above. ), M c0 R e N-CO-NR e '-Group (M c0 , R e And R e 'Represents the same meaning as described above. ), M c0 R e N-C (= NR e ') -NR e '' -Group (M c0 , R e , R e 'And R e '' Represents the same meaning as described above. ), M c0 -SO 2 -NR e -Group (M c0 And R e Represents the same meaning as described above. ) Or M c0 R e N-SO 2 -Group (M c0 And R e Represents the same meaning as described above. ) And R d Represents the same meaning as described above. ].
(3) Z 0 Group: may have a halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group, A 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β 'is
Formula (II'-1)
[Where:
(1) Q α Represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α Is an oxygen atom or -NT α -Group (T α Represents a hydrogen atom or a substituent on a nitrogen atom. ).
(3) K α And L α Are the same or different and each represents a hydrogen atom or a substituent on a carbon atom; α And L α And may be a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (II'-2)
[Where T α Represents the same meaning as described above, and L β Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (II'-3)
[Where T α Represents the same meaning as described above, and L γ Represents a C1-C10 alkyl group. ]
A group represented by
Formula (II-4)
[Where T α Represents the same meaning as described above. ]
A group represented by
Formula (II'-5)
[Where T α Represents the same meaning as described above, and K β Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (II'-6)
[Where W α Represents the same meaning as described above, and K γ And L δ Is a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (II'-7)
[Where Q α And W α Represents the same meaning as described above, and K δ And L ε Is -V α = V α '-V α '' = V α '''-Group (V α , V α ', V α '' And V α '''Represents the same or different methine group which may be substituted, or -N = group, and V α , V α ', V α '' And V α At least one of '''represents a -N = group. ). ]
A group represented by
Formula (II'-8)
[Where T α Represents the same meaning as above, Q β Represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (II'-9)
[Where W α Represents the same meaning as described above. ]
Represents a group represented by
However, when α is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
11. Formula (V ')
[Where:
I. a represents a thiophene ring, a furan ring, a pyrrole ring or a tetrazole ring; a Is a C1-C10 alkyl group substituted with a cyano group, a C1-C10 alkyl group substituted with a tetrahydropyran-4-ylidene group, or a C2-C10 alkenyl group substituted with a halogen atom or a cyano group, Or a C2-C10 alkenyl group substituted with a C1-C10 alkoxycarbonyl group, a C3-C10 alkynyl group substituted with a hydroxy group, or a 0 -R 1 -B-r 1 '-Group {a 0 Is a methyl group substituted with a C1-C10 alkylthio group, a methyl group substituted with a C1-C10 alkylsulfinyl group, a methyl group substituted with a C1-C10 alkylsulfonyl group, a C2-C10 alkenyl group, a C2-C10 alkynyl group Group, r 2 O—CO— group (r 2 Represents a C1-C10 alkyl group or a C2-C10 alkyl group substituted with a hydroxyl group. ), A carboxy group, an rr′N—CO— group (r and r ′ are the same or different and each represents a hydrogen atom or a C1-C10 alkyl group), a 1 -NH-CO- group (a 1 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ), A 1 '-CO- group (a 1 'Represents a morpholino group. ), Rr'N-CH 2 -Group (r and r 'are as defined above), r 0 -(O) l -CONH-CH 2 -Group (r 0 Represents a C1-C10 alkyl group, and l represents 0 or 1. ), R-OCH 2 -Group (r represents the same meaning as described above), r 0 —CO— group (r 0 Represents the same meaning as described above. ), A cyano group or a sulfomethyl group, r 1 Represents a C1-C10 alkylene group, r 1 'Represents a single bond or a C1-C10 alkylene group, and b represents an oxy group, a thio group, a sulfinyl group, a sulfonyl group, or an imino group. } Or a 2 -Y-CO-NH- group (a 2 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group, and y represents an oxy group or an imino group. ) Or rO—COCO—NH— group (where r represents the same meaning as described above), or a 3 -Z-NH- group (a 3 Represents a C2-C10 alkenyl group, or a C1-C10 alkoxy group substituted with a C1-C10 alkoxy group, a C1-C10 alkoxycarbonyl group, a carboxy group or a cyano group, and z represents a carbonyl group or a sulfonyl group. . ) Or a 4 -Nr'CO- group {a 4 Is a C1-C10 alkoxy group, a C3-C10 alkenyloxy group, or r 0 -SO 2 -Group (r 0 Represents the same meaning as described above. ), Or a C2-C10 alkyl group substituted with a hydroxyl group or a C1-C10 alkoxy group, or r 0 r 0 'N-group (r 0 Represents the same meaning as described above, and r 0 'R 0 Same as or different from r 0 Represents the same meaning as ) -Substituted C2-C10 alkyl group, or rO-CO- group (where r represents the same meaning as described above), a C1-C10 alkyl group substituted with a cyano group or an aminocarbonyl group, or rO-CO- (rO-COCH 2 ) CH— group (wherein r represents the same meaning as described above), and r ′ represents the same meaning as described above. } Or a 5 -NHSO 2 -Group (a 5 Represents a C2-C10 alkyl group substituted with a C1-C10 alkoxy group. ) Or r 0 ON = CH-group (r 0 Represents the same meaning as described above. ) Or r 0 NHCSNH-group (r 0 Represents the same meaning as described above. ) Or r 0 NHC (-Sr 0 ') = N-group (r 0 And r 0 'Represents the same meaning as described above. ) Or (rO) 2 P (= O) CH 2 -Represents a group (r represents the same meaning as described above), p represents 0, 1, 2 or 3, and when p is 2 or more, X a Are the same or different,
Y a Is a halogen atom, a C1-C10 alkyl group that may be substituted with a halogen atom, a C1-C10 alkyl group that may be substituted with a C1-C10 alkoxy group, or a C2-C10 alkenyl group, or A C2-C10 alkynyl group, a 2-oxo-oxazolidin-3-yl group, a [1,3] dioxolan-2-yl group, or a C1-C10 alkoxy group substituted with a morpholino group, or a 0 '-B'-group (a 0 'Represents a C1-C10 alkyl group which may be substituted with a halogen atom, and b' represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group. ), A nitro group, a cyano group, or an rO—CO— group (where r represents the same meaning as described above), or r 0 r 0 'N-group (r 0 And r 0 'Represents the same meaning as described above. ) Or r 0 CO—NH— group (r 0 Represents the same meaning as described above. ) Or r 0 r 0 'NCONH-group (r 0 And r 0 'Represents the same meaning as described above. ) Or rr′NCO— group (r and r ′ represent the same meaning as described above) or a hydroxyl group, q represents 0, 1, 2 or 3, and q is 2 or more. When Y a Are the same or different, and when q is 2 or more, adjacent Y a May be condensed with ring a to form a 2,3-dihydro-benzo [1,4] dioxin ring.
II. b '
Formula (V'-1)
[Where Q a R a —O— group {r a Is a hydrogen atom, a C1-C10 alkyl group, a C3-C10 alkenyl group, a C3-C10 alkynyl group, or r 0 r 0 'N-CH 2 -Group (r 0 And r 0 'Represents the same meaning as described above. ), ROCH 2 -Group (r represents the same meaning as described above), r 0 —CO— group (r 0 Represents the same meaning as described above. ), A C1-C10 alkoxycarbonyl group, a carboxy group, an aminocarbonyl group, a C1-C10 alkyl group substituted with a cyano group, or r 3 -R 1 -Group (r 3 Represents a phenyl group or a pyridyl group, and r 1 Represents the same meaning as described above. ). }, Or a piperidino group, or a morpholino group, or r 4 r 4 'N-group (r 4 And r 4 'Is the same or different and is a C2-C10 alkyl substituted with a hydrogen atom, a C1-C10 alkyl group, a C3-C10 alkenyl group, a C3-C10 alkynyl group, or a C1-C10 alkoxy group. Represents a group. However, it does not become a hydrogen atom at the same time. ) And W a Is an oxygen atom or -NT a -Group [T a R b -Group (r b R a Same as or different from r a Represents the same meaning as Or r 3 '-Group (r 3 'R 3 Same as or different from r 3 Represents the same meaning as ). ] And K a Represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group; a Represents a hydrogen atom or a C1-C10 alkyl group, and K a And L a And may form a C3-C10 alkylene group or a 1,3-butadienylene group. ]
A group represented by
Formula (V'-2)
[Where T a Represents the same meaning as described above, and L b Represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (V'-3)
[Where T a Represents the same meaning as described above, and L c Represents a C1-C10 alkyl group. ]
A group represented by
Formula (V'-4)
[Where T a Represents the same meaning as described above. ]
A group represented by
Formula (V'-5)
[Where T a Represents the same meaning as described above, and K b Represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (V'-6)
[Where W a Represents the same meaning as described above, and K c And L d And C3-C10 alkylene group or C4-C10 alkenylene group. ]
A group represented by
Formula (V'-7)
[Where Q a And W a Represents the same meaning as described above, and K d And L e Is -V a = V a '-V a '' = V a '''-Group (V a , V a ', V a '' And V a '''Is the same or different and represents a methine group or -N = group; a , V a ', V a '' And V a At least one of '''represents a -N = group. ). ]
A group represented by
Formula (V'-8)
[Where T a Represents the same meaning as above, Q b R a —O— group (r a Represents the same meaning as described above. ). ]
Or a group represented by
Formula (V-9 ')
[Where W a Represents the same meaning as described above. ]
Represents a group represented by
However, when a is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
12 An extracellular matrix gene transcription repressing composition comprising the compound according to any one of 2 to 6, 10 and 11 and an inert carrier.
13. 12. An extracellular matrix gene transcription repressing composition comprising the compound according to 5 or 11 above and an inert carrier.
14 10. Use of a cinnamoyl compound contained as an active ingredient in the composition according to 1 or 9 above as an active ingredient for suppressing transcription of an extracellular matrix gene.
15. 12. Use of the compound according to the above items 2 to 6, 10 and 11 as an active ingredient for suppressing transcription of an extracellular matrix gene.
16. Use of the compound according to 5 or 11 above as an active ingredient for suppressing transcription of an extracellular matrix gene.
17. It is contained as an active ingredient in the composition of the preceding paragraphs 1 and 9 as an active ingredient for improving tissue fibrosis by reducing the amount of extracellular matrix gene expression and reducing the amount of extracellular matrix accumulation. Use of cinnamoyl compounds.
18. 12. Use of the compound according to the above item 2-6, 10 or 11 as an active ingredient for improving tissue fibrosis by reducing the amount of extracellular matrix gene expression and reducing the amount of extracellular matrix accumulation.
19. 10. An improvement in tissue fibrosis, comprising administering an effective amount of a cinnamoyl compound contained as an active ingredient in the composition according to the above 1 and 9 to a mammalian patient in need of a treatment that improves tissue fibrosis. Method.
20. 12. A method for improving tissue fibrosis, comprising administering an effective amount of the compound described in the above item 2-6, 10 or 11 to a mammalian patient in need of treatment for improving tissue fibrosis.
21. A therapeutic agent for chronic renal failure, comprising a cinnamoyl compound contained as an active ingredient in the composition according to items 1 and 9, or a compound according to items 2 to 6, 10 and 11, and an inert carrier. .
22. Use of the cinnamoyl compound contained as an active ingredient in the composition of the preceding clause 1 and 9, or the compound of the preceding clause 2-6, 10 and 11 as an active ingredient for treating chronic renal failure.
23. An effective amount of the cinnamoyl compound contained as an active ingredient in the composition according to 1 or 9 above or the compound according to 2 to 6, 10 or 11 above to a mammalian patient in need of treatment for chronic renal failure. A method for treating chronic renal failure, comprising administering.
24. A therapeutic agent for heart failure, comprising a cinnamoyl compound contained as an active ingredient in the composition according to the above 1 or 9, or a compound according to the above 2 to 6, 10 and 11, and an inert carrier.
25. Use of the cinnamoyl compound contained as an active ingredient in the composition of the preceding clause 1 and 9, or the compound of the preceding clause 2-6, 10 and 11 as an active ingredient for treating heart failure.
26. An effective amount of the cinnamoyl compound contained as an active ingredient in the composition according to 1 or 9 above or the compound according to 2 to 6, 10 or 11 above is administered to a mammalian patient in need of therapeutic treatment for heart failure. A method for treating heart failure characterized by the above.
27. 10. A TGF-β action-suppressing composition comprising a cinnamoyl compound contained as an active ingredient in the composition according to the above 1 and 9 and an inert carrier.
28. 12. A TGF-β action-suppressing composition comprising the compound according to the above 2-6, 10 and 11 and an inert carrier.
29. Use of the cinnamoyl compound contained as an active ingredient in the composition of said 1 and 9 as an active ingredient for suppressing the effect | action of TGF- (beta).
30. 12. Use of the compound according to the above item 2 to 6, 10 and 11 as an active ingredient for suppressing the action of TGF-β.
31. 10. A hair nourishing composition comprising a cinnamoyl compound contained as an active ingredient in the composition according to the preceding item 1 or 9, or a compound according to the preceding item 2-6, 10 and 11, and an inert carrier.
32. It is contained as an active ingredient in the composition of the preceding paragraphs 1 and 9 as an active ingredient for obtaining a hair nourishing effect by inhibiting the promotion of the transition to the hair regression stage by TGF-β and leading to the extension of the hair growth stage. Cinnamoyl compound, or the use of a compound according to the preceding items 2-6, 10 and 11.
33. An effective amount of the cinnamoyl compound contained as an active ingredient in the composition according to the above 1 or 9 or the compound according to the above 2 to 6, 10 or 11 is administered to a mammalian patient in need of hair restoration treatment. A hair nourishing method characterized by:
Etc. are provided.
本発明により、組織における細胞外マトリックス遺伝子の発現量を減少させ、細胞外マトリックス蓄積量を低下させることにより、組織の線維化を改善させる組成物(即ち、細胞外マトリックス蓄積抑制剤や、線維症治療剤又は心不全治療剤)等の開発・提供が可能となる。 According to the present invention, a composition for improving tissue fibrosis by reducing the amount of extracellular matrix gene expression in a tissue and decreasing the amount of extracellular matrix accumulation (ie, an extracellular matrix accumulation inhibitor, fibrosis) Development or provision of therapeutic agents or therapeutic agents for heart failure).
以下、本発明を詳細に説明する。
本発明において、アルキル基、ハロアルキル基、アルコキシ基、アルコキシカルボニル基、アルキルチオ基、アルキルスルフィニル基、アルキルスルホニル基及びアルキレン基における飽和炭化水素基は、分枝していてもよく、またその炭素原子の一部又は全部で環を形成してもよく、アルケニル基、アルケニルオキシ基、アルキニル基、アルキニルオキシ基、アルケニレン基及びアルキニレン基における不飽和炭化水素基は、分枝をもっていてもよく、またその炭素原子の一部又は全部で環を形成してもよく、その不飽和結合数は単数又は複数である。
本発明において、アルキル基としては、例えば、メチル基、エチル基、イソプロピル基、シクロヘキシル基、シクロプロピルメチル基等があげられ、ハロアルキル基としては、例えば、2,2,2−トリフルオロエチル基等があげられ、アルコキシ基としては、例えば、メトキシ基、エトキシ基、シクロペンチルオキシ基、2−シクロヘキシルエトキシ等があげられ、アルキルチオ基としては、例えば、メチルチオ基等があげられ、アルキルスルフィニル基としては、例えば、メチルスルフィニル基等があげられ、アルキルスルホニル基としては、例えば、メチルスルホニル基等があげられ、アルキレン基としては、例えば、メチレン基、エチルエチレン基、1,4−シクロヘキシレン基等があげられ、、アルケニル基としては、例えば、ビニル基、2−プロペニル基、3−メチル−2−ブテニル基、1,3−ブタジエニル基、3−シクロヘキセニル基等があげられ、アルキニル基としては、例えば、エチニル基、2−プロピニル基、2−ペンテン−4−イニル基等があげられ、アルケニレン基としては、例えば、ビニレン基、プロペニレン、1,3−ブタジエニレン基等があげられ、アルキニレン基としては、例えば、エチニレン基、プロピニレン基等があげられる。
本発明において、ハロゲン原子としては、フッ素原子、塩素原子、臭素原子及びヨウ素原子があげられる。
本発明において、ピリジル基は、2−ピリジル基、3−ピリジル基及び4−ピリジル基を含み、フリル基は、2−フリル基及び3−フリル基を含み、チエニル基は、2−チエニル基及び3−チエニル基を含み、ナフチル基は、1−ナフチル基及び2−ナフチル基を含む。
Hereinafter, the present invention will be described in detail.
In the present invention, the saturated hydrocarbon group in the alkyl group, haloalkyl group, alkoxy group, alkoxycarbonyl group, alkylthio group, alkylsulfinyl group, alkylsulfonyl group and alkylene group may be branched, and The unsaturated hydrocarbon group in the alkenyl group, alkenyloxy group, alkynyl group, alkynyloxy group, alkenylene group and alkynylene group may have a branch, and the carbon thereof may form a ring partially or entirely. A part or all of the atoms may form a ring, and the number of unsaturated bonds is one or more.
In the present invention, examples of the alkyl group include a methyl group, an ethyl group, an isopropyl group, a cyclohexyl group, and a cyclopropylmethyl group. Examples of the haloalkyl group include a 2,2,2-trifluoroethyl group. Examples of the alkoxy group include a methoxy group, an ethoxy group, a cyclopentyloxy group, 2-cyclohexylethoxy, and the like. Examples of the alkylthio group include a methylthio group. Examples of the alkylsulfinyl group include: For example, a methylsulfinyl group and the like can be mentioned. Examples of the alkylsulfonyl group include a methylsulfonyl group. Examples of the alkylene group include a methylene group, an ethylethylene group, and a 1,4-cyclohexylene group. As the alkenyl group, for example, bi Group, 2-propenyl group, 3-methyl-2-butenyl group, 1,3-butadienyl group, 3-cyclohexenyl group and the like. Examples of the alkynyl group include ethynyl group, 2-propynyl group, 2 -Pentene-4-ynyl group and the like, examples of the alkenylene group include vinylene group, propenylene, 1,3-butadienylene group, and examples of the alkynylene group include ethynylene group and propynylene group. It is done.
In the present invention, examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
In the present invention, the pyridyl group includes a 2-pyridyl group, a 3-pyridyl group and a 4-pyridyl group, the furyl group includes a 2-furyl group and a 3-furyl group, the thienyl group includes a 2-thienyl group and It includes a 3-thienyl group, and the naphthyl group includes a 1-naphthyl group and a 2-naphthyl group.
式(I)、(II)、(III)、(IV)、(V)、(I’)及び(II’)で示されるシンナモイル化合物(以下、各々、化合物(I)、(II)、(III)、(IV)、(V)、(I’)及び(II’)と記すこともある)において、α環、A0環、A環及びa環が窒素原子を2以上有する芳香族6員環の場合は、そのN−オキシドも含む。
化合物(I)〜(V)、(I’)及び(II’)のα環、A0環、A環及びa環において、芳香族5員環としては、例えば、チオフェン環、フラン環、ピロール環、イミダゾール環、ピラゾール環、1,2,3−トリアゾール環、1,2,4−トリアゾール環、テトラゾール環、オキサゾール環、イソオキサゾール環、チアゾール環、イソチアゾール環、フラザン環、1,2,5−チアジアゾール環等があげられ、窒素原子を2以上有する芳香族6員環としては、例えば、ピリダジン環、ピリミジン環、ピラジン環、1,3,5−トリアジン環、1,2,4−トリアジン環等があげられる。
Cinnamoyl compounds represented by formulas (I), (II), (III), (IV), (V), (I ′) and (II ′) (hereinafter referred to as compounds (I), (II), ( (III), (IV), (V), (I ′) and (II ′)), the α ring, the A0 ring, the A ring and the a ring have 6 or more aromatic nitrogen atoms. In the case of a ring, the N-oxide is also included.
In the α ring, A0 ring, A ring and a ring of the compounds (I) to (V), (I ′) and (II ′), examples of the aromatic 5-membered ring include a thiophene ring, a furan ring and a pyrrole ring. Imidazole ring, pyrazole ring, 1,2,3-triazole ring, 1,2,4-triazole ring, tetrazole ring, oxazole ring, isoxazole ring, thiazole ring, isothiazole ring, furazane ring, 1,2,5 -Thiadiazole ring and the like, and examples of the aromatic 6-membered ring having two or more nitrogen atoms include pyridazine ring, pyrimidine ring, pyrazine ring, 1,3,5-triazine ring, 1,2,4-triazine ring Etc.
式(I)〜(VI)、(I’)、(II’)及び(V’)で示されるシンナモイル化合物(以下、化合物(I)〜(VI)、(I’)、(II’)及び(V’)と記すこともある)は、それらの薬理学上許容されうる塩も、同時に表す。薬理学上許容されうる塩とは、化合物(I)〜(VI)、(I’)、(II’)及び(V’)(以下、本発明化合物と記すこともある)の、無機酸との塩、有機酸との塩、無機塩基との塩又は有機塩基との塩を表す。無機酸との塩とは、例えば、塩酸塩、臭化水素酸塩等があげられ、有機酸との塩とは、例えば、酢酸塩、安息香酸塩等があげられ、無機塩基との塩とは、例えば、カリウム塩、ナトリウム塩等があげられ、有機塩基との塩とは、例えば、ピリジン塩、モルホリン塩等があげられる。 Cinnamoyl compounds represented by the formulas (I) to (VI), (I ′), (II ′) and (V ′) (hereinafter, compounds (I) to (VI), (I ′), (II ′) and (Sometimes referred to as (V ′)) also represents their pharmacologically acceptable salts. The pharmacologically acceptable salt is an inorganic acid of the compounds (I) to (VI), (I ′), (II ′) and (V ′) (hereinafter sometimes referred to as the compound of the present invention). A salt with an organic acid, a salt with an inorganic base, or a salt with an organic base. Examples of the salt with an inorganic acid include hydrochloride and hydrobromide. Examples of the salt with an organic acid include acetate and benzoate. Examples include potassium salts and sodium salts, and examples of salts with organic bases include pyridine salts and morpholine salts.
化合物(III)におけるXA0、YA0、QA0、KA0、LA0及びTA0は、互いに独立に、D1、D2、D3,D4,D5、R0、R0’、R0’’、R1、R1’、R1’’、R2、R2’、R3、R4、R4’、R5、R6、A1、A2、A3、A4、A5、A6、A7、A7’、A7’’、A8、A8’、A9、A9’、A9’’、A10、A10’、A11、B、B’、B0、B1、B1’、B2、B2’、B3、B3’、B4、B4’、B5、B6、(a0)、(b0)、(c0)、(d0)、(e0)、Ma、Ma’、Ma’’、Ma’’’、Ma’’’’、Mb0、Mc0、Md0、Ra0、Rb、Rc、Rd、Rd’、Re、Re’、Re’’、Re’’’、Ba、Bb、Bc、Ya、Ya’、Yb、Yb’、Yb’’、Yc及びYc’で表される基、及び、k、k’、l、m、m’、n及びn’で表される整数によって表される。
化合物(IV)におけるXA、YA、QA、KA、LA及びTAは、互いに独立に、D1、D2、D3,D4,D5、R0、R0’、R0’’、R1、R1’、R1’’、R2、R2’、R3、R4、R4’、R5、R6、A1、A2、A3、A4、A5、A6、A7、A7’、A7’’、A8、A8’、A9、A9’、A9’’、A10、A10’、A11、B、B’、B0、B1、B1’、B2、B2’、B3、B3’、B4、B4’、B5、B6、(a)、(b)、(c)、(d)、(e)、Ma、Ma’、Ma’’、Ma’’’、Ma’’’’、Mb、Mc、Md、Ra、Rb、Rc、Rd、Rd’、Re、Re’、Re’’、Re’’’、Ba、Bb、Bc、Ya、Ya’、Yb、Yb’、Yb’’、Yc及びYc’で表される基、及び、k、k’、l、m、m’、n及びn’で表される整数によって表される。
化合物(V)及び(V’)におけるXa、Ya、qa及びtaは、互いに独立に、a0、a0’、a1、a1’、a2、a3、a4、a5、b、b’、r、r’、r0、r0’、r1、r1’、r2、r3、r3’、r4、r4’、ra、rb、y及びzで表される基、及び、lで表される整数によって表される。
X A0 , Y A0 , Q A0 , K A0 , L A0 and T A0 in the compound (III) are each independently D 1 , D 2 , D 3 , D 4 , D 5 , R 0 , R 0 ′, R 0 '', R 1, R 1 ', R 1'', R 2, R 2', R 3, R 4, R 4 ', R 5, R 6, A 1, A 2, A 3, A 4 , A 5 , A 6 , A 7 , A 7 ′, A 7 ″, A 8 , A 8 ′, A 9 , A 9 ′, A 9 ″, A 10 , A 10 ′, A 11 , B , B ′, B 0 , B 1 , B 1 ′, B 2 , B 2 ′, B 3 , B 3 ′, B 4 , B 4 ′, B 5 , B 6 , (a 0 ), (b 0 ) , (C 0 ), (d 0 ), (e 0 ), M a , M a ′, M a ″, M a ″ ″, M a ″ ″, M b0 , M c0 , M d0 , R a0, R b, R c , R d, R d ', R e, R e', R e '', R e ''', B a, B b B c, Y a, Y a ', Y b, Y b', Y b ' groups represented by', Y c and Y c ', and, k, k', l, m, m ', n and It is represented by an integer represented by n ′.
In the compound (IV), X A , Y A , Q A , K A , L A and T A are independently of each other, D 1 , D 2 , D 3 , D 4 , D 5 , R 0 , R 0 ′, R 0 '', R 1, R 1 ', R 1'', R 2, R 2', R 3, R 4, R 4 ', R 5, R 6, A 1, A 2, A 3, A 4 , A 5 , A 6 , A 7 , A 7 ′, A 7 ″, A 8 , A 8 ′, A 9 , A 9 ′, A 9 ″, A 10 , A 10 ′, A 11 , B , B ′, B 0 , B 1 , B 1 ′, B 2 , B 2 ′, B 3 , B 3 ′, B 4 , B 4 ′, B 5 , B 6 , (a), (b), ( c), (d), (e), M a , M a ′, M a ″, M a ″ ″, M a ″ ″, M b , M c , M d , R a , R b , R c , R d , R d ′, R e , R e ′, R e ″, R e ′ ″, B a , B b , B c , Y a , Y a ′, Y b , Y b ' , Y b ″, Y c and Y c ′, and integers represented by k, k ′, l, m, m ′, n and n ′.
Compound (V) and (V ') X a in, Y a, q a and t a are, independently of one another, a 0, a 0', a 1, a 1 ', a 2, a 3, a 4, a 5 , b, b ′, r, r ′, r 0 , r 0 ′, r 1 , r 1 ′, r 2 , r 3 , r 3 ′, r 4 , r 4 ′, r a , r b , It is represented by a group represented by y and z and an integer represented by l.
化合物(I)、(II)、(I’)及び(II’)のYαのとりうる置換基Y0群において、「6−10員環のアリール基」とは、単環又は縮合環の芳香族炭化水素環をなす基を表し、例えば、フェニル基、1−ナフチル基、2−ナフチル基、6−インダニル基等があげられ、「5−10員環のヘテロアリール基」とは、単環又は縮合環の芳香族複素環をなす基を表し、例えば、2−フリル基、3−フリル基、2−チエニル基、3−チエニル基2−ピリジル基、3−ピリジル基、4−ピリジル基、2−キノリル基等があげられ、「不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基」とは、単環又は縮合環を含み、2−シクロヘキセニル基、2−モルホリニル基、4−ピペリジル基等があげられ、これらは単数又は同一又は相異なる複数の前記のMa−基で置換されてもよい。
化合物(I)及び(II)のYαのとりうる置換基Z0群において、「A環と縮環する基」は、ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基から選ばれる、単数又は同一又は相異なる複数の原子又は基を有してもよい。
化合物(III)のXA0のとりうる置換基E0群のRa0において、「置換されてもよい5−7員環のアリール基又はヘテロアリール基」とは、単環又は縮合環の芳香族炭化水素環をなす基又は単環又は縮合環の芳香族複素環をなす基を表し、例えば、フェニル基、1−ナフチル基、2−ナフチル基、6−インダニル基、2−フリル基、3−フリル基、2−チエニル基、3−チエニル基、2−ピリジル基、3−ピリジル基、4−ピリジル基、2−キノリル基等があげられ、これらは単数又は同一又は相異なる複数の前記のMa−基で置換されてもよい。
In the group Y 0 that Y α of compounds (I), (II), (I ′) and (II ′) can take, “6- to 10-membered aryl group” means a monocyclic or condensed ring Represents a group that forms an aromatic hydrocarbon ring, and includes, for example, a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 6-indanyl group, and the like. Represents a group forming a ring or condensed aromatic heterocycle, for example, 2-furyl group, 3-furyl group, 2-thienyl group, 3-thienyl group 2-pyridyl group, 3-pyridyl group, 4-pyridyl group , 2-quinolyl group, etc., and “the group that forms a 3-10 membered hydrocarbon ring or heterocyclic ring that may contain an unsaturated bond” includes a monocyclic ring or a condensed ring, and includes a 2-cyclohexenyl group , 2-morpholinyl group, 4-piperidyl group, etc., which are singular or the same or phase Comprising a plurality of said M a - may be substituted with group.
In the group Z 0 of possible substituents of Y α in the compounds (I) and (II), the “group condensed with the A ring” is a halogen atom, a C1-C10 alkoxy group, a C3-C10 alkenyloxy group, a C3- A C10 alkynyloxy group, a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a sulfinyl group or a sulfonyl group may have a single atom, or the same or different plural atoms or groups.
In the R a0 group of the substituent E 0 group that can be taken by X A0 of the compound (III), the “ optionally substituted 5- to 7-membered aryl group or heteroaryl group” means a monocyclic or condensed aromatic ring Represents a group forming a hydrocarbon ring or a group forming a monocyclic or condensed aromatic heterocyclic ring, such as a phenyl group, 1-naphthyl group, 2-naphthyl group, 6-indanyl group, 2-furyl group, 3- A furyl group, a 2-thienyl group, a 3-thienyl group, a 2-pyridyl group, a 3-pyridyl group, a 4-pyridyl group, a 2-quinolyl group, and the like. These include one or a plurality of the same or different Ms. It may be substituted with a group.
化合物(I)、(II)、(III)、(I’)及び(II’)の、Yα及びYA0のとりうる置換基Y0群の(d0)において、「カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす」は、炭素原子の一つ又は複数が、カルボニル基又はチオカルボニル基で置き換えられ、更に、炭素原子の一つ又は複数が、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基から選ばれた、単数又は同一又は相異なる複数の基で置き換えられてもよい5−12員の炭化水素環をなすことを表す。
化合物(I)、(II)、(III)、(I’)及び(II’)の、Yα及びYA0のとりうる置換基Y0群の(e0)において、「カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。」とは、炭素原子の一つ又は複数が、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基から選ばれた、単数又は同一又は相異なる複数の基で置き換えられてもよい5−12員の炭化水素環をなすことを表す。
In the compound (I), (II), (III), (I ′) and (II ′) (d 0 ) of the substituent Y 0 group that Y α and Y A0 can take, “carbonyl group or thiocarbonyl” A 5- to 12-membered carbon atom which may be further substituted with an oxy group, a thio group, an —NR 1 — group (R 1 represents the same meaning as described above), a sulfinyl group or a sulfonyl group. In the “forming a hydrogen ring”, one or more of carbon atoms are replaced with a carbonyl group or a thiocarbonyl group, and one or more of carbon atoms are replaced with an oxy group, a thio group, a —NR 1 — group (R 1 represents the same meaning as described above), and forms a 5- to 12-membered hydrocarbon ring which may be replaced with a single group or a plurality of the same or different groups selected from a sulfinyl group or a sulfonyl group. To express.
In the compounds (I), (II), (III), (I ′) and (II ′) (e 0 ) in the group Y 0 which Y α and Y A0 can take, “carbonyl group, thiocarbonyl” It forms a 5- to 12-membered hydrocarbon ring which may be substituted with a group, an oxy group, a thio group, an —NR 1 — group (R 1 represents the same meaning as described above), a sulfinyl group or a sulfonyl group. "Means that one or more of the carbon atoms are a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a -NR 1 -group (R 1 is as defined above), a sulfinyl group or a sulfonyl group. It represents forming a 5- to 12-membered hydrocarbon ring which may be replaced by a single group or a plurality of the same or different groups selected from the group.
化合物(IV)の、XAのとりうる置換基B群の(a)において、「オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)で置換されてもよいC2-C10アルキレン基」とは、炭素原子の一つ又は複数が、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)から選ばれた、単数又は同一又は相異なる複数の基で置き換えられてもよいC2-C10アルキレン基を表し、また「オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)で置換されてもよいC3-C10アルケニレン基」とは、炭素原子の一つ又は複数が、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)から選ばれた、単数又は同一又は相異なる複数の基で置き換えられてもよいC3-C10アルケニレン基を表す。
化合物(IV)の、XAのとりうる置換基D群の(b)において、「メチル基、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキレン基」とは、炭素原子の一つ又は複数がメチル基で置換されてもよい、又は、炭素原子の一つ又は複数が、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)から選ばれた、単数又は同一又は相異なる複数の基で置き換えられてもよいC2-C10アルキレン基を表し、「メチル基、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)で置換されてもよいC2-C10アルケニレン基」とは、炭素原子の一つ又は複数がメチル基で置換されてもよい、又は、炭素原子の一つ又は複数が、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)から選ばれた、単数又は同一又は相異なる複数の基で置き換えられてもよいC2-C10アルケニレン基を表す。
In the group (a) of the substituent B group that X A can take in the compound (IV), “oxy group, thio group, sulfinyl group, sulfonyl group or —NR 1 ′ -group (R 1 ′ is the same as defined above. . meaning representative of the may also be C2-C10 alkylene group "is substituted with) one or more carbon atoms, oxy, thio, sulfinyl group, a sulfonyl group or a -NR 1 '- group (R 1 'Represents the same meaning as described above), and represents a C2-C10 alkylene group which may be replaced by a single group or a plurality of groups which are the same or different from each other, and “oxy group, thio group, sulfinyl group” , A sulfonyl group or a —NR 1 ′ -group (R 1 ′ represents the same meaning as described above), and “a C3-C10 alkenylene group which may be substituted” means that one or more carbon atoms are oxy Group, thio group, sulfinyl group, sulfonyl group -NR 1 '- group (R 1', the a represents the same meaning.) Represents a member selected from, one or the same or different plural may be replaced with a group C3-C10 alkenylene group.
The compounds of (IV), the substituent D group can take X A (b), the "methylated group, oxy group, a thio group, a sulfinyl group, a sulfonyl group or an -NR 1 - group (R 1, the same The C1-C10 alkylene group optionally substituted with a) represents that one or more carbon atoms may be substituted with a methyl group, or one or more carbon atoms may be substituted with oxy The group may be replaced with a single group or a plurality of the same or different groups selected from a group, a thio group, a sulfinyl group, a sulfonyl group, or a —NR 1 — group (R 1 represents the same meaning as described above). Represents a C2-C10 alkylene group, and may be substituted with a methyl group, an oxy group, a thio group, a sulfinyl group, a sulfonyl group, or a —NR 1 — group (where R 1 represents the same meaning as described above). -C10 alkenylene group means a carbon atom One or more may be substituted by a methyl group, or one or more carbon atoms, oxy, thio, sulfinyl group, a sulfonyl group or an -NR 1 - group (R 1 is the same as the Represents a C2-C10 alkenylene group which may be replaced by a single group or a plurality of the same or different groups selected from.
化合物(I)、(II)、(I’)及び(II’)のYαのとりうるX0群、Y0群及びZ0群に属する基を、各々,下記の表23、表24及び表25〜26に例示する。
化合物(III)のXA0のとりうるA0群、B0群、C0群、D0群、E0群、F0群、G0群、H0群、I0群、J0群、K0群、L0群、M0群及びN0群に属する基を、、各々,下記の表1、表2、表3、表4、表5〜7、表8〜11、表12〜15、表16、表17、表18、表19、表20、表21及び表22に例示し、YA0のとりうるX0群、Y0群及びZ0群に属する基を、各々,下記の表23、表24及び表25〜26に例示し、QA0及びTA0を、各々,下記の表27〜表28及び表29に例示する。
化合物(IV)のXAのとりうるA群、B群、C群、D群、E群、F群、G群、H群、I群、J群、K群、L群、M群及びN群に属する基を、、各々,下記の表1、表2、表3、表4、表5〜7、表8〜11、表12〜15、表16、表17、表18、表19、表20、表21及び表22に例示し、YAのとりうるX群、Y群及びZ群に属する基を、各々,下記の表23、表24及び表25〜26に例示し、QA及びTAを、各々,下記の表27〜表28及び表29に例示する。
In the compounds (I), (II), (I ′) and (II ′), the groups belonging to the X 0 group, the Y 0 group and the Z 0 group which Y α can take are shown in the following Table 23, Table 24 and Examples are shown in Tables 25-26.
A 0 group, B 0 group, C 0 group, D 0 group, E 0 group, F 0 group, G 0 group, H 0 group, I 0 group, J 0 group that X A0 of compound (III) can take, The groups belonging to the K 0 group, the L 0 group, the M 0 group, and the N 0 group are represented by the following Table 1, Table 2, Table 3, Table 4, Tables 5 to 7, Tables 8 to 11, and Tables 12 to 12, respectively. 15, Table 16, Table 17, Table 18, Table 19, Table 20, illustrated in Table 21 and Table 22, X 0 group can take Y A0, belonging group Y 0 group and Z 0 group, respectively, the following Table 23, Table 24, and Tables 25 to 26 are exemplified, and Q A0 and T A0 are exemplified in the following Tables 27 to 28 and Table 29, respectively.
A, B, C, D, E, F, G, H, I, J, K, L, M, and N of Compound (IV) X A The groups belonging to the groups are respectively shown in Table 1, Table 2, Table 3, Table 4, Table 5 to 7, Table 8 to 11, Table 12 to 15, Table 16, Table 17, Table 18, Table 19, Examples exemplified in Table 20, Table 21 and Table 22 and groups belonging to the X group, Y group and Z group that Y A can take are exemplified in the following Table 23, Table 24 and Tables 25 to 26, respectively, and Q A and T a, respectively, illustrated in Table 27 to Table 28 and Table 29 below.
前記の、A0群〜N0群及びA群〜N群に属する基を、以下の表1〜表22に例示するが、幾何異性が可能な基の場合はその全ての幾何異性体を意味し、互変異性が可能な基の場合はその全ての互変異性体を意味する。
A0群及びA群に属する基を、表1に例示する。
The groups belonging to the groups A 0 to N 0 and groups A to N are exemplified in the following Tables 1 to 22. However, in the case of groups capable of geometric isomerism, all the geometric isomers are meant. In the case of a group capable of tautomerization, all tautomers thereof are meant.
Table 1 shows examples of groups belonging to the A0 group and the A group.
B0群及びB群に属する基を、表2に例示する。
Table 2 shows examples of groups belonging to the B0 group and the B group.
C0群及びC群に属する基を、表3に例示する。
Table 3 shows the groups belonging to the C0 group and the C group.
D0群及びD群に属する基を、表4に例示する。
Table 4 shows the groups belonging to the D0 group and the D group.
E0群及びE群に属する基を、表5〜表7に例示する。
Belonging group E 0 group and E group, exemplified in Tables 5 to 7.
F0群及びF群に属する基を、表8〜表11に例示する。
Belonging group F 0 group and F group, exemplified in Tables 8 to 11.
G0群及びG群に属する基を、表12〜表15に例示する。
The group belonging to G 0 group and G group, are illustrated in Table 12 to Table 15.
H0群及びH群に属する基を、表16に例示する。
Belonging group H 0 group and H group, exemplified in Table 16.
I0群及びI群に属する基を、表17に例示する。
Table 17 illustrates the groups belonging to the I0 group and the I group.
J0群及びJ群に属する基を、表18に例示する。
Table 18 shows the groups belonging to the J0 group and the J group.
K0群及びK群に属する基を、表19に例示する。
Table 19 shows the groups belonging to the K0 group and the K group.
L0群及びL群に属する基を、表20に例示する。
Table 20 shows groups belonging to the L0 group and the L group.
M0群及びM群に属する基を、表21に例示する。
Table 21 shows the groups belonging to the M0 group and the M group.
N0群及びN群に属する基を、表22に例示する。
Table 22 shows the groups belonging to the N0 group and the N group.
前記の、X0群〜Z0群及びX群〜Z群に属する基を、以下の表23〜表25に例示するが、幾何異性が可能な基の場合はその全ての幾何異性体を意味し、互変異性が可能な基の場合はその全ての互変異性体を意味する。
X0群及びX群に属する基を、表23に例示する。
Said, the group belonging to X 0 group ~Z 0 group and X groups ~Z group will be illustrated in the following table 23 to table 25, in the case of geometric isomerism group capable meaning that all geometric isomers In the case of a group capable of tautomerization, all tautomers thereof are meant.
Table 23 shows the groups belonging to the X0 group and the X group.
Y0群及びY群に属する基を、表24に例示する。
Belonging group Y 0 group and Y group is exemplified in table 24.
Z0群又はZ群と縮環したα環、A0環又はA環を、表25〜表26に例示する。
Table 25 to Table 26 illustrate α ring, A0 ring or A ring condensed with Z 0 group or Z group.
QA0及びQAを、表27〜表28に例示する。 Q A0 and Q A are exemplified in Table 27 to Table 28.
TA0及びTAを、表29に例示する。
T A0 and T A are illustrated in Table 29.
化合物(II)として、例えば、βが式(II-1)、式(II-7)又は式(II-8)で示される基の場合があげられ、具体的には、式(II'')
[式中、α''は、芳香族5員環を表し、Xαは、前記と同一の意味を表し、xは、メチン基、酸素原子、硫黄原子、−N=基又は1個のメチル基で置換されてもよいイミノ基を表し、β''は、
式(II''-1)
(式中、Tα、Kα及びLαは、前記と同一の意味を表す。)
で示される基、
式(II''-7)
(式中、Tαは、前記と同一の意味を表す。)
で示される基、又は、
式(II''-8)
(式中、Lγは、前記と同一の意味を表す。)
で示される基を表す。]
で示されるシンナモイル化合物があげられる。シンナモイル化合物(II'')において、xがメチン基の場合、xは置換基を有さない。
更に具体的には、シンナモイル化合物(II'')において、α''がチオフェン環の場合があげられる。
より具体的には、シンナモイル化合物(II'')において、α''がチオフェン環であり、β''が基(II''-1)であって、Tαがメチル基であって、Kαが、水素原子であって、Lαが、メチル基である場合があげられる。
また具体的には、シンナモイル化合物(II'')において、α''がチオフェン環であり、β''が基(II''-7)であって、Tαがメチル基である場合があげられる。
一層具体的には、シンナモイル化合物(II'')において、α''がチオフェン環であり、β''が基(II''-8)であって、Lγがメチル基である場合があげられる。
Examples of the compound (II) include a case where β is a group represented by the formula (II-1), the formula (II-7) or the formula (II-8). )
[Wherein α ″ represents an aromatic 5-membered ring, X α represents the same meaning as described above, and x represents a methine group, an oxygen atom, a sulfur atom, —N = group or one methyl group. Represents an imino group which may be substituted with a group, β ''
Formula (II ''-1)
(In the formula, T α , K α and L α represent the same meaning as described above.)
A group represented by
Formula (II ''-7)
(In the formula, T α represents the same meaning as described above.)
Or a group represented by
Formula (II ''-8)
(Wherein L γ represents the same meaning as described above.)
Represents a group represented by ]
The cinnamoyl compound shown by these is mention | raise | lifted. In the cinnamoyl compound (II ″), when x is a methine group, x has no substituent.
More specifically, in the cinnamoyl compound (II ″), α ″ is a thiophene ring.
More specifically, in the cinnamoyl compound (II ″), α ″ is a thiophene ring, β ″ is a group (II ″ -1), T α is a methyl group, and K Examples include a case where α is a hydrogen atom and L α is a methyl group.
More specifically, in the cinnamoyl compound (II ″), α ″ is a thiophene ring, β ″ is a group (II ″ -7), and T α is a methyl group. It is done.
More specifically, in the cinnamoyl compound (II ″), α ″ is a thiophene ring, β ″ is a group (II ″ -8), and L γ is a methyl group. It is done.
化合物(III)として、例えば、B0が式(III-1)、式(III-7)又は式(III-8)で示される基の場合があげられ、具体的には、式(III’)
[式中、A0'は、芳香族5員環を表し、XAO及びxは、前記と同一の意味を表し、B0'は、式(III'-1)
(式中、TAO、KAO及びLAOは、前記と同一の意味を表す。)
で示される基、
式(III'-7)
(式中、TAOは、前記と同一の意味を表す。)
で示される基、又は、
式(III'-8)
(式中、LC0は、前記と同一の意味を表す。)
で示される基を表す。]
で示されるシンナモイル化合物があげられる。シンナモイル化合物(III’)において、xがメチン基の場合、xは置換基を有さない。
更に具体的には、シンナモイル化合物(III’)において、A0'がチオフェン環の場合があげられる。
より具体的には、シンナモイル化合物(III')において、A0'がチオフェン環であり、B0'が基(III'-1)であって、TAOがメチル基であって、KAOが、水素原子であって、LAOが、メチル基である場合があげられる。
また具体的には、シンナモイル化合物(III')において、A0'がチオフェン環であり、B0'が基(III'-7)であって、TAOがメチル基である場合があげられる。
一層具体的には、シンナモイル化合物(III')において、α''がチオフェン環であり、β''が基(III'-8)であって、LCOがメチル基である場合があげられる。
Examples of the compound (III) include a case where B0 is a group represented by the formula (III-1), the formula (III-7) or the formula (III-8), specifically, the formula (III ′)
[Wherein, A0 ′ represents an aromatic 5-membered ring, X AO and x represent the same meaning as described above, and B0 ′ represents the formula (III′-1)
(In the formula, T AO , K AO and L AO represent the same meaning as described above.)
A group represented by
Formula (III'-7)
(In the formula, T AO represents the same meaning as described above.)
Or a group represented by
Formula (III'-8)
(Wherein L C0 represents the same meaning as described above.)
Represents a group represented by ]
The cinnamoyl compound shown by these is mention | raise | lifted. In the cinnamoyl compound (III ′), when x is a methine group, x has no substituent.
More specifically, in the cinnamoyl compound (III ′), A0 ′ is a thiophene ring.
More specifically, in the cinnamoyl compound (III ′), A0 ′ is a thiophene ring, B0 ′ is a group (III′-1), T AO is a methyl group, and K AO is hydrogen. An example is an atom in which L AO is a methyl group.
Further Specifically, 'in, A0 cinnamoyl compound (III)' is a thiophene ring, B0 'is a group (III'-7), if T AO is a methyl group.
More specifically, in the cinnamoyl compound (III ′), α ″ is a thiophene ring, β ″ is a group (III′-8), and L 2 CO is a methyl group.
化合物(IV)として、例えば、Bが式(IV-1)、式(IV-7)又は式(IV-8)で示される基の場合があげられ、具体的には、式(IV’)
[式中、A’は、芳香族5員環を表し、XA及びxは、前記と同一の意味を表し、B’は、式(IV'-1)
(式中、TA、KA及びLAは、前記と同一の意味を表す。)
で示される基、
式(IV'-7)
(式中、TAは、前記と同一の意味を表す。)
で示される基、又は、
式(IV'-8)
(式中、LCは、前記と同一の意味を表す。)
で示される基を表す。]
で示されるシンナモイル化合物があげられる。シンナモイル化合物(IV’)において、xがメチン基の場合、xは置換基を有さない。
更に具体的には、シンナモイル化合物(IV’)において、A’がチオフェン環である場合があげられる。
より具体的には、シンナモイル化合物(IV')において、A’がチオフェン環であり、B’が基(IV'-1)であって、TAがメチル基であって、KAが、水素原子であって、LAが、メチル基である場合があげられる。
また具体的には、シンナモイル化合物(IV')において、A’がチオフェン環であり、B'が基(IV'-7)であって、TAがメチル基である場合があげられる。
一層具体的には、シンナモイル化合物(IV')において、A’がチオフェン環であり、B'が基(III'-8)であって、LCがメチル基である場合があげられる。
Examples of the compound (IV) include a case where B is a group represented by the formula (IV-1), formula (IV-7) or formula (IV-8), specifically, the formula (IV ′)
[Wherein, A ′ represents an aromatic 5-membered ring, X A and x represent the same meaning as described above, and B ′ represents the formula (IV′-1)
(In the formula, T A , K A and L A represent the same meaning as described above.)
A group represented by
Formula (IV'-7)
(Wherein, T A represents the same meaning as above.)
Or a group represented by
Formula (IV'-8)
(Wherein L C represents the same meaning as described above.)
Represents a group represented by ]
The cinnamoyl compound shown by these is mention | raise | lifted. In the cinnamoyl compound (IV ′), when x is a methine group, x has no substituent.
More specifically, in the cinnamoyl compound (IV ′), A ′ is a thiophene ring.
More specifically, 'in, A cinnamoyl compound (IV)' is a thiophene ring, B 'is a group (IV'-1), T A is a methyl group, K A is hydrogen an atomic, L a may be mentioned be a methyl group.
More specifically, in the cinnamoyl compound (IV ′), A ′ is a thiophene ring, B ′ is a group (IV′-7), and T A is a methyl group.
In more specifically, 'in, A cinnamoyl compound (IV)' is a thiophene ring, B 'is a group (III'-8), if L C is a methyl group.
化合物(V)として、例えば、bが式(V-1)、式(V-7)又は式(V-8)で示される基の場合があげられ、具体的には、式(V'')
[式中、a''は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa及びxは、前記と同一の意味を表し、b''は、式(V''-1)
(式中、Ta、Ka及びLaは、前記と同一の意味を表す。)
で示される基、
式(V''-7)
(式中、Taは、前記と同一の意味を表す。)
で示される基、又は、
式(V''-8)
(式中、Lcは、前記と同一の意味を表す。)
で示される基を表す。]
で示されるシンナモイル化合物があげられる。
更に具体的には、シンナモイル化合物(V'')において、a''がチオフェン環である場合があげられる。
より具体的には、シンナモイル化合物(V'')において、a''がチオフェン環であり、b''が基(V''-1)であって、Taがメチル基であって、Kaが、水素原子であって、Laが、メチル基である場合があげられる。
また具体的には、シンナモイル化合物(V'')において、a''がチオフェン環であり、b''が基(V''-7)であって、Taがメチル基である場合があげられる。
一層具体的には、シンナモイル化合物(V'')において、a''がチオフェン環であり、b''が基(V''-8)であって、Lcがメチル基である場合があげられる。
Examples of the compound (V) include the case where b is a group represented by the formula (V-1), the formula (V-7) or the formula (V-8). )
[Wherein a ″ represents a thiophene ring, a furan ring, a pyrrole ring or a thiazole ring, X a and x represent the same meaning as described above, and b ″ represents a formula (V ″ -1)
(In the formula, T a , K a and L a represent the same meaning as described above.)
A group represented by
Formula (V ''-7)
(Wherein, T a represents the same meaning as above.)
Or a group represented by
Formula (V ''-8)
(Wherein L c represents the same meaning as described above.)
Represents a group represented by ]
The cinnamoyl compound shown by these is mention | raise | lifted.
More specifically, in the cinnamoyl compound (V ″), a ″ is a thiophene ring.
More specifically, in the cinnamoyl compound (V ″), a ″ is a thiophene ring, b ″ is a group (V ″ -1), Ta is a methyl group, and K A case where a is a hydrogen atom and L a is a methyl group can be mentioned.
More specifically, in the cinnamoyl compound (V ″), a ″ is a thiophene ring, b ″ is a group (V ″ -7), and Ta is a methyl group. It is done.
More specifically, in the cinnamoyl compound (V ″), a ″ is a thiophene ring, b ″ is a group (V ″ -8), and L c is a methyl group. It is done.
化合物(VI)として、例えば、a1がチオフェン環であり、b1が基(VI-1)であって、rb1がメチル基であって、Ka1が水素原子であって、La1がメチル基である場合、a1がチオフェン環であり、b1が基(VI-7)であって、rb1がメチル基である場合、又は、a1がチオフェン環であり、b1が基(VI-8)であって、rb1がメチル基である場合があげられる。 As the compound (VI), for example, a1 is a thiophene ring, b1 is a group (VI-1), rb1 is a methyl group, Ka1 is a hydrogen atom, and La1 is a methyl group. A1 is a thiophene ring, b1 is a group (VI-7) and rb1 is a methyl group, or a1 is a thiophene ring and b1 is a group (VI-8). In this case, rb1 is a methyl group.
WO97/35565号公報、JP09227547号公報、WO00/20371号公報、JP2002371078号公報、WO01/79187号公報及びWO92/18483号公報にある種の概念的な骨格を有する化合物が開示されているが、当該文献には組織内における細胞外マトリックス遺伝子の転写抑制の効果、ひいては細胞外マトリックス蓄積量抑制の効果についての記載は無い。 WO97 / 35565, JP09227547, WO00 / 20371, JP20022371078, WO01 / 79187 and WO92 / 18483 disclose compounds having a certain conceptual skeleton. There is no description in the literature about the effect of suppressing transcription of extracellular matrix genes in tissues, and hence the effect of suppressing the amount of extracellular matrix accumulation.
化合物(I)又は(II)は、例えば、式(α)(式中、α、Xα、Yα、p及びqは前記と同一の意味を表す。)で示される化合物と、式(β)(式中、βは前記と同一の意味を表す。)で示される化合物とを反応させる(Russian J.General Chem.(2001),71,1257 、Indian J.Chem.(1974),12,956 及びJP50046666号公報参照)ことにより製造することができる。
化合物(III)は、例えば、式(AO)(式中、A、XA0、YA0、p及びqは前記と同一の意味を表す。)で示される化合物と、式(BO)(式中、B0は前記と同一の意味を表す。)で示される化合物とを、上記と同様に反応させることにより製造することができる。
化合物(IV)は、例えば、式(A)(式中、A、XA、YA、p及びqは前記と同一の意味を表す。)で示される化合物と、式(B)(式中、Bは前記と同一の意味を表す。)で示される化合物とを、上記と同様に反応させることにより製造することができる。
化合物(V)は、例えば、式(a)(式中、a、Xa、Ya、p及びqは前記と同一の意味を表す。)で示される化合物と、式(b)(式中、bは前記と同一の意味を表す。)で示される化合物とを、上記と同様に反応させることにより製造することができる。
化合物(VI)は、例えば、式(a1)(式中、a1及びXa1は前記と同一の意味を表す。)で示される化合物と、式(b1)(式中、b1は前記と同一の意味を表す。)で示される化合物とを、上記と同様に反応させることにより製造することができる。
Compound (I) or (II) includes, for example, a compound represented by the formula (α) (wherein α, X α , Y α , p and q represent the same meanings as described above) and a formula (β ) (Wherein β represents the same meaning as described above) (Russian J. General Chem. (2001), 71, 1257, Indian J. Chem. (1974), 12, 956 and JP50046666).
Compound (III) includes, for example, a compound represented by formula (AO) (wherein A, X A0 , Y A0 , p and q represent the same meaning as described above), and formula (BO) (wherein , B0 represents the same meaning as described above) and can be produced by reacting in the same manner as described above.
Compound (IV) includes, for example, a compound represented by formula (A) (wherein A, X A , Y A , p and q represent the same meaning as described above), and formula (B) (wherein , B represents the same meaning as described above) and can be produced by reacting in the same manner as described above.
Compound (V) includes, for example, a compound represented by formula (a) (wherein a, X a , Y a , p and q represent the same meaning as described above), and formula (b) (wherein , B represents the same meaning as described above.) And can be produced by reacting in the same manner as described above.
Compound (VI) includes, for example, a compound represented by formula (a1) (wherein a1 and Xa1 represent the same meaning as described above), and formula (b1) (wherein b1 is the same as defined above). Can be produced by reacting the compound represented by the above) in the same manner as described above.
式(a1)で示される化合物の一部は公知物質であるが、前記の式(VII)で示されるアルデヒド誘導体(以下、本発明アルデヒド誘導体と記すこともある。)は、これまで報告された例はなく新規物質である。 Some of the compounds represented by the formula (a1) are known substances, but the aldehyde derivatives represented by the above formula (VII) (hereinafter sometimes referred to as the aldehyde derivatives of the present invention) have been reported so far. There is no example and it is a new substance.
本発明アルデヒド誘導体のうち、式(VII-1)
[式中、Wbは、酸素原子、硫黄原子又は−NMe−基を表し、r5は、水酸基、C1-C10アルコキシ基又はrr’N−基(r及びr’は、前記と同一の意味を表す。)を表し、Wcは、−CO−基又は−CH2−基を表し、r6は、水素原子又はC1-C10アルキル基を表す。但し、Wcが−CH2−基のとき、r及びr’は水素原子となることはない。]
で示される化合物は、例えば、式(VII-2)
[式中、Wbは、前記と同一の意味を表す。]
で示される化合物を、式(VII-3)
[式中、r5、Wc及びr6は、前記と同一の意味を表す。]
で示される化合物と反応させることで製造することができる。当該反応において、反応温度の範囲は、通常,室温〜溶媒還流温度であり、反応時間の範囲は、通常,瞬時〜約24時間である。当該反応は、通常、脱水剤の存在下で行うが、用いられる脱水剤としては、カルボニルジイミダゾール等があげられる。当該反応に供せられる試剤の量は、化合物(VII-2)1モルに対して、化合物(VII-3)は通常1〜2モル、脱水剤は通常1〜7モルである。上記反応において、溶媒は必ずしも必要ではないが、通常は溶媒の存在下に行われる。当該反応に使用しうる溶媒としては、ヘキサン、石油エーテル等の脂肪族炭化水素類、ベンゼン、トルエン等の芳香族炭化水素類、クロロホルム、ジクロロエタン等のハロゲン化炭化水素類、ジエチルエーテル、ジオキサン、テトラヒドロフラン等のエーテル類、アセトン、メチルエチルケトン等のケトン類、酢酸エチル、炭酸ジエチル等のエステル類、アセトニトリル、イソブチルニトリル等のニトリル類、ホルムアミド、N,N−ジメチルホルムアミド等のアミド類、ジメチルスルホキシド等の硫黄化合物類等又はそれらの混合物があげられる。反応終了後の反応液は、有機溶媒抽出、水洗後、有機層を減圧濃縮する等の通常の後処理を行い、必要に応じ、クロマトグラフィー、再結晶等の操作によって精製することにより、本発明ベンズアルデヒド誘導体を得ることができる。化合物(VII-2)は、例えば、Tetrahedron(1985)41,3803等の文献に記載されており公知である。化合物(VII-3)としては、例えば、2−メトキシエチルアミン、2−アミノエタノール、N−(2−メトキシエチル)メチルアミン、2−(メチルアミノ)エタノール、グリシン、グリシンメチルエステル、グリシンアミド及びN,N−ジメチルエチレンジアミン等が挙げられる。
具体的には、化合物(VII-2)と、化合物(VII-3)として、2−メトキシエチルアミン、2−アミノエタノール、N−(2−メトキシエチル)メチルアミン又はグリシンアミドを反応させることで、(VII-1)を製造することがあげられる。
Among the aldehyde derivatives of the present invention, the formula (VII-1)
[Wherein, W b represents an oxygen atom, a sulfur atom or a —NMe— group, r 5 represents a hydroxyl group, a C 1 -C 10 alkoxy group or an rr′N— group (where r and r ′ have the same meanings as described above). represents represents) a, W c is -CO- group or a -CH 2 -. a group, r 6 represents a hydrogen atom or a C1-C10 alkyl group. However, when W c is a —CH 2 — group, r and r ′ do not become a hydrogen atom. ]
The compound represented by the formula is, for example, the formula (VII-2)
[Wherein W b represents the same meaning as described above. ]
A compound represented by the formula (VII-3)
[Wherein, r 5 , W c and r 6 represent the same meaning as described above. ]
It can manufacture by making it react with the compound shown by these. In the reaction, the reaction temperature range is usually from room temperature to the solvent reflux temperature, and the reaction time range is usually from instantaneous to about 24 hours. The reaction is usually carried out in the presence of a dehydrating agent, and examples of the dehydrating agent used include carbonyldiimidazole. The amount of the reagent used for the reaction is usually 1 to 2 mol for compound (VII-3) and 1 to 7 mol for dehydrating agent, relative to 1 mol of compound (VII-2). In the above reaction, a solvent is not always necessary, but it is usually performed in the presence of a solvent. Solvents that can be used for the reaction include aliphatic hydrocarbons such as hexane and petroleum ether, aromatic hydrocarbons such as benzene and toluene, halogenated hydrocarbons such as chloroform and dichloroethane, diethyl ether, dioxane, and tetrahydrofuran. Ethers such as acetone and methyl ethyl ketone, esters such as ethyl acetate and diethyl carbonate, nitriles such as acetonitrile and isobutyl nitrile, amides such as formamide and N, N-dimethylformamide, sulfur such as dimethyl sulfoxide Examples thereof include compounds and the like or mixtures thereof. The reaction solution after completion of the reaction is subjected to usual post-treatment such as organic solvent extraction, washing with water, and concentration of the organic layer under reduced pressure, etc., and if necessary, it is purified by operations such as chromatography, recrystallization, etc. A benzaldehyde derivative can be obtained. Compound (VII-2) is known in the literature such as Tetrahedron (1985) 41, 3803. Examples of the compound (VII-3) include 2-methoxyethylamine, 2-aminoethanol, N- (2-methoxyethyl) methylamine, 2- (methylamino) ethanol, glycine, glycine methyl ester, glycinamide and N , N-dimethylethylenediamine and the like.
Specifically, by reacting compound (VII-2) with 2-methoxyethylamine, 2-aminoethanol, N- (2-methoxyethyl) methylamine or glycinamide as compound (VII-3), (VII-1) can be produced.
また、本発明アルデヒド誘導体のうち、式(VII'-1)
[式中、Wdは、酸素原子又は硫黄原子を表し、Wcは前記と同一の意味を表し、r7は、水酸基又はC1-C10アルコキシ基を表す。]
で示される化合物は、例えば、式(VII'-2)
[式中、rxはハロゲン原子を表す。]
で示される化合物を、式(VII'-3)
[式中、r7、Wc及びWdは、前記と同一の意味を表す。]
で示される化合物と反応させることで製造することができる。当該反応において、反応温度の範囲は、通常,室温〜溶媒還流温度であり、反応時間の範囲は、通常,瞬時〜約24時間である。当該反応は、通常、塩基の存在下で行うが、用いられる塩基としては、水素化ナトリウム、水酸化カリウム、炭酸カリウム、ノルマルブチルリチウム等があげられる。当該反応に供せられる試剤の量は、化合物(VII'-2)1モルに対して、化合物(VII'-3)は通常1〜2モル、塩基は通常1〜7モルである。上記反応において、溶媒は必ずしも必要ではないが、通常は溶媒の存在下に行われる。当該反応に使用しうる溶媒としては、ジエチルエーテル、ジオキサン、テトラヒドロフラン等のエーテル類、アセトン、メチルエチルケトン等のケトン類、酢酸エチル、炭酸ジエチル等のエステル類、アセトニトリル、イソブチルニトリル等のニトリル類、ホルムアミド、N,N−ジメチルホルムアミド等のアミド類、ジメチルスルホキシド等の硫黄化合物類等又はそれらの混合物があげられる。反応終了後、前記と同様にして、本発明ベンズアルデヒド誘導体を得ることができる。化合物(VII'-2)は、例えば、WO00/32598号公報等の文献に記載されており公知である。化合物(VII'-3)としては、例えば、エチレングリコール、2−メトキシエタノール、グリコール酸メチル、チオグリコール酸メチル等が挙げられる。
具体的には、化合物(VII'-2)と、化合物(VII'-3)として、エチレングリコール又はチオグリコール酸メチルを反応させることで、(VII'-1)を製造することがあげられる。
Among the aldehyde derivatives of the present invention, the formula (VII′-1)
[Wherein, W d represents an oxygen atom or a sulfur atom, W c represents the same meaning as described above, and r 7 represents a hydroxyl group or a C1-C10 alkoxy group. ]
The compound represented by the formula is, for example, the formula (VII′-2)
[Wherein r x represents a halogen atom. ]
A compound represented by the formula (VII'-3)
[Wherein, r 7 , W c and W d represent the same meaning as described above. ]
It can manufacture by making it react with the compound shown by these. In the reaction, the reaction temperature range is usually from room temperature to the solvent reflux temperature, and the reaction time range is usually from instantaneous to about 24 hours. The reaction is usually performed in the presence of a base. Examples of the base used include sodium hydride, potassium hydroxide, potassium carbonate, and normal butyl lithium. The amount of the reagent used for the reaction is usually 1 to 2 mol for compound (VII′-3) and 1 to 7 mol for base, relative to 1 mol of compound (VII′-2). In the above reaction, a solvent is not always necessary, but it is usually performed in the presence of a solvent. Solvents that can be used in the reaction include ethers such as diethyl ether, dioxane and tetrahydrofuran, ketones such as acetone and methyl ethyl ketone, esters such as ethyl acetate and diethyl carbonate, nitriles such as acetonitrile and isobutyl nitrile, formamide, Examples thereof include amides such as N, N-dimethylformamide, sulfur compounds such as dimethyl sulfoxide, and the like, or a mixture thereof. After completion of the reaction, the benzaldehyde derivative of the present invention can be obtained in the same manner as described above. Compound (VII′-2) is publicly known, for example, described in documents such as WO00 / 32598. Examples of the compound (VII′-3) include ethylene glycol, 2-methoxyethanol, methyl glycolate, methyl thioglycolate and the like.
Specifically, (VII'-1) can be produced by reacting compound (VII'-2) with ethylene glycol or methyl thioglycolate as compound (VII'-3).
また、本発明アルデヒド誘導体のうち、式(VII''-1)
[式中、r8は、C1-C10アルコキシ基で置換されたC1-C10アルキル基又はC1-C10アルコキシ基で置換されたC2-C10アルコキシ基を表す。]
で示される化合物は、例えば、式(VII''-2)
[式中、rxは前記と同一の意味を表す。]
で示される化合物を、式(VII'-3)
[式中、r8は、前記と同一の意味を表す。]
で示される化合物と反応させることで製造することができる。当該反応において、反応温度の範囲は、通常,室温〜溶媒還流温度であり、反応時間の範囲は、通常,瞬時〜約24時間である。当該反応は、通常、塩基及び銅触媒の存在下で行うが、用いられる塩基としては、水素化ナトリウム、水酸化カリウム、炭酸カリウム等があげられ、銅触媒としては、銅(粉末)、臭化銅(I)、よう化銅(I)があげられる。N,N’−ジメチルエチレンジアミンなどの脂肪族アミンを加えることで、収率よく製造することができる。当該反応に供せられる試剤の量は、化合物(VII''-2)1モルに対して、化合物(VII''-3)は通常1〜2モル、塩基は通常1〜7モルであり、銅触媒は通常0.1〜2モルである。上記反応において、溶媒は必ずしも必要ではないが、通常は溶媒の存在下に行われる。当該反応に使用しうる溶媒としては、ジエチルエーテル、ジオキサン、テトラヒドロフラン等のエーテル類、アセトン、メチルエチルケトン等のケトン類、酢酸エチル、炭酸ジエチル等のエステル類、アセトニトリル、イソブチルニトリル等のニトリル類、ホルムアミド、N,N−ジメチルホルムアミド等のアミド類、ジメチルスルホキシド等の硫黄化合物類等又はそれらの混合物があげられる。反応終了後、前記と同様にして、本発明ベンズアルデヒド誘導体を得ることができる。化合物(VII''-3)は、例えば、US3449406号公報等の文献に記載されており公知である。化合物(VII'-3)としては、例えば、メトキシアセトアミド、カルバミン酸2−メトキシエチル等が挙げられる。
Among the aldehyde derivatives of the present invention, the formula (VII ″ -1)
[Wherein r 8 represents a C1-C10 alkyl group substituted with a C1-C10 alkoxy group or a C2-C10 alkoxy group substituted with a C1-C10 alkoxy group. ]
The compound represented by the formula is, for example, formula (VII ″ -2)
[Wherein r x represents the same meaning as described above. ]
A compound represented by the formula (VII'-3)
[Wherein r 8 represents the same meaning as described above. ]
It can manufacture by making it react with the compound shown by these. In the reaction, the reaction temperature range is usually from room temperature to the solvent reflux temperature, and the reaction time range is usually from instantaneous to about 24 hours. The reaction is usually carried out in the presence of a base and a copper catalyst. Examples of the base used include sodium hydride, potassium hydroxide, potassium carbonate and the like, and examples of the copper catalyst include copper (powder), bromide. Examples include copper (I) and copper (I) iodide. By adding an aliphatic amine such as N, N′-dimethylethylenediamine, it can be produced with good yield. The amount of the reagent used for the reaction is usually 1 to 2 mol for compound (VII ″ -3) and 1 to 7 mol for base, relative to 1 mol for compound (VII ″ -2). A copper catalyst is 0.1-2 mol normally. In the above reaction, a solvent is not always necessary, but it is usually performed in the presence of a solvent. Solvents that can be used in the reaction include ethers such as diethyl ether, dioxane and tetrahydrofuran, ketones such as acetone and methyl ethyl ketone, esters such as ethyl acetate and diethyl carbonate, nitriles such as acetonitrile and isobutyl nitrile, formamide, Examples thereof include amides such as N, N-dimethylformamide, sulfur compounds such as dimethyl sulfoxide, and the like, or a mixture thereof. After completion of the reaction, the benzaldehyde derivative of the present invention can be obtained in the same manner as described above. Compound (VII ″ -3) is known and described in documents such as US Pat. No. 3,449,406. Examples of compound (VII′-3) include methoxyacetamide, 2-methoxyethyl carbamate and the like.
また、本発明アルデヒド誘導体のうち、式(VII'''-1)
[式中、Weは、メチン基又は−N=基を表し、r8は、前記と同一の意味を表す。]
で示される化合物は、例えば、式(VII'''-2)
[式中、Weは前記と同一の意味を表す。]
で示される化合物を、式(VII''-3)
[式中、rxは、前記と同一の意味を表す。]
で示される化合物と反応させることで製造することができる。当該反応において、反応温度の範囲は、通常,室温〜溶媒還流温度であり、反応時間の範囲は、通常,瞬時〜約24時間である。当該反応は、通常、塩基の存在下で行うが、用いられる塩基としては、水酸化カリウム、炭酸カリウム等の無機塩基、ピリジン、トリエチルアミン、N,N−ジエチルアニリン等の有機塩基があげられる。当該反応に供せられる試剤の量は、化合物(VII'''-2)1モルに対して、化合物(VII'''-3)は通常1〜2モル、塩基は通常1〜7モルである。上記反応において、溶媒は必ずしも必要ではないが、通常は溶媒の存在下に行われる。当該反応に使用しうる溶媒としては、ジエチルエーテル、ジオキサン、テトラヒドロフラン等のエーテル類、アセトン、メチルエチルケトン等のケトン類、酢酸エチル、炭酸ジエチル等のエステル類、アセトニトリル、イソブチルニトリル等のニトリル類、ホルムアミド、N,N−ジメチルホルムアミド等のアミド類、ジメチルスルホキシド等の硫黄化合物類等又はそれらの混合物があげられる。反応終了後、前記と同様にして、本発明ベンズアルデヒド誘導体を得ることができる。化合物(VII'''-2)は、例えば、Bioorg.Med.Chem.Lett.14(1),235(2004)等の文献に記載されており公知である。化合物(VII'''-3)としては、例えば、メトキシアセチルクロリド、クロロぎ酸2−メトキシエチル等が挙げられる。
Among the aldehyde derivatives of the present invention, the formula (VII '''-1)
[Wherein W e represents a methine group or —N═ group, and r 8 represents the same meaning as described above. ]
For example, the compound represented by the formula (VII '''-2)
[Wherein W e represents the same meaning as described above. ]
A compound of formula (VII ''-3)
[Wherein r x represents the same meaning as described above. ]
It can manufacture by making it react with the compound shown by these. In the reaction, the reaction temperature range is usually from room temperature to the solvent reflux temperature, and the reaction time range is usually from instantaneous to about 24 hours. The reaction is usually performed in the presence of a base. Examples of the base used include inorganic bases such as potassium hydroxide and potassium carbonate, and organic bases such as pyridine, triethylamine, and N, N-diethylaniline. The amount of the reagent used for the reaction is usually 1 to 2 moles for compound (VII '''-3) and 1 to 7 moles for base relative to 1 mole of compound (VII'''-2). is there. In the above reaction, a solvent is not always necessary, but it is usually performed in the presence of a solvent. Solvents that can be used in the reaction include ethers such as diethyl ether, dioxane and tetrahydrofuran, ketones such as acetone and methyl ethyl ketone, esters such as ethyl acetate and diethyl carbonate, nitriles such as acetonitrile and isobutyl nitrile, formamide, Examples thereof include amides such as N, N-dimethylformamide, sulfur compounds such as dimethyl sulfoxide, and the like, or a mixture thereof. After completion of the reaction, the benzaldehyde derivative of the present invention can be obtained in the same manner as described above. Compound (VII ′ ″-2) is described in, for example, Bioorg. Med. Chem. Lett. 14 (1), 235 (2004) and the like, which are publicly known. Examples of the compound (VII ′ ″-3) include methoxyacetyl chloride, 2-methoxyethyl chloroformate and the like.
本発明アルデヒド誘導体と、前記の化合物(VIII')とを反応させることにより、前記の化合物(VIII'')を製造することができる。 The compound (VIII ″) can be produced by reacting the aldehyde derivative of the present invention with the compound (VIII ′).
表30〜表31に、化合物番号(a)〜(p)で表される新規な本発明アルデヒド誘導体(VII-1)を例示する。 Tables 30 to 31 exemplify novel aldehyde derivatives (VII-1) of the present invention represented by compound numbers (a) to (p).
表32に、化合物番号(q)〜(r)で表される新規な本発明アルデヒド誘導体(VII'-1)を例示する。 Table 32 exemplifies the novel aldehyde derivative (VII′-1) of the present invention represented by compound numbers (q) to (r).
表33〜表34に、化合物番号(s)〜(v)で表される新規な本発明アルデヒド誘導体(VII''-1)を例示する。 Tables 33 to 34 exemplify novel aldehyde derivatives (VII ″ -1) of the present invention represented by compound numbers (s) to (v).
表35に、化合物番号(w)で表される新規な本発明アルデヒド誘導体(VII'''-1)を例示する。 Table 35 illustrates a novel aldehyde derivative (VII ′ ″-1) of the present invention represented by the compound number (w).
化合物(V)のうち、化合物番号(1a-1)〜(72a-1)で表される化合物(Va-1)、化合物番号(1a-2)〜(16a-2)で表される化合物(Va-2)及び化合物番号(1a-3)〜(11a-3)で表される化合物(Va-3)を、表36〜表43に例示する。
(表36〜表43)
本発明化合物(Va-1)、(Va-2)及び(Va-3)
Among the compounds (V), compounds (Va-1) represented by compound numbers (1a-1) to (72a-1), compounds represented by compound numbers (1a-2) to (16a-2) ( The compounds (Va-3) represented by Va-2) and compound numbers (1a-3) to (11a-3) are exemplified in Tables 36 to 43.
(Table 36 to Table 43)
Compounds of the present invention (Va-1), (Va-2) and (Va-3)
(表44〜45)
化合物(Va’)
(Tables 44-45)
Compound (Va ')
化合物(V)のうち、化合物番号(1b)〜(13b)で表される化合物(Vb)を、表46に例示する。
(表46)
化合物(Vb)
Of the compounds (V), compounds (Vb) represented by compound numbers (1b) to (13b) are exemplified in Table 46.
(Table 46)
Compound (Vb)
化合物(V)のうち、化合物番号(1c)〜(11c)で表される化合物(Vc)を、表47に例示する。
(表47)
化合物(Vc)
Of the compounds (V), compounds (Vc) represented by compound numbers (1c) to (11c) are exemplified in Table 47.
(Table 47)
Compound (Vc)
化合物(V)のうち、化合物番号(1d)〜(3d)で表される化合物(Vd)を、表48に例示する。
(表48)
化合物(Vd)
Among the compounds (V), compounds (Vd) represented by compound numbers (1d) to (3d) are exemplified in Table 48.
(Table 48)
Compound (Vd)
化合物(V)のうち、化合物番号(1e)〜(70e)で表される化合物(Ve)を、表49〜表51に例示する。
(表49〜表51)
本発明化合物(Ve)
Of compound (V), compounds (Ve) represented by compound numbers (1e) to (70e) are exemplified in Table 49 to Table 51.
(Table 49 to Table 51)
Compound of the present invention (Ve)
化合物(V)のうち、化合物番号(1f)〜(70f)で表される化合物(Vf)を、表52〜54に例示する。
(表52〜54)
本発明化合物(Vf)
Of compounds (V), compounds (Vf) represented by compound numbers (1f) to (70f) are exemplified in Tables 52 to 54.
(Tables 52-54)
Compound of the present invention (Vf)
化合物(V)のうち、化合物番号(1g)〜(70g)で表される化合物(Vg)を、表55〜57に例示する。
(表55〜57)
本発明化合物(Vg)
Of compound (V), compounds (Vg) represented by compound numbers (1 g) to (70 g) are exemplified in Tables 55 to 57.
(Tables 55-57)
Compound of the present invention (Vg)
化合物(V)のうち、化合物番号(1h)〜(16h)で表される化合物(Vh)を、表58〜表59に例示する。
(表58〜表59)
化合物(Vh)
Of compound (V), compounds (Vh) represented by compound numbers (1h) to (16h) are exemplified in Tables 58 to 59.
(Table 58 to Table 59)
Compound (Vh)
化合物(V)のうち、化合物番号(1i)〜(4i)で表される化合物(Vi)を、表60に例示する。
(表60)
化合物(Vi)
Table 60 shows compounds (Vi) represented by compound numbers (1i) to (4i) among the compounds (V).
(Table 60)
Compound (Vi)
化合物(I)〜(VI)、(I’)、(II’)及び(V’)は、I型コラーゲン遺伝子、フィブロネクチン遺伝子等の細胞外マトリックス遺伝子の転写を抑制する能力を有する。当該能力は、I型コラーゲン遺伝子、フィブロネクチン遺伝子等の細胞外マトリックス遺伝子の発現量を減少させて、コラーゲン、フィブロネクチン等の細胞外マトリックスの蓄積量の低下を導くことにより組織の線維化を改善するために重要である。よって、化合物(I)〜(VI)、(I’)、(II’)及び(V’)は、I型コラーゲン遺伝子、フィブロネクチン遺伝子等の細胞外マトリックス遺伝子の発現量を減少させてコラーゲン、フィブロネクチン等の細胞外マトリックスの蓄積量の低下を導くことにより組織の線維化を改善するための組成物(医薬品、化粧品、食品添加物等)の有効成分として利用することができる。
本発明転写抑制組成物や本発明線維化改善組成物の適用可能な疾患としては、例えば、コラーゲン、フィブロネクチン等の細胞外マトリックスの過度の集積により組織が線維化することにより硬化し、その結果、臓器等の組織の機能低下や瘢痕形成等を来たす疾患(即ち、線維症等)をあげることができる。具体的には例えば、肝硬変、慢性膵炎、スキルス胃癌、間質性肺疾患、喘息、慢性閉塞性肺疾患、糸球体腎炎、ループス腎炎、尿細管間質性腎炎、IgA腎症、腎硬化症、糖尿病性腎症、遺伝性腎疾患、心筋線維症、心不全、PTCA後の再狭窄、動脈硬化、骨髄線維症、関節リウマチ、炎症後の過形成痕跡、術後の瘢痕や熱傷性瘢痕、アトピー性皮膚炎、肥厚性瘢痕、子宮筋腫、前立腺肥大症、強皮症、アルツハイマー病、硬化性腹膜炎、糖尿病性網膜症、I型糖尿病等をあげることができる。因みに、肝硬変においては、1つの例として、C型又はB型肝炎ウイルスが慢性的な炎症を誘発し、TGF−βの量が上昇することにより、肝線維化(特に、I型・III型コラーゲンの蓄積)を引き起こして当該疾患となることがすでに知られている(例えば、Clin.Liver Dis.,7,195−210(2003)参照)。間質性肺疾患においては、1つの例として、ダニ・ウイルス・結核菌等による肺炎を誘発してTGF-βの量が上昇し、肺線維化を引き起こして当該疾患となると考えられている。糖尿病性腎症やIgA腎症等の慢性腎不全においては、前者では高血糖によって腎糸球体でTGF−βの量が上昇し、後者ではIgAが腎糸球体に蓄積することにより、腎炎を誘発してTGF−βの量が上昇し、腎線維化(特に、I型・IV型コラーゲンの蓄積)を引き起こして当該疾患となることがすでに示唆されている(例えば、Am.J.Physiol.Renal Phsiol.,278,F830−F838(2000)、Kidney Int.,64,149−159(2003)参照)。尚、糖尿病性腎症のモデル動物であるdb/dbマウスとは、摂食を抑制するレプチン受容体に変異をもつため、過食により高血糖となり自然発症的に糖尿病を併発するものである。db/dbマウスは、正常マウスに比較して血中グルコース濃度が約4倍高く、腎糸球体線維化とTGF−β量との増加が認められている(例えば、Am.J.Pathol.,158,1653−1663(2001)参照)。またIgA腎症のモデル動物である抗Thy−1ラットとは、抗Thy−1抗体を正常ラットに投与することにより、人工的に腎線維化を引き起こさせたものである。当該モデル動物に対して抗TGF−β受容体抗体を投与することにより、腎線維化が抑制されることが示されている(例えば、Kidney Int.,60,1745−1755(2001)参照)。強皮症においては、その原因は不明だが、そのモデル動物であるTskマウスに対し、TGF−β阻害剤を投与することにより皮膚線維化の改善が認められている(例えば、J.Invest.Dermatol.,118,461−470(2001)参照)。以上のことから、TGF−βの作用を抑制する化合物は、TGF−βによるコラーゲン合成促進を阻害して組織の線維化を抑制し、線維症治療効果を得るための組成物(医薬品、化粧品、食品添加物等)の有効成分として利用することができるのである。一方、左室拡張不全等の心不全の病因は、高血圧状態の心臓線維化がその1つとされている。以上のことから、TGF−βによるフィブロネクチン合成促進を阻害して組織の線維化を抑制し、心不全治療効果を得るための組成物(医薬品等)の有効成分として利用することができるのである。
かかる本発明転写抑制組成物や本発明線維化改善組成物は、化合物(I)〜(VI)、(I’)、(II’)及び(V’)と不活性担体とを含有する。これらの組成物中に含有される化合物(I)〜(VI)、(I’)、(II’)及び(V’)は、通常、0.01重量%〜99.99重量%であり、不活性担体は、通常、99.99重量%〜0.01重量%である。該不活性担体は、薬学的に許容される担体や賦形剤であり、本発明転写抑制組成物や本発明線維化改善組成物はさらに、医薬品添加剤、化粧品添加剤、食品添加剤等を含有してもよい。
Compounds (I) to (VI), (I ′), (II ′) and (V ′) have the ability to suppress transcription of extracellular matrix genes such as type I collagen gene and fibronectin gene. This ability is to improve tissue fibrosis by reducing the expression level of extracellular matrix genes such as type I collagen gene and fibronectin gene, leading to a decrease in the accumulated amount of extracellular matrix genes such as collagen and fibronectin. Is important to. Therefore, the compounds (I) to (VI), (I ′), (II ′) and (V ′) reduce the expression level of extracellular matrix genes such as type I collagen gene and fibronectin gene, thereby reducing collagen and fibronectin. It can be used as an active ingredient of a composition (pharmaceutical, cosmetic, food additive, etc.) for improving tissue fibrosis by leading to a decrease in the amount of extracellular matrix accumulated.
Examples of the diseases to which the transcription repressing composition of the present invention and the composition for improving fibrosis of the present invention can be applied include, for example, hardening by tissue fibrosis due to excessive accumulation of extracellular matrix such as collagen and fibronectin. Diseases (ie, fibrosis, etc.) that cause decreased function of tissues such as organs and scar formation can be mentioned. Specifically, for example, cirrhosis, chronic pancreatitis, Skills gastric cancer, interstitial lung disease, asthma, chronic obstructive pulmonary disease, glomerulonephritis, lupus nephritis, tubulointerstitial nephritis, IgA nephropathy, nephrosclerosis, Diabetic nephropathy, hereditary kidney disease, myocardial fibrosis, heart failure, restenosis after PTCA, arteriosclerosis, myelofibrosis, rheumatoid arthritis, post-inflammation hyperplasia, postoperative scar or burn scar, atopic Examples include dermatitis, hypertrophic scar, uterine fibroids, prostatic hypertrophy, scleroderma, Alzheimer's disease, sclerosing peritonitis, diabetic retinopathy, type I diabetes and the like. Incidentally, in cirrhosis, as an example, hepatitis C virus or hepatitis B induces chronic inflammation and increases the amount of TGF-β, resulting in liver fibrosis (particularly type I and type III collagen). (See, for example, Clin. Liver Dis., 7, 195-210 (2003)). In interstitial lung disease, as an example, it is considered that pneumonia caused by mites, viruses, tuberculosis bacteria, and the like is induced to increase the amount of TGF-β, causing pulmonary fibrosis and causing the disease. In chronic renal failure such as diabetic nephropathy and IgA nephropathy, the amount of TGF-β increases in the glomeruli due to hyperglycemia in the former, and the latter induces nephritis by accumulation of IgA in the glomeruli. It has already been suggested that the amount of TGF-β increases and causes renal fibrosis (particularly, accumulation of type I and type IV collagen), resulting in the disease (for example, Am. J. Physiol. Phsiol., 278, F830-F838 (2000), Kidney Int., 64, 149-159 (2003)). The db / db mouse, which is a model animal for diabetic nephropathy, has a mutation in the leptin receptor that suppresses feeding, and thus hyperglycemia occurs due to overeating and spontaneously accompanies diabetes. In db / db mice, blood glucose concentration is about 4 times higher than in normal mice, and glomerular fibrosis and increase in TGF-β amount are observed (for example, Am. J. Pathol.,). 158, 1653-1663 (2001)). The anti-Thy-1 rat, which is a model animal of IgA nephropathy, is an artificially induced renal fibrosis by administering an anti-Thy-1 antibody to a normal rat. It has been shown that renal fibrosis is suppressed by administering an anti-TGF-β receptor antibody to the model animal (see, for example, Kidney Int., 60, 1745-1755 (2001)). Although the cause of scleroderma is unknown, improvement of skin fibrosis has been observed by administering a TGF-β inhibitor to the Tsk mouse, which is the model animal (for example, J. Invest. Dermatol). , 118, 461-470 (2001)). From the above, the compound that suppresses the action of TGF-β inhibits the promotion of collagen synthesis by TGF-β, suppresses tissue fibrosis, and obtains a fibrosis therapeutic effect (pharmaceuticals, cosmetics, It can be used as an active ingredient of food additives and the like. On the other hand, heart fibrosis in a hypertensive state is one of the causes of heart failure such as left ventricular diastolic failure. From the above, it can be used as an active ingredient of a composition (medicine or the like) for inhibiting fibronectin synthesis promotion by TGF-β to suppress tissue fibrosis and obtaining a therapeutic effect on heart failure.
Such a transcription repressing composition of the present invention and a composition for improving fibrosis of the present invention contain compounds (I) to (VI), (I ′), (II ′) and (V ′) and an inert carrier. The compounds (I) to (VI), (I ′), (II ′) and (V ′) contained in these compositions are usually 0.01% to 99.99% by weight, The inert carrier is usually 99.99% to 0.01% by weight. The inert carrier is a pharmaceutically acceptable carrier or excipient, and the transcription inhibitor composition or the fibrosis improving composition of the present invention further contains a pharmaceutical additive, a cosmetic additive, a food additive, etc. You may contain.
また、化合物(I)〜(VI)、(I’)、(II’)及び(V’)は、後述する実施例3,4にも示されるように、TGF−βが有するI型コラーゲン遺伝子の転写促進能力を阻害する。即ち、化合物(I)〜(VI)、(I’)、(II’)及び(V’)はTGF−βの作用を抑制する能力を有するTGF−βアンタゴニストである。よって、化合物(I)〜(VI)、(I’)、(II’)及び(V’)は、TGF−β作用抑制組成物の有効成分として利用することもできる。TGF−βは、毛髪の成長サイクルにおける成長期(以下、毛髪成長期と記すこともある。)から退行期(以下、毛髪退行期と記すこともある。)への移行を促進する能力を有することが知られている[J.Invest.Dermatol.,111,948−954(1998)、FASEB J.,16,1967−1969(2002)]。さらに、抗TGF−β抗体や、TGF−β阻害剤であるFetuin等は、TGF−βによる毛の伸長抑制作用に対して拮抗的に働き、毛の伸長促進作用を示すことが報告されている[J.Invest.Dermatol.,118,993−997(2002)、公開特許公報 特開2000−342296]。よって、本発明化合物(及びこれを有効成分として含有するTGF−β作用抑制組成物)は、TGF−βによる毛髪退行期への移行促進を阻害して毛髪成長期の延長を導くことにより養毛効果を得るために利用してもよい。
かかる本発明TGF−β抑制組成物や本発明養毛組成物は、化合物(I)〜(VI)、(I’)、(II’)及び(V’)と不活性担体とを含有する。これらの組成物中に含有される化合物(I)〜(VI)、(I’)、(II’)及び(V’)は、通常、0.01重量%〜99.99重量%であり、不活性担体は、通常、99.99重量%〜0.01重量%である。当該不活性担体は、薬学的に許容される担体や賦形剤であり、本発明TGF−β抑制組成物や本発明養毛組成物はさらに、医薬品添加剤、化粧品添加剤、食品添加剤等を含有してもよい。
In addition, compounds (I) to (VI), (I ′), (II ′) and (V ′) are a type I collagen gene possessed by TGF-β as shown in Examples 3 and 4 described later. Inhibits the ability to promote transcription. That is, compounds (I) to (VI), (I ′), (II ′) and (V ′) are TGF-β antagonists having an ability to suppress the action of TGF-β. Therefore, the compounds (I) to (VI), (I ′), (II ′) and (V ′) can also be used as active ingredients of the TGF-β action inhibitory composition. TGF-β has the ability to promote the transition from the growth phase (hereinafter sometimes referred to as hair growth phase) to the regression phase (hereinafter also referred to as hair regression phase) in the hair growth cycle. It is known [J. Invest. Dermatol. 111, 948-954 (1998), FASEB J. et al. 16, 1967-1969 (2002)]. Furthermore, it has been reported that anti-TGF-β antibody, Teutin, which is a TGF-β inhibitor, act antagonistically to TGF-β to suppress hair elongation and show hair elongation promoting effect. [J. Invest. Dermatol. , 118, 993-997 (2002), published patent publication JP 2000-342296]. Therefore, the compound of the present invention (and the TGF-β action-suppressing composition containing this as an active ingredient) inhibits the promotion of the transition to the hair regression phase by TGF-β and leads to the extension of the hair growth phase. It may be used to obtain an effect.
Such a TGF-β inhibitory composition of the present invention and a hair nourishing composition of the present invention contain compounds (I) to (VI), (I ′), (II ′) and (V ′) and an inert carrier. The compounds (I) to (VI), (I ′), (II ′) and (V ′) contained in these compositions are usually 0.01% to 99.99% by weight, The inert carrier is usually 99.99% to 0.01% by weight. The inert carrier is a pharmaceutically acceptable carrier or excipient, and the TGF-β-suppressing composition of the present invention and the hair nourishing composition of the present invention further include pharmaceutical additives, cosmetic additives, food additives, etc. It may contain.
上記組成物に用いられる薬学的に許容される担体、賦形剤、医薬品添加剤、食品添加剤、化粧品添加剤等は、当該組成物の具体的用途に応じて適宜選択することができる。また、当該組成物の形態も、具体的用途に応じて、例えば、種々の固体、液体等の形態とすることができる。
例えば、化合物(I)〜(VI)、(I’)、(II’)及び(V’)を医薬品の有効成分として用いる場合には、具体的な形態として、例えば、散剤、細粒剤、顆粒剤、錠剤、シロップ剤、カプセル剤、懸濁化剤、エマルジョン剤、エキス剤及び丸剤等の経口剤、注射剤、外用液剤や軟膏剤等の経皮吸収剤、坐剤及び局所剤等の非経口剤等をあげることができる。
経口剤は、例えば、ゼラチン、アルギン酸ナトリウム、澱粉、コーンスターチ、白糖、乳糖、ぶどう糖、マンニット、カルボキシメチルセルロース、デキストリン、ポリビニルピロリドン、結晶セルロース、大豆レシチン、ショ糖、脂肪酸エステル、タルク、ステアリン酸マグネシウム、ポリエチレングリコール、ケイ酸マグネシウム、無水ケイ酸等の担体や賦形剤、結合剤、崩壊剤、界面活性剤、滑沢剤、流動性促進剤、希釈剤、保存剤、着色剤、香料、安定化剤、保湿剤、防腐剤、酸化防止剤等の医薬品添加剤を用いて、通常の方法に従って製造することができる。
投与量は、投与される哺乳動物の年令、性別、体重、疾患の程度、本発明の組成物の種類、投与形態等によって異なるが、通常は経口の場合にはヒト成人で1日あたり有効成分量として約1mg〜約2g、好ましくは有効成分量として約5mg〜約1gを投与すればよい。また、前記の1日の投与量を1回又は数回に分けて投与することができる。
非経口剤のうち、注射剤は、生理食塩水、滅菌水リンゲル液等の水溶性溶剤、植物油、脂肪酸エステル等の非水溶性溶剤、ブドウ糖、塩化ナトリウム等の等張化剤、溶解補助剤、安定化剤、防腐剤、懸濁化剤、乳化剤等の医薬品添加剤を用いて、通常の方法に従って製造することができる。外用液剤、ゲル状軟膏等の経皮吸収剤、直腸内投与のための坐剤等も通常の方法に従って製造することができる。このような非経口剤を投与するには、注射(皮下、静脈内等)、経皮投与、直腸投与すればよい。局所剤は、例えば、化合物(I)〜(VI)、(I’)、(II’)及び(V’)をエチレンビニル酢酸ポリマー等の徐放性ポリマーのペレットに取り込ませて製造することができる。このペレットを治療すべき組織中に外科的に移植すればよい。
投与量は、投与される哺乳動物の年令、性別、体重、疾患の程度、本発明の組成物の種類、投与形態等によって異なるが、通常は注射の場合にはヒト成人で有効成分量として約0.1mg〜約500mgを投与すればよい。また、前記の1日の投与量を1回又は数回に分けて投与することができる。
化合物(I)〜(VI)、(I’)、(II’)及び(V’)を化粧品に添加して用いる場合には、当該化合物が添加された化粧品の具体的な形態としては、例えば、液状、乳状、クリーム、ローション、軟膏、ゲル、エアゾール、ムース等をあげることができる。ローションは、例えば、懸濁剤、乳化剤、保存剤等の化粧品添加剤を用いて、通常の方法に従って製造することができる。
投与量は、投与される哺乳動物の年令、性別、体重、疾患の程度、本発明の組成物の種類、投与形態等によって異なるが、通常ヒト成人で有効成分量として約0.01mg〜約50mgを投与すればよい。また、前記の1日の投与量を1回又は数回に分けて投与することができる。
化合物(I)〜(VI)、(I’)、(II’)及び(V’)を食品添加物として用いる場合には、当該添加物が添加された食品の具体的な形態としては、例えば、粉末、錠剤、飲料、摂取可能なゲル若しくはシロップとの混合液状物、例えば、調味料、和菓子、洋菓子、氷菓、飲料、スプレッド、ペースト、漬物、ビン缶詰、畜肉加工品、魚肉・水産加工品、乳・卵加工品、野菜加工品、果実加工品、穀類加工品等の一般的な飲食物や嗜好物等をあげることができる。また、家畜、家禽、蜜蜂、蚕、魚等の飼育動物のための飼料や餌料への添加も可能である。
投与量は、投与される哺乳動物の年令、性別、体重、疾患の程度、本発明の組成物の種類、投与形態等によって異なるが、通常ヒト成人で有効成分量として約0.1mg〜約500mgを投与すればよい。また、前記の1日の投与量を1回又は数回に分けて投与することができる。
The pharmaceutically acceptable carrier, excipient, pharmaceutical additive, food additive, cosmetic additive and the like used in the composition can be appropriately selected depending on the specific use of the composition. Moreover, the form of the said composition can also be made into forms, such as various solid and liquid, according to a specific use, for example.
For example, when the compounds (I) to (VI), (I ′), (II ′) and (V ′) are used as active ingredients of pharmaceuticals, as specific forms, for example, powders, fine granules, Oral preparations such as granules, tablets, syrups, capsules, suspending agents, emulsions, extracts and pills, transdermal absorption agents such as injections, external liquids and ointments, suppositories, and topical agents Parenteral preparations and the like.
Oral preparations include, for example, gelatin, sodium alginate, starch, corn starch, sucrose, lactose, glucose, mannitol, carboxymethylcellulose, dextrin, polyvinylpyrrolidone, crystalline cellulose, soy lecithin, sucrose, fatty acid ester, talc, magnesium stearate, Carriers and excipients such as polyethylene glycol, magnesium silicate, and silicic anhydride, binders, disintegrants, surfactants, lubricants, fluidity promoters, diluents, preservatives, colorants, fragrances, stabilization It can be produced according to a usual method using a pharmaceutical additive such as an agent, a humectant, a preservative, and an antioxidant.
The dose varies depending on the age, sex, weight, disease level, type of composition of the present invention, dosage form, etc., but is usually effective for human adults per day. About 1 mg to about 2 g may be administered as the component amount, preferably about 5 mg to about 1 g may be administered as the active component amount. In addition, the above-mentioned daily dose can be administered once or divided into several times.
Among parenterals, injections are water-soluble solvents such as physiological saline and sterile water Ringer's solution, water-insoluble solvents such as vegetable oils and fatty acid esters, isotonic agents such as glucose and sodium chloride, solubilizing agents, stable It can be produced according to a usual method using a pharmaceutical additive such as an agent, a preservative, a suspending agent and an emulsifier. External liquid preparations, transdermal absorption agents such as gel ointments, suppositories for rectal administration, and the like can also be produced according to ordinary methods. In order to administer such a parenteral preparation, injection (subcutaneous, intravenous, etc.), transdermal administration, or rectal administration may be used. The topical agent can be produced, for example, by incorporating the compounds (I) to (VI), (I ′), (II ′) and (V ′) into pellets of a sustained release polymer such as ethylene vinyl acetate polymer. it can. This pellet may be surgically implanted into the tissue to be treated.
The dose varies depending on the age, sex, weight, disease level, type of composition of the present invention, dosage form, etc. of the mammal to be administered. About 0.1 mg to about 500 mg may be administered. In addition, the above-mentioned daily dose can be administered once or divided into several times.
When the compounds (I) to (VI), (I ′), (II ′) and (V ′) are used by being added to cosmetics, as specific forms of the cosmetics to which the compounds are added, for example, , Liquid, milky, cream, lotion, ointment, gel, aerosol, mousse and the like. Lotions can be produced according to conventional methods using cosmetic additives such as suspending agents, emulsifying agents, preservatives and the like.
The dosage varies depending on the age, sex, weight, disease level, type of composition of the present invention, dosage form, etc. of the mammal to be administered. 50 mg may be administered. In addition, the above-mentioned daily dose can be administered once or divided into several times.
When the compounds (I) to (VI), (I ′), (II ′) and (V ′) are used as food additives, specific forms of foods to which the additives are added include, for example, , Powders, tablets, beverages, mixed liquids with ingestible gel or syrup, such as seasonings, Japanese confectionery, Western confectionery, ice confectionery, beverages, spreads, pastes, pickles, canned bottles, processed meat products, processed fish and fishery products And general foods and beverages such as processed milk / eggs, processed vegetables, processed fruits, processed cereals, and the like. Further, it can be added to feed and feed for domestic animals such as domestic animals, poultry, bees, cormorants and fish.
The dose varies depending on the age, sex, body weight, degree of disease, type of composition of the present invention, dosage form, etc. of the mammal to be administered, but it is usually about 0.1 mg to about 0.1 mg as an active ingredient in human adults. 500 mg may be administered. In addition, the above-mentioned daily dose can be administered once or divided into several times.
以下に実施例を挙げ、本発明を更に具体的に説明する。
実施例1 実施例1−1から1−15に、本発明アルデヒド誘導体の合成を記す。
Hereinafter, the present invention will be described in more detail with reference to examples.
Example 1 Synthesis of the aldehyde derivative of the present invention is described in Examples 1-1 to 1-15.
実施例1−1 本発明アルデヒド誘導体[化合物番号(a)]の合成
5-ホルミルチオフェン-2-カルボン酸1.56gのテトラヒドロフラン40ml溶液に、カルボニルジイミダゾール2.11gを添加し、室温で2時間30分攪拌した。ここに、2-メトキシエチルアミン1mlを添付し、室温で1時間30分攪拌した後、減圧濃縮した。得られた残渣を酢酸エチル70mlに溶解して2規定塩酸、飽和重曹水の順に洗浄し、無水硫酸ナトリウムで乾燥した後、減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに供することにより、5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミド[化合物番号(a)]の白色固体0.88gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.27(s,3H),3.38〜3.50(m,4H),7.89(d,1H,J=4.1Hz),8.01(d,1H,J=4.1Hz),8.91(broad,1H),9.95(s,1H)
Example 1-1 Synthesis of the present aldehyde derivative [Compound No. (a)]
To a solution of 1.56 g of 5-formylthiophene-2-carboxylic acid in 40 ml of tetrahydrofuran was added 2.11 g of carbonyldiimidazole, and the mixture was stirred at room temperature for 2 hours and 30 minutes. To this was added 1 ml of 2-methoxyethylamine, and the mixture was stirred at room temperature for 1 hour 30 minutes, and then concentrated under reduced pressure. The obtained residue was dissolved in 70 ml of ethyl acetate, washed with 2N hydrochloric acid and saturated aqueous sodium bicarbonate in this order, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.88 g of white solid of 5-formylthiophene-2-carboxylic acid 2-methoxyethylamide [Compound No. (a)].
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.27 (s, 3H), 3.38 to 3.50 (m, 4H), 7.89 (d, 1H, J = 4) .1 Hz), 8.01 (d, 1 H, J = 4.1 Hz), 8.91 (broad, 1 H), 9.95 (s, 1 H)
実施例1−2 本発明アルデヒド誘導体[化合物番号(b)]の合成
5-ホルミルフラン-2-カルボン酸2.80gのテトラヒドロフラン30ml及びジメチルホルムアミド30ml溶液に、カルボニルジイミダゾール4.22gを添加し、室温で1時間攪拌し、2-メトキシエチルアミン6mlを添加して、室温で一夜攪拌した。還流下で5時間加熱した後、2規定塩酸を加えて酢酸エチルで抽出し、有機層を飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥して減圧濃縮し、5-ホルミルフラン-2-カルボン酸 2-メトキシエチルアミド[化合物番号(b)]の白色固体3.01gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.26(s,3H),3.37〜3.48(m,4H),7.32(d,1H,J=3.6Hz),7.60(d,1H,J=3.6Hz),8.77(broad,1H),9.70(s,1H)
Example 1-2 Synthesis of the present aldehyde derivative [Compound No. (b)]
To a solution of 2.80 g of 5-formylfuran-2-carboxylic acid in 30 ml of tetrahydrofuran and 30 ml of dimethylformamide, 4.22 g of carbonyldiimidazole is added and stirred at room temperature for 1 hour, and 6 ml of 2-methoxyethylamine is added. And stirred overnight. After heating at reflux for 5 hours, 2N hydrochloric acid was added and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give 5-formylfuran-2- 3.01 g of a white solid of carboxylic acid 2-methoxyethylamide [Compound No. (b)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.26 (s, 3H), 3.37 to 3.48 (m, 4H), 7.32 (d, 1H, J = 3) .6 Hz), 7.60 (d, 1 H, J = 3.6 Hz), 8.77 (broad, 1 H), 9.70 (s, 1 H)
実施例1−3 本発明アルデヒド誘導体[化合物番号(c)]の合成
5-ホルミルチオフェン-2-カルボン酸の代わりに、5-ホルミル-1-メチル-1H-ピロール-2-カルボン酸2.30gを用いた以外は実施例1−1と同様にして、5-ホルミル-1-メチル-1H-ピロール-2-カルボン酸 2-メトキシエチルアミド[化合物番号(c)]の黄色結晶1.10gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.28(s,3H),3.31〜3.54(m,4H),4.14(s,3H),6.82(d,1H,J=4.1Hz),7.02(d,1H,J=4.1Hz),8.55(broad t,1H,J=4.9Hz),9.68(s,1H)
Example 1-3 Synthesis of the present aldehyde derivative [Compound No. (c)]
5-Formyl was obtained in the same manner as in Example 1-1 except that 2.30 g of 5-formyl-1-methyl-1H-pyrrole-2-carboxylic acid was used instead of 5-formylthiophene-2-carboxylic acid. 1.10 g of yellow crystals of -1-methyl-1H-pyrrole-2-carboxylic acid 2-methoxyethylamide [Compound No. (c)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.28 (s, 3H), 3.31 to 3.54 (m, 4H), 4.14 (s, 3H), 6. 82 (d, 1H, J = 4.1 Hz), 7.02 (d, 1H, J = 4.1 Hz), 8.55 (broad t, 1H, J = 4.9 Hz), 9.68 (s, 1H)
実施例1−4 本発明アルデヒド誘導体[化合物番号(d)]の合成
5-ホルミルチオフェン-2-カルボン酸の代わりに、4-ホルミル-1-メチル-1H-ピロール-2-カルボン酸2.00gを用いた以外は実施例1−1と同様にして、4-ホルミル-1-メチル-1H-ピロール-2-カルボン酸 2-メトキシエチルアミド[化合物番号(d)]の白色結晶0.52gを得た。
1H−NMR(270MHz,CDCl3)δ(ppm):3.37(s,3H),3.49〜3.65(m,4H),4.00(s,3H),6.38(broad,1H),7.01(d,1H,J=1.6Hz),7.33(d,1H,J=1.6Hz),9.75(s,1H)
Example 1-4 Synthesis of the present aldehyde derivative [Compound No. (d)]
4-Formyl was obtained in the same manner as in Example 1-1 except that 2.00 g of 4-formyl-1-methyl-1H-pyrrole-2-carboxylic acid was used instead of 5-formylthiophene-2-carboxylic acid. 0.52 g of white crystals of -1-methyl-1H-pyrrole-2-carboxylic acid 2-methoxyethylamide [Compound No. (d)] was obtained.
1 H-NMR (270 MHz, CDCl 3 ) δ (ppm): 3.37 (s, 3H), 3.49 to 3.65 (m, 4H), 4.00 (s, 3H), 6.38 ( broadcast, 1H), 7.01 (d, 1H, J = 1.6 Hz), 7.33 (d, 1H, J = 1.6 Hz), 9.75 (s, 1H)
実施例1−5 本発明アルデヒド誘導体[化合物番号(e)]の合成
5-ホルミルチオフェン-2-カルボン酸1.56g及びN-ヒドロキシこはく酸イミド1.15gのジメチルホルムアミド15ml溶液に、N,N’-ジシクロヘキシルカルボジイミド2.06gのジメチルホルムアミド5ml溶液を添加し、室温で30分攪拌した。不溶物を濾別してジメチルホルムアミド10mlで洗浄し、濾液に2-ヒドロキシエチルアミン1.2mlを添加し、室温で1時間30分攪拌した。不溶物を濾別して濾液を減圧濃縮し、残渣をメタノール50mlに溶解して10%塩酸30mlを添加し、室温で一夜攪拌した。反応液を減圧濃縮し、得られた残渣を酢酸エチル400mlに溶解して水洗し、無水硫酸ナトリウムで乾燥した後、減圧濃縮して、5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミド[化合物番号(e)]の黄色固体0.58gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.29〜3.37(m,2H),3.48〜3.55(m,2H),4.78(t,1H,J=5.7Hz),7.89(d,1H,J=3.9Hz),8.01(d,1H,J=3.9Hz),8.83(t,1H,J=5.4Hz),9.95(s,1H)
Example 1-5 Synthesis of the present aldehyde derivative [Compound No. (e)]
To a solution of 1.56 g of 5-formylthiophene-2-carboxylic acid and 1.15 g of N-hydroxysuccinimide in 15 ml of dimethylformamide was added 2.06 g of N, N'-dicyclohexylcarbodiimide in 5 ml of dimethylformamide at room temperature. Stir for 30 minutes. The insoluble material was filtered off and washed with 10 ml of dimethylformamide. 1.2 ml of 2-hydroxyethylamine was added to the filtrate, and the mixture was stirred at room temperature for 1 hour and 30 minutes. Insoluble matters were filtered off, and the filtrate was concentrated under reduced pressure. The residue was dissolved in 50 ml of methanol, 30 ml of 10% hydrochloric acid was added, and the mixture was stirred overnight at room temperature. The reaction solution was concentrated under reduced pressure, and the resulting residue was dissolved in 400 ml of ethyl acetate, washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide [ 0.58 g of a yellow solid of Compound No. (e)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.29 to 3.37 (m, 2H), 3.48 to 3.55 (m, 2H), 4.78 (t, 1H , J = 5.7 Hz), 7.89 (d, 1H, J = 3.9 Hz), 8.01 (d, 1H, J = 3.9 Hz), 8.83 (t, 1H, J = 5. 4Hz), 9.95 (s, 1H)
実施例1−6 本発明アルデヒド誘導体[化合物番号(k)]の合成
5-ホルミルチオフェン-2-カルボン酸0.80gのテトラヒドロフラン10ml溶液に、カルボニルジイミダゾール1.25gを添加し、室温で30分攪拌した。この反応液を、グリシンアミド0.85g、トリエチルアミン1ml及びテトラヒドロフラン10mlの混合物に添加し、室温で一夜攪拌した。10%塩酸を加えて酢酸エチルで抽出し、有機層を重曹水で洗浄した後、無水硫酸ナトリウムで乾燥して減圧濃縮し、得られた固体をヘキサンで洗浄して、5-ホルミルチオフェン-2-カルボン酸 カルバモイルメチルアミド[化合物番号(k)]の黄色固体0.21gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.82(d,2H,J=6.2Hz),7.09(broad s,1H),7.46(broad s,1H),7.92(d,1H,J=4.1Hz),8.03(d,1H,J=4.1Hz),9.06(t,1H,J=5.9Hz),9.97(s,1H)
Example 1-6 Synthesis of the present aldehyde derivative [Compound No. (k)]
To a solution of 0.80 g of 5-formylthiophene-2-carboxylic acid in 10 ml of tetrahydrofuran was added 1.25 g of carbonyldiimidazole, and the mixture was stirred at room temperature for 30 minutes. This reaction solution was added to a mixture of 0.85 g of glycinamide, 1 ml of triethylamine and 10 ml of tetrahydrofuran, and stirred overnight at room temperature. 10% Hydrochloric acid was added and the mixture was extracted with ethyl acetate. The organic layer was washed with aqueous sodium hydrogen carbonate, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting solid was washed with hexane to give 5-formylthiophene-2. -Carboxylic acid 0.21 g of yellow solid of carbamoylmethylamide [Compound No. (k)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.82 (d, 2H, J = 6.2 Hz), 7.09 (broads, 1H), 7.46 (broads, 1H) ), 7.92 (d, 1H, J = 4.1 Hz), 8.03 (d, 1H, J = 4.1 Hz), 9.06 (t, 1H, J = 5.9 Hz), 9.97 (S, 1H)
実施例1−7 本発明アルデヒド誘導体[化合物番号(o)]の合成
5-ホルミルチオフェン-2-カルボン酸400mgのジメチルホルムアミド溶液に、塩酸1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド540mg及びトリエチルアミン410μlを添加し、氷冷下30分攪拌した。この反応液に、N-(2-メトキシエチル)メチルアミン300μlを添加し、室温で攪拌した。10%塩酸を加えて酢酸エチルで抽出し、有機層を重曹水で洗浄した後、無水硫酸ナトリウムで乾燥して減圧濃縮し、得られた残渣を酢酸エチルで洗浄して、5-ホルミルチオフェン-2-カルボン酸 N-(2-メトキシエチル)メチルアミド[化合物番号(o)]221mgを得た。
1H−NMR(300MHz,CDCl3)δ(ppm):3.22(broad s,3H),3.42(s,3H),3.55〜3.75(4H),7.45(d,1H,J=3.6Hz),7.69(d,1H,J=3.9Hz),9.95(s,1H)
Example 1-7 Synthesis of aldehyde derivative of the present invention [Compound No. (o)]
To a dimethylformamide solution of 400 mg of 5-formylthiophene-2-carboxylic acid, 540 mg of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride and 410 μl of triethylamine were added and stirred for 30 minutes under ice cooling. To this reaction solution, 300 μl of N- (2-methoxyethyl) methylamine was added and stirred at room temperature. 10% Hydrochloric acid was added and the mixture was extracted with ethyl acetate. The organic layer was washed with aqueous sodium hydrogen carbonate, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was washed with ethyl acetate and washed with 5-formylthiophene- 221 mg of 2-carboxylic acid N- (2-methoxyethyl) methylamide [Compound No. (o)] was obtained.
1 H-NMR (300 MHz, CDCl 3 ) δ (ppm): 3.22 (roads, 3H), 3.42 (s, 3H), 3.55 to 3.75 (4H), 7.45 (d , 1H, J = 3.6 Hz), 7.69 (d, 1H, J = 3.9 Hz), 9.95 (s, 1H)
実施例1−8 本発明アルデヒド誘導体[化合物番号(p)]の合成
5-ホルミルフラン-2-カルボン酸1.20gのテトラヒドロフラン15ml及びジメチルホルムアミド5ml溶液に、カルボニルジイミダゾール1.67gを添加して室温で攪拌した後、N-(2-メトキシエチル)メチルアミン1.11mlを添加して、室温で2時間30分攪拌した。溶媒を留去した後、10%塩酸を加えて酢酸エチルで抽出し、有機層を重曹水と飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに供することにより、5-ホルミルフラン-2-カルボン酸 N-(2-メトキシエチル)メチルアミド[化合物番号(p)]の黄色油状物を得た。
1H−NMR(270MHz,CDCl3)δ(ppm):3.10(broad s,3H),3.36(s,3H),3.60〜3.80(4H),7.15〜7.25(1H),7.25〜7.30(1H),9.73(s,1H)
Examples 1-8 Synthesis of the present aldehyde derivative [Compound No. (p)]
To a solution of 1.20 g of 5-formylfuran-2-carboxylic acid in 15 ml of tetrahydrofuran and 5 ml of dimethylformamide, 1.67 g of carbonyldiimidazole was added and stirred at room temperature, and then N- (2-methoxyethyl) methylamine 1. 11 ml was added and stirred at room temperature for 2 hours 30 minutes. After the solvent was distilled off, 10% hydrochloric acid was added and the mixture was extracted with ethyl acetate. The organic layer was washed with aqueous sodium bicarbonate and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain a yellow oil of 5-formylfuran-2-carboxylic acid N- (2-methoxyethyl) methylamide [Compound No. (p)].
1 H-NMR (270 MHz, CDCl 3 ) δ (ppm): 3.10 (broad s, 3H), 3.36 (s, 3H), 3.60 to 3.80 (4H), 7.15 to 7 .25 (1H), 7.25 to 7.30 (1H), 9.73 (s, 1H)
実施例1−9 本発明アルデヒド誘導体[化合物番号(q)]の合成
5-ブロモメチルチオフェン-2-カルバルデヒド0.95g及び水酸化ナトリウム0.31gのエチレングリコール2.01g溶液を、55℃で2時間攪拌した。反応液を氷水に添加し、酢酸エチルで抽出し、有機層を飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに供することにより、5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒド[化合物番号(q)]0.15gを得た。
1H−NMR(270MHz,CDCl3)δ(ppm):3.66(t,1H,J=4.9Hz),3.79(t,1H,J=4.3Hz),4.78(s,2H), 7.10(d,1H,J=3.5Hz),7.67(d,1H,J=4.1Hz),9.89(s,1H)
Examples 1-9 Synthesis of the present aldehyde derivative [Compound No. (q)]
A solution of 0.91 g of 5-bromomethylthiophene-2-carbaldehyde and 2.01 g of ethylene glycol in 0.31 g of sodium hydroxide was stirred at 55 ° C. for 2 hours. The reaction mixture was added to ice water and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.15 g of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde [Compound No. (q)].
1 H-NMR (270 MHz, CDCl 3 ) δ (ppm): 3.66 (t, 1 H, J = 4.9 Hz), 3.79 (t, 1 H, J = 4.3 Hz), 4.78 (s) , 2H), 7.10 (d, 1H, J = 3.5 Hz), 7.67 (d, 1H, J = 4.1 Hz), 9.89 (s, 1H)
実施例1−10 本発明アルデヒド誘導体[化合物番号(r)]の合成
5-ブロモメチルチオフェン-2-カルバルデヒド3.52g、チオグリコール酸メチル2.74g及び炭酸カリウム2.84gのジメチルスルホキシド22ml溶液を、室温で2時間攪拌した。反応液を氷水に添加し、酢酸エチルで抽出し、有機層を飽和食塩水で洗浄した後、無水硫酸ナトリウムで乾燥して減圧濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに供することにより、[(5-ホルミルチオフェン-2-イル)メチルチオ]酢酸メチル[化合物番号(r)]3.16gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.36(s,3H),3.62(s,2H),4.15(s,2H),7.21(d,1H,J=3.8Hz),7.89(d,1H,J=4.1Hz),9.86(s,1H)
Example 1-10 Synthesis of aldehyde derivative of the present invention [Compound No. (r)]
A solution of 3.52 g of 5-bromomethylthiophene-2-carbaldehyde, 2.74 g of methyl thioglycolate and 2.84 g of potassium carbonate in 22 ml of dimethyl sulfoxide was stirred at room temperature for 2 hours. The reaction mixture was added to ice water and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 3.16 g of methyl [(5-formylthiophen-2-yl) methylthio] acetate [Compound No. (r)].
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.36 (s, 3H), 3.62 (s, 2H), 4.15 (s, 2H), 7.21 (d, 1H, J = 3.8 Hz), 7.89 (d, 1H, J = 4.1 Hz), 9.86 (s, 1H)
実施例1−11 本発明アルデヒド誘導体[化合物番号(s)]の合成
4-ブロモチオフェン-2-カルバルデヒド8.21g、メトキシアセトアミド4.60g、N,N’−ジメチルエチレンジアミン380mg、炭酸カリウム25.57g、よう化銅(I)829mg及びジオキサン55mlの混合物を、還流下に5時間45分加熱した。反応液をシリカゲルカラムクロマトグラフィーに供することにより、N-(2-ホルミルチオフェン-4-イル)-2-メトキシアセトアミド[化合物番号(s)]の淡黄色粉体2.52gを得た。
1H−NMR(270MHz,CDCl3)δ(ppm):3.52(s,3H),4.05(s,2H),7.87(d,1H,J=1.6Hz),7.93(d,1H,J=1.6Hz),8.57(broad s,1H),9.78(s,1H)
Example 1-11 Synthesis of aldehyde derivative of the present invention [Compound No. (s)]
A mixture of 8.21 g of 4-bromothiophene-2-carbaldehyde, 4.60 g of methoxyacetamide, 380 mg of N, N′-dimethylethylenediamine, 25.57 g of potassium carbonate, 829 mg of copper (I) iodide and 55 ml of dioxane was refluxed. For 5 hours 45 minutes. The reaction solution was subjected to silica gel column chromatography to obtain 2.52 g of a pale yellow powder of N- (2-formylthiophen-4-yl) -2-methoxyacetamide [Compound No. (s)].
1 H-NMR (270 MHz, CDCl 3 ) δ (ppm): 3.52 (s, 3H), 4.05 (s, 2H), 7.87 (d, 1H, J = 1.6 Hz), 7. 93 (d, 1H, J = 1.6 Hz), 8.57 (broad s, 1H), 9.78 (s, 1H)
実施例1−12 本発明アルデヒド誘導体[化合物番号(t)]の合成
4-ブロモチオフェン-2-カルバルデヒドの代わりに、2-ブロモチオフェン-5-カルバルデヒド2.92gを用いた以外は実施例1−11と同様にして、N-(5-ホルミルチオフェン-2-イル)-2-メトキシアセトアミド[化合物番号(t)]0.11gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.37(s,3H),4.15(s,2H),7.01(d,1H,J=4.3Hz),7.81(d,1H,J=4.3Hz),9.78(s,1H),11.72(broad,1H)
Examples 1-12 Synthesis of the present aldehyde derivative [Compound No. (t)]
N- (5-formylthiophene-2-2) was obtained in the same manner as in Example 1-11 except that 2.92 g of 2-bromothiophene-5-carbaldehyde was used instead of 4-bromothiophene-2-carbaldehyde. Yl) -2-methoxyacetamide [Compound No. (t)] 0.11 g was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.37 (s, 3H), 4.15 (s, 2H), 7.01 (d, 1H, J = 4.3 Hz), 7.81 (d, 1H, J = 4.3 Hz), 9.78 (s, 1H), 11.72 (broad, 1H)
実施例1−13 本発明アルデヒド誘導体[化合物番号(u)]の合成
メトキシアセトアミドの代わりに、カルバミン酸2-メトキシエチル2.02gを用いた以外は実施例1−11と同様にして、N-(2-ホルミルチオフェン-4-イル)カルバミン酸2-メトキシエチル[化合物番号(u)]0.12gを得た。
1H−NMR(300MHz,DMSO-d6)δ(ppm):3.28(s,3H),3.57(t,2H,J=4.5Hz),4.22(t,2H,J=4.5Hz),7.72(s,1H),7.85(s,1H),9.88(s,1H),10.31(broad,1H)
Example 1-13 Synthesis of aldehyde derivative of the present invention [Compound No. (u)] In the same manner as in Example 1-11 except that 2.02 g of 2-methoxyethyl carbamate was used instead of methoxyacetamide, N- 0.12 g of 2-methoxyethyl (2-formylthiophen-4-yl) carbamate [Compound No. (u)] was obtained.
1 H-NMR (300 MHz, DMSO-d 6 ) δ (ppm): 3.28 (s, 3H), 3.57 (t, 2H, J = 4.5 Hz), 4.22 (t, 2H, J = 4.5 Hz), 7.72 (s, 1H), 7.85 (s, 1H), 9.88 (s, 1H), 10.31 (broad, 1H)
実施例1−14 本発明アルデヒド誘導体[化合物番号(v)]の合成
4-ブロモチオフェン-2-カルバルデヒドの代わりに、2-ブロモチオフェン-5-カルバルデヒド3.76gを用い、メトキシアセトアミドの代わりに、カルバミン酸2-メトキシエチル2.81gを用いた以外は実施例1−11と同様にして、、N-(5-ホルミルチオフェン-2-イル)カルバミン酸2-メトキシエチル[化合物番号(v)]0.15gを得た。
1H−NMR(300MHz,DMSO-d6)δ(ppm):3.28(s,3H),3.57〜3.60(2H),4.27〜4.30(2H),6.69(d,1H,J=4.2Hz),7.78(d,1H,J=3.9Hz),9.72(s,1H),11.55(broad,1H)
Example 1-14 Synthesis of the present aldehyde derivative [Compound No. (v)]
Example except that 3.76 g of 2-bromothiophene-5-carbaldehyde was used instead of 4-bromothiophene-2-carbaldehyde, and 2.81 g of 2-methoxyethyl carbamate was used instead of methoxyacetamide In the same manner as in 1-11, 0.15 g of 2-methoxyethyl N- (5-formylthiophen-2-yl) carbamate [Compound No. (v)] was obtained.
1 H-NMR (300 MHz, DMSO-d 6 ) δ (ppm): 3.28 (s, 3H), 3.57 to 3.60 (2H), 4.27 to 4.30 (2H), 6. 69 (d, 1H, J = 4.2 Hz), 7.78 (d, 1H, J = 3.9 Hz), 9.72 (s, 1H), 11.55 (broad, 1H)
実施例1−15 本発明アルデヒド誘導体[化合物番号(w)]の合成
2-アミノ-5-ホルミルチアゾール2.50g及びトリエチルアミン2.44gのテトラヒドロフラン30ml溶液に、メトキシアセチルクロリド2.22gのテトラヒドロフラン8ml溶液を氷冷下に滴下し、室温で2時間30分攪拌した。不溶物を濾別し、濾液を氷水に添加して酢酸エチルで抽出し、有機層を10%塩酸と飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥して減圧濃縮し、N-(5-ホルミルチアゾール-2-イル)-2-メトキシアセトアミド[化合物番号(w)]の淡黄色粉体2.83gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.36(s,3H),4.22(s,2H),8.42(s,1H),9.97(s,1H)
Example 1-15 Synthesis of aldehyde derivative of the present invention [Compound No. (w)]
To a solution of 2.50 g of 2-amino-5-formylthiazole and 2.44 g of triethylamine in 30 ml of tetrahydrofuran was added dropwise a solution of 2.22 g of methoxyacetyl chloride in 8 ml of tetrahydrofuran under ice cooling, and the mixture was stirred at room temperature for 2 hours and 30 minutes. The insoluble material was filtered off, the filtrate was added to ice water and extracted with ethyl acetate. The organic layer was washed with 10% hydrochloric acid and saturated brine, dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and N- (5 There was obtained 2.83 g of a pale yellow powder of -formylthiazol-2-yl) -2-methoxyacetamide [Compound No. (w)].
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.36 (s, 3H), 4.22 (s, 2H), 8.42 (s, 1H), 9.97 (s, 1H)
実施例2 実施例2−1〜2−27に、本発明化合物の合成を記す。 Example 2 Synthesis of the compound of the present invention is described in Examples 2-1 to 2-27.
実施例2−1 本発明化合物[化合物番号(27a-1)]の合成
メタノール2ml及びピペリジン0.02gの混合物に、3-アセチル-4-ヒドロキシ-1,6-ジメチル-2(1H)-ピリジノン0.14g及び5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒド0.15gを溶解し、還流下に2時間30分加熱した。室温に冷却後、反応液を濃縮してシリカゲルカラムクロマトグラフィーに付し、得られた結晶をヘキサンと酢酸エチルで再結晶し、4-ヒドロキシ-3-[3-[5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-イル]-1-オキソ-2-プロペニル]-1,6-ジメチル-2(1H)-ピリジノン[化合物番号(27a-1)]の黄褐色結晶0.13gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.40(s,3H),3.49〜3.55(m, 4H),4.70(s,2H),6.04(s,1H),7.10(d,1H,J=4.1Hz),7.46(d,1H,J=3.8Hz),7.96(d,1H,J=15.1Hz),8.28(d,1H,J=15.4Hz),13.78(broad,1H)
Example 2-1 Synthesis of Compound of the Present Invention [Compound No. (27a-1)] To a mixture of 2 ml of methanol and 0.02 g of piperidine was added 3-acetyl-4-hydroxy-1,6-dimethyl-2 (1H) -pyridinone. 0.14 g and 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde 0.15 g were dissolved and heated under reflux for 2 hours 30 minutes. After cooling to room temperature, the reaction mixture was concentrated and subjected to silica gel column chromatography. The obtained crystals were recrystallized from hexane and ethyl acetate to give 4-hydroxy-3- [3- [5-[(2-hydroxy 0.13 g of yellowish brown crystals of [ethoxy) methyl] thiophen-2-yl] -1-oxo-2-propenyl] -1,6-dimethyl-2 (1H) -pyridinone [Compound No. (27a-1)] It was.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.40 (s, 3H), 3.49 to 3.55 (m, 4H), 4. 70 (s, 2H), 6.04 (s, 1H), 7.10 (d, 1H, J = 4.1 Hz), 7.46 (d, 1H, J = 3.8 Hz), 7.96 ( d, 1H, J = 15.1 Hz), 8.28 (d, 1H, J = 15.4 Hz), 13.78 (broad, 1H)
実施例2−2 本発明化合物[化合物番号(34a-1)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、[(5-ホルミルチオフェン-2-イル)メチルチオ]酢酸メチル2.56gを用いた以外は実施例2−1と同様にして、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルチオ]酢酸メチル[化合物番号(34a-1)]の黄褐色結晶1.22gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.29(s,2H),3.40(s,3H),3.63(s,3H),4.10(s,2H),6.04(s,1H),7.05(d,1H,J=3.8Hz),7.43(d,1H,J=3.2Hz),7.94(d,1H,J=15.4Hz),8.26(d,1H,J=15.7Hz),16.23(broad s,1H)
Example 2-2 Synthesis of Compound of the Present Invention [Compound No. (34a-1)]
Example 2-1 except that 2.56 g of methyl [(5-formylthiophen-2-yl) methylthio] acetate was used instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde Similarly, [[5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl ] 1.22 g of yellow-brown crystals of [methylthio] acetic acid methyl [Compound No. (34a-1)] were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.29 (s, 2H), 3.40 (s, 3H), 3.63 (s, 3H), 4.10 (s, 2H), 6.04 (s, 1H), 7.05 (d, 1H, J = 3.8 Hz), 7.43 (d, 1H, J = 3.2 Hz) 7.94 (d, 1H, J = 15.4 Hz), 8.26 (d, 1H, J = 15.7 Hz), 16.23 (broad s, 1H)
実施例2−3 本発明化合物[化合物番号(35a-1)]の合成
[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルチオ]酢酸メチル0.51gの塩化メチレン10ml溶液に、氷冷下にm−クロロ過安息香酸0.24gを添加し、氷冷下に攪拌した。反応液を減圧濃縮し、酢酸エチルを加え、有機層を炭酸水素ナトリウム水と飽和食塩水で洗浄した後減圧濃縮し、残渣をシリカゲルカラムクロマトグラフィーに付し、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルフィニル]酢酸メチル[化合物番号(35a-1)]の黄色結晶0.20gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.40(s,3H),3.70(s,3H),3.73(d,1H,J=12.4Hz),4.02(d,1H,J=14.3Hz),4.43(d,1H,J=13.8Hz),4.59(d,1H,J=13.8Hz),6.04(s,1H),7.14(d,1H,J=3.5Hz),7.53(d,1H,J=3.8Hz),7.95(d,1H,J=15.7Hz),8.31(d,1H,J=15.7Hz),16.18(s,1H)
Example 2-3 Synthesis of Compound of the Present Invention [Compound No. (35a-1)]
[[5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylthio] acetic acid To a solution of 0.51 g of methyl in 10 ml of methylene chloride was added 0.24 g of m-chloroperbenzoic acid under ice cooling, and the mixture was stirred under ice cooling. The reaction mixture was concentrated under reduced pressure, ethyl acetate was added, the organic layer was washed with aqueous sodium hydrogen carbonate and saturated brine, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, [[5- [3- (4 -Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylsulfinyl] acetate [Compound No. (35a-1) )] Yellow crystals 0.20 g was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.40 (s, 3H), 3.70 (s, 3H), 3.73 (d, 1H, J = 12.4 Hz), 4.02 (d, 1H, J = 14.3 Hz), 4.43 (d, 1H, J = 13.8 Hz), 4.59 (d, 1H, J = 13) .8 Hz), 6.04 (s, 1 H), 7.14 (d, 1 H, J = 3.5 Hz), 7.53 (d, 1 H, J = 3.8 Hz), 7.95 (d, 1 H) , J = 15.7 Hz), 8.31 (d, 1H, J = 15.7 Hz), 16.18 (s, 1H)
実施例2−4 本発明化合物[化合物番号(36a-1)]の合成
[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルチオ]酢酸メチル0.49gの塩化メチレン10ml溶液に、氷冷下にm−クロロ過安息香酸0.60gを添加し、氷冷下に3時間攪拌した。反応液を実施例2−3と同様にして処理し、 [[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルホニル]酢酸メチル[化合物番号(36a-1)]の黄色結晶0.28gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.41(s,3H),3.40(s,3H),3.74(s,3H),4.44(s,2H),5.00(s,2H),6.05(s,1H),7.22(d,1H,J=3.8Hz),7.53(d,1H,J=3.5Hz),7.96(d,1H,J=15.7Hz),8.33(d,1H,J=15.7Hz),16.11(s,1H)
Example 2-4 Synthesis of the present compound [Compound No. (36a-1)]
[[5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylthio] acetic acid To a solution of 0.49 g of methyl in 10 ml of methylene chloride, 0.60 g of m-chloroperbenzoic acid was added under ice cooling, and the mixture was stirred for 3 hours under ice cooling. The reaction solution was treated in the same manner as in Example 2-3 to obtain [[5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3- 0.28 g of yellow crystals of oxo-1-propenyl] thiophen-2-yl] methylsulfonyl] acetate [Compound No. (36a-1)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.41 (s, 3H), 3.40 (s, 3H), 3.74 (s, 3H), 4.44 (s, 2H), 5.00 (s, 2H), 6.05 (s, 1H), 7.22 (d, 1H, J = 3.8 Hz), 7.53 (d, 1H, J = 3.5 Hz) 7.96 (d, 1H, J = 15.7 Hz), 8.33 (d, 1H, J = 15.7 Hz), 16.11 (s, 1H)
実施例2−5 本発明化合物[化合物番号(37a-1)]の合成
[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルフィニル]酢酸メチル0.17gのメタノール5ml溶液に、1規定水酸化ナトリウム水溶液5mlを添加した。室温で攪拌し、溶媒を減圧留去して10%塩酸で酸性とし、析出した結晶を濾取して乾燥することにより、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルフィニル]酢酸[化合物番号(37a-1)]の褐色結晶0.09gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.40(s,3H),3.88〜4.04(2H),4.36〜4.58(2H),6.04(s,1H),7.13(d,1H,J=3.5Hz),7.53(d,1H,J=3.8Hz),7.96(d,1H,J=15.7Hz),8.32(d,1H,J=15.4Hz),16.19(1H)
Example 2-5 Synthesis of Compound of the Present Invention [Compound No. (37a-1)]
[[5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylsulfinyl] To a solution of 0.17 g of methyl acetate in 5 ml of methanol was added 5 ml of a 1N aqueous sodium hydroxide solution. The mixture was stirred at room temperature, the solvent was distilled off under reduced pressure, acidified with 10% hydrochloric acid, and the precipitated crystals were collected by filtration and dried to give [[5- [3- (4-hydroxy-1,6-dimethyl- 0.09 g of brown crystals of 2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylsulfinyl] acetic acid [Compound No. (37a-1)] It was.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.40 (s, 3H), 3.88 to 4.04 (2H), 4.36 to 4.58 (2H), 6.04 (s, 1H), 7.13 (d, 1H, J = 3.5 Hz), 7.53 (d, 1H, J = 3.8 Hz), 7.96 ( d, 1H, J = 15.7 Hz), 8.32 (d, 1H, J = 15.4 Hz), 16.19 (1H)
実施例2−6 本発明化合物[化合物番号(38a-1)]の合成
[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルフィニル]酢酸メチルの代わりに、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルホニル]酢酸メチル0.22gを用いた以外は実施例2−5と同様にして、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルホニル]酢酸[化合物番号(38a-1)]の黄褐色結晶0.18gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.40(s,3H),4.28(s,2H),4.97(s,2H),6.05(s,1H),7.22(d,1H,J=3.5Hz),7.53(d,1H,J=4.1Hz),7.96(d,1H,J=15.7Hz),8.33(d,1H,J=15.7Hz)
Example 2-6 Synthesis of the present compound [Compound No. (38a-1)]
[[5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylsulfinyl] Instead of methyl acetate, [[5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophene-2 [[5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2], except that 0.22 g of methyl -yl] methylsulfonyl] acetate was used 0.18 g of yellowish brown crystals of 2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylsulfonyl] acetic acid [Compound No. (38a-1)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.40 (s, 3H), 4.28 (s, 2H), 4.97 (s, 2H), 6.05 (s, 1H), 7.22 (d, 1H, J = 3.5 Hz), 7.53 (d, 1H, J = 4.1 Hz), 7.96 (d, 1H, J = 15.7 Hz), 8.33 (d, 1H, J = 15.7 Hz)
実施例2−7 本発明化合物[化合物番号(40a-1)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、N-(5-ホルミルチオフェン-2-イル)カルバミン酸2-メトキシエチル0.15gを用い、メタノールの代わりに、エタノール3mlを用いた以外は実施例2−1と同様にして、[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル] カルバミン酸2-メトキシエチル[化合物番号(40a-1)]の赤色結晶0.16gを得た。
1H−NMR(300MHz,DMSO-d6)δ(ppm):2.39(s,3H),3.29(s,3H),3.40(s,3H),3.58〜3.60(2H),4.27〜4.30(2H),6.05(s,1H),6.59(d,1H,J=3.9Hz),7.37(d,1H,J=4.2Hz),7.95(d,1H,J=15.3Hz),8.18(d,1H,J=15.6Hz),11.51(broad,1H),16.59(s,1H)
Example 2-7 Synthesis of Compound of the Present Invention [Compound No. (40a-1)]
Instead of methanol, instead of 0.15 g of 2-methoxyethyl N- (5-formylthiophen-2-yl) carbamate instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde [5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3] was prepared in the same manner as in Example 2-1, except that 3 ml of ethanol was used. -Oxo-1-propenyl] thiophen-2-yl] 0.16 g of red crystals of 2-methoxyethyl carbamate [Compound No. (40a-1)] was obtained.
1 H-NMR (300 MHz, DMSO-d 6 ) δ (ppm): 2.39 (s, 3H), 3.29 (s, 3H), 3.40 (s, 3H), 3.58-3. 60 (2H), 4.27 to 4.30 (2H), 6.05 (s, 1H), 6.59 (d, 1H, J = 3.9 Hz), 7.37 (d, 1H, J = 4.2 Hz), 7.95 (d, 1 H, J = 15.3 Hz), 8.18 (d, 1 H, J = 15.6 Hz), 11.51 (broad, 1 H), 16.59 (s, 1H)
実施例2−8 本発明化合物[化合物番号(46a-1)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、N-(5-ホルミルチオフェン-2-イル)-2-メトキシアセトアミド0.11gを用い、メタノールの代わりに、エタノール2mlを用いた以外は実施例2−1と同様にして、4-ヒドロキシ-3-[3-[5-(メトキシアセチルアミノ)チオフェン-2-イル]-1-オキソ-2-プロペニル]-1,6-ジメチル-2(1H)-ピリジノン[化合物番号(46a-1)]の赤褐色結晶0.11gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.40(s,6H),4.14(s,2H),6.01(s,1H),6.90(d,1H,J=3.8Hz),7.40(d,1H,J=4.1Hz),7.97(d,1H,J=15.1Hz),8.21(d,1H,J=15.7Hz)
Example 2-8 Synthesis of Compound of the Present Invention [Compound No. (46a-1)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 0.11 g of N- (5-formylthiophen-2-yl) -2-methoxyacetamide was used, and ethanol was used instead of methanol. 4-Hydroxy-3- [3- [5- (5- (methoxyacetylamino) thiophen-2-yl] -1-oxo-2-propenyl] -1 in the same manner as in Example 2-1, except that 2 ml was used. , 6-Dimethyl-2 (1H) -pyridinone [Compound No. (46a-1)] 0.11 g of reddish brown crystals was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.40 (s, 6H), 4.14 (s, 2H), 6.01 (s, 1H), 6.90 (d, 1H, J = 3.8 Hz), 7.40 (d, 1H, J = 4.1 Hz), 7.97 (d, 1H, J = 15.1 Hz), 8. 21 (d, 1H, J = 15.7 Hz)
実施例2−9 本発明化合物[化合物番号(54a-1)]の合成
エタノール6ml及びピペリジン84μlの混合物に、3-アセチル-4-ヒドロキシ-1,6-ジメチル-2(1H)-ピリジノン440mg及び5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミド569mgを溶解し、還流下に5時間加熱した。室温に冷却後、析出した結晶を濾取してエタノール及びヘキサンで洗浄し、5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-カルボン酸 2-ヒドロキシエチルアミド[化合物番号(54a-1)]の黄色結晶678mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.24(s,3H),3.20〜3.40(m, 2H),3.45〜3.55(m, 2H),4.77(t,1H,J=5.4Hz),6.05(s,1H),7.55(d,1H,J=4.1Hz),7.76(d,1H,J=4.1Hz),7.91(d,1H,J=15.4Hz),8.37(d,1H,J=15.4Hz),8.65(t,1H,J=5.4Hz),15.95(broad,1H)
Example 2-9 Synthesis of Compound of the Present Invention [Compound No. (54a-1)] To a mixture of 6 ml of ethanol and 84 μl of piperidine, 440 mg of 3-acetyl-4-hydroxy-1,6-dimethyl-2 (1H) -pyridinone and 569 mg of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide was dissolved and heated under reflux for 5 hours. After cooling to room temperature, the precipitated crystals were collected by filtration and washed with ethanol and hexane to give 5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) 678 mg of yellow crystals of 3-oxo-1-propenyl] thiophene-2-carboxylic acid 2-hydroxyethylamide [Compound No. (54a-1)] were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.24 (s, 3H), 3.20 to 3.40 (m, 2H), 3. 45-3.55 (m, 2H), 4.77 (t, 1H, J = 5.4 Hz), 6.05 (s, 1H), 7.55 (d, 1H, J = 4.1 Hz), 7.76 (d, 1H, J = 14.1 Hz), 7.91 (d, 1H, J = 15.4 Hz), 8.37 (d, 1H, J = 15.4 Hz), 8.65 (t , 1H, J = 5.4 Hz), 15.95 (broad, 1H)
実施例2−10 本発明化合物[化合物番号(56a-1)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミドの代わりに、5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミド0.30gを用いた以外は実施例2−9と同様にして、5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-カルボン酸 2-メトキシエチルアミド[化合物番号(56a-1)]の黄色結晶0.27gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.41(s,3H),3.27(s,3H),3.30(s,3H),3.40〜3.53(m, 4H),6.06(s,1H),7.56(d,1H,J=4.1Hz),7.78(d,1H,J=4.1Hz),7.93(d,1H,J=16.9Hz),8.38(d,1H,J=16.9Hz),8.74(t,1H,J=5.0Hz),14.00(broad s,1H)
Example 2-10 Synthesis of the present compound [Compound No. (56a-1)]
In the same manner as in Example 2-9, except that 0.30 g of 5-formylthiophene-2-carboxylic acid 2-methoxyethylamide was used instead of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide, 5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophene-2-carboxylic acid 2-methoxyethylamide 0.27 g of yellow crystals of [Compound No. (56a-1)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.41 (s, 3H), 3.27 (s, 3H), 3.30 (s, 3H), 3.40-3. 53 (m, 4H), 6.06 (s, 1H), 7.56 (d, 1H, J = 4.1 Hz), 7.78 (d, 1H, J = 4.1 Hz), 7.93 ( d, 1H, J = 16.9 Hz), 8.38 (d, 1H, J = 16.9 Hz), 8.74 (t, 1H, J = 5.0 Hz), 14.00 (broad s, 1H)
実施例2−11 本発明化合物[化合物番号(58a-1)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、5-ホルミルチオフェン-2-カルボン酸 N-(2-メトキシエチル)メチルアミド150mgを用い、メタノールの代わりに、エタノールを用いた以外は実施例2−1と同様にして、[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル] カルボン酸 N-(2-メトキシエチル)メチルアミド[化合物番号(58a-1)]の黄色結晶113mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.14(3H),3.27(s,3H),3.40(s,3H),3.55(t,2H,J=4.9Hz),3.65(t,2H,J=4.9Hz),6.05(s,1H),7.51(d,1H,J=4.1Hz),7.54(d,1H,J=3.8Hz),7.94(d,1H,J=15.4Hz),8.35(d,1H,J=15.4Hz),14.00(broad s,1H)
Example 2-11 Synthesis of the compound of the present invention [Compound No. (58a-1)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 150 mg of 5-formylthiophene-2-carboxylic acid N- (2-methoxyethyl) methylamide was used, and ethanol was used instead of methanol. [5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-] was carried out in the same manner as in Example 2-1, except that it was used. 1-propenyl] thiophen-2-yl] carboxylic acid N- (2-methoxyethyl) methylamide [Compound No. (58a-1)] 113 mg of yellow crystals was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.14 (3H), 3.27 (s, 3H), 3.40 (s, 3H) 3.55 (t, 2H, J = 4.9 Hz), 3.65 (t, 2H, J = 4.9 Hz), 6.05 (s, 1H), 7.51 (d, 1H, J = 4.1 Hz), 7.54 (d, 1 H, J = 3.8 Hz), 7.94 (d, 1 H, J = 15.4 Hz), 8.35 (d, 1 H, J = 15.4 Hz), 14.00 (broad s, 1H)
実施例2−12 本発明化合物[化合物番号(63a-1)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミドの代わりに、5-ホルミルチオフェン-2-カルボン酸 カルバモイルメチルアミド100mgを用いた以外は実施例2−9と同様にして、5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-カルボン酸 カルバモイルメチルアミド[化合物番号(63a-1)]の黄色結晶77.6mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.41(s,3H),3.40(s,3H),3.41(d,1H,J=5.9Hz),6.05(s,1H),7.07(broad,1H),7.43(broad,1H),7.57(d,1H,J=4.0Hz),7.79(d,1H,J=3.9Hz),7.93(d,1H,J=15.7Hz),8.39(d,1H,J=15.4Hz),8.88(t,1H,J=5.9Hz),15.97(broad,1H)
Example 2-12 Synthesis of the present compound [Compound No. (63a-1)]
5-formylthiophene-2-carboxylic acid In the same manner as in Example 2-9 except that 100 mg of 5-formylthiophene-2-carboxylic acid carbamoylmethylamide was used instead of 2-hydroxyethylamide, 5- [3 -(4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophene-2-carboxylic acid carbamoylmethylamide [Compound No. (63a- 17.6] of yellow crystals was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.41 (s, 3H), 3.40 (s, 3H), 3.41 (d, 1H, J = 5.9 Hz), 6.05 (s, 1H), 7.07 (road, 1H), 7.43 (road, 1H), 7.57 (d, 1H, J = 4.0 Hz), 7.79 (d, 1H, J = 3.9 Hz), 7.93 (d, 1H, J = 15.7 Hz), 8.39 (d, 1H, J = 15.4 Hz), 8.88 (t, 1H, J = 5.9 Hz) ), 15.97 (broad, 1H)
実施例2−13 本発明化合物[化合物番号(71a-1)]の合成
[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルスルフィニル]酢酸メチルの代わりに、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルチオ]酢酸メチル0.10gを用いた以外は実施例2−5と同様にして、[[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル]メチルチオ]酢酸[化合物番号(71a-1)]の黄褐色結晶0.09gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.25(s,2H),3.40(s,3H),4.10(s,2H),6.04(s,1H),7.05(d,1H,J=3.8Hz),7.43(d,1H,J=3.5Hz),7.95(d,1H,J=15.7Hz),8.26(d,1H,J=15.7Hz),16.24(s,1H)
Example 2-13 Synthesis of the compound of the present invention [Compound No. (71a-1)]
[[5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylsulfinyl] Instead of methyl acetate, [[5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophene-2 [[5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2] in the same manner as in Example 2-5, except that 0.10 g of methyl -yl] methylthio] acetate was used. 0.09 g of tan crystals of -dihydropyridin-3-yl) -3-oxo-1-propenyl] thiophen-2-yl] methylthio] acetic acid [Compound No. (71a-1)] were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.25 (s, 2H), 3.40 (s, 3H), 4.10 (s, 2H), 6.04 (s, 1H), 7.05 (d, 1H, J = 3.8 Hz), 7.43 (d, 1H, J = 3.5 Hz), 7.95 (d, 1H, J = 15.7 Hz), 8.26 (d, 1H, J = 15.7 Hz), 16.24 (s, 1H)
実施例2−14 本発明化合物[化合物番号(72a-1)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、5-[N-(2-ジメチルアミノエチル)メチルアミノ]チオフェン-2-カルバルデヒド0.32gを用い、メタノールの代わりに、エタノールを用いた以外は実施例2−1と同様にして、4-ヒドロキシ-3-[3-[5-[N-(2-ジメチルアミノエチル)メチルアミノ]チオフェン-2-イル]-1-オキソ-2-プロペニル]-1,6-ジメチル-2(1H)-ピリジノン[化合物番号(72a-1)]の赤褐色結晶80mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.19(s,6H),2.36(s,3H),2.45〜2.55(2H),3.09(s,3H),3.36(s,3H),3.51(t,2H,J=8.1Hz),5.92(s,1H),6.09(d,1H,J=5.4Hz),7.40(d,1H,J=5.4Hz),7.84(d,1H,J=16.2Hz),7.96(d,1H,J=16.2Hz)
Example 2-14 Synthesis of Compound of the Present Invention [Compound No. (72a-1)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 0.32 g of 5- [N- (2-dimethylaminoethyl) methylamino] thiophene-2-carbaldehyde was used. Instead, 4-hydroxy-3- [3- [5- [N- (2-dimethylaminoethyl) methylamino] thiophen-2-yl] was prepared in the same manner as in Example 2-1, except that ethanol was used. 80 mg of reddish brown crystals of 1-oxo-2-propenyl] -1,6-dimethyl-2 (1H) -pyridinone [Compound No. (72a-1)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.19 (s, 6H), 2.36 (s, 3H), 2.45 to 2.55 (2H), 3.09 ( s, 3H), 3.36 (s, 3H), 3.51 (t, 2H, J = 8.1 Hz), 5.92 (s, 1H), 6.09 (d, 1H, J = 5. 4 Hz), 7.40 (d, 1 H, J = 5.4 Hz), 7.84 (d, 1 H, J = 16.2 Hz), 7.96 (d, 1 H, J = 16.2 Hz)
実施例2−15 本発明化合物[化合物番号(10a-2)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミドの代わりに、5-ホルミルフラン-2-カルボン酸 2-メトキシエチルアミド0.59gを用いた以外は実施例2−9と同様にして、5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]フラン-2-カルボン酸 2-メトキシエチルアミド[化合物番号(10a-2)]の黄色結晶0.82gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm): 2.41(s,3H),3.28(s,3H),3.41〜3.47(m, 7H),6.05(s,1H),7.10(d,1H,J=3.6Hz),7.26(d,1H,J=3.6Hz),7.61(d,1H,J=15.7Hz),8.35(d,1H,J=15.7Hz),8.60(broad,1H),15.95(broad s,1H)
Example 2-15 Synthesis of the present compound [Compound No. (10a-2)]
In the same manner as in Example 2-9, except that 0.59 g of 5-formylfuran-2-carboxylic acid 2-methoxyethylamide was used instead of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide, 5- [3- (4-Hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] furan-2-carboxylic acid 2-methoxyethylamide 0.82 g of yellow crystals of [Compound No. (10a-2)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.41 (s, 3H), 3.28 (s, 3H), 3.41 to 3.47 (m, 7H), 6. 05 (s, 1H), 7.10 (d, 1H, J = 3.6 Hz), 7.26 (d, 1H, J = 3.6 Hz), 7.61 (d, 1H, J = 15.7 Hz) ), 8.35 (d, 1H, J = 15.7 Hz), 8.60 (broad, 1H), 15.95 (broads, 1H)
実施例2−16 本発明化合物[化合物番号(12a-2)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、5-ホルミルフラン-2-カルボン酸 N-(2-メトキシエチル)メチルアミド150mgを用い、メタノールの代わりに、エタノールを用いた以外は実施例2−1と同様にして、[5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]フラン-2-イル] カルボン酸 N-(2-メトキシエチル)メチルアミド[化合物番号(12a-2)]の黄色結晶57mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.02(broad s,3H),3.28(s,3H),3.40(s,3H),3.50〜3.75(4H),6.05(s,1H),7.09〜7.15(2H),7.63(d,1H,J=15.7Hz),8.39(d,1H,J=15.9Hz),16.04(s,1H)
Example 2-16 Synthesis of the present compound [compound number (12a-2)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 150 mg of 5-formylfuran-2-carboxylic acid N- (2-methoxyethyl) methylamide was used, and ethanol was used instead of methanol. [5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-] was carried out in the same manner as in Example 2-1, except that it was used. 1-propenyl] furan-2-yl] carboxylic acid N- (2-methoxyethyl) methylamide [Compound No. (12a-2)] (57 mg) was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.02 (broad s, 3H), 3.28 (s, 3H), 3.40 (s , 3H), 3.50 to 3.75 (4H), 6.05 (s, 1H), 7.09 to 7.15 (2H), 7.63 (d, 1H, J = 15.7 Hz), 8.39 (d, 1H, J = 15.9 Hz), 16.04 (s, 1H)
実施例2−17 本発明化合物[化合物番号(1a-3)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミドの代わりに、5-ホルミル-1-メチル-1H-ピロール-2-カルボン酸 2-メトキシエチルアミド1.17gを用いた以外は実施例2−9と同様にして、5-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]-1-メチル-1H-ピロール-2-カルボン酸 2-メトキシエチルアミド[化合物番号(1a-3)]の黄色結晶0.72gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm): 2.39(s,3H),3.27(s,3H),3.41(s,3H),3.43〜3.46(m, 4H),3.99(s,3H),6.02(s,1H),6.76(d,1H,J=4.3Hz),6.86(d,1H,J=4.3Hz),7.82(d,1H,J=15.5Hz),8.20(t,1H,J=4.8Hz),8.37(d,1H,J=15.5Hz)
Example 2-17 Synthesis of Compound of the Present Invention [Compound No. (1a-3)]
Example 2 except that 1.17 g of 5-formyl-1-methyl-1H-pyrrole-2-carboxylic acid 2-methoxyethylamide was used instead of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide In the same manner as -9, 5- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] -1-methyl 0.72 g of yellow crystals of -1H-pyrrole-2-carboxylic acid 2-methoxyethylamide [Compound No. (1a-3)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.39 (s, 3H), 3.27 (s, 3H), 3.41 (s, 3H), 3.43-3. 46 (m, 4H), 3.99 (s, 3H), 6.02 (s, 1H), 6.76 (d, 1H, J = 4.3 Hz), 6.86 (d, 1H, J = 4.3 Hz), 7.82 (d, 1 H, J = 15.5 Hz), 8.20 (t, 1 H, J = 4.8 Hz), 8.37 (d, 1 H, J = 15.5 Hz)
実施例2−18 本発明化合物[化合物番号(2a-3)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミドの代わりに、4-ホルミル-1-メチル-1H-ピロール-2-カルボン酸 2-メトキシエチルアミド361mgを用いた以外は実施例2−9と同様にして、4-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]-1-メチル-1H-ピロール-2-カルボン酸 2-メトキシエチルアミド[化合物番号(2a-3)]の黄色結晶506mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm): 2.39(s,3H),3.23(s,3H),3.33(s,3H),3.89(s,3H),3.30〜3.50(m, 4H),5.99(s,1H),7.25(d,1H,J=1.9Hz),7.46(d,1H,J=1.9Hz),7.76(d,1H,J=15.4Hz),8.24(d,1H,J=15.7Hz),8.37(t,1H,J=5.4Hz),16.71(broad s,1H)
Example 2-18 Synthesis of Compound of the Present Invention [Compound No. (2a-3)]
Example 2-9, except that 361 mg of 4-formyl-1-methyl-1H-pyrrole-2-carboxylic acid 2-methoxyethylamide was used instead of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide 4- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3-oxo-1-propenyl] -1-methyl-1H 506 mg of yellow crystals of 2-pyrrole-2-carboxylic acid 2-methoxyethylamide [Compound No. (2a-3)] were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.39 (s, 3H), 3.23 (s, 3H), 3.33 (s, 3H), 3.89 (s, 3H), 3.30 to 3.50 (m, 4H), 5.99 (s, 1H), 7.25 (d, 1H, J = 1.9 Hz), 7.46 (d, 1H, J = 1.9 Hz), 7.76 (d, 1 H, J = 15.4 Hz), 8.24 (d, 1 H, J = 15.7 Hz), 8.37 (t, 1 H, J = 5.4 Hz), 16.71 (broad s, 1H)
実施例2−19 本発明化合物[化合物番号(9a-3)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、N-(5-ホルミルチアゾール-2-イル)-2-メトキシアセトアミド0.15gを用い、メタノールの代わりに、エタノールを用いた以外は実施例2−1と同様にして、4-ヒドロキシ-3-[3-[2-(メトキシアセチルアミノ)チアゾール-5-イル]-1-オキソ-2-プロペニル]-1,6-ジメチル-2(1H)-ピリジノン[化合物番号(9a-3)]の黄色結晶0.13gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.37(s,3H),3.41(s,3H),4.21(s,2H),6.04(s,1H),7.98(s,1H),8.02(d,1H,J=18.9Hz),8.22(d,1H,J=16.2Hz),12.49(broad s,1H),16.25(s,1H)
Example 2-19 Synthesis of Compound of the Present Invention [Compound No. (9a-3)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 0.15 g of N- (5-formylthiazol-2-yl) -2-methoxyacetamide was used, and ethanol was used instead of methanol. 4-hydroxy-3- [3- [2- (methoxyacetylamino) thiazol-5-yl] -1-oxo-2-propenyl] -1, similar to Example 2-1, except that 0.13 g of yellow crystals of 6-dimethyl-2 (1H) -pyridinone [Compound No. (9a-3)] was obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.37 (s, 3H), 3.41 (s, 3H), 4.21 (s, 2H), 6.04 (s, 1H), 7.98 (s, 1H), 8.02 (d, 1H, J = 18.9 Hz), 8.22 (d, 1H, J = 16.2 Hz) , 12.49 (broad s, 1H), 16.25 (s, 1H)
実施例2−20 本発明化合物[化合物番号(10a-3)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、N-(2-ホルミルチオフェン-4-イル)-2-メトキシアセトアミド0.15gを用い、メタノールの代わりに、エタノール2mlを用いた以外は実施例2−1と同様にして、4-ヒドロキシ-3-[3-[4-(メトキシアセチルアミノ)チオフェン-2-イル]-1-オキソ-2-プロペニル]-1,6-ジメチル-2(1H)-ピリジノン[化合物番号(10a-3)]の黄褐色結晶0.20gを得た。
1H−NMR(300MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.38(s,3H),3.40(s,3H),4.01(s,2H),6.04(s,1H),7.69(s,1H),7.79(s,1H),7.92(d,1H,J=15.6Hz),8.34(d,1H,J=15.6Hz),10.34(s,1H)
Example 2-20 Synthesis of the present compound [Compound No. (10a-3)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 0.15 g of N- (2-formylthiophen-4-yl) -2-methoxyacetamide was used, and ethanol was used instead of methanol. 4-hydroxy-3- [3- [4- (methoxyacetylamino) thiophen-2-yl] -1-oxo-2-propenyl] -1 in the same manner as in Example 2-1, except that 2 ml was used. , 6-Dimethyl-2 (1H) -pyridinone [Compound No. (10a-3)] 0.20 g of tan crystals were obtained.
1 H-NMR (300 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.38 (s, 3H), 3.40 (s, 3H), 4.01 (s, 2H), 6.04 (s, 1H), 7.69 (s, 1H), 7.79 (s, 1H), 7.92 (d, 1H, J = 15.6 Hz), 8.34 (d , 1H, J = 15.6 Hz), 10.34 (s, 1H)
実施例2−21 本発明化合物[化合物番号(11a-3)]の合成
5-[(2-ヒドロキシエトキシ)メチル]チオフェン-2-カルバルデヒドの代わりに、N-(2-ホルミルチオフェン-4-イル)カルバミン酸2-メトキシエチル0.12gを用い、メタノールの代わりに、エタノール2mlを用いた以外は実施例2−1と同様にして、[4-[3-(4-ヒドロキシ-1,6-ジメチル-2-オキソ-1,2-ジヒドロピリジン-3-イル)-3-オキソ-1-プロペニル]チオフェン-2-イル] カルバミン酸2-メトキシエチル[化合物番号(11a-3)]の黄褐色結晶0.09gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.40(s,3H),3.28(s,3H),3.39(s,3H),3.56(t,2H,J=5.4Hz),4.21(t,2H,J=5.4Hz),6.04(s,1H),7.39(s,1H),7.44(s,1H),7.90(d,1H,J=13.5Hz),8.31(d,1H,J=16.2Hz),10.16(broad,1H),16.18(s,1H)
Example 2-21 Synthesis of the compound of the present invention [Compound No. (11a-3)]
Instead of 5-[(2-hydroxyethoxy) methyl] thiophene-2-carbaldehyde, 0.12 g of 2-methoxyethyl N- (2-formylthiophen-4-yl) carbamate was used, and instead of methanol, [4- [3- (4-hydroxy-1,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) -3] was prepared in the same manner as in Example 2-1, except that 2 ml of ethanol was used. -Oxo-1-propenyl] thiophen-2-yl] 0.09 g of tan crystals of 2-methoxyethyl carbamate [Compound No. (11a-3)] were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.40 (s, 3H), 3.28 (s, 3H), 3.39 (s, 3H), 3.56 (t, 2H, J = 5.4 Hz), 4.21 (t, 2H, J = 5.4 Hz), 6.04 (s, 1H), 7.39 (s, 1H), 7.44 (s, 1H) 7.90 (d, 1H, J = 13.5 Hz), 8.31 (d, 1H, J = 16.2 Hz), 10.16 (road, 1H), 16.18 (s, 1H)
実施例2−22 本発明化合物[化合物番号(10h)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミド0.10gのエタノール3ml溶液に、3-アセチル-4-ヒドロキシ-1-メチル-1H-[1,8]ナフチリジン-2-オン0.10g及びピペリジン0.015mlを加え、還流下に4時間加熱した。室温に冷却後、析出した結晶を濾取して酢酸エチル及びヘキサンで洗浄し、4-ヒドロキシ-1-メチル-3-[3-[5-[(2-メトキシエチル)アミノカルボニル]チオフェン-2-イル]アクリロイル]-1H-[1,8]ナフチリジン-2-オン[化合物番号(10h)]の黄褐色結晶0.13gを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.28(s,3H),3.41〜3.48(m,4H),3.65(s,3H),7.35〜7.42(1H),7.63〜7.65(1H),7.79〜7.81(1H),8.08(d,1H,J=15.9Hz),8.41〜8.51(1H),8.47(dd,1H,J=1.9,5.9Hz),8.77〜8.78(2H),17.75(broad,1H)
Example 2-22 Synthesis of the compound of the present invention [Compound No. (10h)]
3-Acetyl-4-hydroxy-1-methyl-1H- [1,8] naphthyridin-2-one 0.10 g in a solution of 5-formylthiophene-2-carboxylic acid 2-methoxyethylamide 0.10 g in ethanol 3 ml And piperidine (0.015 ml) were added, and the mixture was heated under reflux for 4 hours. After cooling to room temperature, the precipitated crystals were collected by filtration and washed with ethyl acetate and hexane to give 4-hydroxy-1-methyl-3- [3- [5-[(2-methoxyethyl) aminocarbonyl] thiophene-2. 0.13 g of tan crystals of -yl] acryloyl] -1H- [1,8] naphthyridin-2-one [Compound No. (10h)] were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.28 (s, 3H), 3.41 to 3.48 (m, 4H), 3.65 (s, 3H), 7. 35-7.42 (1H), 7.63-7.65 (1H), 7.79-7.81 (1H), 8.08 (d, 1H, J = 15.9 Hz), 8.41- 8.51 (1H), 8.47 (dd, 1H, J = 1.9, 5.9 Hz), 8.77-8.78 (2H), 17.75 (broad, 1H)
実施例2−23 本発明化合物[化合物番号(14h)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミド500mgのエタノール8ml溶液に、3-アセチル-4-ヒドロキシ-2-メチル-2H-1,2-ベンゾチアジン-1,1-ジオキシド593mg及びピペリジン60mgを加え、還流下に8時間加熱した。室温に冷却後、析出した結晶を濾取してメタノールで洗浄し、4-ヒドロキシ-3-[3-[5-[(2-メトキシエチル)アミノカルボニル]チオフェン-2-イル]アクリロイル]-2-メチル-2H-1,2-ベンゾチアジン-1,1-ジオキシド[化合物番号(14h)]の橙色結晶777mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.95(s,3H),3.28(s,3H),3.41〜3.46(m,4H),7.18(d,1H,J=13.5Hz),7.74〜7.79(broad,1H),7.83(d,1H,J=2.7Hz),7.93〜8.06(m,4H),8.14〜8.17(m,1H),8.74〜8.79(m,1H)
Example 2-23 Synthesis of the compound of the present invention [Compound No. (14h)]
5-formylthiophene-2-carboxylic acid 2-methoxyethylamide 500 mg in ethanol 8 ml solution, 3-acetyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-1,1-dioxide 593 mg and piperidine 60 mg And heated under reflux for 8 hours. After cooling to room temperature, the precipitated crystals were collected by filtration and washed with methanol to give 4-hydroxy-3- [3- [5-[(2-methoxyethyl) aminocarbonyl] thiophen-2-yl] acryloyl] -2 There was obtained 777 mg of orange crystals of -methyl-2H-1,2-benzothiazine-1,1-dioxide [Compound No. (14h)].
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.95 (s, 3H), 3.28 (s, 3H), 3.41 to 3.46 (m, 4H), 7. 18 (d, 1H, J = 13.5 Hz), 7.74-7.79 (road, 1H), 7.83 (d, 1H, J = 2.7 Hz), 7.93-8.06 (m , 4H), 8.14 to 8.17 (m, 1H), 8.74 to 8.79 (m, 1H)
実施例2−24 本発明化合物[化合物番号(1i)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミドの代わりに、5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミド111mgを用いた以外は実施例2−22と同様にして、4-ヒドロキシ-1-メチル-3-[3-[5-[(2-ヒドロキシエチル)アミノカルボニル]チオフェン-2-イル]アクリロイル]-1H-[1,8]ナフチリジン-2-オン[化合物番号(1i)]の黄色結晶151mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.32(q,2H,J=5.4Hz),3.45〜3.55(2H),3.62(s,3H),4.85(broad,1H),7.35(dd,1H,J=5.4,8.1Hz),7.60(d,1H,J=2.7Hz),7.77(d,1H,J=2.7Hz),8.04(d,1H,J=16.2Hz),8.39(d,1H,J=16.2Hz),8.45〜8.50(m,1H),8.68(t,1H,J=5.4Hz),8.77〜8.82(m,1H)
Example 2-24 Synthesis of Compound of the Present Invention [Compound No. (1i)]
4-Formylthiophene-2-carboxylic acid In the same manner as in Example 2-22 except that 111 mg of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide was used instead of 2-methoxyethylamide, 4- Hydroxy-1-methyl-3- [3- [5-[(2-hydroxyethyl) aminocarbonyl] thiophen-2-yl] acryloyl] -1H- [1,8] naphthyridin-2-one [Compound No. (1i )] Yellow crystals of 151 mg were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.32 (q, 2H, J = 5.4 Hz), 3.45 to 3.55 (2H), 3.62 (s, 3H) ), 4.85 (road, 1H), 7.35 (dd, 1H, J = 5.4, 8.1 Hz), 7.60 (d, 1H, J = 2.7 Hz), 7.77 (d , 1H, J = 2.7 Hz), 8.04 (d, 1H, J = 16.2 Hz), 8.39 (d, 1H, J = 16.2 Hz), 8.45-8.50 (m, 1H), 8.68 (t, 1H, J = 5.4 Hz), 8.77 to 8.82 (m, 1H)
実施例2−25 本発明化合物[化合物番号(2i)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミドの代わりに、N-(2-ホルミルチオフェン-4-イル)-2-メトキシアセトアミド100mgを用いた以外は実施例2−22と同様にして、4-ヒドロキシ-1-メチル-3-[3-[4-(メトキシアセチルアミノ)チオフェン-2-イル]アクリロイル]-1H-[1,8]ナフチリジン-2-オン[化合物番号(2i)]の黄褐色結晶131mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):3.39(s,3H),3.64(s,3H),4.02(s,2H),7.36(dd,1H,J=5.4,8.1Hz),7.77(s,1H),7.86(s,1H),8.07(d,1H,J=13.5Hz),8.38(d,1H,J=13.5Hz),8.45〜8.55(m,1H),8.75〜8.85(m,1H),10.37(broad,1H)
Example 2-25 Synthesis of the compound of the present invention [Compound No. (2i)]
5-formylthiophene-2-carboxylic acid In the same manner as in Example 2-22 except that 100 mg of N- (2-formylthiophen-4-yl) -2-methoxyacetamide was used instead of 2-methoxyethylamide. 4-hydroxy-1-methyl-3- [3- [4- (methoxyacetylamino) thiophen-2-yl] acryloyl] -1H- [1,8] naphthyridin-2-one [Compound No. (2i)] 131 mg of tan crystals were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 3.39 (s, 3H), 3.64 (s, 3H), 4.02 (s, 2H), 7.36 (dd, 1H, J = 5.4, 8.1 Hz), 7.77 (s, 1H), 7.86 (s, 1H), 8.07 (d, 1H, J = 13.5 Hz), 8.38 ( d, 1H, J = 13.5 Hz), 8.45 to 8.55 (m, 1H), 8.75 to 8.85 (m, 1H), 10.37 (broad, 1H)
実施例2−26 本発明化合物[化合物番号(3i)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミドの代わりに、5-ホルミルチオフェン-2-カルボン酸 2-ヒドロキシエチルアミド329mgを用いた以外は実施例2−23と同様にして、4-ヒドロキシ-3-[3-[5-[(2-ヒドロキシエチル)アミノカルボニル]チオフェン-2-イル]アクリロイル]-2-メチル-2H-1,2-ベンゾチアジン-1,1-ジオキシド[化合物番号(3i)]の橙色結晶330mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.99(s,3H),3.60〜3.70(m,2H),3.80〜3.90(2H),6.53(broad,1H),7.19(d,1H,J=16.2Hz),7.35(d,1H,J=2.7Hz),7.50(d,1H,J=2.7Hz),7.89(d,1H,J=16.2Hz),7.75〜7.85(m,2H),7.90〜7.95(m,1H),8.15〜8.20(m,1H)
Example 2-26 Synthesis of the present compound [Compound No. (3i)]
In the same manner as in Example 2-23 except that 329 mg of 5-formylthiophene-2-carboxylic acid 2-hydroxyethylamide was used instead of 5-formylthiophene-2-carboxylic acid 2-methoxyethylamide, 4- Hydroxy-3- [3- [5-[(2-hydroxyethyl) aminocarbonyl] thiophen-2-yl] acryloyl] -2-methyl-2H-1,2-benzothiazine-1,1-dioxide [Compound No. ( 3i)] orange crystals (330 mg) were obtained.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.99 (s, 3H), 3.60 to 3.70 (m, 2H), 3.80 to 3.90 (2H), 6.53 (broad, 1H), 7.19 (d, 1H, J = 16.2 Hz), 7.35 (d, 1H, J = 2.7 Hz), 7.50 (d, 1H, J = 2) .7 Hz), 7.89 (d, 1H, J = 16.2 Hz), 7.75-7.85 (m, 2H), 7.90-7.95 (m, 1H), 8.15-8 .20 (m, 1H)
実施例2−27 本発明化合物[化合物番号(4i)]の合成
5-ホルミルチオフェン-2-カルボン酸 2-メトキシエチルアミドの代わりに、N-(2-ホルミルチオフェン-4-イル)-2-メトキシアセトアミド300mgを用いた以外は実施例2−23と同様にして、4-ヒドロキシ-3-[3-[4-(メトキシアセチルアミノ)チオフェン-2-イル]アクリロイル]-2-メチル-2H-1,2-ベンゾチアジン-1,1-ジオキシド[化合物番号(4i)]の橙色結晶560mgを得た。
1H−NMR(270MHz,DMSO-d6)δ(ppm):2.93(s,3H),3.38(s,3H),4.02(s,2H),7.01(d,1H,J=16.2Hz),7.83(s,1H),7.90(s,1H),7.92〜8.00(m,3H),8.02(d,1H,J=16.2Hz),8.10〜8.18(m,1H)
Example 2-27 Synthesis of Compound of the Present Invention [Compound No. (4i)]
5-formylthiophene-2-carboxylic acid In the same manner as in Example 2-23, except that 300 mg of N- (2-formylthiophen-4-yl) -2-methoxyacetamide was used instead of 2-methoxyethylamide. 4-hydroxy-3- [3- [4- (methoxyacetylamino) thiophen-2-yl] acryloyl] -2-methyl-2H-1,2-benzothiazine-1,1-dioxide [Compound No. (4i) Of 560 mg of orange crystals.
1 H-NMR (270 MHz, DMSO-d 6 ) δ (ppm): 2.93 (s, 3H), 3.38 (s, 3H), 4.02 (s, 2H), 7.01 (d, 1H, J = 16.2 Hz), 7.83 (s, 1H), 7.90 (s, 1H), 7.92 to 8.00 (m, 3H), 8.02 (d, 1H, J = 16.2 Hz), 8.10 to 8.18 (m, 1H)
実施例3(I型コラーゲン遺伝子の転写調節領域と結合されたレポーター遺伝子を有するプラスミドの調製)
正常ヒト胎児皮膚線維芽細胞(Clontech社、カタログ番号CC−2509)1x108細胞を37℃、5% CO2雰囲気下で一晩培養した。培養された細胞をリン酸ナトリウム緩衝液(以下、PBSと記す。)で2回洗浄した後、PBS 3mlを加えセルスクレイパー(Nalgen、カタログ番号179693)を用いて細胞を器壁から剥がした。剥がされた細胞を遠心分離(1,500rpm、4℃、15分間)により集め、これをPBS 20mlに懸濁して再度遠心分離した。得られた沈殿に、DNA Extraction Kit(Stratagene社、カタログ番号200600)のSolution2を11ml、pronaseを4.8μlそれぞれ加えて60℃にて1時間振とうした後、得られた混合液を氷中に10分間放置した。次に、当該混合液に上記キットのSolution 3を4ml加えて混合した後、これを氷中に5分間放置した。遠心分離(3,000rpm、4℃、15分間)し、上清を回収した。回収された上清に、当該上清1ml当たり2μlのRNaseを加え、37℃で15分間放置した。この混合液に、2倍容量のエタノールを加えて混合し、出現した白い糸状の物質(ゲノムDNA)を回収した。回収されたゲノムDNAを70%エタノールで洗浄した後、風乾した。風乾されたゲノムDNAを10mM Tris−HCl,1mM EDTA(pH 8.0)(以下、TEと記す。)500μlに溶解した。
得られたゲノムDNA溶解液(ゲノムDNA 1μg相当量)と、配列番号1(配列番号1:コラーゲンプロモーターDNAを増幅するために設計されたオリゴヌクレオチドプライマー:ccaagctagc gaaattatct tttctttcat ag 32)で示される塩基配列からなるオリゴヌクレオチド及び配列番号2(配列番号2:コラーゲンプロモーターDNAを増幅するために設計されたオリゴヌクレオチドプライマー:ccaaaagctt gcagtcgtgg ccagtacc 28)で示される塩基配列からなるオリゴヌクレオチド(10pmol/μl)各1μl、蒸留水 29μl、TaKaRa LA Taq(宝酒造社、カタログ番号RR002A)に添付されたbuffer 5μl、Mg2+溶液 5μl、dNTP mixture 5μl及びTaKaRa LA Taq(宝酒造社、カタログ番号RR002A)0.5μlを混合した。得られた混合液を94℃、5分間保温した後、94℃、1分間次いで60℃、1分間さらに72℃、1分間の保温を1サイクルとしてこれを30サイクル行った。当該混合液を2%アガロースゲル電気泳動に供することにより、約0.5kbのDNAを回収した。回収されたDNAをフェノール・クロロホルム処理した後、エタノール沈殿することによりDNAを回収した。回収されたDNAを超純水に溶解し、この溶解液にNheI 2.5μl及びHindIII 2.5μlを加え、37℃で3時間保温した。次いで、当該溶解液を2%アガロースゲル電気泳動に供することにより、約3.5kbのDNAを回収した。回収されたDNAをエタノール沈殿することにより再びDNA(以下、コラーゲンプロモーターDNAと記す。)を回収した。
一方、ホタルルシフェラーゼをコードする塩基配列を有するベクターpGL3(Promega社、カタログ番号E1751)をNheI及びHindIIIで消化した後、上記と同様にアガロースゲル電気泳動に供することにより、約5kbのDNAを回収した。回収されたDNAをエタノール沈殿することにより再びDNAを回収した。回収されたDNAに蒸留水44μl、Alkaline Phosphatase(宝酒造、カタログ番号2120A)に添付されたBuffer5μl及びAlkaline Phosphatase(宝酒造社、カタログ番号2120A)1μlを加えて、この混合液を65℃で30分間保温した。次に、当該混合液を2回フェノール・クロロホルム処理した後、エタノール沈澱することによりDNA(以下、LucベクターDNAと記す。)を回収した。次いで、上記コラーゲンプロモーターDNA 約20ngとLucベクターDNA 約20ngとを混合した後、DNA Ligation kit Ver2酵素溶液を同量添加して16℃で一昼夜保温した。当該混合液に大腸菌5Hdα(TOYOBO社、カタログ番号DNA−903)を加えて氷中に30分間放置し、次いで42℃、45秒間保温した後、得られた大腸菌を50μg/ml アンピシリンナトリウム(ナカライ社、カタログ番号027−39)を含むLBプレートに播種し、37℃、一昼夜放置した。出現したシングルコロニーを50μg/ml アンピシリンを含むLB培地2mlで37℃、12時間培養した。得られた培養液からAUTOMATIC DNA ISOLATION SYSTEM PI−50(KURABO社)を用いてプラスミドDNAを調製した。調製されたプラスミドDNAの塩基配列をDNAシークエンサーで分析した。その結果、当該プラスミド(以下、COL−Lucと記す。)は、ヒト由来のI型コラーゲンα2鎖遺伝子の転写調節領域の−3500〜+57(転写開始点を+1とする。)の塩基配列の下流に、レポーター遺伝子としてホタルルシフェラーゼのアミノ酸配列をコードする塩基配列が接続されてなる塩基配列を保有していることが確認された。
Example 3 (Preparation of plasmid having reporter gene linked to transcriptional regulatory region of type I collagen gene)
Normal human fetal skin fibroblasts (Clontech, catalog number CC-2509) 1 × 10 8 cells were cultured overnight at 37 ° C. in a 5% CO 2 atmosphere. The cultured cells were washed twice with a sodium phosphate buffer (hereinafter referred to as PBS), 3 ml of PBS was added, and the cells were detached from the vessel wall using a cell scraper (Nalgen, catalog number 179963). The detached cells were collected by centrifugation (1,500 rpm, 4 ° C., 15 minutes), suspended in 20 ml of PBS, and centrifuged again. To the obtained precipitate, 11 ml of Solution 2 of DNA Extraction Kit (Stratagene, Catalog No. 200600) and 4.8 μl of pronase were added and shaken at 60 ° C. for 1 hour, and the resulting mixture was put in ice. Left for 10 minutes. Next, 4 ml of Solution 3 from the above kit was added to the mixture and mixed, and the mixture was left on ice for 5 minutes. Centrifugation (3,000 rpm, 4 ° C., 15 minutes) was performed, and the supernatant was collected. To the collected supernatant, 2 μl of RNase per 1 ml of the supernatant was added and left at 37 ° C. for 15 minutes. To this mixture, 2 volumes of ethanol was added and mixed, and the white filamentous material (genomic DNA) that appeared was recovered. The collected genomic DNA was washed with 70% ethanol and then air-dried. The air-dried genomic DNA was dissolved in 500 μl of 10 mM Tris-HCl, 1 mM EDTA (pH 8.0) (hereinafter referred to as TE).
The nucleotide sequence shown by the resulting genomic DNA lysate (equivalent to 1 μg of genomic DNA) and SEQ ID NO: 1 (SEQ ID NO: 1: oligonucleotide primer designed for amplifying collagen promoter DNA: ccaagctagc gaaattatct tttctttcat ag 32) 1 μl each of oligonucleotides consisting of the nucleotide sequence shown in SEQ ID NO: 2 and SEQ ID NO: 2 (SEQ ID NO: 2 oligonucleotide primer designed to amplify collagen promoter DNA: ccaaaagctt gcagtcgtgg ccagtacc 28), 10 pmol / μl, distilled water 29 [mu] l, TaKaRa LA Taq (Takara Shuzo, catalog No. RR002A) in the appended buffer 5 [mu] l, Mg 2+ solution 5 [mu] l, dNTPs Mixture 5 [mu] l and TaKaRa LA Taq (Takara Shuzo, catalog No. RR002 ) Was mixed with 0.5μl. The obtained mixed solution was kept at 94 ° C. for 5 minutes, and then kept at 94 ° C., 1 minute, then 60 ° C., 1 minute, further 72 ° C., and 1 minute, and this was repeated for 30 cycles. The mixture was subjected to 2% agarose gel electrophoresis to recover about 0.5 kb of DNA. The recovered DNA was treated with phenol / chloroform and then precipitated with ethanol to recover the DNA. The recovered DNA was dissolved in ultrapure water, and 2.5 μl of NheI and 2.5 μl of HindIII were added to this lysate and incubated at 37 ° C. for 3 hours. Next, the lysate was subjected to 2% agarose gel electrophoresis to recover about 3.5 kb of DNA. The recovered DNA was ethanol precipitated to recover DNA (hereinafter referred to as collagen promoter DNA) again.
On the other hand, a vector pGL3 (Promega, catalog number E1751) having a base sequence encoding firefly luciferase was digested with NheI and HindIII, and then subjected to agarose gel electrophoresis in the same manner as above to recover about 5 kb of DNA. . DNA was recovered again by ethanol precipitation of the recovered DNA. 44 μl of distilled water, 5 μl of Buffer attached to Alkaline Phosphatase (Takara Shuzo, catalog number 2120A) and 1 μl of Alkaline Phosphatase (Takara Shuzo, catalog number 2120A) were added to the recovered DNA, and this mixture was incubated at 65 ° C. for 30 minutes. . Next, the mixed solution was treated twice with phenol / chloroform and then precipitated with ethanol to recover DNA (hereinafter referred to as Luc vector DNA). Next, about 20 ng of the collagen promoter DNA and about 20 ng of the Luc vector DNA were mixed, the same amount of the DNA Ligation Kit Ver2 enzyme solution was added, and the mixture was kept at 16 ° C. overnight. Escherichia coli 5Hdα (TOYOBO, catalog number DNA-903) was added to the mixed solution, left on ice for 30 minutes, and then incubated at 42 ° C. for 45 seconds. Then, the obtained Escherichia coli was 50 μg / ml ampicillin sodium (Nacalai). LB plate containing catalog number 027-39) and left at 37 ° C. overnight. The appearing single colony was cultured at 37 ° C. for 12 hours in 2 ml of LB medium containing 50 μg / ml ampicillin. Plasmid DNA was prepared from the obtained culture solution using AUTOMATIC DNA ISOLATION SYSTEM PI-50 (KURABO). The nucleotide sequence of the prepared plasmid DNA was analyzed with a DNA sequencer. As a result, the plasmid (hereinafter referred to as COL-Luc) is downstream of the base sequence of −3500 to +57 (transcription start point is +1) of the transcriptional regulatory region of human type I collagen α2 chain gene. In addition, it was confirmed that a reporter gene possesses a base sequence connected to a base sequence encoding the amino acid sequence of firefly luciferase.
実施例4(レポーター遺伝子の発現量を指標とした被験化合物が有するI型コラーゲン遺伝子の転写調節能力の測定)
正常ヒト胎児皮膚線維芽細胞 1x106細胞を100mmディッシュに播種し、非働化牛胎児血清(以下、FBSと記す。Gibco社、カタログ番号21140−079)を10(v/v)%含むDulbecco’s−MEM(日水製薬社、カタログ番号05919)培地(以下、当該培地をD−MEM(+)と記す。)中で37℃、5%CO2雰囲気下において一晩培養した。次いで培地を、FBSを含まないDulbecco’s−MEM培地(以下、当該培地をD−MEM(−)と記す。)に置換した。
D−MEM(−) 300μlに、COL−Luc 5μg及びpCMV−β−gal(Invitrogen社、カタログ番号10586−014)5μgを加え、得られた混合液を室温で5分間放置した(溶液1)。また、D−MEM(−) 300μlにLipofectine(Gibco社、カタログ番号18292−011)20μlを加え、得られた混合液を室温で45分間放置した(溶液2)。次に、溶液1と溶液2とを混合し、これを室温で10分間放置した後、当該混合液にD−MEM(−)5.4mlを加えて混合した。当該混合液を前記正常ヒト胎児皮膚線維芽細胞に添加した後、当該細胞を37℃、5%CO2雰囲気下で培養した。6時間後、ディッシュから培養上清を除き、細胞をPBSで2回洗浄した後、ディッシュに0.25%トリプシンを含むPBS 1mlを添加してディッシュから細胞を剥がした。剥がされた細胞にD−MEM(+)を加えてよく混合した後、当該混合物を12ウエルプレートに1mlずつ分注し、これを37℃、5%CO2雰囲気下で終夜培養した。翌日、各ウエルをD−MEM(−)で2回洗浄した後、0.1% FBSを含むDulbecco’s−MEM培地(以下、当該培地をD−MEM(0.1%)と記す。)1mlに置換した。
このようにして培養された細胞に、化合物番号(34a-1)、(54a-1)、(56a-1)、(71a-1)、(10a-3)、(1i)及び(3i)で示される本発明化合物が1mMになるよう10%ジメチルスルホキシド(以下、DMSOと記す。)で溶解し、その溶液を10μl添加した(本発明化合物最終濃度10μM、DMSO最終濃度0.1%)。また、化合物番号(14h)で示される本発明化合物が0.3mMになるよう10%ジメチルスルホキシド(以下、DMSOと記す。)で溶解し、その溶液を10μl添加した(本発明化合物最終濃度3μM、DMSO最終濃度0.1%)。尚、対照では10%DMSOを10μl添加した。
1時間後、TGF−β(Pepro Tech社)の0.5μg/ml水溶液又は蒸留水を10μl添加し、37℃、5%CO2雰囲気下でさらに40時間培養した。培養された細胞をPBSで2回洗浄した後、これに細胞溶解剤(東洋インキ社、カタログ番号PD10)200μlを加え細胞を剥がした。剥がされた細胞を細胞懸濁液として回収した後、これを遠心分離(15,000rpm、4℃、5分間)することにより、上清を回収した。回収された上清各50μlを96ウエルプレートに移した後、MICROLUMAT LB96P(EG&G BERTHOLD社製)を用いて、Lucアッセイ溶液(20mM Tricine(pH7.8)、2.67mM MgSO4、0.1mM EDTA、33.3mM DTT、270μM Coenzyme A、530μMATP、470μM Luciferin)50μlを当該プレートに自動分注した後、各ウエル内の発光量を測定した(Delay:1.6秒、Meas.Interval:20秒)。
一方、回収された上清又は細胞溶解剤50μlを、予め96ウエルプレートに分注されたβ−gal基質溶液(5.8mM o−nitrophenyl−beta−D−galactopyranoside、1mM MgCl2、45mM 2−メルカプトエタノール)50μlに加えて37℃、2時間インキュベートした後、マイクロプレートリーダーを用いて各ウエル内の420nmの吸光度を測定した。得られた値を基にし、次式に従って転写活性を算出した。
転写活性=[発光量(上清添加区)−発光量(細胞溶解剤添加区)]/[420nm吸光度(上清添加区)−420nm吸光度(細胞溶解剤添加区)]
次に、算出された転写活性を基にし、次式に従って、TGF−βが有するI型コラーゲン遺伝子の転写促進能力に対する被験化合物の阻害効果を阻害度として算出した。
阻害度=[転写活性(DMSO及びTGF−β添加試験区)−転写活性(化合物及びTGF−β添加試験区)]/[転写活性(DMSO及びTGF−β添加試験区)−転写活性(DMSO及びTGF−β無添加試験区)]×100
化合物番号(34a-1)、(54a-1)、(56a-1)、(71a-1)、(10a-3)、(1i)及び(3i)で示される本発明化合物が本発明化合物最終濃度10μMにおいて、化合物番号(14h)で示される本発明化合物が本発明化合物最終濃度3μMにおいて、阻害度は、70以上であった。本発明化合物が、TGF−βが有するI型コラーゲン遺伝子の転写促進能力を阻害し、I型コラーゲン遺伝子の転写を抑制する能力を有することが確認された。
Example 4 (Measurement of transcriptional regulatory ability of type I collagen gene of test compound using reporter gene expression level as index)
Normal human fetal skin fibroblasts 1 × 10 6 cells were seeded in a 100 mm dish, and Dulbecco's containing 10 (v / v)% inactivated fetal bovine serum (hereinafter referred to as FBS, Gibco, catalog number 21140-079). -Cultured overnight in a MEM (Nissui Pharmaceutical Co., Ltd., Catalog No. 05919) medium (hereinafter, the medium is referred to as D-MEM (+)) at 37 ° C in a 5% CO 2 atmosphere. Next, the medium was replaced with Dulbecco's-MEM medium not containing FBS (hereinafter, the medium is referred to as D-MEM (−)).
To 300 μl of D-MEM (−), 5 μg of COL-Luc and 5 μg of pCMV-β-gal (Invitrogen, catalog number 10586-014) were added, and the resulting mixture was allowed to stand at room temperature for 5 minutes (Solution 1). Moreover, 20 microliters of Lipofectine (Gibco, catalog number 18292-011) was added to 300 microliters of D-MEM (-), and the obtained liquid mixture was left for 45 minutes at room temperature (solution 2). Next, Solution 1 and Solution 2 were mixed and allowed to stand at room temperature for 10 minutes, and then 5.4 ml of D-MEM (−) was added to the mixture and mixed. After the mixture was added to the normal human fetal skin fibroblasts, the cells were cultured at 37 ° C. in a 5% CO 2 atmosphere. After 6 hours, the culture supernatant was removed from the dish, and the cells were washed twice with PBS. Then, 1 ml of PBS containing 0.25% trypsin was added to the dish, and the cells were detached from the dish. After D-MEM (+) was added to the detached cells and mixed well, 1 ml of the mixture was dispensed into a 12-well plate and cultured overnight at 37 ° C. in a 5% CO 2 atmosphere. The next day, each well was washed twice with D-MEM (−), and then Dulbecco's-MEM medium containing 0.1% FBS (hereinafter, the medium is referred to as D-MEM (0.1%)). Replaced with 1 ml.
The cells cultured in this manner were subjected to compound numbers (34a-1), (54a-1), (56a-1), (71a-1), (10a-3), (1i) and (3i). The indicated compound of the present invention was dissolved in 10% dimethyl sulfoxide (hereinafter referred to as DMSO) so as to be 1 mM, and 10 μl of the solution was added (final compound concentration of the present compound of 10 μM, DMSO final concentration of 0.1%). Further, the compound of the present invention represented by the compound number (14h) was dissolved in 10% dimethyl sulfoxide (hereinafter referred to as DMSO) so as to be 0.3 mM, and 10 μl of the solution was added (final concentration of the compound of the present invention of 3 μM, DMSO final concentration 0.1%). As a control, 10 μl of 10% DMSO was added.
One hour later, 10 μl of a 0.5 μg / ml aqueous solution of TGF-β (Pepro Tech) or distilled water was added, and the cells were further cultured at 37 ° C. in a 5% CO 2 atmosphere for 40 hours. The cultured cells were washed twice with PBS, and then 200 μl of a cell lysing agent (Toyo Ink, Catalog No. PD10) was added to peel the cells. After the peeled cells were collected as a cell suspension, the supernatant was collected by centrifuging (15,000 rpm, 4 ° C., 5 minutes). 50 μl of each collected supernatant was transferred to a 96-well plate, and then a Luc assay solution (20 mM Tricine (pH 7.8), 2.67 mM MgSO 4 , 0.1 mM EDTA using MICROLUMAT LB96P (EG & G BERTHOLD). , 33.3 mM DTT, 270 μM Coenzyme A, 530 μMATP, 470 μM Luciferin) was automatically dispensed on the plate, and the amount of luminescence in each well was measured (Delay: 1.6 seconds, Meas. Interval: 20 seconds) .
On the other hand, 50 μl of the collected supernatant or cell lysing agent was added to a β-gal substrate solution (5.8 mM o-nitrophenyl-beta-D-galactopyranoside, 1 mM MgCl 2 , 45 mM 2-mercapto previously dispensed in a 96-well plate. Ethanol) was added to 50 μl and incubated at 37 ° C. for 2 hours, and then the absorbance at 420 nm in each well was measured using a microplate reader. Based on the obtained value, the transcription activity was calculated according to the following formula.
Transcriptional activity = [Luminescence (supernatant addition) -Luminescence (cell lysate addition)] / [420 nm absorbance (supernatant addition) -420 nm absorbance (cell lysate addition)]
Next, based on the calculated transcription activity, the inhibitory effect of the test compound on the ability of TGF-β to promote transcription of type I collagen gene was calculated as the degree of inhibition according to the following formula.
Degree of inhibition = [transcriptional activity (DMSO and TGF-β addition test group) −transcription activity (compound and TGF-β addition test group)] / [transcription activity (DMSO and TGF-β addition test group) −transcription activity (DMSO and TGF-β-free test section)] × 100
The compound of the present invention represented by compound numbers (34a-1), (54a-1), (56a-1), (71a-1), (10a-3), (1i) and (3i) is the final compound of the present invention. At a concentration of 10 μM, the compound of the present invention represented by compound number (14h) had a degree of inhibition of 70 or more at a final concentration of 3 μM of the compound of the present invention. It was confirmed that the compound of the present invention has the ability to inhibit the type I collagen gene transcription promoting ability of TGF-β and to suppress the type I collagen gene transcription.
実施例5(フィブロネクチンの発現量を指標とした被験化合物が有するTGF−β抑制能力の測定)
正常ヒト皮膚線維芽細胞(Clonetics社、カタログ番号CC−2509)5x103個/ウエルを、96ウエルプレート(BECTON DICKINSON社、カタログ番号35−3075)に播き、37℃、5% CO2下のインキュベーターで一晩培養した。翌日、0.1%牛胎児血清を含むD−MEM培地(日水製薬(株)社、コード番号05919)0.1mlに交換した。その1時間後、化合物番号(2a-3)で示される本発明化合物を最終濃度10μMになるように添加し、また、化合物番号(63a-1)で示される本発明化合物を最終濃度3μMになるように添加し、1時間培養した後に、最終濃度5ng/mlのTGF−β(Peprotech社、カタログ番号100−21R)を添加し、さらに26時間培養した。リン酸緩衝液で2回洗浄した後に、SV96 Total RNA Isolation System(Promega社、カタログ番号Z3505)を用いて全RNAを分離した。分離された全RNA 5μlに、20μM オリゴdT 1μl及びRNaseフリー蒸留水 4μlを加えて65℃、5分間インキュベートし、直ぐに氷冷した。当該溶液10μlに、5×バッファー 4μl、MgCl2 2.4μl、10mM dNTP 1μl、RNasin 1μl、ImpromII 1μl、RNaseフリー蒸留水0.6μl(以上、全てPromega社)を加えて25℃ 5分間、42℃ 1時間、70℃ 15分間の条件で逆転写反応した。
逆転写反応溶液5μlに、配列番号3(配列番号3:フィブロネクチン遺伝子のDNAを検出するために、PCR用プライマーとして設計されたオリゴヌクレオチド:tcgccatcag tagaaggtag ca 22)、配列番号4(配列番号4:フィブロネクチン遺伝子のDNAを検出するために、PCR用プライマーとして設計されたオリゴヌクレオチド:tatactgaac accaggttgc aagtc 25)で示される各20pmol/μlのプライマー1μl及び配列番号5(配列番号5:フィブロネクチン遺伝子のDNAを検出するために、プローブとして設計されたオリゴヌクレオチド:ctcaaccttc ctgaaactgc aaactccgtc 30)で示されるフィブロネクチン遺伝子のDNA検出用プローブ1.25μl、又はHuman GAPDHプラーマー・プローブ(Applied Biosystems社、カタログ番号4310884E)1.25μlを加え、TaqMan Universal PCR Master Mix(Applied Biosystems社、カタログ番号4304437) 12.5μl及び滅菌水を加えて50μlに調整し、Optical 96−Well Reaction Plate(Applied Biosystems社、カタログ番号N801−0560)のウエル中で混合した。スタンダードは、TGF−βのみを添加した細胞から全RNAを調製し、その250、125、62.5、31.25、15.625、7.8125ngをそれぞれ逆転写反応したcDNA溶液を用いた。その後、Gene Amp 7900(Applied Biosystems社)を用いて50℃ 5分間 1サイクル、95℃ 15秒間及び60℃ 1分間の40サイクルの条件でPCRした。定量は各スタンダード直線を作成した後、フィブロネクチン量及びGAPDH量をそれぞれ算出し、次式に従って転写量を算出した。
フィブロネクチン転写量=フィブロネクチン量/GAPDH量
阻害度=[転写量(DMSO及びTGF−β添加試験区)−転写量(化合物及びTGF−β添加試験区)]/[転写量(DMSO及びTGF−β添加試験区)−転写量(DMSO及びTGF−β無添加試験区)]x100
化合物番号(2a-3)及び(63a-1)で示される本発明化合物の阻害度は、70%以上であった。
本発明化合物が、TGF−βによって促進される皮膚線維芽細胞のフィブロネクチン遺伝子の転写量を抑制することが確認された。
Example 5 (Measurement of TGF-β inhibitory ability of test compound having fibronectin expression level as index)
Normal human dermal fibroblasts (Clonetics, catalog number CC-2509) 5 × 10 3 cells / well are seeded in a 96-well plate (BECTON DICKINSON, catalog number 35-3075) in an incubator at 37 ° C. under 5% CO 2. Incubated overnight. The next day, the medium was replaced with 0.1 ml of D-MEM medium (Nissui Pharmaceutical Co., Ltd., code number 05919) containing 0.1% fetal bovine serum. One hour later, the compound of the present invention represented by compound number (2a-3) was added to a final concentration of 10 μM, and the compound of the present invention represented by compound number (63a-1) was added to a final concentration of 3 μM. After culturing for 1 hour, TGF-β (Peprotech, Catalog No. 100-21R) at a final concentration of 5 ng / ml was added, and further cultured for 26 hours. After washing twice with phosphate buffer, total RNA was isolated using SV96 Total RNA Isolation System (Promega, catalog number Z3505). To 5 μl of the separated total RNA, 1 μl of 20 μM oligo dT and 4 μl of RNase-free distilled water were added, incubated at 65 ° C. for 5 minutes, and immediately ice-cooled. 5 μl buffer 4 μl, MgCl 2 2.4 μl, 10 mM dNTP 1 μl, RNasin 1 μl, ImpromII 1 μl, RNase-free distilled water 0.6 μl (all above from Promega) are added to 10 μl of the solution at 25 ° C. for 5 minutes, 42 ° C. Reverse transcription reaction was performed for 1 hour at 70 ° C. for 15 minutes.
In 5 μl of the reverse transcription reaction solution, SEQ ID NO: 3 (SEQ ID NO: 3: oligonucleotide designed as a primer for PCR for detecting DNA of fibronectin gene: tcgccatcag tagaaggtag ca 22), SEQ ID NO: 4 (SEQ ID NO: 4: fibronectin) In order to detect the DNA of the gene, 1 μl of each 20 pmol / μl primer represented by the oligonucleotide designed as a primer for PCR: tatactgaac accaggttgc aagtc 25 and SEQ ID NO: 5 (SEQ ID NO: 5: detect the DNA of fibronectin gene) For this purpose, 1.25 μl of a probe for detecting DNA of fibronectin gene represented by oligonucleotide designed as a probe: ctcaaccttc ctgaaactgc aaactccgtc 30), or Human GAPDH primer probe (Applied Biosystems, Inc. Log number 4310884E) 1.25 μl was added, TaqMan Universal PCR Master Mix (Applied Biosystems, catalog number 4304437) was added to 12.5 μl and sterilized water to adjust to 50 μl, and Optical 96-Well Reaction Plate (Ap catalog, Bio 96 No. N801-0560). As the standard, total RNA was prepared from cells to which only TGF-β was added, and cDNA solutions obtained by reverse transcription reaction of 250, 125, 62.5, 31.25, 15.625, and 7.8125 ng were used. Thereafter, PCR was performed using Gene Amp 7900 (Applied Biosystems) under conditions of 40 cycles of 50 ° C. for 5 minutes, 1 cycle, 95 ° C. for 15 seconds and 60 ° C. for 1 minute. For quantification, after preparing each standard line, the amount of fibronectin and the amount of GAPDH were calculated, and the amount of transcription was calculated according to the following formula.
Fibronectin transcription amount = fibronectin amount / GAPDH amount inhibition = [transcription amount (DMSO and TGF-β addition test group)]-transcription amount (compound and TGF-β addition test group)] / [transcription amount (DMSO and TGF-β addition) Test group)-Transcription amount (Test group without DMSO and TGF-β)] x 100
The degree of inhibition of the compounds of the present invention represented by compound numbers (2a-3) and (63a-1) was 70% or more.
It was confirmed that the compound of the present invention suppresses the transcription amount of fibronectin gene in skin fibroblasts promoted by TGF-β.
本発明により、組織における細胞外マトリックス遺伝子の発現量を減少させ、細胞外マトリックス蓄積量を低下させることにより、組織の線維化を改善させる組成物(即ち、細胞外マトリックス蓄積抑制剤や、線維症治療剤又は心不全治療剤)等の開発・提供が可能となる。
According to the present invention, a composition that improves the fibrosis of a tissue by reducing the amount of extracellular matrix gene expression in the tissue and decreasing the amount of extracellular matrix accumulation (ie, an extracellular matrix accumulation inhibitor, fibrosis) Development or provision of therapeutic agents or therapeutic agents for heart failure).
Claims (33)
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.βは、
式(I-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(I-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(I-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(I-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(I-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(I-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(I-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(I-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(I-9)
[式中、U及びWαは、前記と同一の意味を表す。]
で示される基を表す。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物と不活性担体とを含有することを特徴とする細胞外マトリックス遺伝子転写抑制組成物。 Formula (I)
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms. In (Y α ) q , Y α represents a group of the following X 0 group or Y 0 group, and q is , 0, 1, 2, or 3 and when q is 2 or more, Y α is the same or different, and when q is 2 or more, two adjacent Y α that are adjacent to each other are Z It may be condensed with an α ring by forming a group of 0 group, and in (X α ) p , X α represents a substituent not belonging to the following X 0 group, Y 0 group and Z 0 group, p Represents 0, 1, 2 or 3, and when p is 2 or more, X α is the same or different, and the sum of p and q is 3 or less.
(1) X 0 group: M a - group [M a is R b - group (. R b is representative of a is C1-C10 may be an alkyl group substituted with a halogen atom), a halogen atom, a nitro group, a cyano group, a hydroxyl group, R c -B a -R d - group (R c represents a halogen atom which may be substituted with C1-C10 alkyl group, B a is oxy, thio, sulfinyl or sulfonyl group R d represents a single bond or a C1-C10 alkylene group.), HOR d -group (R d represents the same meaning as described above), R e -CO-R d -group (R e represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and R d represents the same meaning as described above), R e —CO—O—R d — group ( R e and R d represent the same meaning), R e O-CO- R d -. group (R e and R d are the same Means represents a), HO-CO-CH = CH- group, R e R e. 'N -R d - group (R e and R e' are the same or different, R e, the same meaning R e ′ represents the same meaning as R e , R d represents the same meaning as described above), R e —CO—NR e ′ —R d — group (R e , R e 'And R d represent the same meaning as described above.), R b O—CO—N (R e ) —R d — group (R b , R e and R d represent the same meaning as described above. ), R e R e 'N-CO-R d -group (R e , R e ' and R d represent the same meaning as described above), R e R e 'N-CO-NR e '. '-R d -groups (R e , R e ′ and R e ″ are the same or different, R e and R e ′ have the same meaning as described above, and R e ″ represents R e and Represents the same meaning, and R d is the same as above. ), R e R e ′ NC (═NR e ″) —NR e ″ ″ —R d — groups (R e , R e ′, R e ″ and R e ″). 'Is the same or different, R e , R e ′ and R e ″ represent the same meaning as described above, R e ′ ″ represents the same meaning as R e, and R d represents the above And R b —SO 2 —NR e —R d — group (R b , R e and R d represent the same meaning as described above), R e R e 'N— SO 2 —R d — group (R e , R e ′ and R d represent the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 group: M b0 -R d -group [M b0 is M c0 -group {M c0 is M d0 -R d ' -group {M d0 is M a -group (M a is It represents the same meaning as described above) and may be substituted with a 6-10-membered aryl group which may be substituted or a M a -group (M a represents the same meaning as described above). 5-10 membered heteroaryl group, or M a -group (M a represents the same meaning as described above) 3-10 membered ring carbonization which may contain an unsaturated bond which may be substituted A hydrogen or heterocyclic group, or
(b 0 ) — group (in (b 0 ), G 0 represents a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
A (c 0 ) -group (in (c 0 ), J 0 may contain a nitrogen atom and forms an aromatic 5- to 7-membered ring);
(D 0 ) -group {d 0 is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, a —NR 1 -group {R 1 is a hydrogen atom or a C1-C10 alkyl group, Or a halogen atom or an R 2 —B 1 — group (R 2 represents a C 1 -C 10 alkyl group, a C 3 -C 10 alkenyl group or a C 3 -C 10 alkynyl group, and B 1 represents an oxy group, a thio group, a sulfinyl group or A C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group substituted with a sulfonyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -group {e 0 is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a —NR 1 — group (R 1 is as defined above), a sulfinyl group or a sulfonyl group. It forms an optionally substituted 5-12 membered hydrocarbon ring. Represents}, R d 'are the same or different and R d, it represents the same meaning as R d. }. }, M c0 -B a - group (. M c0 and B a are representing the same meaning), M c0 -CO- group (. M c0 is representative of the same meaning as), M c0 -CO-O- group (M c0 represents the same meaning as described above), M c0 O-CO- group (M c0 represents the same meaning as described above), M c0 R e N- group (M c0 and R e represent the same meaning as described above), M c0 —CO—NR e — group (M c0 and R e represent the same meaning as described above), M c0 O—CO —NR e — group (M c0 and R e represent the same meaning as described above), M c0 R e N—CO— group (M c0 and R e represent the same meaning as described above), M c0 R e N-CO- NR e '- group (M c0, R e and R e'. are representing the same meaning as), M c0 R e N- C (= N e ') -NR e' '- group (M c0, R e, R e' and R e '' represents the same meaning), M c0 -SO 2 -NR e -. group (M c0 And R e represent the same meaning as described above) or a M c0 R e N—SO 2 — group (M c0 and R e represent the same meaning as described above), and R d represents the above Represents the same meaning as ].
(3) Z 0 group: having halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group It may be a 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β is
Formula (I-1)
[Where:
(1) Qα represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α represents an oxygen atom or a —NT α — group (T α represents a hydrogen atom or a substituent on a nitrogen atom).
(3) K α and L α are the same or different and represent a hydrogen atom or a substituent on a carbon atom, and K α and L α are a C3-C10 alkylene group which may have a substituent. Alternatively, it may form a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (I-2)
[Wherein, T α represents the same meaning as described above, and L β represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (I-3)
[Wherein, T α represents the same meaning as described above, and L γ represents a C1-C10 alkyl group. ]
A group represented by
Formula (I-4)
[Wherein, T α represents the same meaning as described above. ]
A group represented by
Formula (I-5)
[Wherein, T α represents the same meaning as described above, and K β represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (I-6)
[Wherein W α represents the same meaning as described above, and K γ and L δ represent a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene which may have a substituent. Make a basis. ]
A group represented by
Formula (I-7)
[Wherein Q α and W α represent the same meaning as described above, and K δ and L ε represent -V α = V α '-V α ″ = V α ''' -group (V α , V α ′, V α ″ and V α ″ ″ are the same or different and each represents an optionally substituted methine group or —N = group, and V α , V α ′, V α ″ And at least one of V α ′ ″ represents —N = group. ]
A group represented by
Formula (I-8)
[Wherein, T α represents the same meaning as described above, and Q β represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (I-9)
[Wherein U and W α represent the same meaning as described above. ]
Represents a group represented by
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A composition for inhibiting transcription of an extracellular matrix gene, comprising a cinnamoyl compound represented by the formula (1) and an inert carrier.
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.βは、
式(II-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(II-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(II-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(II-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(II-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(II-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(II-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(II-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(II-9)
[式中、U及びWαは、前記と同一の意味を表す。]
で示される基を表す。
但し、αがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (II)
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms. In (Y α ) q , Y α represents a group of the following X 0 group or Y 0 group, and q is , 0, 1, 2, or 3 and when q is 2 or more, Y α is the same or different, and when q is 2 or more, two adjacent Y α that are adjacent to each other are Z It may be condensed with an α ring by forming a group of 0 group, and in (X α ) p , X α represents a substituent not belonging to the following X 0 group, Y 0 group and Z 0 group, p Represents 0, 1, 2 or 3, and when p is 2 or more, X α is the same or different, and the sum of p and q is 3 or less.
(1) X 0 group: M a - group [M a is R b - group (. R b is representative of a is C1-C10 may be an alkyl group substituted with a halogen atom), a halogen atom, a nitro group, a cyano group, a hydroxyl group, R c -B a -R d - group (R c represents a halogen atom which may be substituted with C1-C10 alkyl group, B a is oxy, thio, sulfinyl or sulfonyl group R d represents a single bond or a C1-C10 alkylene group.), HOR d -group (R d represents the same meaning as described above), R e -CO-R d -group (R e represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and R d represents the same meaning as described above), R e —CO—O—R d — group ( R e and R d represent the same meaning), R e O-CO- R d -. group (R e and R d are the same Means represents a), HO-CO-CH = CH- group, R e R e. 'N -R d - group (R e and R e' are the same or different, R e, the same meaning R e ′ represents the same meaning as R e , R d represents the same meaning as described above), R e —CO—NR e ′ —R d — group (R e , R e 'And R d represent the same meaning as described above.), R b O—CO—N (R e ) —R d — group (R b , R e and R d represent the same meaning as described above. ), R e R e 'N-CO-R d -group (R e , R e ' and R d represent the same meaning as described above), R e R e 'N-CO-NR e '. '-R d -groups (R e , R e ′ and R e ″ are the same or different, R e and R e ′ have the same meaning as described above, and R e ″ represents R e and Represents the same meaning, and R d is the same as above. ), R e R e ′ NC (═NR e ″) —NR e ″ ″ —R d — groups (R e , R e ′, R e ″ and R e ″). 'Is the same or different, R e , R e ′ and R e ″ represent the same meaning as described above, R e ′ ″ represents the same meaning as R e, and R d represents the above And R b —SO 2 —NR e —R d — group (R b , R e and R d represent the same meaning as described above), R e R e 'N— SO 2 —R d — group (R e , R e ′ and R d represent the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 group: M b0 -R d -group [M b0 is M c0 -group {M c0 is M d0 -R d ' -group {M d0 is M a -group (M a is It represents the same meaning as described above) and may be substituted with a 6-10-membered aryl group which may be substituted or a M a -group (M a represents the same meaning as described above). 5-10 membered heteroaryl group, or M a -group (M a represents the same meaning as described above) 3-10 membered ring carbonization which may contain an unsaturated bond which may be substituted A hydrogen or heterocyclic group, or
(b 0 ) — group (in (b 0 ), G 0 represents a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
A (c 0 ) -group (in (c 0 ), J 0 may contain a nitrogen atom and forms an aromatic 5- to 7-membered ring);
(D 0 ) -group {d 0 is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, a —NR 1 -group {R 1 is a hydrogen atom or a C1-C10 alkyl group, Or a halogen atom or an R 2 —B 1 — group (R 2 represents a C 1 -C 10 alkyl group, a C 3 -C 10 alkenyl group or a C 3 -C 10 alkynyl group, and B 1 represents an oxy group, a thio group, a sulfinyl group or A C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group substituted with a sulfonyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -group {e 0 is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a —NR 1 — group (R 1 is as defined above), a sulfinyl group or a sulfonyl group. It forms an optionally substituted 5-12 membered hydrocarbon ring. Represents}, R d 'are the same or different and R d, it represents the same meaning as R d. }. }, M c0 -B a - group (. M c0 and B a are representing the same meaning), M c0 -CO- group (. M c0 is representative of the same meaning as), M c0 -CO-O- group (M c0 represents the same meaning as described above), M c0 O-CO- group (M c0 represents the same meaning as described above), M c0 R e N- group (M c0 and R e represent the same meaning as described above), M c0 —CO—NR e — group (M c0 and R e represent the same meaning as described above), M c0 O—CO —NR e — group (M c0 and R e represent the same meaning as described above), M c0 R e N—CO— group (M c0 and R e represent the same meaning as described above), M c0 R e N-CO- NR e '- group (M c0, R e and R e'. are representing the same meaning as), M c0 R e N- C (= N e ') -NR e' '- group (M c0, R e, R e' and R e '' represents the same meaning), M c0 -SO 2 -NR e -. group (M c0 And R e represent the same meaning as described above) or a M c0 R e N—SO 2 — group (M c0 and R e represent the same meaning as described above), and R d represents the above Represents the same meaning as ].
(3) Z 0 group: having halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group It may be a 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β is
Formula (II-1)
[Where:
(1) Qα represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α represents an oxygen atom or a —NT α — group (T α represents a hydrogen atom or a substituent on a nitrogen atom).
(3) K α and L α are the same or different and represent a hydrogen atom or a substituent on a carbon atom, and K α and L α are a C3-C10 alkylene group which may have a substituent. Alternatively, it may form a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (II-2)
[Wherein, T α represents the same meaning as described above, and L β represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (II-3)
[Wherein, T α represents the same meaning as described above, and L γ represents a C1-C10 alkyl group. ]
A group represented by
Formula (II-4)
[Wherein, T α represents the same meaning as described above. ]
A group represented by
Formula (II-5)
[Wherein, T α represents the same meaning as described above, and K β represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (II-6)
[Wherein W α represents the same meaning as described above, and K γ and L δ represent a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene which may have a substituent. Make a basis. ]
A group represented by
Formula (II-7)
[Wherein Q α and W α represent the same meaning as described above, and K δ and L ε represent -V α = V α '-V α ″ = V α ''' -group (V α , V α ′, V α ″ and V α ″ ″ are the same or different and each represents an optionally substituted methine group or —N = group, and V α , V α ′, V α ″ And at least one of V α ′ ″ represents —N = group. ]
A group represented by
Formula (II-8)
[Wherein, T α represents the same meaning as described above, and Q β represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (II-9)
[Wherein U and W α represent the same meaning as described above. ]
Represents a group represented by
However, when α is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
[式中、
I.A0は、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表す。
II.(XA0)pにおいて、XA0は、下記のA0群からN0群までのいずれかの群に含まれる基を表し、pは、0、1、2又は3を表し、pが2以上のとき、XA0は、同一又は相異なる。
(1)A0群:D1−R4−基[D1は、(R1−(O)k−)A1N−(O)k’−基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表し、kは、0又は1を表し、A1は、R3−(CHR0)m−(B2−B3)m’−基{R3は、水素原子、又は、ハロゲン原子若しくはR2−B1−基(R2及びB1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基を表し、R0は、水素原子、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、mは、0又は1を表し、B2は、単結合、オキシ基、チオ基又は−N((O)nR1’)−基(R1’は、R1と同一又は相異なり、R1と同一の意味を表し、nは、0又は1を表す。)を表し、B3は、カルボニル基、チオカルボニル基又はスルホニル基を表し、m’は、0又は1を表し、B3がスルホニル基のとき、mは0となりかつR3が水素原子となることはない。}を表し、k’は、0又は1を表す。}を表し、R4は、C1-C10アルキレン基を表す。但し、R0’R0 ’’N−R4−基(R0’及びR0’’は、R0と同一又は相異なり、R0と同一の意味を表し、R4は、前記と同一の意味を表す。)を除く。]、D2−R4−基[D2は、シアノ基、R1R1’NC(=N−(O)n−A1)−基(R1、R1’、n、及びA1は、前記と同一の意味を表す。)、A1N=C(−OR2)−基(A1及びR2は、前記と同一の意味を表す。)又はNH2−CS−基を表し、R4は前記と同一の意味を表す。]、D3−R4−基{D3は、ニトロ基又はR1OSO2−基(R1は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}又はR1OSO2−基(R1は、前記と同一の意味を表す。)である。
(2)B0群:
(a0)−基
((a0)において、E0は、置換基を有してもよい、飽和又は不飽和の、芳香族又は非芳香族の、5〜14員の炭化水素環又は複素環をなし、R1は、前記と同一の意味を表す。)である。
(3)C0群:ハロゲン原子 、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D4−R4−基[D4は、水酸基又はA1−O−基(A1は、前記と同一の意味を表す。)を表し、R4は前記と同一の意味を表す。]、D5−基[D5は、O=C(R3)−基(R3は、前記と同一の意味を表す。)、A1−(O)n−N=C(R3)−基(A1、n及びR3は、前記と同一の意味を表す。)、R1−B0−CO−R4−(O)n−N=C(R3)−基{R1、R4、n及びR3は、前記と同一の意味を表し、B0は、オキシ基、チオ基又は−N((O)mR1’)−基(R1’及びmは、前記と同一の意味を表す。)を表す。}、D2−R4−(O)n−N=C(R3)−基(D2、R4、n及びR3は、前記と同一の意味を表す。)又はR1A1N−N=C(R3)−基(R1、A1及びR3は、前記と同一の意味を表す。)を表す。]、R1A1N−O−R4−基(R1、A1及びR4は、前記と同一の意味を表す。)、R1(A1−(O)n−)N−基(R1、A1及びnは、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−基(D3は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(4)D0群:
(b0) −R4−基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−R4−基
((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなし、R4は、前記と同一の意味を表す。)、ハロゲン原子、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−R4−基(D3及びR4は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基
である。
(5)E0群:A2−CO−R5−基
である。但し、A2が水酸基のとき、R5がビニレン基ではない。
[A2は、
(i)A3−B4−基
{A3は、水素原子、又は、C1-C10アルキル基、又は、C2-C10ハロアルキル基、又は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、又は、ハロゲン原子で置換されてもよいC3-C10アルキニル基、又は、Ra0−(R4)m−基(Ra0は、置換されてもよい5−7員環のアリール基又はヘテロアリール基を表し、R4及びmは前記と同一の意味を表す。)、又は、(b0)−R4−基((b0)及びR4は、前記と同一の意味を表す。)、(c0)−R4−基((c0)及びR4は、前記と同一の意味を表す。)、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)若しくはA4−SO2−R4−基{A4は、(b0)−基((b0)は、前記と同一の意味を表す。)、(c0)−基((c0)は、前記と同一の意味を表す。)又はR1R1’N−基(R1及びR1’は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}で置換されたC1-C10アルキル基を表し、
B4は、オキシ基、チオ基又は−N((O)mR1)−基(R1及びmは、前記と同一の意味を表す。)を表す。但し、B4がチオ基のとき、A3が水素原子ではない。}、
(ii)R1−B4−CO−R4−B4’−基(R1、B4及びR4は、前記と同一の意味を表し、B4’は、B4と同一又は相異なり、B4と同一の意味を表す。但し、B4がチオ基のとき、R2が水素原子ではない。)又はD2−R4−B4−基(D2、R4及びB4は、前記と同一の意味を表す。)、
(iii)R2−SO2−NR1−基(R2は、前記と同一の意味を表す。但し、水素原子を除く。R1は、前記と同一の意味を表す。)、
(iv)(b0)−基((b0)は、前記と同一の意味を表す。)、
(v)(c0)−基((c0)は、前記と同一の意味を表す。)又は
(vi)R1A1N−NR1’−基(R1、A1及びR1’は、前記と同一の意味を表す。)を表し、R5は、ハロゲン原子で置換されてもよいC2-C10アルケニレン基、又は、C2-C10アルキニレン基を表す。]
(6)F0群:A5−B5−R6−基[A5は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)、D3−基(D3は、前記と同一の意味を表す。)若しくはA4−SO2−基(A4は、前記と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC1-C10アルキル基を表し、B5は、B1−基(B1は、前記と同一の意味を表す。)又は−NA1−基(A1は、前記と同一の意味を表す。)を表し、R6は、単結合又はC1-C10アルキレン基を表す。]
である。
(7)G0群:A6−B5−R6−基
[A6は、(a0)−R4−基((a0)及びR4は、前記と同一の意味を表す。)、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基、又は、(b0)−基((b0)は、前記と同一の意味を表す。)、(c0)−基((c0)は、前記と同一の意味を表す。)、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルケニル基、又は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルキニル基を表し、B5及びR6は、前記と同一の意味を表す。]
である。
(8)H0群:
D2−N(−(O)n−A1)−R6−基(D2、n、A1及びR6は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。但し、シアノ基を除く。)、R1(R1’(O)n)N−CR1’’=N−R6−基(R1、R1’、n及びR6は、前記と同一の意味を表し、R1’’は、R1と同一又は相異なり、R1と同一の意味を表す。)、R1−(O)n−N=CR1’−NR2−R6−基(R1、n、R1’、R2及びR6は、前記と同一の意味を表す。)、R2−B3−NR1−CO−NR1’−R6−基(R2、B3、R1、R1’及びR6は、前記と同一の意味を表す。)、D2−CO−NR1−R6−基(D2、R1及びR6は、前記と同一の意味を表す。)又はA2−COCO−NR1−R6−基(A2、R1及びR6は、前記と同一の意味を表す。)
である。
(9)I0群:
A7−B6−N((O)nR1)−R6−基[A7は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、C2-C10アルキニル基、C3-C10ハロアルキニル基、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、(b0)−R4−基((b0)及びR4は、前記と同一の意味を表す。)、(c0)−R4−基((c0)及びR4は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)、A4−SO2−R4−基(A4及びR4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B6は、カルボニル基又はチオカルボニル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8−CS−N((O)nR1)−R6−基[A8は、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、
A7’−B2’−B3−N((O)nR1)−R6−基[A7’は、ハロゲン原子で置換されてもよいC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2及びB1は、前記と同一の意味を表し、R4’は、C2-C10アルキレン基を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b0)−R4’−基((b0)及びR4’は、前記と同一の意味を表す。)、(c0)−R4’−基((c0)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4’−基(D3及びR4’は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B2’は、オキシ基、チオ基又は−N((O)n’R1’)−基(n’は、nと同一又は相異なり、nと同一の意味を表し、R1’は、前記と同一の意味を表す。)を表し、B3、n、R1及びR6は、前記と同一の意味を表す。]、A8’−B2’−CS−N((O)nR1)−R6−基[A8’は、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、B2’は、前記と同一の意味を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8’−S−B3’−N((O)nR1)−R6−基[A8’、n、R1及びR6は、前記と同一の意味を表し、B3’は、カルボニル基又はスルホニル基を表す。]又はA7’’−SO2−N((O)nR1)−R6−基[A7’’は、C2-C10アルケニル基、ハロゲン原子で置換されたC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2、B1及びR4’は、前記と同一の意味を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b0)−R4’−基((b0)及びR4’は、前記と同一の意味を表す。)、(c0)−R4’−基((c0)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、NO2−R4−基(R4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(10)J0群:A7−CO−基(A7は、前記と同一の意味を表す。)、又は、A9−CS−基(A9は、A7又はA8を表す。)、又は、A9’(O)mN=C(A9)−基(A9’は、A7’又はA8’を表し、m及びA9は、前記と同一の意味を表す。)、又は、D2−CO−基(D2は、前記と同一の意味を表す。)、又は、A2−COCO−基(A2は、前記と同一の意味を表す。)、又は、A9−CO−B1’−R6−基(A9及びR6は、前記と同一の意味を表し、B1’は、オキシ基又はチオ基を表す。但し、B1’がオキシ基のとき、A9は、A8ではない。)、又は、A9−CS−B1’−R6−基(A9、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A7’’−SO2−B1’−R6−基(A7’’、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A8−SO2−B1’−R6−基(A8、B1’及びR6は、は、前記と同一の意味を表す。但し、A8は、水素原子となることはない。)、又は、A9’−B2’−B3−B1’−R6−基(A9’、B2’、B3、B1’及びR6は、は、前記と同一の意味を表す。)、又は、(b0)−基((b0)は、前記と同一の意味を表す。)若しくは(c0)−基((c0)は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(11)K0群:A10−N((O)nR1)−CO−R6−基[A10は、水素原子(但し、nは0ではない。)、A7’’−SO2−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−基(A8は、前記と同一の意味を表す。但し、A8は、水素原子とはならない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2OCH2−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(12)L0群:A10’−N((O)nR1)−SO2−R6−基[A10’は、水素原子(但し、nは0ではない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2−CO−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]、A9’’R1N−SO2−N((O)nR1’)−R6−基[A9’’は、水素原子又はA9’−基(A9’は、前記と同一の意味を表す。)を表し、R1、n、R1’及びR6は、前記と同一の意味を表す。]又は(b0)−SO2−N((O)nR1’)−R6−基[(b0)、n、R1’及びR6は、前記と同一の意味を表す。]
である。
(13)M0群:R1(R2S)C=N−R6−基(R1、R2及びR6は、前記と同一の意味を表す。)、R2B(R2’B’)C=N−R6−基(R2及びR6は、前記と同一の意味を表し、R2’は、R2と同一又は相異なり、R2と、同一の意味を表し、B及びB’は、同一又は相異なり、オキシ基又はチオ基を表す。)、R1R1’N−(R2S)C=N−R6−基(R1、R1’、R2及びR6は、前記と同一の意味を表す。)、R1N=C(SR2)−NR2’−R6−基(R1、R2、R2’及びR6は、前記と同一の意味を表す。)又はR1(R1’O)N−R6−基(R1、R1’及びR6は、前記と同一の意味を表す。)
である。
(14)N0群:A11−P(=O)(OR1’)−R4−基[A11は、R1−基(R1は、前記と同一の意味を表す。)、R1O−R6−基(R1及びR6は、前記と同一の意味を表す。)又はR1OCO−CHR0−基(R1及びR0は、前記と同一の意味を表す。)を表し、R1’及びR4は、前記と同一の意味を表す。]
である。
III.(YA0)qにおいて、YA0は、下記のX0群及びY0群の基を表し、qは、0、1、2又は3を表し、p(pは、前記と同一の意味を表す。)とqとの和は3以下であり、qが2以上のとき、YA0は同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYA0は、Z0群の基をなして、A0環と縮環してもよい。
(1)X0群:
Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:
Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)は、前記と同一の意味を表す。)、
(c0)−基((c0)は、前記と同一の意味を表す。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、A0環と縮環する基である。
IV.B0は、
式(III-1)
[式中、
(1)QA0は、水酸基、(b0)−基((b0)は、前記と同一の意味を表す。)、A9−B6−Bc−基[A9及びB6は、前記と同一の意味を表し、Bcは、オキシ基又は−N((O)mR1)−基(m及びR1は、前記と同一の意味を表す。)を表す。但し、A9が水素原子のとき、Bcは、スルホニル基ではない。]、A7’’−SO2−Bc−基(A7’’及びBcは、前記と同一の意味を表す。)、A8−SO2−Bc−基(A8及びBcは、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−Bc−基(R1、R1’及びBcは、前記と同一の意味を表す。)、(b0)−SO2−Bc−基((b0)及びBcは、前記と同一の意味を表す。)、A9’−Bc−基(A9’及びBcは、前記と同一の意味を表す。)、D5−R4−Bc−基(D5、R4及びBcは、前記と同一の意味を表す。)、Mc0−B3−Bc−基(Mc0、B3及びBcは、前記と同一の意味を表す。)又はMc0−Bc−基(Mc0及びBcは、前記と同一の意味を表す。)を表す。
(2)WA0は、酸素原子又は−NTA0−基[TA0は、水素原子、A9’−基(A9’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)又はMc0−基(Mc0は、前記と同一の意味を表す。)を表す。]を表す。
(3)KA0は、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、LA0は、水素原子、C1-C10アルキル基又はMb0−基(Mb0は、前記と同一の意味を表す。)を表し、KA0とLA0とは、C3-C10アルキレン基、又は、単数又は同一又は相異なる複数のMa−基(Maは、前記と同一の意味を表す。)で置換されてもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(III-2)
[式中、TA0は、前記と同一の意味を表し、LB0は水酸基又はメチル基を表す。]
で示される基、
式(III-3)
[式中、TA0は、前記と同一の意味を表し、LC0は、C1-C10アルキル基を表す。]
で示される基、
式(III-4)
[式中、TA0は、前記と同一の意味を表す。]
で示される基、
式(III-5)
[式中、TA0は、前記と同一の意味を表し、KB0は、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(III-6)
[式中、WA0は、前記と同一の意味を表し、KC0とLD0とは、C3-C10アルキレン基又は単数又は同一又は相異なる複数のMa−基(Maは、前記と同一の意味を表す。)で置換されてもよいC4-C10アルケニレン基をなす。]
で示される基、
式(III-7)
[式中、QA0及びWA0は、前記と同一の意味を表し、KD0とLE0とは、−VA0=VA0’−VA0’’=VA0’’’−基{VA0、VA0’、VA0’’及びVA0’’’は、同一又は相異なり、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいメチン基、又は、−N=基を表し、VA0、VA0’、VA0’’及びVA0’’’のうち少なくとも一つは−N=基を表す。}をなす。]
で示される基、
式(III-8)
[式中、TA0は、前記と同一の意味を表し、QB0は、水酸基、A9−B6−O−基[A9及びB6は、前記と同一の意味を表す。]、A7’’−SO2−O−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−O−基(A8は、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−O−基(R1及びR1’は、前記と同一の意味を表す。)、(b0)−SO2−O−基((b0)は、前記と同一の意味を表す。)、A9’−O−基(A9’は、前記と同一の意味を表す。)、D5−R4−O−基(D5及びR4は、前記と同一の意味を表す。)、Mc0−B3−O−基(Mc0及びB3は、前記と同一の意味を表す。)又はMc0−O−基(Mc0は、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(III-9)
[式中、U及びWA0は、前記と同一の意味を表す。]
で示される基を表す。
但し、A0がフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (III)
[Where:
I. A0 represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms.
II. (X A0 ) In p , X A0 represents a group included in any of the following groups A 0 to N 0 , p represents 0, 1, 2, or 3, and p is 2 or more In this case, X A0 is the same or different.
(1) Group A 0 : D 1 -R 4 -group [D 1 is (R 1- (O) k- ) A 1 N- (O) k ' -group {R 1 is a hydrogen atom or a C1-C10 alkyl group, a or a halogen atom or R 2 -B 1 - group (R 2 represents a C1-C10 alkyl group, a C3-C10 alkenyl group or C3-C10 alkynyl group, B 1 is an oxy group, A C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group substituted with a thio group, a sulfinyl group, or a sulfonyl group), k represents 0 or 1, 1 represents R 3 — (CHR 0 ) m — (B 2 —B 3 ) m ′ — group {R 3 represents a hydrogen atom, a halogen atom or an R 2 —B 1 — group (R 2 and B 1 represent Represents a C1-C10 alkyl group, a C2-C10 alkenyl group, or a C2-C10 alkynyl group which may be substituted. R 0 is a hydrogen atom, C1-C10 alkyl or C2-C10 haloalkyl group, m represents 0 or 1, B 2 represents a single bond, oxy group, thio group, or -N ((O) n R 1. ') - group (R 1' is different from R 1 identical or different, represent the same meaning as R 1, n denotes the representative) 0 or 1, B 3 is a carbonyl group, thio A carbonyl group or a sulfonyl group, m ′ represents 0 or 1, and when B 3 is a sulfonyl group, m is 0 and R 3 is not a hydrogen atom. }, And k ′ represents 0 or 1. }, And R 4 represents a C1-C10 alkylene group. However, R 0 'R 0'' N-R 4 - group (R 0' and R 0 '' is different from R 0 and same or different, represent the same meaning as R 0, R 4 is the same Represents the meaning of. ], D 2 -R 4 - group [D 2 is a cyano group, R 1 R 1 'NC ( = N- (O) n -A 1) - group (R 1, R 1', n, and A 1 Represents the same meaning as described above.), Represents an A 1 N═C (—OR 2 ) — group (A 1 and R 2 represent the same meaning as described above) or an NH 2 —CS— group. , R 4 represents the same meaning as described above. ], D 3 -R 4 -group {D 3 represents a nitro group or R 1 OSO 2 -group (R 1 represents the same meaning as described above), and R 4 represents the same meaning as described above. To express. } Or R 1 OSO 2 — group (R 1 represents the same meaning as described above).
(2) B 0 group:
(A 0 ) — group (in (a 0 ), E 0 is a saturated or unsaturated, aromatic or non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic group which may have a substituent. It forms a ring and R 1 represents the same meaning as described above.
(3) C 0 group: halogen atom, R 2 —B 1 — group (R 2 and B 1 are as defined above), D 4 —R 4 — group [D 4 is a hydroxyl group or A 1- O-group (A 1 represents the same meaning as described above) and R 4 represents the same meaning as described above. ], D 5 - group [D 5 is, O = C (R 3) - group (R 3 represents the same meaning as above.), A 1 - (O ) n -N = C (R 3) A group (A 1 , n and R 3 are as defined above), R 1 —B 0 —CO—R 4 — (O) n —N═C (R 3 ) — group {R 1 , R 4 , n and R 3 represent the same meaning as described above, and B 0 represents an oxy group, a thio group, or a —N ((O) m R 1 ′)-group (R 1 ′ and m Represents the same meaning as }, D 2 —R 4 — (O) n —N═C (R 3 ) — group (D 2 , R 4 , n and R 3 represent the same meaning as described above) or R 1 A 1 N —N═C (R 3 ) — group (wherein R 1 , A 1 and R 3 represent the same meaning as described above). ], R 1 A 1 N—O—R 4 — group (R 1 , A 1 and R 4 represent the same meaning as described above), R 1 (A 1- (O) n —) N— group (R 1 , A 1 and n represent the same meaning as described above), D 2 -group (D 2 represents the same meaning as described above) or D 3 -group (D 3 represents the same as above. C2-C10 alkenyl group substituted with the same meaning.
(4) D group 0 :
(b 0 ) —R 4 — group (in (b 0 ), G 0 is a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic group which may have a substituent. A ring)
(C 0 ) —R 4 — group (in (c 0 ), J 0 may contain a nitrogen atom, forms an aromatic 5- to 7-membered ring, and R 4 has the same meaning as described above). , A halogen atom, an R 2 -B 1 -R 4 -group (R 2 , B 1 and R 4 are as defined above), a D 4 -R 4 -group (D 4 and R 4 are The same meaning as above), D 5 -group (D 5 represents the same meaning as above), D 1 -R 4 -group (D 1 and R 4 have the same meaning as above). represented), D 2 -. group (D 2, the representative of the same meaning as) or D 3 -R 4 -. group (D 3, and R 4 is substituted with representing) the same meaning as above. A C2-C10 alkynyl group.
(5) Group E 0 : A 2 —CO—R 5 — group. However, when A 2 is a hydroxyl group, R 5 is not a vinylene group.
[A 2 is,
(i) A 3 -B 4 -group {A 3 is a hydrogen atom, a C1-C10 alkyl group, a C2-C10 haloalkyl group, or a C2-C10 alkenyl group optionally substituted with a halogen atom, Or a C3-C10 alkynyl group that may be substituted with a halogen atom, or a R a0- (R 4 ) m -group (R a0 is an optionally substituted aryl group or heteroaryl group of 5-7 membered ring) R 4 and m represent the same meaning as described above), or (b 0 ) —R 4 — group ((b 0 ) and R 4 represent the same meaning as described above), ( c 0 ) —R 4 — group ((c 0 ) and R 4 are as defined above), R 2 —B 1 —R 4 — group (R 2 , B 1 and R 4 are represents the same meaning as), D 4 -R 4 -. group (D 4 and R 4 represent the same meaning as above), D 5 -. group (D 5, the a Represents the same meaning.), D 1 -R 4 -group (D 1 and R 4 represent the same meaning as described above), D 2 -group (D 2 represents the same meaning as described above). ), D 3 -R 4 -group (D 3 and R 4 are as defined above) or A 4 -SO 2 -R 4 -group {A 4 is a (b 0 ) -group (( b 0) represent the same meaning), (c 0) -. . group ((c 0) represents the same meaning as) or R 1 R 1 'N- group (R 1 and R 1 ′ represents the same meaning as described above.), And R 4 represents the same meaning as described above. } Represents a C1-C10 alkyl group substituted with
B 4 represents an oxy group, a thio group, or a —N ((O) m R 1 ) — group (where R 1 and m represent the same meaning as described above). However, when B 4 is a thio group, A 3 is not a hydrogen atom. },
(ii) R 1 —B 4 —CO—R 4 —B 4 ′ — group (R 1 , B 4 and R 4 have the same meaning as described above, and B 4 ′ is the same as or different from B 4. represents B 4 same meaning as the proviso that when B 4 is a thio group, R 2 is not hydrogen atom) or D 2 -R 4 -B 4 -. . group (D 2, R 4 and B 4 is Represents the same meaning as described above).
(iii) R 2 —SO 2 —NR 1 — group (R 2 represents the same meaning as described above, except for a hydrogen atom; R 1 represents the same meaning as described above),
(iv) (b 0 ) -group ((b 0 ) represents the same meaning as described above),
(v) (c 0 ) -group ((c 0 ) represents the same meaning as described above) or
(vi) R 1 A 1 N—NR 1 ′ -group (R 1 , A 1 and R 1 ′ have the same meaning as described above), and R 5 may be substituted with a halogen atom. A C2-C10 alkenylene group or a C2-C10 alkynylene group is represented. ]
(6) F 0 Group: A 5 -B 5 -R 6 - group [A 5 is D 4 - group (. D 4 may represent the same meaning as described above), D 1 - group (D 1 is It represents the same meaning as described above), D 3 -group (D 3 represents the same meaning as described above) or A 4 —SO 2 — group (A 4 represents the same meaning as described above). A C2-C10 alkyl group substituted with or R 2 —B 1 — group (R 2 and B 1 are as defined above), D 2 — group (D 2 is the same as defined above) C1 substituted with a D 5 -group (D 5 represents the same meaning as described above) or an A 2 —CO— group (A 2 represents the same meaning as described above). represents -C10 alkyl group, B 5 is B 1 - group (B 1, the represent the same meaning as.) or -NA 1 - group (a 1 represent the same meanings as the above.) the It represents, R 6 is, Bond or an C1-C10 alkylene group. ]
It is.
(7) G 0 Group: A 6 -B 5 -R 6 - group [A 6 is, (a 0) -R 4 - group ((a 0) and R 4 represents the same meaning as above.) or C2-C10 alkenyl group, or C2-C10 alkynyl group, or a halogen atom, R 2 -B 1 - group (. R 2 and B 1 may represent the same meaning as described above), D 5 - group (D 5 represents the same meaning as.), D 2 - group (. D 2, the representative of the same meaning as) or a 2 -CO- group (a 2, the same as the A C2-C10 alkenyl group substituted with a meaning) or a halogen atom, an R 2 -B 1 -group (R 2 and B 1 have the same meaning as described above), a D 5 -group ( D 5 represents the same meaning), D 2 -.. group (D 2, the representative of the same meaning as) or a 2 -CO- group (a 2, the same meaning . Representing) C2-C10 alkynyl group substituted with, or, (b 0) - group ((b 0) represent the same meaning as above),. (C 0) - group ((c 0) is , D 4 -group (D 4 represents the same meaning as described above), D 1 -group (D 1 represents the same meaning as described above) or D 3 - group (. D 3 may represent the same meanings as the above) C3-C10 alkenyl group substituted with, or, D 4 - group (. D 4 may represent the same meaning as described above), D 1 - group (D 1, the represent the same meaning as.) or D 3 - group (. D 3 may represent the same meanings as the above) represents a C3-C10 alkynyl group substituted with, B 5 and R 6 represents the same meaning as described above. ]
It is.
(8) H 0 group:
D 2 —N (— (O) n —A 1 ) —R 6 — group (D 2 , n, A 1 and R 6 are as defined above), D 2 — group (D 2 is Represents the same meaning as described above, except for a cyano group.), R 1 (R 1 ′ (O) n ) N—CR 1 ″ = N—R 6 — group (R 1 , R 1 ′, n and R 6 represent the same meanings, R 1 '' are the same or different phase and R 1, represents the same meaning as R 1), R 1 -. (O) n -N = CR 1 '-NR 2 -R 6 - group (R 1, n, R 1 '., R 2 and R 6 represent the same meaning as described above), R 2 -B 3 -NR 1 -CO-NR 1 '-R 6 -group (R 2 , B 3 , R 1 , R 1 ' and R 6 represent the same meaning as described above), D 2 -CO-NR 1 -R 6 -group (D 2 , R 1 and R 6 represent the same meanings as the above. Or A 2 -COCO-NR 1 -R 6 - group (A 2, R 1 and R 6 represent the same meanings as the above.)
It is.
(9) I 0 group:
A 7 -B 6 -N ((O ) n R 1) -R 6 - group [A 7 is optionally substituted C2-C10 alkenyl group with a halogen atom, C2-C10 alkynyl group, C3-C10 haloalkynyl A group, R 2 -B 1 -R 4 -group (R 2 , B 1 and R 4 are as defined above), D 4 -R 4 -group (D 4 and R 4 are represents the same meaning), D 5 -R 4 -. group (D 5 and R 4 represents the same meaning), D 1 -R 4 -. group (D 1 and R 4, the a Represents the same meaning.), (B 0 ) —R 4 — group ((b 0 ) and R 4 represent the same meaning as described above), (c 0 ) —R 4 — group ((c 0 ) And R 4 represent the same meaning as described above.), D 2 -R 4 -group (D 2 and R 4 represent the same meaning as described above), D 3 -R 4 -group (D 3 and R 4 are the Represents the same meaning), A 4 -SO 2 -R 4 -. Group (A 4 and R 4 represent the same meanings as the above) or A 2 -CO-R 4 -. Group (A 2 and R 4 represents the same meaning as described above), B 6 represents a carbonyl group or a thiocarbonyl group, and n, R 1 and R 6 represent the same meaning as described above. ], A 8 -CS-N ( (O) n R 1) -R 6 - group [A 8 is a hydrogen atom, or represents a optionally substituted C1-C10 alkyl group with a halogen atom, n, R 1 and R 6 represent the same meaning as described above. ],
A 7 '-B 2' -B 3 -N ((O) n R 1) -R 6 - group [A 7 'is optionally substituted C3-C10 alkenyl group with a halogen atom, is substituted with a halogen atom and it may be C3-C10 alkynyl group, R 2 -B 1 -R 4 ' - group (R 2 and B 1 represent the same meaning as, R 4' represents a C2-C10 alkylene group.) , D 4 -R 4 '- group (D 4 and R 4' represents the same meaning as.), D 1 -R 4 ' - group (D 1 and R 4', wherein the same meaning ), (B 0 ) -R 4 ′ -group ((b 0 ) and R 4 ′ represent the same meaning as described above), (c 0 ) -R 4 ′ -group ((c 0 ) and R 4 'represents the same meaning), D 2 -R 4 -. group (D 2 and R 4 represent the same meaning as above), D 3 -R 4.' - group (D 3 and R 4 ′ have the same meaning as above. Represents a taste) or A 2 —CO—R 4 — group (where A 2 and R 4 represent the same meaning as described above), and B 2 ′ represents an oxy group, a thio group or —N ((( O) n ′ R 1 ′) -group (where n ′ is the same as or different from n and represents the same meaning as n, and R 1 ′ represents the same meaning as described above), B 3 , n, R 1 and R 6 represent the same meaning as described above. ], A 8 '-B 2' -CS-N ((O) n R 1) -R 6 - group [A 8 'represents a C1-C10 alkyl or C2-C10 haloalkyl group, B 2' is , And the same meaning as described above, and n, R 1 and R 6 represent the same meaning as described above. ], A 8 '-S-B 3' -N ((O) n R 1) -R 6 - group [A 8 ', n, R 1 and R 6 represent the same meanings as above, B 3 'Represents a carbonyl group or a sulfonyl group. ] Or A 7 '' -SO 2 -N ( (O) n R 1) -R 6 - group [A 7 '' is, C2-C10 alkenyl group, C3-C10 alkenyl group substituted with a halogen atom, a halogen optionally substituted C3-C10 alkynyl group atom, R 2 -B 1 -R 4 ' - group (R 2, B 1 and R 4'. is representing the same meaning as above), D 4 -R 4 '- group (D 4 and R 4' represents the same meaning.), D 5 -R 4 - group (. D 5 and R 4 represent the same meaning as described above), D 1 -R 4 '-group (D 1 and R 4 ' represent the same meaning as described above), (b 0 ) -R 4 '-group ((b 0 ) and R 4 ' are the same as defined above. Represents a meaning), (c 0 ) -R 4 '-group ((c 0 ) and R 4 ' represent the same meaning as described above), D 2 -R 4 -group (D 2 and R 4 Represents the same meaning as described above). NO 2 —R 4 — group (R 4 represents the same meaning as described above) or A 2 —CO—R 4 — group (A 2 and R 4 represent the same meaning as described above). , N, R 1 and R 6 represent the same meaning as described above. ]
It is.
(10) J 0 Group: A 7 -CO- group (A 7 represents the same meaning as.), Or, A 9 -CS- group (A 9 represents A 7 or A 8.) Or A 9 ′ (O) m N═C (A 9 ) — group (A 9 ′ represents A 7 ′ or A 8 ′, and m and A 9 represent the same meaning as described above). Or D 2 —CO— group (D 2 represents the same meaning as described above), A 2 —COCO— group (A 2 represents the same meaning as described above), or A 9- CO-B 1 '-R 6 -group (A 9 and R 6 represent the same meaning as described above, B 1 ' represents an oxy group or a thio group, provided that B 1 'is an oxy group, When A 9 is not A 8 ), or A 9 -CS-B 1 '-R 6 -group (A 9 , B 1 ' and R 6 represent the same meaning as described above. ), or, A 7 '' -SO 2 -B '-R 6 - group (A 7'', B 1 ' and R 6 represents the same meaning as.), Or, A 8 -SO 2 -B 1 ' -R 6 - group (A 8 , B 1 ′ and R 6 represent the same meaning as described above, provided that A 8 is not a hydrogen atom.) Or A 9 ′ -B 2 ′ -B 3 -B 1 '-R 6 - group (a 9', B 2 ' , B 3, B 1' and R 6 represent the same meanings as the above.), or, (b 0) - group ((b 0) represents the same meaning) or (c 0) -. group ((c 0) is a C2-C10 alkenyl group substituted with representing) the same meaning as above..
(11) K 0 group: A 10 -N ((O) n R 1 ) —CO—R 6 — group [A 10 is a hydrogen atom (where n is not 0), A 7 ″ -SO 2 -group (A 7 ″ represents the same meaning as described above), A 8 —SO 2 — group (A 8 represents the same meaning as described above, provided that A 8 is a hydrogen atom. . which become not), a 9 'O-group (a 9' represents the same meaning where, n is not a 1), a 9.. ' - group (a 9', the same meaning Provided that when n is 0, A 8 ′ is excluded), R 2 OCH 2 — group (R 2 represents the same meaning as described above), A 2 —CO—R 4 — group ( A 2 and R 4 represent the same meaning as described above.) Or A 2 —CO—CH (CH 2 CO—A 2 ) — group (A 2 represents the same meaning as described above), n, R 1 and R 6 are This means the same meaning as above. ]
It is.
(12) L 0 groups: - (. Here, n is not 0) A 10 '-N (( O) n R 1) -SO 2 -R 6 group [A 10' is a hydrogen atom, A 9 ' O-group (A 9 'represents the same meaning as described above, provided that n is not 1), A 9 ' -group (A 9 'represents the same meaning as described above, provided that n is When 0, A 8 ′ is excluded.), R 2 —CO— group (R 2 represents the same meaning as described above), A 2 —CO—R 4 — group (A 2 and R 4 are Represents the same meaning as described above) or A 2 —CO—CH (CH 2 CO—A 2 ) — group (A 2 represents the same meaning as described above), and represents n, R 1 and R 6. Represents the same meaning as described above. ] A 9 ″ R 1 N—SO 2 —N ((O) n R 1 ′) —R 6 — group [A 9 ″ is a hydrogen atom or A 9 ′ -group (A 9 ′ R 1 , n, R 1 ′ and R 6 represent the same meaning as described above. ] Or (b 0 ) —SO 2 —N ((O) n R 1 ′) —R 6 — group [(b 0 ), n, R 1 ′ and R 6 represent the same meaning as described above. ]
It is.
(13) M 0 group: R 1 (R 2 S) C═N—R 6 — group (R 1 , R 2 and R 6 represent the same meaning as described above), R 2 B (R 2 ′ B ') C = N-R 6 - group (R 2 and R 6 represent the same meaning, R 2' are identical or different phase and R 2, and R 2, represent the same meaning, B and B ′ are the same or different and represent an oxy group or a thio group.), R 1 R 1 ′ N— (R 2 S) C═N—R 6 —group (R 1 , R 1 ′, R 2 and R 6 represent the same meaning as described above.), R 1 N═C (SR 2 ) —NR 2 ′ —R 6 — group (R 1 , R 2 , R 2 ′ and R 6 are Or R 1 (R 1 ′ O) N—R 6 — group (R 1 , R 1 ′ and R 6 represent the same meaning as described above.)
It is.
(14) N 0 group: (. R 1 may represent the same meanings as the above) A 11 -P (= O) (OR 1 ') -R 4 - - group [A 11 is R 1 radical, R 1 O—R 6 — group (R 1 and R 6 are as defined above) or R 1 OCO—CHR 0 — group (where R 1 and R 0 are as defined above). R 1 ′ and R 4 represent the same meaning as described above. ]
It is.
III. (Y A0 ) In q , Y A0 represents a group of the following X 0 group and Y 0 group, q represents 0 , 1, 2, or 3, and p (p represents the same meaning as described above). .) And q is 3 or less, and when q is 2 or more, Y A0 is the same or different, and when q is 2 or more, two adjacent same or different Y A0 are It forms a Z 0 group group, may be condensed with A0 ring.
(1) X 0 group:
M a -group [M a is an R b -group (R b represents a C1-C10 alkyl group optionally substituted with a halogen atom), halogen atom, nitro group, cyano group, hydroxyl group, R c- B a -R d - the group (R c, represents a substituted C1-C10 may be an alkyl group with a halogen atom, B a represents oxy, thio, sulphinyl group or a sulfonyl group, R d is A single bond or a C1-C10 alkylene group), a HOR d -group (R d is as defined above), a R e -CO-R d -group (R e is a hydrogen atom, or Represents a C1-C10 alkyl group which may be substituted with a halogen atom, R d represents the same meaning as described above), R e —CO—O—R d — group (R e and R d are represents the same meaning), R e O-CO- R d -. group (R e and R d represent the same meaning as above ), HO-CO-CH = CH- group, R e R e 'N- R d - group (R e and R e' are the same or different, R e represents the same meanings as defined, R e ′ represents the same meaning as R e, and R d represents the same meaning as described above.), R e —CO—NR e ′ —R d — group (R e , R e ′ and R d Represents the same meaning as described above), R b O—CO—N (R e ) —R d — group (R b , R e and R d represent the same meaning as described above), R. e R e 'N—CO—R d — group (R e , R e ′ and R d are as defined above), R e R e ′ N—CO—NR e ″ —R d - group (R e, R e 'and R e' 'are the same or different, R e and R e' represents the same meaning as, R e '' are the same meaning as R e R d represents the same meaning as described above. ), R e R e ′ N—C (═NR e ″) —NR e ′ ″ —R d — groups (R e , R e ′, R e ″ and R e ″ ″ are identical) Or, differently, R e , R e ′ and R e ″ have the same meaning as described above, R e ′ ″ has the same meaning as R e, and R d has the same meaning as described above. the represented), R b -SO 2 -NR e -R d -.. group (R b, R e and R d, which represents the same meaning as above), R e R e 'N -SO 2 -R d -group (R e , R e ′ and R d represent the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y group 0 :
M b0 -R d -group [M b0 is M c0 -group {M c0 is M d0 -R d ' -group {M d0 is M a -group (M a represents the same meaning as described above) 5-10-membered ring hetero group optionally substituted with 6-10-membered ring aryl group or M a -group (M a represents the same meaning as described above). An aryl group, or a M a -group (M a represents the same meaning as described above), and a 3- to 10-membered hydrocarbon ring or heterocyclic ring that may contain an unsaturated bond may be formed. Group or
(b 0 ) -group ((b 0 ) represents the same meaning as described above),
(C 0 ) -group ((c 0 ) represents the same meaning as described above),
(D 0 ) -group {d 0 is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, an —NR 1 -group (R 1 represents the same meaning as described above), sulfinyl. A 5- to 12-membered hydrocarbon ring which may be substituted with a group or a sulfonyl group. } Or
(E 0 ) -group {e 0 is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a —NR 1 — group (R 1 is as defined above), a sulfinyl group or a sulfonyl group. It forms an optionally substituted 5-12 membered hydrocarbon ring. Represents}, R d 'are the same or different and R d, it represents the same meaning as R d. }. }, M c0 -B a - group (. M c0 and B a are representing the same meaning), M c0 -CO- group (. M c0 is representative of the same meaning as), M c0 -CO-O- group (M c0 represents the same meaning as described above), M c0 O-CO- group (M c0 represents the same meaning as described above), M c0 R e N- group (M c0 and R e represent the same meaning as described above), M c0 —CO—NR e — group (M c0 and R e represent the same meaning as described above), M c0 O—CO —NR e — group (M c0 and R e represent the same meaning as described above), M c0 R e N—CO— group (M c0 and R e represent the same meaning as described above), M c0 R e N-CO- NR e '- group (M c0, R e and R e'. are representing the same meaning as), M c0 R e N- C (= N e ') -NR e' '- group (M c0, R e, R e' and R e '' represents the same meaning), M c0 -SO 2 -NR e -. group (M c0 And R e represent the same meaning as described above) or a M c0 R e N—SO 2 — group (M c0 and R e represent the same meaning as described above), and R d represents the above Represents the same meaning as ].
(3) Z 0 group: having halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group It may be a 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the A0 ring.
IV. B0 is
Formula (III-1)
[Where:
(1) Q A0 is a hydroxyl group, (b 0 ) -group ((b 0 ) represents the same meaning as described above), A 9 -B 6 -B c -group [A 9 and B 6 are B c represents an oxy group or —N ((O) m R 1 ) — group (m and R 1 represent the same meaning as described above). However, when A 9 is a hydrogen atom, B c is not a sulfonyl group. ], A 7 '' -SO 2 -B c - group (A 7 '' and B c represents the same meaning as.), A 8 -SO 2 -B c - group (A 8 and B c Represents the same meaning as described above, provided that A 8 is not a hydrogen atom.), R 1 R 1 ′ N—SO 2 —B c — group (R 1 , R 1 ′ and B c are represents the same meaning as),. (b 0) -SO 2 -B c - groups ((b 0) and B c represent the same meaning as above), a 9 '-B c - . group ( A 9 ′ and B c represent the same meaning as described above.), D 5 —R 4 —B c — group (D 5 , R 4 and B c represent the same meaning as described above), M c0 -B 3 -B c - groups (M c0, B 3 and B c, the represent the same meaning as.) or M c0 -B c - groups (M c0 and B c, the same meaning Represents).
(2) W A0 represents an oxygen atom or -NT A0 - group [T A0 is a hydrogen atom, A 9 '- group (A 9'. Are representing the same meaning as above), D 5 -R 4 - A group (D 5 and R 4 represent the same meaning as described above) or a M c0 -group (M c0 represents the same meaning as described above). ].
(3) K A0 represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group, L A0 represents a hydrogen atom, a C1-C10 alkyl group or an M b0 -group (M b0 represents the same meaning as described above). ) And K A0 and L A0 may be substituted with a C3-C10 alkylene group, or a single or a plurality of Ma-groups (Ma represents the same meaning as described above). May form a good C4-C10 alkenylene group. ]
A group represented by
Formula (III-2)
[Wherein, T A0 represents the same meaning as described above, and L B0 represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (III-3)
[Wherein, T A0 represents the same meaning as described above, and L C0 represents a C1-C10 alkyl group. ]
A group represented by
Formula (III-4)
[Wherein, T A0 represents the same meaning as described above. ]
A group represented by
Formula (III-5)
[Wherein, T A0 represents the same meaning as described above, and K B0 represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (III-6)
[Wherein W A0 represents the same meaning as described above, and K C0 and L D0 represent a C3-C10 alkylene group or a single or a plurality of Ma-groups (Ma is the same as defined above). Represents a C4-C10 alkenylene group which may be substituted. ]
A group represented by
Formula (III-7)
[In the formula, Q A0 and W A0 represent the same meaning as described above, and KD0 and LE0 represent -V A0 = V A0 '-V A0 ''= V A0 ''' -group {V A0 , V A0 ', V A0' ' and V A0' '' are the same or different, M a - group (. M a is that the represent the same meaning as) methine group optionally substituted by a, or , -N = group, and at least one of V A0 , V A0 ′, V A0 ″ and V A0 ″ ″ represents —N = group. }. ]
A group represented by
Formula (III-8)
[Wherein, T A0 represents the same meaning as described above, Q B0 represents a hydroxyl group, and an A 9 -B 6 -O- group [A 9 and B 6 represent the same meaning as described above. ], A 7 '' -SO 2 -O- group (A 7 '' represents the same meaning as.), A 8 -SO 2 -O- group (A 8 are the same meaning as above Provided that A 8 is not a hydrogen atom.), R 1 R 1 ′ N—SO 2 —O— group (R 1 and R 1 ′ represent the same meaning as described above), (b 0 ) -SO 2 -O- group ((b 0) is. representing the same meaning), a 9 '-O- group (a 9' represents the same meaning as above.), D 5 —R 4 —O— group (D 5 and R 4 represent the same meaning as described above), M c0 —B 3 —O— group (M c0 and B 3 represent the same meaning as described above). ) Or a M c0 —O— group (M c0 represents the same meaning as described above). ]
Or a group represented by
Formula (III-9)
[Wherein U and W A0 represent the same meaning as described above. ]
Represents a group represented by
However, when A0 is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
[式中、
I.Aは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表す。
II.(XA)pにおいて、XAは、下記のA群からN群までのいずれかの群に含まれる基を表し、pは、0、1、2又は3を表し、pが2以上のとき、XAは、同一又は相異なる。
(1)A群:D1−R4−基[D1は、(R1−(O)k−)A1N−(O)k’−基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表し、kは、0又は1を表し、A1は、R3−(CHR0)m−(B2−B3)m’−基{R3は、水素原子、又は、ハロゲン原子若しくはR2−B1−基(R2及びB1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基を表し、R0は、水素原子、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、mは、0又は1を表し、B2は、単結合、オキシ基、チオ基又は−N((O)nR1’)−基(R1’は、R1と同一又は相異なり、R1と同一の意味を表し、nは、0又は1を表す。)を表し、B3は、カルボニル基、チオカルボニル基又はスルホニル基を表し、m’は、0又は1を表し、B3がスルホニル基のとき、mは0となりかつR3が水素原子となることはない。}を表し、k’は、0又は1を表す。}を表し、R4は、C1-C10アルキレン基を表す。但し、R0’R0 ’’N−R4−基(R0’及びR0’’は、R0と同一又は相異なり、R0と同一の意味を表し、R4は、前記と同一の意味を表す。)を除く。]、D2−R4−基[D2は、シアノ基、R1R1’NC(=N−(O)n−A1)−基(R1、R1’、n、及びA1は、前記と同一の意味を表す。)、A1N=C(−OR2)−基(A1及びR2は、前記と同一の意味を表す。)又はNH2−CS−基を表し、R4は前記と同一の意味を表す。]、D3−R4−基{D3は、ニトロ基又はR1OSO2−基(R1は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}又はR1OSO2−基(R1は、前記と同一の意味を表す。)である。
(2)B群:
(a)−基
[(a)において、E1及びE1’は、C1-C10アルキル基若しくはC1-C10アルコキシ基で置換されてもよいメチレン基、又は、カルボニル基を表す。但し、E1及びE1’は、同時にカルボニル基となることはない。E2は、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)で置換されてもよいC2-C10アルキレン基、又は、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1’−基(R1’は、前記と同一の意味を表す。)で置換されてもよいC3-C10アルケニレン基を表し、R1は、前記と同一の意味を表す。]
である。
(3)C群:ハロゲン原子 、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D4−R4−基[D4は、水酸基又はA1−O−基(A1は、前記と同一の意味を表す。)を表し、R4は前記と同一の意味を表す。]、D5−基[D5は、O=C(R3)−基(R3は、前記と同一の意味を表す。)、A1−(O)n−N=C(R3)−基(A1、n及びR3は、前記と同一の意味を表す。)、R1−B0−CO−R4−(O)n−N=C(R3)−基{R1、R4、n及びR3は、前記と同一の意味を表し、B0は、オキシ基、チオ基又は−N((O)mR1’)−基(R1’及びmは、前記と同一の意味を表す。)を表す。}、D2−R4−(O)n−N=C(R3)−基(D2、R4、n及びR3は、前記と同一の意味を表す。)又はR1A1N−N=C(R3)−基(R1、A1及びR3は、前記と同一の意味を表す。)を表す。]、R1A1N−O−R4−基(R1、A1及びR4は、前記と同一の意味を表す。)、R1(A1−(O)n−)N−基(R1、A1及びnは、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−基(D3は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(4)D群:
(b) −R4−基[(b)において、G1、G2、G4及びG5は、隣接原子と単結合で結ばれた、メチル基で置換されてもよいメチレン基、又は、隣接原子と二重結合で結ばれた、メチル基で置換されてもよいメチン基を表し、G3は、単結合、又は、二重結合、又は、メチル基、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)で置換されてもよいC1-C10アルキレン基、又は、メチル基、オキシ基、チオ基、スルフィニル基、スルホニル基若しくは−NR1−基(R1は、前記と同一の意味を表す。)で置換されてもよいC2-C10アルケニレン基を表し、R4は、前記と同一の意味を表す。]、
(c)−R4−基
((c)において、J1、J2及びJ3は、同一又は相異なり、メチル基で置換されてもよいメチン基、又は、窒素原子を表し、R4は、前記と同一の意味を表す。)、ハロゲン原子、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)又はD3−R4−基(D3及びR4は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基
である。
(5)E群:A2−CO−R5−基
である。但し、A2が水酸基のとき、R5がビニレン基ではない。
[A2は、
(i)A3−B4−基
{A3は、水素原子、又は、C1-C10アルキル基、又は、C2-C10ハロアルキル基、又は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、又は、ハロゲン原子で置換されてもよいC3-C10アルキニル基、又は、Ra−(R4)m−基(Raは、ハロゲン原子、C1-C10アルキル基、C1-C10アルコキシ基若しくはニトロ基で置換されてもよい、フェニル基、ピリジル基、フリル基若しくはチエニル基を表し、R4及びmは前記と同一の意味を表す。)、又は、(b)−R4−基((b)及びR4は、前記と同一の意味を表す。)、(c)−R4−基((c)及びR4は、前記と同一の意味を表す。)、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)若しくはA4−SO2−R4−基{A4は、(b)−基((b)は、前記と同一の意味を表す。)、(c)−基((c)は、前記と同一の意味を表す。)又はR1R1’N−基(R1及びR1’は、前記と同一の意味を表す。)を表し、R4は、前記と同一の意味を表す。}で置換されたC1-C10アルキル基を表し、
B4は、オキシ基、チオ基又は−N((O)mR1)−基(R1及びmは、前記と同一の意味を表す。)を表す。但し、B4がチオ基のとき、A3が水素原子ではない。}、
(ii)R1−B4−CO−R4−B4’−基(R1、B4及びR4は、前記と同一の意味を表し、B4’は、B4と同一又は相異なり、B4と同一の意味を表す。但し、B4がチオ基のとき、R2が水素原子ではない。)又はD2−R4−B4−基(D2、R4及びB4は、前記と同一の意味を表す。)、
(iii)R2−SO2−NR1−基(R2は、前記と同一の意味を表す。但し、水素原子を除く。R1は、前記と同一の意味を表す。)、
(iv)(b)−基((b)は、前記と同一の意味を表す。)、
(v)(c)−基((c)は、前記と同一の意味を表す。)又は
(vi)R1A1N−NR1’−基(R1、A1及びR1’は、前記と同一の意味を表す。)を表し、R5は、ハロゲン原子で置換されてもよいC2-C10アルケニレン基、又は、C2-C10アルキニレン基を表す。]
(6)F群:A5−B5−R6−基[A5は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)、D3−基(D3は、前記と同一の意味を表す。)若しくはA4−SO2−基(A4は、前記と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC1-C10アルキル基を表し、B5は、B1−基(B1は、前記と同一の意味を表す。)又は−NA1−基(A1は、前記と同一の意味を表す。)を表し、R6は、単結合又はC1-C10アルキレン基を表す。]
である。
(7)G群:A6−B5−R6−基
[A6は、(a)−R4−基((a)及びR4は、前記と同一の意味を表す。)、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基、又は、ハロゲン原子、R2−B1−基(R2及びB1は、前記と同一の意味を表す。)、D5−基(D5は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。)若しくはA2−CO−基(A2は、前記と同一の意味を表す。)で置換されたC2-C10アルキニル基、又は、(b)−基((b)は、前記と同一の意味を表す。)、(c)−基((c)は、前記と同一の意味を表す。)、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルケニル基、又は、D4−基(D4は、前記と同一の意味を表す。)、D1−基(D1は、前記と同一の意味を表す。)若しくはD3−基(D3は、前記と同一の意味を表す。)で置換されたC3-C10アルキニル基を表し、B5及びR6は、前記と同一の意味を表す。]
である。
(8)H群:
D2−N(−(O)n−A1)−R6−基(D2、n、A1及びR6は、前記と同一の意味を表す。)、D2−基(D2は、前記と同一の意味を表す。但し、シアノ基を除く。)、R1(R1’(O)n)N−CR1’’=N−R6−基(R1、R1’、n及びR6は、前記と同一の意味を表し、R1’’は、R1と同一又は相異なり、R1と同一の意味を表す。)、R1−(O)n−N=CR1’−NR2−R6−基(R1、n、R1’、R2及びR6は、前記と同一の意味を表す。)、R2−B3−NR1−CO−NR1’−R6−基(R2、B3、R1、R1’及びR6は、前記と同一の意味を表す。)、D2−CO−NR1−R6−基(D2、R1及びR6は、前記と同一の意味を表す。)又はA2−COCO−NR1−R6−基(A2、R1及びR6は、前記と同一の意味を表す。)
である。
(9)I群:
A7−B6−N((O)nR1)−R6−基[A7は、ハロゲン原子で置換されてもよいC2-C10アルケニル基、C2-C10アルキニル基、C3-C10ハロアルキニル基、R2−B1−R4−基(R2、B1及びR4は、前記と同一の意味を表す。)、D4−R4−基(D4及びR4は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4−基(D1及びR4は、前記と同一の意味を表す。)、(b)−R4−基((b)及びR4は、前記と同一の意味を表す。)、(c)−R4−基((c)及びR4は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4−基(D3及びR4は、前記と同一の意味を表す。)、A4−SO2−R4−基(A4及びR4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B6は、カルボニル基又はチオカルボニル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8−CS−N((O)nR1)−R6−基[A8は、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、n、R1及びR6は、前記と同一の意味を表す。]、
A7’−B2’−B3−N((O)nR1)−R6−基[A7’は、ハロゲン原子で置換されてもよいC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2及びB1は、前記と同一の意味を表し、R4’は、C2-C10アルキレン基を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b)−R4’−基((b)及びR4’は、前記と同一の意味を表す。)、(c)−R4’−基((c)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、D3−R4’−基(D3及びR4’は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、B2’は、オキシ基、チオ基又は−N((O)n’R1’)−基(n’は、nと同一又は相異なり、nと同一の意味を表し、R1’は、前記と同一の意味を表す。)を表し、B3、n、R1及びR6は、前記と同一の意味を表す。]、A8’−B2’−CS−N((O)nR1)−R6−基[A8’は、C1-C10アルキル基又はC2-C10ハロアルキル基を表し、B2’は、前記と同一の意味を表し、n、R1及びR6は、前記と同一の意味を表す。]、A8’−S−B3’−N((O)nR1)−R6−基[A8’、n、R1及びR6は、前記と同一の意味を表し、B3’は、カルボニル基又はスルホニル基を表す。]又はA7’’−SO2−N((O)nR1)−R6−基[A7’’は、C2-C10アルケニル基、ハロゲン原子で置換されたC3-C10アルケニル基、ハロゲン原子で置換されてもよいC3-C10アルキニル基、R2−B1−R4’−基(R2、B1及びR4’は、前記と同一の意味を表す。)、D4−R4’−基(D4及びR4’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)、D1−R4’−基(D1及びR4’は、前記と同一の意味を表す。)、(b)−R4’−基((b)及びR4’は、前記と同一の意味を表す。)、(c)−R4’−基((c)及びR4’は、前記と同一の意味を表す。)、D2−R4−基(D2及びR4は、前記と同一の意味を表す。)、NO2−R4−基(R4は、前記と同一の意味を表す。)又はA2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(10)J群:A7−CO−基(A7は、前記と同一の意味を表す。)、又は、A9−CS−基(A9は、A7又はA8を表す。)、又は、A9’(O)mN=C(A9)−基(A9’は、A7’又はA8’を表し、m及びA9は、前記と同一の意味を表す。)、又は、D2−CO−基(D2は、前記と同一の意味を表す。)、又は、A2−COCO−基(A2は、前記と同一の意味を表す。)、又は、A9−CO−B1’−R6−基(A9及びR6は、前記と同一の意味を表し、B1’は、オキシ基又はチオ基を表す。但し、B1’がオキシ基のとき、A9は、A8ではない。)、又は、A9−CS−B1’−R6−基(A9、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A7’’−SO2−B1’−R6−基(A7’’、B1’及びR6は、は、前記と同一の意味を表す。)、又は、A8−SO2−B1’−R6−基(A8、B1’及びR6は、は、前記と同一の意味を表す。但し、A8は、水素原子となることはない。)、又は、A9’−B2’−B3−B1’−R6−基(A9’、B2’、B3、B1’及びR6は、は、前記と同一の意味を表す。)、又は、(b)−基((b)は、前記と同一の意味を表す。)若しくは(c)−基((c)は、前記と同一の意味を表す。)で置換されたC2-C10アルケニル基
である。
(11)K群:A10−N((O)nR1)−CO−R6−基[A10は、水素原子(但し、nは0ではない。)、A7’’−SO2−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−基(A8は、前記と同一の意味を表す。但し、A8は、水素原子とはならない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2OCH2−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]
である。
(12)L群:A10’−N((O)nR1)−SO2−R6−基[A10’は、水素原子(但し、nは0ではない。)、A9’O−基(A9’は、前記と同一の意味を表す。但し、nは1ではない。)、A9’−基(A9’は、前記と同一の意味を表す。但し、nが0のとき、A8’を除く。)、R2−CO−基(R2は、前記と同一の意味を表す。)、A2−CO−R4−基(A2及びR4は、前記と同一の意味を表す。)又はA2−CO−CH(CH2CO−A2)−基(A2は、前記と同一の意味を表す。)を表し、n、R1及びR6は、前記と同一の意味を表す。]、A9’’R1N−SO2−N((O)nR1’)−R6−基[A9’’は、水素原子又はA9’−基(A9’は、前記と同一の意味を表す。)を表し、R1、n、R1’及びR6は、前記と同一の意味を表す。]又は(b)−SO2−N((O)nR1’)−R6−基[(b)、n、R1’及びR6は、前記と同一の意味を表す。]
である。
(13)M群:R1(R2S)C=N−R6−基(R1、R2及びR6は、前記と同一の意味を表す。)、R2B(R2’B’)C=N−R6−基(R2及びR6は、前記と同一の意味を表し、R2’は、R2と同一又は相異なり、R2と、同一の意味を表し、B及びB’は、同一又は相異なり、オキシ基又はチオ基を表す。)、R1R1’N−(R2S)C=N−R6−基(R1、R1’、R2及びR6は、前記と同一の意味を表す。)、R1N=C(SR2)−NR2’−R6−基(R1、R2、R2’及びR6は、前記と同一の意味を表す。)又はR1(R1’O)N−R6−基(R1、R1’及びR6は、前記と同一の意味を表す。)
である。
(14)N群:A11−P(=O)(OR1’)−R4−基[A11は、R1−基(R1は、前記と同一の意味を表す。)、R1O−R6−基(R1及びR6は、前記と同一の意味を表す。)又はR1OCO−CHR0−基(R1及びR0は、前記と同一の意味を表す。)を表し、R1’及びR4は、前記と同一の意味を表す。]
である。
III.(YA)qにおいて、YAは、下記のX群又はY群の基を表し、qは、0、1、2又は3を表し、p(pは、前記と同一の意味を表す。)とqとの和は3以下であり、qが2以上のとき、YAは、同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYAは、Z群の基をなして、A環と縮環してもよい。
(1)X群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HO−Rd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y群:Mb−Rd−基[Mbは、Mc−基{Mcは、Md−Rd’−基{Mdは、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいフェニル基、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいピリジル基、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいナフチル基、(b)−基((b)は、前記と同一の意味を表す。)、(c)−基((c)は、前記と同一の意味を表す。)、
(d)−基(lは、2、3又は4であり、Bbは、オキシ基又はチオ基を表す。)又は
(e)−基(l及びBbは、前記と同一の意味を表す。)を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc−Ba−基(Mc及びBaは、前記と同一の意味を表す。)、Mc−CO−基(Mcは、前記と同一の意味を表す。)、Mc−CO−O−基(Mcは、前記と同一の意味を表す。)、McO−CO−基(Mcは、前記と同一の意味を表す。)、McReN−基(Mc及びReは、前記と同一の意味を表す。)、Mc−CO−NRe−基(Mc及びReは、前記と同一の意味を表す。)、McO−CO−NRe−基(Mc及びReは、前記と同一の意味を表す。)、McReN−CO−基(Mc及びReは、前記と同一の意味を表す。)、McReN−CO−NRe’−基(Mc、Re及びRe’は、前記と同一の意味を表す。)、McReN−C(=NRe’)−NRe’’−基(Mc、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc−SO2−NRe−基(Mc及びReは、前記と同一の意味を表す。)又はMcReN−SO2−基(Mc及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z群:−Ya’’=C(Ya)−Ya’−基(Yaは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基、又は、C1-C10アルコキシ基を表し、Ya’は、オキシ基、又は、チオ基、又は、C1-C10アルキル基で置換されてもよいイミノ基を表し、Ya’’は、−N=基又はメチン基を表す。)、C3-C10アルキレン基又は−Yb=Yb’−Yb’’=Yb’’’−基[Yb、Yb’、Yb’’及びYb’’’は、同一又は相異なり、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいメチン基、又は、−N=基を表す。]である。
IV.Bは、
式(IV-1)
[式中、
(1)QAは、水酸基、(b)−基((b)は、前記と同一の意味を表す。)、A9−B6−Bc−基[A9及びB6は、前記と同一の意味を表し、Bcは、オキシ基又は−N((O)mR1)−基(m及びR1は、前記と同一の意味を表す。)を表す。但し、A9が水素原子のとき、Bcは、スルホニル基ではない。]、A7’’−SO2−Bc−基(A7’’及びBcは、前記と同一の意味を表す。)、A8−SO2−Bc−基(A8及びBcは、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−Bc−基(R1、R1’及びBcは、前記と同一の意味を表す。)、(b)−SO2−Bc−基((b)及びBcは、前記と同一の意味を表す。)、A9’−Bc−基(A9’及びBcは、前記と同一の意味を表す。)、D5−R4−Bc−基(D5、R4及びBcは、前記と同一の意味を表す。)、Mc−B3−Bc−基(Mc、B3及びBcは、前記と同一の意味を表す。)又はMc−Bc−基(Mc及びBcは、前記と同一の意味を表す。)を表す。
(2)WAは、酸素原子又は−NTA−基[TAは、水素原子、A9’−基(A9’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)又はMc−基(Mcは、前記と同一の意味を表す。)を表す。]を表す。TAは、水素原子、A9’−基(A9’は、前記と同一の意味を表す。)、D5−R4−基(D5及びR4は、前記と同一の意味を表す。)又はMc−基(Mcは、前記と同一の意味を表す。)を表す。
(3)KAは、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、LAは、水素原子、C1-C10アルキル基又はMb−基(Mbは、前記と同一の意味を表す。)を表し、KAとLAとは、C3-C10アルキレン基又は−C(Ma’)=C(Ma’’)−C(Ma’’’)=C(Ma’’’’)−基(Ma’、Ma’’、Ma’’’及びMa’’’’は、同一又は相異なり、Maと同一又は相異なり、水素原子又はMaを表す。)をなすことがある。]
で示される基、
式(IV-2)
[式中、TAは、前記と同一の意味を表し、LBは水酸基又はメチル基を表す。]
で示される基、
式(IV-3)
[式中、TAは、前記と同一の意味を表し、LCは、C1-C10アルキル基を表す。]
で示される基、
式(IV-4)
[式中、TAは、前記と同一の意味を表す。]
で示される基、
式(IV-5)
[式中、TAは、前記と同一の意味を表し、KBは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(IV-6)
[式中、WAは、前記と同一の意味を表し、KCとLDとは、C3-C10アルキレン基又は単数又は同一又は相異なる複数のMa−基(Maは、前記と同一の意味を表す。)で置換されてもよいC4-C10アルケニレン基をなす。]
で示される基、
式(IV-7)
[式中、QA及びWAは、前記と同一の意味を表し、KDとLEとは、−VA=VA’−VA’’=VA’’’−基{VA、VA’、VA’’及びVA’’’は、同一又は相異なり、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよいメチン基、又は、−N=基を表し、VA、VA’、VA’’及びVA’’’のうち少なくとも一つは−N=基を表す。}をなす。]
で示される基、
式(IV-8)
[式中、TAは、前記と同一の意味を表し、QBは、水酸基、A9−B6−O−基[A9及びB6は、前記と同一の意味を表す。]、A7’’−SO2−O−基(A7’’は、前記と同一の意味を表す。)、A8−SO2−O−基(A8は、前記と同一の意味を表す。但し、A8は水素原子とはならない。)、R1R1’N−SO2−O−基(R1及びR1’は、前記と同一の意味を表す。)、(b)−SO2−O−基((b)は、前記と同一の意味を表す。)、A9’−O−基(A9’は、前記と同一の意味を表す。)、D5−R4−O−基(D5及びR4は、前記と同一の意味を表す。)、Mc−B3−O−基(Mc及びB3は、前記と同一の意味を表す。)又はMc−O−基(Mcは、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(IV-9)
[式中、U及びWAは、前記と同一の意味を表す。]
で示される基を表す。
但し、Aがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (IV)
[Where:
I. A represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms.
II. (X A ) In p , X A represents a group included in any of the following groups A to N, p represents 0, 1, 2, or 3, and when p is 2 or more , X A are the same or different.
(1) Group A: D 1 -R 4 -group [D 1 is (R 1- (O) k- ) A 1 N- (O) k ' -group {R 1 is a hydrogen atom or C 1 -C10 alkyl group, or a halogen atom or R 2 -B 1 -group (R 2 represents a C1-C10 alkyl group, a C3-C10 alkenyl group or a C3-C10 alkynyl group, B 1 represents an oxy group, thio group, Represents a C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group substituted with a group, sulfinyl group or sulfonyl group), k represents 0 or 1, and A 1 R 3 — (CHR 0 ) m — (B 2 —B 3 ) m ′ — group {R 3 is a hydrogen atom, a halogen atom or an R 2 —B 1 — group (R 2 and B 1 are Represents a C1-C10 alkyl group, or a C2-C10 alkenyl group, or a C2-C10 alkynyl group, which may be substituted with the same meaning as above. 0 represents a hydrogen atom, C1-C10 alkyl or C2-C10 haloalkyl group, m represents 0 or 1, B 2 represents a single bond, oxy group, thio group, or -N ((O) n R 1. ') - group (R 1' are identical or different phase and R 1, it represents the same meaning as R 1, n denotes the representative) 0 or 1, B 3 represents a carbonyl group, a thiocarbonyl Represents a group or a sulfonyl group, m ′ represents 0 or 1, and when B 3 is a sulfonyl group, m is 0 and R 3 is not a hydrogen atom. }, And k ′ represents 0 or 1. }, And R 4 represents a C1-C10 alkylene group. However, R 0 'R 0'' N-R 4 - group (R 0' and R 0 '' is different from R 0 and same or different, represent the same meaning as R 0, R 4 is the same Represents the meaning of. ], D 2 -R 4 - group [D 2 is a cyano group, R 1 R 1 'NC ( = N- (O) n -A 1) - group (R 1, R 1', n, and A 1 Represents the same meaning as described above.), Represents an A 1 N═C (—OR 2 ) — group (A 1 and R 2 represent the same meaning as described above) or an NH 2 —CS— group. , R 4 represents the same meaning as described above. ], D 3 -R 4 -group {D 3 represents a nitro group or R 1 OSO 2 -group (R 1 represents the same meaning as described above), and R 4 represents the same meaning as described above. To express. } Or R 1 OSO 2 — group (R 1 represents the same meaning as described above).
(2) Group B:
(A) -Group [In (a), E 1 and E 1 ′ represent a methylene group which may be substituted with a C1-C10 alkyl group or a C1-C10 alkoxy group, or a carbonyl group. However, E 1 and E 1 ′ are not simultaneously carbonyl groups. E 2 is oxy, thio, sulfinyl group, a sulfonyl group or a -NR 1 '- group (R 1'. Is that the represent the same meaning as) that is substituted may be C2-C10 alkylene group, or , oxy, thio, sulfinyl group, a sulfonyl group or a -NR 1 '- group (R 1'. is representative of the same meaning as) represents may be substituted with C3-C10 alkenylene group, R 1 Represents the same meaning as described above. ]
It is.
(3) Group C: halogen atom, R 2 —B 1 — group (R 2 and B 1 are as defined above), D 4 —R 4 — group [D 4 is a hydroxyl group or A 1 —O— represents a group (A 1 represents the same meaning as described above), and R 4 represents the same meaning as described above. ], D 5 - group [D 5 is, O = C (R 3) - group (R 3 represents the same meaning as above.), A 1 - (O ) n -N = C (R 3) A group (A 1 , n and R 3 are as defined above), R 1 —B 0 —CO—R 4 — (O) n —N═C (R 3 ) — group {R 1 , R 4 , n and R 3 represent the same meaning as described above, and B 0 represents an oxy group, a thio group, or a —N ((O) m R 1 ′)-group (R 1 ′ and m Represents the same meaning as }, D 2 —R 4 — (O) n —N═C (R 3 ) — group (D 2 , R 4 , n and R 3 represent the same meaning as described above) or R 1 A 1 N —N═C (R 3 ) — group (wherein R 1 , A 1 and R 3 represent the same meaning as described above). ], R 1 A 1 N—O—R 4 — group (R 1 , A 1 and R 4 represent the same meaning as described above), R 1 (A 1- (O) n —) N— group (R 1 , A 1 and n represent the same meaning as described above), D 2 -group (D 2 represents the same meaning as described above) or D 3 -group (D 3 represents the same as above. C2-C10 alkenyl group substituted with the same meaning.
(4) Group D:
(b) -R 4 -group [In (b), G 1 , G 2 , G 4 and G 5 are methylene groups bonded to adjacent atoms by a single bond, which may be substituted with methyl groups, or Represents a methine group which may be substituted with a methyl group connected to a neighboring atom by a double bond, and G 3 represents a single bond, a double bond, or a methyl group, an oxy group, a thio group, a sulfinyl group , A sulfonyl group or a —NR 1 — group (R 1 represents the same meaning as described above), or a C1-C10 alkylene group, or a methyl group, an oxy group, a thio group, a sulfinyl group, a sulfonyl group Represents a C2-C10 alkenylene group which may be substituted with a group or a —NR 1 — group (R 1 represents the same meaning as described above), and R 4 represents the same meaning as described above. ],
(C) -R 4 -group (in (c), J 1 , J 2 and J 3 are the same or different and represent a methine group which may be substituted with a methyl group or a nitrogen atom, and R 4 represents Represents the same meaning as described above), a halogen atom, an R 2 —B 1 —R 4 — group (wherein R 2 , B 1 and R 4 represent the same meaning as described above), D 4 —R 4. A group (D 4 and R 4 have the same meaning as described above), a D 5 group (D 5 has the same meaning as described above), a D 1 -R 4 -group (D 1 and R 4 represents the same meaning as described above), D 2 -group (D 2 represents the same meaning as described above) or D 3 -R 4 -group (D 3 and R 4 represent C2-C10 alkynyl group substituted with the same meaning.
(5) Group E: A 2 —CO—R 5 — group. However, when A 2 is a hydroxyl group, R 5 is not a vinylene group.
[A 2 is,
(i) A 3 -B 4 -group {A 3 is a hydrogen atom, a C1-C10 alkyl group, a C2-C10 haloalkyl group, or a C2-C10 alkenyl group optionally substituted with a halogen atom, Or a C3-C10 alkynyl group optionally substituted with a halogen atom, or R a- (R 4 ) m -group (R a is a halogen atom, a C1-C10 alkyl group, a C1-C10 alkoxy group or a nitro group; Represents a phenyl group, a pyridyl group, a furyl group or a thienyl group which may be substituted with R 4 and m have the same meaning as described above.) Or (b) -R 4 -group ((b) And R 4 represent the same meaning as described above.), (C) -R 4 — group ((c) and R 4 represent the same meaning as described above), R 2 —B 1 —R 4. - group (R 2, B 1 and R 4 represent the same meanings.), D 4 -R 4 - group (D 4 and R 4 Represents the same meaning), D 5 -. Group (D 5 represents the same meaning), D 1 -R 4 -. Group (D 1 and R 4 are the same meaning the represented), D 2 -. group (D 2 represents the same meaning), D 3 -R 4 -. . group (D 3 and R 4 represent the same meanings as the above) or a 4 -SO 2 -R 4 - group {a 4 are (b) - group, (c) ((b) represents the same meanings.) - group ((c), the same Or R 1 R 1 ′ N-group (R 1 and R 1 ′ represent the same meaning as described above), and R 4 represents the same meaning as described above. } Represents a C1-C10 alkyl group substituted with
B 4 represents an oxy group, a thio group, or a —N ((O) m R 1 ) — group (where R 1 and m represent the same meaning as described above). However, when B 4 is a thio group, A 3 is not a hydrogen atom. },
(ii) R 1 —B 4 —CO—R 4 —B 4 ′ — group (R 1 , B 4 and R 4 have the same meaning as described above, and B 4 ′ is the same as or different from B 4. represents B 4 same meaning as the proviso that when B 4 is a thio group, R 2 is not hydrogen atom) or D 2 -R 4 -B 4 -. . group (D 2, R 4 and B 4 is Represents the same meaning as described above).
(iii) R 2 —SO 2 —NR 1 — group (R 2 represents the same meaning as described above, except for a hydrogen atom; R 1 represents the same meaning as described above),
(iv) (b) -group ((b) represents the same meaning as described above),
(v) (c) -group ((c) represents the same meaning as described above) or
(vi) R 1 A 1 N—NR 1 ′ -group (R 1 , A 1 and R 1 ′ have the same meaning as described above), and R 5 may be substituted with a halogen atom. A C2-C10 alkenylene group or a C2-C10 alkynylene group is represented. ]
(6) F Group: A 5 -B 5 -R 6 - group [A 5 is D 4 - group (. D 4 may represent the same meaning as described above), D 1 - group (D 1, the represents the same meaning as), D 3 -. group (D 3, the representative of the same meaning as) or a 4 -SO 2 -. group (a 4 is a representative) the same meaning as above. A substituted C2-C10 alkyl group, or an R 2 —B 1 — group (R 2 and B 1 are as defined above), a D 2 — group (D 2 is as defined above); ), D 5 -group (D 5 represents the same meaning as described above) or A 2 —CO— group (A 2 represents the same meaning as described above) substituted with C 1-. Represents a C10 alkyl group, and B 5 represents a B 1 -group (B 1 represents the same meaning as described above) or a -NA 1 -group (A 1 represents the same meaning as described above). , R 6 is a single It represents a case or C1-C10 alkylene group. ]
It is.
(7) G Group: A 6 -B 5 -R 6 - group [A 6 are (a) -R 4 - group (. (A) and R 4 represents the same meaning as above), or, C2-C10 alkenyl group, C2-C10 alkynyl group, halogen atom, R 2 -B 1 -group (R 2 and B 1 are as defined above), D 5 -group (D 5 represents the same meaning as described above), D 2 -group (D 2 represents the same meaning as described above) or A 2 -CO- group (A 2 represents the same meaning as described above). ) -Substituted C2-C10 alkenyl group, or a halogen atom, an R 2 -B 1 -group (R 2 and B 1 have the same meaning as described above), a D 5 -group (D 5 is , D 2 -group (D 2 represents the same meaning as described above) or A 2 —CO— group (A 2 represents the same meaning as described above). A C2-C10 alkynyl group substituted with or (b) -group ((b) represents the same meaning as described above), (c) -group ((c) represents the same meaning as described above. represented), D 4 -. group (D 4, the representative of the same meaning as), D 1 -. group (D 1, the representative of the same meaning as) or D 3 -. group (D 3 is , C3-C10 alkenyl group substituted with representing) the same meaning as above, or, D 4 -. group (D 4 represents the same meaning as above), D 1 -. group (D 1 is . the represents the same meaning as) or D 3 -. group (D 3 represents a C3-C10 alkynyl group substituted with representing) the same meaning as above, B 5 and R 6 are the same Represents the meaning of ]
It is.
(8) Group H:
D 2 —N (— (O) n —A 1 ) —R 6 — group (D 2 , n, A 1 and R 6 are as defined above), D 2 — group (D 2 is Represents the same meaning as described above, except for a cyano group.), R 1 (R 1 ′ (O) n ) N—CR 1 ″ = N—R 6 — group (R 1 , R 1 ′, n and R 6 represent the same meanings, R 1 '' are the same or different phase and R 1, represents the same meaning as R 1), R 1 -. (O) n -N = CR 1 '-NR 2 -R 6 - group (R 1, n, R 1 '., R 2 and R 6 represent the same meaning as described above), R 2 -B 3 -NR 1 -CO-NR 1 '-R 6 -group (R 2 , B 3 , R 1 , R 1 ' and R 6 represent the same meaning as described above), D 2 -CO-NR 1 -R 6 -group (D 2 , R 1 and R 6 represent the same meanings as the above. Or A 2 -COCO-NR 1 -R 6 - group (A 2, R 1 and R 6 represent the same meanings as the above.)
It is.
(9) Group I:
A 7 -B 6 -N ((O ) n R 1) -R 6 - group [A 7 is optionally substituted C2-C10 alkenyl group with a halogen atom, C2-C10 alkynyl group, C3-C10 haloalkynyl A group, R 2 -B 1 -R 4 -group (R 2 , B 1 and R 4 are as defined above), D 4 -R 4 -group (D 4 and R 4 are represents the same meaning), D 5 -R 4 -. group (D 5 and R 4 represents the same meaning), D 1 -R 4 -. group (D 1 and R 4, the a Represents the same meaning.), (B) -R 4 -group ((b) and R 4 represent the same meaning as described above), (c) -R 4 -group ((c) and R 4 Represents the same meaning as described above), D 2 -R 4 -group (D 2 and R 4 represent the same meaning as described above), D 3 -R 4 -group (D 3 and R 4 Means the same as above Be), A 4 -SO 2 -R 4 -. Group (A 4 and R 4 represents the same meaning) or A 2 -CO-R 4 -. Group (A 2 and R 4 are the And B 6 represents a carbonyl group or a thiocarbonyl group, and n, R 1 and R 6 represent the same meaning as described above. ], A 8 -CS-N ( (O) n R 1) -R 6 - group [A 8 is a hydrogen atom, or represents a optionally substituted C1-C10 alkyl group with a halogen atom, n, R 1 and R 6 represent the same meaning as described above. ],
A 7 '-B 2' -B 3 -N ((O) n R 1) -R 6 - group [A 7 'is optionally substituted C3-C10 alkenyl group with a halogen atom, is substituted with a halogen atom and it may be C3-C10 alkynyl group, R 2 -B 1 -R 4 ' - group (R 2 and B 1 represent the same meaning as, R 4' represents a C2-C10 alkylene group.) , D 4 -R 4 '- group (D 4 and R 4' represents the same meaning as.), D 1 -R 4 ' - group (D 1 and R 4', wherein the same meaning ), (B) -R 4 '-group ((b) and R 4 ' represent the same meaning as described above), (c) -R 4 '-group ((c) and R 4 'Represents the same meaning as described above), D 2 -R 4 -group (D 2 and R 4 represent the same meaning as described above), D 3 -R 4 ' -group (D 3 and R 4 'represents the same meaning as above.) The A 2 -CO-R 4 - group (. A 2 and R 4 represent the same meanings as the above) represents, B 2 'is an oxy group, thio group, or -N ((O) n' R 1 ′)-group (where n ′ is the same as or different from n and represents the same meaning as n, and R 1 ′ represents the same meaning as described above), B 3 , n, R 1 and R 6 represents the same meaning as described above. ], A 8 '-B 2' -CS-N ((O) n R 1) -R 6 - group [A 8 'represents a C1-C10 alkyl or C2-C10 haloalkyl group, B 2' is , And the same meaning as described above, and n, R 1 and R 6 represent the same meaning as described above. ], A 8 '-S-B 3' -N ((O) n R 1) -R 6 - group [A 8 ', n, R 1 and R 6 represent the same meanings as above, B 3 'Represents a carbonyl group or a sulfonyl group. ] Or A 7 '' -SO 2 -N ( (O) n R 1) -R 6 - group [A 7 '' is, C2-C10 alkenyl group, C3-C10 alkenyl group substituted with a halogen atom, a halogen optionally substituted C3-C10 alkynyl group atom, R 2 -B 1 -R 4 ' - group (R 2, B 1 and R 4'. is representing the same meaning as above), D 4 -R 4 '- group (D 4 and R 4' represents the same meaning.), D 5 -R 4 - group (. D 5 and R 4 represent the same meaning as described above), D 1 -R 4 '-group (D 1 and R 4 ' are as defined above), (b) -R 4 '-group ((b) and R 4 ' are as defined above) ), (C) -R 4 '-group ((c) and R 4 ' represent the same meaning as described above), D 2 -R 4 -group (D 2 and R 4 are as defined above. represents the same meaning.), NO 2 -R - group (R 4, the representative of the same meaning as.) Or A 2 -CO-R 4 - group (. A 2 and R 4 represent the same meanings as the above) represents, n, R 1 And R 6 represent the same meaning as described above. ]
It is.
(10) Group J: A 7 -CO— group (A 7 represents the same meaning as described above), or A 9 -CS- group (A 9 represents A 7 or A 8 ), Or A 9 ′ (O) m N═C (A 9 ) — group (A 9 ′ represents A 7 ′ or A 8 ′, and m and A 9 represent the same meaning as described above), Or D 2 —CO— group (D 2 represents the same meaning as described above), A 2 —COCO— group (A 2 represents the same meaning as described above), or A 9. -CO-B 1 '-R 6 -group (A 9 and R 6 represent the same meaning as described above, B 1 ' represents an oxy group or a thio group, provided that B 1 'is an oxy group. , A 9 is not A 8 ), or A 9 -CS-B 1 ′ -R 6 -group (A 9 , B 1 ′ and R 6 represent the same meaning as described above). or, A 7 '' -SO 2 -B 1 ' R 6 - group (A 7 '', B 1 ' and R 6 represent the same meanings as the above.), Or, A 8 -SO 2 -B 1' -R 6 - group (A 8, B 1 ′ and R 6 represent the same meaning as described above, provided that A 8 cannot be a hydrogen atom.) Or A 9 ′ -B 2 ′ -B 3 -B 1 ′ —R 6 — group (A 9 ′, B 2 ′, B 3 , B 1 ′ and R 6 represent the same meaning as described above), or (b) -group ((b) is It is a C2-C10 alkenyl group substituted with the same meaning as described above) or a (c) -group (wherein (c) represents the same meaning as described above).
(11) Group K: A 10 -N ((O) n R 1 ) —CO—R 6 — group [A 10 is a hydrogen atom (where n is not 0), A 7 ″ -SO 2. -Group (A 7 ″ represents the same meaning as described above), A 8 —SO 2 — group (A 8 represents the same meaning as described above, provided that A 8 is not a hydrogen atom. .), a 9 'O- group (a 9' represents the same meaning where, n is not a 1), a 9.. ' - group (a 9' has the same meaning It represents the proviso that when n is 0, except a 8 '), R 2 OCH 2 -.. group (R 2 represents the same meaning as above), a 2 -CO-R 4 -. group (a 2 and R 4 represent the same meaning as described above) or an A 2 —CO—CH (CH 2 CO—A 2 ) — group (A 2 represents the same meaning as described above), and n , R 1 and R 6 are the Represent the same meaning. ]
It is.
(12) L group: - (. Here, n is not 0) A 10 '-N (( O) n R 1) -SO 2 -R 6 group [A 10' is a hydrogen atom, A 9 'O - group (a 9 'represents the same meaning where, n is not a 1..), a 9' -. group (a 9 'represents the same meaning as above where, n is 0 . when, except for a 8 '), R 2 -CO- group (R 2 represents the same meaning), a 2 -CO-R 4 -. group (a 2 and R 4 are the And A 2 —CO—CH (CH 2 CO—A 2 ) — group (A 2 represents the same meaning as described above), and n, R 1 and R 6 represent Represents the same meaning as described above. ] A 9 ″ R 1 N—SO 2 —N ((O) n R 1 ′) —R 6 — group [A 9 ″ is a hydrogen atom or A 9 ′ -group (A 9 ′ R 1 , n, R 1 ′ and R 6 represent the same meaning as described above. ] Or (b) -SO 2 -N (( O) n R 1 ') -R 6 - group [(b), n, R 1' and R 6 represent the same meanings. ]
It is.
(13) M group: R 1 (R 2 S) C = N-R 6 - group (. R 1, R 2 and R 6 represent the same meaning as described above), R 2 B (R 2 'B ') C = N-R 6 - group (R 2 and R 6 represent the same meaning, R 2' are identical or different phase and R 2, and R 2, represent the same meaning, B And B ′ are the same or different and represent an oxy group or a thio group.), R 1 R 1 ′ N— (R 2 S) C═N—R 6 —group (R 1 , R 1 ′, R 2 And R 6 represent the same meaning as described above.), R 1 N═C (SR 2 ) —NR 2 ′ —R 6 — group (R 1 , R 2 , R 2 ′ and R 6 are Represents the same meaning.) Or R 1 (R 1 ′ O) N—R 6 — group (R 1 , R 1 ′ and R 6 represent the same meaning as described above.)
It is.
(14) N group: (. R 1 may represent the same meanings as the above) A 11 -P (= O) (OR 1 ') -R 4 - - group [A 11 is R 1 group, R 1 An O—R 6 — group (R 1 and R 6 are as defined above) or an R 1 OCO—CHR 0 — group (where R 1 and R 0 are as defined above); R 1 ′ and R 4 represent the same meaning as described above. ]
It is.
III. (Y A ) In q , Y A represents a group of the following X group or Y group, q represents 0, 1, 2, or 3, and p (p represents the same meaning as described above). And q are 3 or less, and when q is 2 or more, Y A is the same or different, and when q is 2 or more, two adjacent same or different Y A are Z A group may be formed and condensed with the A ring.
(1) Group X: M a -group [M a represents an R b -group (R b represents a C1-C10 alkyl group optionally substituted with a halogen atom), a halogen atom, a nitro group, a cyano group. , R c -B a -R d - group (R c represents an optionally substituted C1-C10 alkyl group with a halogen atom, B a represents oxy, thio, sulphinyl group or a sulfonyl group, R d represents a single bond or a C1-C10 alkylene group.), A HO—R d — group (R d represents the same meaning as described above), a R e —CO—R d — group (R e Represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and R d represents the same meaning as described above), R e —CO—O—R d — group (R e and R d represent the same meaning), R e O-CO- R d -. group (R e and R d are the same meaning as . Be), HO-CO-CH = CH- group, R e R e 'N- R d - group (R e and R e' are the same or different, R e represents the same meaning as above , R e ′ represents the same meaning as R e, and R d represents the same meaning as described above.), R e —CO—NR e ′ —R d — group (R e , R e ′ and R d represents the same meaning as described above.), R b O—CO—N (R e ) —R d — group (R b , R e and R d represent the same meaning as described above.) , R e R e ′ N—CO—R d — group (R e , R e ′ and R d represent the same meaning as described above), R e R e ′ N—CO—NR e ″ — R d - group (R e, R e 'and R e' 'are the same or different, R e and R e' represents the same meanings, R e '' are the same and R e the meaning, the R d are the same meaning as Be), R e R e 'N -C (= NR e'') -NR e''.' -R d - group (R e, R e ', R e'' and R e' '' is, R e , R e ′ and R e ″ have the same meaning as described above, R e ′ ″ has the same meaning as R e, and R d has the same meaning as above. R b —SO 2 —NR e —R d — group (R b , R e and R d represent the same meaning as described above), R e R e ′ N—SO 2 —. R d -group (R e , R e ′ and R d represent the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y group: M b -R d -group [M b is M c -group {M c is M d -R d '-group {M d is M a -group (M a is A phenyl group which may be substituted with M a -group (M a represents the same meaning as described above), a pyridyl group which may be substituted with M a -group (M a represents a naphthyl group which may be substituted with the same meaning as described above, and (b) -group ((b) represents the same meaning as described above), (c) -group ((c ) Represents the same meaning as described above.),
(D) -group (l is 2, 3 or 4 and B b represents an oxy group or a thio group) or
(E) - group (. L and B b are representing the same meaning as above) represents, R d 'are different from R d and same or different, represent the same meaning as R d. }. }, M c -B a - group (. M c and B a are representing the same meaning), M c -CO- group (. M c is representative of the same meaning as above), M c -CO-O- group (M c represents the same meaning as.), M c O-CO- group (M c represent the same meanings as the above.), M c R e N- group (M c and R e represent the same meaning as described above), M c —CO—NR e — group (M c and R e represent the same meaning as described above), M c O—CO —NR e — group (M c and R e represent the same meaning as described above), M c R e N—CO— group (M c and R e represent the same meaning as described above), M c R e N-CO- NR e '- group (M c, R e and R e'. are representative of the same meaning), M c R e N- C (= NR e ') -NR e ″ -group (M c , R e , R e ′ and R e ″ represent the same meaning as described above.), M c —SO 2 —NR e — group (M c and R e represent the same meaning as described above) or M c. R e N—SO 2 — represents a group (M c and R e represent the same meaning as described above), and R d represents the same meaning as described above. ].
(3) Z group: —Y a ″ = C (Y a ) —Y a ′ — group (Y a is a C1-C10 alkyl group optionally substituted with a hydrogen atom or a halogen atom, or C1 represents -C10 alkoxy group, Y a 'is an oxy group, or a thio group, or represents a C1-C10 alkyl optionally imino group which may be substituted with a group, Y a' 'is -N = group or methine . representing the group), C3-C10 alkylene group or a -Y b = Y b '-Y b ''= Y b''' - radical [Y b, Y b ', Y b'' and Y b' '' Are the same or different and each represents a methine group which may be substituted with a Ma-group (Ma has the same meaning as described above) or a -N = group. ].
IV. B is
Formula (IV-1)
[Where:
(1) Q A is a hydroxyl group, (b) -group ((b) represents the same meaning as described above), A 9 -B 6 -B c -group [A 9 and B 6 are as defined above. B c represents an oxy group or —N ((O) m R 1 ) — group (m and R 1 represent the same meaning as described above). However, when A 9 is a hydrogen atom, B c is not a sulfonyl group. ], A 7 '' -SO 2 -B c - group (A 7 '' and B c represents the same meaning as.), A 8 -SO 2 -B c - group (A 8 and B c Represents the same meaning as described above, provided that A 8 is not a hydrogen atom.), R 1 R 1 ′ N—SO 2 —B c — group (R 1 , R 1 ′ and B c are represents the same meaning as),. (b) -SO 2 -B c - groups ((b) and B c represent the same meaning as above), a 9 '-B c - . group (a 9 'And B c represent the same meaning as described above.), D 5 —R 4 —B c — group (D 5 , R 4 and B c represent the same meaning as described above), M c —. B 3 -B c -group (M c , B 3 and B c represent the same meaning as described above) or M c -B c -group (M c and B c represent the same meaning as described above). .)
(2) W A is an oxygen atom or -NT A - is a group [T A, a hydrogen atom, A 9 '- group (A 9'. Are representing the same meaning as above), D 5 -R 4 - A group (D 5 and R 4 represent the same meaning as described above) or a M c -group (M c represents the same meaning as described above). ]. T A is a hydrogen atom, A 9 '-group (A 9 ' represents the same meaning as described above), D 5 -R 4 -group (D 5 and R 4 represent the same meaning as described above). Or M c -group (M c represents the same meaning as described above).
(3) K A represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group, L A is a hydrogen atom, C1-C10 alkyl group or M b - group (M b represents the same meaning as above .) represents, and K a and L a, C3-C10 alkylene group or -C (M a ') = C (M a'') -C (M a''') = C (M a '' ″) -Groups (M a ′, M a ″, M a ″ ″ and M a ″ ″ are the same or different and are the same or different from M a and represent a hydrogen atom or M a . ). ]
A group represented by
Formula (IV-2)
Wherein, T A represents the same meaning, L B represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (IV-3)
[Wherein, T A represents the same meaning as described above, and L C represents a C1-C10 alkyl group. ]
A group represented by
Formula (IV-4)
[Wherein, T A represents the same meaning as described above. ]
A group represented by
Formula (IV-5)
Wherein, T A represents the same meanings, K B is a cyano group or UOCO- group (U represents. A hydrogen atom or a C1-C10 alkyl group);. ]
A group represented by
Formula (IV-6)
Wherein, W A represents the same meaning, and K C and L D, C3-C10 alkylene group, or one or the same or different plurality of Ma- groups (Ma, the same meaning Represents a C4-C10 alkenylene group optionally substituted. ]
A group represented by
Formula (IV-7)
Wherein the Q A and W A, represents the same meaning as, the K D and L E, -V A = V A '-V A''= V A''' - group {V A , V a ', V a' ' and V a' '' are the same or different, M a - group (. M a is that the represent the same meaning as) methine group optionally substituted by a, or , -N = group, and at least one of V A , V A ', V A ″ and V A ''' represents -N = group. }. ]
A group represented by
Formula (IV-8)
[Wherein, T A represents the same meaning as described above, Q B represents a hydroxyl group, and A 9 -B 6 -O- group [A 9 and B 6 represent the same meaning as described above]. ], A 7 '' -SO 2 -O- group (A 7 '' represents the same meaning as.), A 8 -SO 2 -O- group (A 8 are the same meaning as above Provided that A 8 is not a hydrogen atom.), R 1 R 1 ′ N—SO 2 —O— group (R 1 and R 1 ′ represent the same meaning as described above), (b) -SO 2 -O- group ((b) is a. representing the same meaning), a 9 '-O- group (a 9' represents the same meaning as above.), D 5 -R 4 -O- group (D 5 and R 4. representing the same meaning), M c -B 3 -O- group (M c and B 3 represent the same meanings as the above.) or M c —O— group (M c represents the same meaning as described above). ]
Or a group represented by
Formula (IV-9)
Wherein, U and W A represent the same meaning as above. ]
Represents a group represented by
However, when A is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
[式中、
I.aは、チオフェン環、フラン環、ピロール環、ピラゾール環、1,2,3−トリアゾール環、テトラゾール環、イソオキサゾール環、チアゾール環、ピリダジン環又はピリミジン環を表し、Xaは、シアノ基で置換されたC1-C10アルキル基、又は、テトラヒドロピラン−4−イリデン基で置換されたC1-C10アルキル基、又は、ハロゲン原子若しくはシアノ基で置換されたC2-C10アルケニル基、又は、C1-C10アルコキシカルボニル基で置換されたC2-C10アルケニル基、又は、ヒドロキシ基で置換されたC3-C10アルキニル基、又は、a0−r1−b−r1’−基{a0は、C1-C10アルキルチオ基で置換されたメチル基、C1-C10アルキルスルフィニル基で置換されたメチル基、C1-C10アルキルスルホニル基で置換されたメチル基、C2-C10アルケニル基、C2-C10アルキニル基、r2O−CO−基(r2は、C1-C10アルキル基又は水酸基で置換されたC2-C10アルキル基を表す。)、カルボキシ基、rr’N−CO−基(r及びr’は、同一又は相異なり、水素原子又はC1-C10アルキル基を表す。)、a1−NH−CO−基(a1は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、a1’−CO−基(a1’は、モルホリノ基を表す。)、rr’N−CH2−基(r及びr’は、前記と同一の意味を表す。)、r0−(O)l−CONH−CH2−基(r0は、C1-C10アルキル基を表し、lは0又は1を表す。)、r−OCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、シアノ基又はスルホメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、bは、オキシ基、チオ基、スルフィニル基、スルホニル基又はメチル基で置換されてもよいイミノ基を表す。}、又は、a2−y−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表し、yは、オキシ基又はイミノ基を表す。)、又は、rO−COCO−NH−基(rは、前記と同一の意味を表す。)、又は、a3−z−NH−基(a3は、C2-C10アルケニル基、又は、C1-C10アルコキシ基、C1-C10アルコキシカルボニル基、カルボキシ基若しくはシアノ基で置換されたC1-C10アルキル基を表し、zは、カルボニル基又はスルホニル基を表す。)、又は、a4−Nr’CO−基{a4は、C1-C10アルコキシ基、又は、C3-C10アルケニルオキシ基、又は、r0−SO2−基(r0は、前記と同一の意味を表す。)、又は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、r0r0’N−基(r0は、前記と同一の意味を表し、r0’は、r0と同一又は相異なり、r0と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、シアノ基若しくはアミノカルボニル基で置換されたC1-C10アルキル基、又は、rO−CO−(rO−COCH2)CH−基(rは、前記と同一の意味を表す。)を表し、r’は、前記と同一の意味を表す。}、又は、a5−NHSO2−基(a5は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、r0ON=CH−基(r0は、前記と同一の意味を表す。)、又は、r0NHCSNH−基(r0は、前記と同一の意味を表す。)、又は、r0NHC(−Sr0’)=N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、(rO)2P(=O)CH2−基(rは、前記と同一の意味を表す。)を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xaは、同一又は相異なり、
Yaは、ハロゲン原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基、又は、C1-C10アルコキシ基で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、2−オキソ−オキサゾリジン−3−イル基、又は、[1,3]ジオキソラン−2−イル基、又は、モルホリノ基で置換されたC1-C10アルコキシ基、又は、a0’−b’−基(a0’は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、b’は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)、又は、ニトロ基、又は、シアノ基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、又は、r0r0’N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、r0CO−NH−基(r0は、前記と同一の意味を表す。)、又は、r0r0’NCONH−基(r0及びr0’は、前記と同一の意味を表す。)、又は、rr’NCO−基(r及びr’は、前記と同一の意味を表す。)、又は、水酸基を表し、qは、0、1、2又は3を表し、qが2以上のとき、Yaは、同一又は相異なり、qが2以上のとき、隣接しているYaは、a環と縮環して4,5,6,7−テトラヒドロベンゾ[b]チオフェン環をなしてもよい。
II.bは、
式(V-1)
[式中、Qaは、ra−O−基{raは、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、r0r0’N−CH2−基(r0及びr0’は、前記と同一の意味を表す。)、rOCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、C1-C10アルコキシカルボニル基、カルボキシ基、アミノカルボニル基若しくはシアノ基で置換されたC1-C10アルキル基、又は、r3−r1−基(r3は、フェニル基又はピリジル基を表し、r1は、前記と同一の意味を表す。)を表す。}、又は、ピペリジノ基、又は、モルホリノ基、又は、r4r4’N−基(r4及びr4’は、同一又は相異なり、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。但し、同時に水素原子となることはない。)を表し、Waは、酸素原子又は−NTa−基[Taは、rb−基(rbは、raと同一又は相異なり、raと同一の意味を表す。)又はr3’−基(r3’は、r3と同一又は相異なり、r3と同一の意味を表す。)を表す。]を表し、Kaは、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、Laは、水素原子又はC1-C10アルキル基を表し、KaとLaとは、C3-C10アルキレン基又は1,3−ブタジエニレン基をなすことがある。]
で示される基、
式(V-2)
[式中、Taは、前記と同一の意味を表し、Lbは水酸基又はメチル基を表す。]
で示される基、
式(V-3)
[式中、Taは、前記と同一の意味を表し、Lcは、C1-C10アルキル基を表す。]
で示される基、
式(V-4)
[式中、Taは、前記と同一の意味を表す。]
で示される基、
式(V-5)
[式中、Taは、前記と同一の意味を表し、Kbは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(V-6)
[式中、Waは、前記と同一の意味を表し、KcとLdとは、C3-C10アルキレン基又はC4-C10アルケニレン基をなす。]
で示される基、
式(V-7)
[式中、Qa及びWaは、前記と同一の意味を表し、KdとLeとは、−Va=Va’−Va’’=Va’’’−基(Va、Va’、Va’’及びVa’’’は、同一又は相異なり、メチン基、又は、−N=基を表し、Va、Va’、Va’’及びVa’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(V-8)
[式中、Taは、前記と同一の意味を表し、Qbは、ra−O−基(raは、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(V-9)
[式中、U及びWaは、前記と同一の意味を表す。]
で示される基を表す。
但し、aがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (V)
[Where:
I. a represents a thiophene ring, furan ring, pyrrole ring, pyrazole ring, 1,2,3-triazole ring, tetrazole ring, isoxazole ring, thiazole ring, pyridazine ring or pyrimidine ring, and X a is substituted with a cyano group C1-C10 alkyl group substituted with a tetrahydropyran-4-ylidene group, C2-C10 alkenyl group substituted with a halogen atom or a cyano group, or C1-C10 alkoxy A C2-C10 alkenyl group substituted with a carbonyl group, a C3-C10 alkynyl group substituted with a hydroxy group, or an a 0 -r 1 -br 1 ′ -group {a 0 is a C 1 -C 10 alkylthio A methyl group substituted with a C1-C10 alkylsulfinyl group, a methyl group substituted with a C1-C10 alkylsulfonyl group, a C2-C10 alkenyl group, a C2-C10 alkynyl group Group, r 2 O-CO- group (r 2 represents a C2-C10 alkyl group substituted with C1-C10 alkyl group or a hydroxyl group.), A carboxy group, RR'N-CO- group (r and r ' are the same or different, represent a hydrogen atom or a C1-C10 alkyl group.), a 1 -NH-CO- group (a 1 represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group. ), A 1 '-CO- group (a 1 ' represents a morpholino group), rr'N-CH 2 -group (r and r 'represent the same meaning as described above), r 0- . (O) l -CONH-CH 2 - group (r 0 denotes a C1-C10 alkyl group, l represents 0 or 1.), r-OCH 2 - group (r is the same meaning as above represents.), r 0 -CO- group (r 0 represents the same meaning as above.), a cyano group or a sulfomethyl group, r 1 represents a C1-C10 alkylene group r 1 'represents a single bond or a C1-C10 alkylene group, b represents an oxy group, a thio group, a sulfinyl group, an imino group optionally substituted by a sulfonyl group or a methyl group. }, Or, a 2 -y-CO-NH- group (a 2 represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group, y represents an oxy group or an imino group.), Or , rO-COCO-NH- group (r represents the same meaning as above.), or, a 3 -z-NH- group (a 3 is C2-C10 alkenyl group, or, C1-C10 alkoxy group Represents a C1-C10 alkyl group substituted with a C1-C10 alkoxycarbonyl group, a carboxy group or a cyano group, and z represents a carbonyl group or a sulfonyl group) or an a 4 -Nr′CO— group {a 4, C1-C10 alkoxy group, or a C3-C10 alkenyloxy group, or, r 0 -SO 2 - group (. r 0 represents the same meaning as), or a hydroxyl or C1-C10 alkoxy A C2-C10 alkyl group substituted with a group, or an r 0 r 0 'N- group (where r 0 is the same as defined above) Represents one meaning of, r 0 'is different from r 0 the same or different, C2-C10 alkyl group substituted with represents the same meaning as r 0.), Or, and rO-CO- group (r is Represents the same meaning as described above), a C1-C10 alkyl group substituted with a cyano group or an aminocarbonyl group, or an rO—CO— (rO—COCH 2 ) CH— group (r is as defined above). And r ′ represents the same meaning as described above. }, Or, a 5 -NHSO 2 - group (. A 5 represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group), or, r 0 ON = CH- group (r 0, the Or r 0 NHCSNH- group (r 0 represents the same meaning as described above), or r 0 NHC (-Sr 0 ') = N- group (r 0 and r 0 ′ represents the same meaning as described above.) or (rO) 2 P (═O) CH 2 — group (r represents the same meaning as described above), and p represents 0. , 1, 2 or 3 and when p is 2 or more, X a is the same or different,
Y a is a halogen atom, a C1-C10 alkyl group that may be substituted with a halogen atom, a C1-C10 alkyl group that may be substituted with a C1-C10 alkoxy group, or a C2-C10 alkenyl group, Or a C2-C10 alkynyl group, a 2-oxo-oxazolidin-3-yl group, a [1,3] dioxolan-2-yl group, or a C1-C10 alkoxy group substituted with a morpholino group, or , A 0 '-b'- group (a 0 ' represents a C1-C10 alkyl group which may be substituted with a halogen atom, and b 'represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group). Or a nitro group, a cyano group, or an rO—CO— group (where r represents the same meaning as described above), or an r 0 r 0 ′ N-group (r 0 and r 0 ′ are represents the same meaning as.), or, r 0 CO-NH- group (r 0, the same Meanings.), Or, r 0 r 0 'NCONH- group (r 0 and r 0', the. Represents the same meaning as), or, Rr'NCO- group (r and r 'are, Represents the same meaning as described above), or represents a hydroxyl group, q represents 0, 1, 2 or 3, and when q is 2 or more, Y a is the same or different and q is 2 or more. In some cases, adjacent Y a may be condensed with a ring to form a 4,5,6,7-tetrahydrobenzo [b] thiophene ring.
II. b is
Formula (V-1)
Wherein, Q a is r a -O- group {r a is a hydrogen atom, or, C1-C10 alkyl group, or, C3-C10 alkenyl group, or, C3-C10 alkynyl group, or, r 0 r 0 'N-CH 2 - group (r 0 and r 0' represents the same meaning as.), Roch 2 - group (. r is representative of the same meaning as above), r 0 -CO - group (. r 0 is representative of the same meaning), C1-C10 alkoxycarbonyl group, a carboxy group, C1-C10 alkyl group substituted with aminocarbonyl group or a cyano group, or, r 3 -r 1 -Represents a group (wherein r 3 represents a phenyl group or a pyridyl group, and r 1 represents the same meaning as described above). }, Or piperidino group, morpholino group, or r 4 r 4 ′ N-group (where r 4 and r 4 ′ are the same or different, a hydrogen atom, a C1-C10 alkyl group, or C 3 -C10 alkenyl group, or C3-C10 alkynyl group, or a C2-C10 alkyl group substituted with C1-C10 alkoxy group. However, not hydrogen atoms at the same time.) represents, W a is , oxygen atom or -NT a - group [T a is r b - group (r b may be the same or different phases and r a, represents the same meaning as r a.) or r 3 '- group (r 3 'differs r 3 and same or different, represent a representative.) the same meaning as r 3. Represents], K a represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group, a L a represents a hydrogen atom or a C1-C10 alkyl group, a and K a and L a, C3-C10 alkylene group Alternatively, it may form a 1,3-butadienylene group. ]
A group represented by
Formula (V-2)
Wherein, T a represents the same meaning as above, L b represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (V-3)
Wherein, T a represents the same meaning as, L c represents a C1-C10 alkyl group. ]
A group represented by
Formula (V-4)
Wherein, T a represents the same meaning as above. ]
A group represented by
Formula (V-5)
Wherein, T a represents the same meaning as above, K b is cyano group or UOCO- group (U represents. A hydrogen atom or a C1-C10 alkyl group);. ]
A group represented by
Formula (V-6)
[Wherein W a represents the same meaning as described above, and K c and L d form a C3-C10 alkylene group or a C4-C10 alkenylene group. ]
A group represented by
Formula (V-7)
Wherein, Q a and W a represents the same meaning as, the K d and L e, -V a = V a '-V a''= V a''' - group (V a , V a ′, V a ″ and V a ″ are the same or different and represent a methine group or —N = group, and V a , V a ′, V a ″ and V a ″ At least one of-represents -N = group. ]
A group represented by
Formula (V-8)
Wherein, T a represents the same meaning as, Q b is r a -O- group (r a represents. The same meanings as the above) represents a. ]
Or a group represented by
Formula (V-9)
[Wherein U and W a represent the same meaning as described above. ]
Represents a group represented by
However, when a is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
[式中、a1は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa1は、a0’−r1−b0−r1’−基{a0’は、rO−CO−基(rは、水素原子又はC1-C10アルキル基を表す。)、r0r0’N−CH2−基(r0及びr0’は、同一又は相異なり、C1-C10アルキル基を表す。)、又は、ヒドロキシメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、b0は、オキシ基、チオ基、スルフィニル基、スルホニル基又は1個のメチル基で置換されたイミノ基を表す。}、又は、a2−O−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、a3’−CO−NH−基(a3’は、C1-C10アルコキシ基で置換されたC1-C10アルキル基を表す。)、又は、a4’−NrCO−基
(a4’は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、
アミノカルボニル基で置換されたC1-C10アルキル基を表し、rは、前記と同一の意味を表す。)を表し、b1は、
式(VI-1)
(式中、rb1は、水素原子又はC1-C10アルキル基を表し、Ka1は、水素原子を表し、La1は、C1-C10アルキル基を表し、Ka1とLa1とは、1,3−ブタジエニレン基をなすことがある。)
で示される基、
式(VI-7)
(式中、rb1は、前記と同一の意味を表す。)
で示される基、又は、
式(VI-8)
(式中、rb1は、前記と同一の意味を表す。)
で示される基を表す。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (VI)
Wherein, a1 is a thiophene ring, a furan ring, represents a pyrrole ring or a thiazole ring, X a1 is, a 0 '-r 1 -b 0 -r 1' - groups {a 0 'is and rO-CO- group (r represents a hydrogen atom or a C1-C10 alkyl group.), r 0 r 0 ' N-CH 2 - group (r 0 and r 0' are the same or different and represent a C1-C10 alkyl group ) Or a hydroxymethyl group, r 1 represents a C1-C10 alkylene group, r 1 ′ represents a single bond or a C1-C10 alkylene group, and b 0 represents an oxy group, a thio group, or a sulfinyl group. Represents an imino group substituted with a group, a sulfonyl group or one methyl group. }, Or, a 2 -O-CO-NH- group (a 2 is. Represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group), or, a 3 '-CO-NH- group ( a 3 'is. represents a C1-C10 alkyl group substituted with C1-C10 alkoxy group), or, a 4' -NRCO- group (a 4 'is substituted with a hydroxyl or C1-C10 alkoxy group A C2-C10 alkyl group, or
Represents a C1-C10 alkyl group substituted with an aminocarbonyl group, and r represents the same meaning as described above. ) And b1 is
Formula (VI-1)
( Wherein , r b1 represents a hydrogen atom or a C1-C10 alkyl group, K a1 represents a hydrogen atom, L a1 represents a C1-C10 alkyl group, and K a1 and L a1 represent 1, (May form 3-butadienylene group.)
A group represented by
Formula (VI-7)
(Wherein, r b1 represents the same meaning as described above.)
Or a group represented by
Formula (VI-8)
(Wherein, r b1 represents the same meaning as described above.)
Represents a group represented by
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
[式中、a1は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa1は、a0’−r1−b0−r1’−基{a0’は、r0O−CO−基(r0は、C1-C10アルキル基を表す。)、r0r0’N−CH2−基(r0及びr0’は、同一又は相異なり、r0’は、r0と同一の意味を表す。)、又は、ヒドロキシメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、b0は、オキシ基、チオ基、スルフィニル基、スルホニル基又は1個のメチル基で置換されたイミノ基を表す。}、又は、a2−O−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、a3’−CO−NH−基(a3’は、C1-C10アルコキシ基で置換されたC1-C10アルキル基を表す。)、又は、a4’−NrCO−基
(a4’は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、
アミノカルボニル基で置換されたC1-C10アルキル基を表し、rは、水素原子又はC1-C10アルキル基を表す。)を表す。但し、a1がチオフェン環のとき、同時に、a0’がジメチルアミノメチル基又はヒドロキシメチル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、オキシ基、チオ基又は1個のメチル基で置換されたイミノ基であることはなく、また、a1がチオフェン環のとき、a0’がメトキシカルボニル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、チオ基であることはない。]
で示されるアルデヒド誘導体。 Formula (VII)
Wherein, a1 is a thiophene ring, a furan ring, represents a pyrrole ring or a thiazole ring, X a1 is, a 0 '-r 1 -b 0 -r 1' - groups {a 0 'is r 0 O- CO-group (r 0 represents a C1-C10 alkyl group), r 0 r 0 'N-CH 2 -group (r 0 and r 0 ' are the same or different, and r 0 'represents r 0 It represents the same meaning as.), or represents a hydroxymethyl group, r 1 represents a C1-C10 alkylene group, r 1 'represents a single bond or a C1-C10 alkylene group, b 0 is oxy Represents an imino group substituted by a group, a thio group, a sulfinyl group, a sulfonyl group or one methyl group. }, Or, a 2 -O-CO-NH- group (a 2 is. Represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group), or, a 3 '-CO-NH- group ( a 3 'is. represents a C1-C10 alkyl group substituted with C1-C10 alkoxy group), or, a 4' -NRCO- group (a 4 'is substituted with a hydroxyl or C1-C10 alkoxy group A C2-C10 alkyl group, or
Represents a C1-C10 alkyl group substituted with an aminocarbonyl group, and r represents a hydrogen atom or a C1-C10 alkyl group. ). Provided that when a1 is thiophene ring, at the same time, a 0 'a dimethyl aminomethyl group or a hydroxymethyl group, at the same time, a r 1 is methylene group, simultaneously, r 1' is a single bond, At the same time, b 0 is not an oxy group, a thio group or an imino group substituted with one methyl group, and when a 1 is a thiophene ring, a 0 ′ is a methoxycarbonyl group, , R 1 is a methylene group, and at the same time, r 1 ′ is a single bond, and b 0 is not a thio group at the same time. ]
An aldehyde derivative represented by
[式中、a1は、チオフェン環、フラン環、ピロール環又はチアゾール環を表し、Xa1は、a0’−r1−b0−r1’−基{a0’は、r0O−CO−基(r0は、C1-C10アルキル基を表す。)、r0r0’N−CH2−基(r0及びr0’は、同一又は相異なり、r0’は、r0と同一の意味を表す。)、又は、ヒドロキシメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、b0は、オキシ基、チオ基、スルフィニル基、スルホニル基又は1個のメチル基で置換されたイミノ基を表す。}、又は、a2−O−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、a3’−CO−NH−基(a3’は、C1-C10アルコキシ基で置換されたC1-C10アルキル基を表す。)、又は、a4’−NrCO−基
(a4’は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、
アミノカルボニル基で置換されたC1-C10アルキル基を表し、rは、水素原子又はC1-C10アルキル基を表す。)を表す。但し、a1がチオフェン環のとき、同時に、a0’がジメチルアミノメチル基又はヒドロキシメチル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、オキシ基、チオ基又は1個のメチル基で置換されたイミノ基であることはなく、また、a1がチオフェン環のとき、a0’がメトキシカルボニル基であって、同時に、r1がメチレン基であって、同時に、r1’が単結合であって、同時に、b0は、チオ基であることはない。]
で示されるアルデヒド誘導体と、式(VIII’)
[式中、b1は、
式(VIII-1)
(式中、rb1は、水素原子又はC1-C10アルキル基を表し、Ka1は、水素原子を表し、La1は、C1-C10アルキル基を表し、Ka1とLa1とは、1,3−ブタジエニレン基をなすことがある。)
で示される基、
式(VIII-7)
(式中、rb1は、前記と同一の意味を表す。)
で示される基、又は、
式(VIII-8)
(式中、rb1は、前記と同一の意味を表す。)
で示される基を表す。]
で示される化合物とを反応させることを特徴とする、式(VIII’’)
[式中、a1、Xa1及びb1は、前記と同一の意味を表す。]
で示されるシンナモイル化合物の製造法。 Formula (VIII)
Wherein, a1 is a thiophene ring, a furan ring, represents a pyrrole ring or a thiazole ring, X a1 is, a 0 '-r 1 -b 0 -r 1' - groups {a 0 'is r 0 O- CO-group (r 0 represents a C1-C10 alkyl group), r 0 r 0 'N-CH 2 -group (r 0 and r 0 ' are the same or different, and r 0 'represents r 0 It represents the same meaning as.), or represents a hydroxymethyl group, r 1 represents a C1-C10 alkylene group, r 1 'represents a single bond or a C1-C10 alkylene group, b 0 is oxy Represents an imino group substituted by a group, a thio group, a sulfinyl group, a sulfonyl group or one methyl group. }, Or, a 2 -O-CO-NH- group (a 2 is. Represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group), or, a 3 '-CO-NH- group ( a 3 'is. represents a C1-C10 alkyl group substituted with C1-C10 alkoxy group), or, a 4' -NRCO- group (a 4 'is substituted with a hydroxyl or C1-C10 alkoxy group A C2-C10 alkyl group, or
Represents a C1-C10 alkyl group substituted with an aminocarbonyl group, and r represents a hydrogen atom or a C1-C10 alkyl group. ). Provided that when a1 is thiophene ring, at the same time, a 0 'a dimethyl aminomethyl group or a hydroxymethyl group, at the same time, a r 1 is methylene group, simultaneously, r 1' is a single bond, At the same time, b 0 is not an oxy group, a thio group or an imino group substituted with one methyl group, and when a 1 is a thiophene ring, a 0 ′ is a methoxycarbonyl group, , R 1 is a methylene group, and at the same time, r 1 ′ is a single bond, and b 0 is not a thio group at the same time. ]
An aldehyde derivative represented by formula (VIII ′)
[Wherein b1 is
Formula (VIII-1)
( Wherein , r b1 represents a hydrogen atom or a C1-C10 alkyl group, K a1 represents a hydrogen atom, L a1 represents a C1-C10 alkyl group, and K a1 and L a1 represent 1, (May form 3-butadienylene group.)
A group represented by
Formula (VIII-7)
(Wherein, r b1 represents the same meaning as described above.)
Or a group represented by
Formula (VIII-8)
(Wherein, r b1 represents the same meaning as described above.)
Represents a group represented by ]
Characterized by reacting with a compound of formula (VIII ″)
[Wherein, a1, X a1 and b1 represent the same meaning as described above. ]
The manufacturing method of the cinnamoyl compound shown by these.
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.β'は、
式(I'-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(I'-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(I'-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(I'-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(I'-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(I'-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(I'-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(I'-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(I'-9)
[式中、Wαは、前記と同一の意味を表す。]
で示される基を表す。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物と不活性担体とを含有することを特徴とする細胞外マトリックス遺伝子転写抑制組成物。 Formula (I ')
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms. In (Y α ) q , Y α represents a group of the following X 0 group or Y 0 group, and q is , 0, 1, 2, or 3 and when q is 2 or more, Y α is the same or different, and when q is 2 or more, two adjacent Y α that are adjacent to each other are Z It may be condensed with an α ring by forming a group of 0 group, and in (X α ) p , X α represents a substituent not belonging to the following X 0 group, Y 0 group and Z 0 group, p Represents 0, 1, 2 or 3, and when p is 2 or more, X α is the same or different, and the sum of p and q is 3 or less.
(1) X 0 group: M a - group [M a is R b - group (. R b is representative of a is C1-C10 may be an alkyl group substituted with a halogen atom), a halogen atom, a nitro group, a cyano group, a hydroxyl group, R c -B a -R d - group (R c represents a halogen atom which may be substituted with C1-C10 alkyl group, B a is oxy, thio, sulfinyl or sulfonyl group R d represents a single bond or a C1-C10 alkylene group.), HOR d -group (R d represents the same meaning as described above), R e -CO-R d -group (R e represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and R d represents the same meaning as described above), R e —CO—O—R d — group ( R e and R d represent the same meaning), R e O-CO- R d -. group (R e and R d are the same Means represents a), HO-CO-CH = CH- group, R e R e. 'N -R d - group (R e and R e' are the same or different, R e, the same meaning R e ′ represents the same meaning as R e , R d represents the same meaning as described above), R e —CO—NR e ′ —R d — group (R e , R e 'And R d represent the same meaning as described above.), R b O—CO—N (R e ) —R d — group (R b , R e and R d represent the same meaning as described above. ), R e R e 'N-CO-R d -group (R e , R e ' and R d represent the same meaning as described above), R e R e 'N-CO-NR e '. '-R d -groups (R e , R e ′ and R e ″ are the same or different, R e and R e ′ have the same meaning as described above, and R e ″ represents R e and Represents the same meaning, and R d is the same as above. ), R e R e ′ NC (═NR e ″) —NR e ″ ″ —R d — groups (R e , R e ′, R e ″ and R e ″). 'Is the same or different, R e , R e ′ and R e ″ represent the same meaning as described above, R e ′ ″ represents the same meaning as R e, and R d represents the above And R b —SO 2 —NR e —R d — group (R b , R e and R d represent the same meaning as described above), R e R e 'N— SO 2 —R d — group (R e , R e ′ and R d represent the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 group: M b0 -R d -group [M b0 is M c0 -group {M c0 is M d0 -R d ' -group {M d0 is M a -group (M a is It represents the same meaning as described above) and may be substituted with a 6-10-membered aryl group which may be substituted or a M a -group (M a represents the same meaning as described above). 5-10 membered heteroaryl group, or M a -group (M a represents the same meaning as described above) 3-10 membered ring carbonization which may contain an unsaturated bond which may be substituted A hydrogen or heterocyclic group, or
(b 0 ) — group (in (b 0 ), G 0 represents a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
A (c 0 ) -group (in (c 0 ), J 0 may contain a nitrogen atom and forms an aromatic 5- to 7-membered ring);
(D 0 ) -group {d 0 is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, a —NR 1 -group {R 1 is a hydrogen atom or a C1-C10 alkyl group, Or a halogen atom or an R 2 —B 1 — group (R 2 represents a C 1 -C 10 alkyl group, a C 3 -C 10 alkenyl group or a C 3 -C 10 alkynyl group, and B 1 represents an oxy group, a thio group, a sulfinyl group or A C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group substituted with a sulfonyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -group {e 0 is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a —NR 1 — group (R 1 is as defined above), a sulfinyl group or a sulfonyl group. It forms an optionally substituted 5-12 membered hydrocarbon ring. Represents}, R d 'are the same or different and R d, it represents the same meaning as R d. }. }, M c0 -B a - group (. M c0 and B a are representing the same meaning), M c0 -CO- group (. M c0 is representative of the same meaning as), M c0 -CO-O- group (M c0 represents the same meaning as described above), M c0 O-CO- group (M c0 represents the same meaning as described above), M c0 R e N- group (M c0 and R e represent the same meaning as described above), M c0 —CO—NR e — group (M c0 and R e represent the same meaning as described above), M c0 O—CO —NR e — group (M c0 and R e represent the same meaning as described above), M c0 R e N—CO— group (M c0 and R e represent the same meaning as described above), M c0 R e N-CO- NR e '- group (M c0, R e and R e'. are representing the same meaning as), M c0 R e N- C (= N e ') -NR e' '- group (M c0, R e, R e' and R e '' represents the same meaning), M c0 -SO 2 -NR e -. group (M c0 And R e represent the same meaning as described above) or a M c0 R e N—SO 2 — group (M c0 and R e represent the same meaning as described above), and R d represents the above Represents the same meaning as ].
(3) Z 0 group: having halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group It may be a 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β 'is
Formula (I'-1)
[Where:
(1) Qα represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α represents an oxygen atom or a —NT α — group (T α represents a hydrogen atom or a substituent on a nitrogen atom).
(3) K α and L α are the same or different and represent a hydrogen atom or a substituent on a carbon atom, and K α and L α are a C3-C10 alkylene group which may have a substituent. Alternatively, it may form a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (I'-2)
[Wherein, T α represents the same meaning as described above, and L β represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (I'-3)
[Wherein, T α represents the same meaning as described above, and L γ represents a C1-C10 alkyl group. ]
A group represented by
Formula (I'-4)
[Wherein, T α represents the same meaning as described above. ]
A group represented by
Formula (I'-5)
[Wherein, T α represents the same meaning as described above, and K β represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (I'-6)
[Wherein W α represents the same meaning as described above, and K γ and L δ represent a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene which may have a substituent. Make a basis. ]
A group represented by
Formula (I'-7)
[Wherein Q α and W α represent the same meaning as described above, and K δ and L ε represent -V α = V α '-V α ″ = V α ''' -group (V α , V α ′, V α ″ and V α ″ ″ are the same or different and each represents an optionally substituted methine group or —N = group, and V α , V α ′, V α ″ And at least one of V α ′ ″ represents —N = group. ]
A group represented by
Formula (I'-8)
[Wherein, T α represents the same meaning as described above, and Q β represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (I'-9)
[Wherein W α represents the same meaning as described above. ]
Represents a group represented by
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A composition for inhibiting transcription of an extracellular matrix gene, comprising a cinnamoyl compound represented by the formula (1) and an inert carrier.
[式中、
I.αは、芳香族5員環又は窒素原子を2以上有する芳香族6員環を表し、(Yα)qにおいて、Yαは、下記のX0群又はY0群の基を表し、qは、0、1、2又は3を表して、qが2以上のとき、Yαは同一又は相異なり、qが2以上のとき、隣接している2個の同一又は相異なるYαは、Z0群の基をなしてα環と縮環してもよく、(Xα)pにおいて、Xαは、下記のX0群、Y0群及びZ0群に属さない置換基を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xαは同一又は相異なり、pとqとの和は3以下である。
(1)X0群:Ma−基[Maは、Rb−基(Rbは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表す。)、ハロゲン原子、ニトロ基、シアノ基、水酸基、Rc−Ba−Rd−基(Rcは、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Baは、オキシ基、チオ基、スルフィニル基又はスルホニル基を表し、Rdは、単結合又はC1-C10アルキレン基を表す。)、HORd−基(Rdは、前記と同一の意味を表す。)、Re−CO−Rd−基(Reは、水素原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、Rdは、前記と同一の意味を表す。)、Re−CO−O−Rd−基(Re及びRdは、前記と同一の意味を表す。)、ReO−CO−Rd−基(Re及びRdは、前記と同一の意味を表す。)、HO−CO−CH=CH−基、ReRe’N−Rd−基(Re及びRe’は、同一又は相異なり、Reは、前記と同一の意味を表し、Re’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Re−CO−NRe’−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、RbO−CO−N(Re)−Rd−基(Rb、R e及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、ReRe’N−CO−NRe’’−Rd−基(Re、Re’及びRe’’は、同一又は相異なり、Re及びRe’は、前記と同一の意味を表し、Re’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、ReRe’N−C(=NRe’’)−NRe’’’−Rd−基(Re、Re’、Re’’及びRe’’’は、同一又は相異なり、Re、Re’及びRe’’は、前記と同一の意味を表し、Re’’’は、Reと同一の意味を表し、Rdは、前記と同一の意味を表す。)、Rb−SO2−NRe−Rd−基(Rb、Re及びRdは、前記と同一の意味を表す。)、ReR e’N−SO2−Rd−基(Re、Re’及びRdは、前記と同一の意味を表す。)、C2-C10アルケニル基又はC2-C10アルキニル基を表す。]である。
(2)Y0群:Mb0−Rd−基[Mb0は、Mc0−基{Mc0は、Md0−Rd’−基{Md0は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい6−10員環のアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい5−10員環のヘテロアリール基、又は、Ma−基(Maは、前記と同一の意味を表す。)で置換されてもよい不飽和結合を含んでもよい3−10員環の炭化水素環若しくは複素環をなす基、又は、
(b0) −基((b0)において、G0は、置換基を有してもよい、飽和又は不飽和の、非芳香族の、5〜14員の炭化水素環又は複素環をなす。)、
(c0)−基((c0)において、J0は、窒素原子を含んでもよく、芳香族5−7員環をなす。)、
(d0)−基{d0は、カルボニル基又はチオカルボニル基で置換され、更に、オキシ基、チオ基、−NR1-基{R1は、水素原子、又は、C1-C10アルキル基、又は、ハロゲン原子若しくはR2−B1−基(R2は、C1-C10アルキル基、C3-C10アルケニル基又はC3-C10アルキニル基を表し、B1は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)で置換されたC2-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基を表す。}、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}又は
(e0)−基{e0は、カルボニル基、チオカルボニル基、オキシ基、チオ基、−NR1-基(R1は、前記と同一の意味を表す。)、スルフィニル基若しくはスルホニル基で置換されてもよい5−12員の炭化水素環をなす。}を表し、Rd’は、Rdと同一又は相異なり、Rdと同一の意味を表す。}を表す。}、Mc0−Ba−基(Mc0及びBaは、前記と同一の意味を表す。)、Mc0−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0−CO−O−基(Mc0は、前記と同一の意味を表す。)、Mc0O−CO−基(Mc0は、前記と同一の意味を表す。)、Mc0ReN−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0O−CO−NRe−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−基(Mc0及びReは、前記と同一の意味を表す。)、Mc0ReN−CO−NRe’−基(Mc0、Re及びRe’は、前記と同一の意味を表す。)、Mc0ReN−C(=NRe’)−NRe’’−基(Mc0、Re、Re’及びRe’’は、前記と同一の意味を表す。)、Mc0−SO2−NRe−基(Mc0及びReは、前記と同一の意味を表す。)又はMc0ReN−SO2−基(Mc0及びReは、前記と同一の意味を表す。)を表し、Rdは、前記と同一の意味を表す。]である。
(3)Z0群:ハロゲン原子、C1-C10アルコキシ基、C3-C10アルケニルオキシ基、C3-C10アルキニルオキシ基、カルボニル基、チオカルボニル基、オキシ基、チオ基、スルフィニル基若しくはスルホニル基を有してもよい、5−12員環の炭化水素環又は複素環であって、芳香族又は非芳香族の、単環又は縮環であって、α環と縮環する基である。
II.β'は、
式(II'-1)
[式中、
(1)Qαは、置換されてもよい水酸基、又は、置換されてもよいアミノ基を表す。
(2)Wαは、酸素原子又は−NTα−基(Tαは、水素原子、又は、窒素原子上の置換基を表す。)を表す。
(3)Kα及びLαは、同一又は相異なり、水素原子、又は、炭素原子上の置換基を表し、KαとLαとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなすことがある。]
で示される基、
式(II'-2)
[式中、Tαは、前記と同一の意味を表し、Lβは水酸基又はメチル基を表す。]
で示される基、
式(II'-3)
[式中、Tαは、前記と同一の意味を表し、Lγは、C1-C10アルキル基を表す。]
で示される基、
式(II-4)
[式中、Tαは、前記と同一の意味を表す。]
で示される基、
式(II'-5)
[式中、Tαは、前記と同一の意味を表し、Kβは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(II'-6)
[式中、Wαは、前記と同一の意味を表し、KγとLδとは、置換基を有してもよいC3-C10アルキレン基又は置換基を有してもよいC4-C10アルケニレン基をなす。]
で示される基、
式(II'-7)
[式中、Qα及びWαは、前記と同一の意味を表し、KδとLεとは、−Vα=Vα’−Vα’’=Vα’’’−基(Vα、Vα’、Vα’’及びVα’’’は、同一又は相異なり、置換されてもよいメチン基、又は、−N=基を表し、Vα、Vα’、Vα’’及びVα’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(II'-8)
[式中、Tαは、前記と同一の意味を表し、Qβは、置換されてもよい水酸基を表す。]
で示される基、又は、
式(II'-9)
[式中、Wαは、前記と同一の意味を表す。]
で示される基を表す。
但し、αがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (II ')
[Where:
I. α represents an aromatic 5-membered ring or an aromatic 6-membered ring having two or more nitrogen atoms. In (Y α ) q , Y α represents a group of the following X 0 group or Y 0 group, and q is , 0, 1, 2, or 3 and when q is 2 or more, Y α is the same or different, and when q is 2 or more, two adjacent Y α that are adjacent to each other are Z It may be condensed with an α ring by forming a group of 0 group, and in (X α ) p , X α represents a substituent not belonging to the following X 0 group, Y 0 group and Z 0 group, p Represents 0, 1, 2 or 3, and when p is 2 or more, X α is the same or different, and the sum of p and q is 3 or less.
(1) X 0 group: M a - group [M a is R b - group (. R b is representative of a is C1-C10 may be an alkyl group substituted with a halogen atom), a halogen atom, a nitro group, a cyano group, a hydroxyl group, R c -B a -R d - group (R c represents a halogen atom which may be substituted with C1-C10 alkyl group, B a is oxy, thio, sulfinyl or sulfonyl group R d represents a single bond or a C1-C10 alkylene group.), HOR d -group (R d represents the same meaning as described above), R e -CO-R d -group (R e represents a hydrogen atom or a C1-C10 alkyl group which may be substituted with a halogen atom, and R d represents the same meaning as described above), R e —CO—O—R d — group ( R e and R d represent the same meaning), R e O-CO- R d -. group (R e and R d are the same Means represents a), HO-CO-CH = CH- group, R e R e. 'N -R d - group (R e and R e' are the same or different, R e, the same meaning R e ′ represents the same meaning as R e , R d represents the same meaning as described above), R e —CO—NR e ′ —R d — group (R e , R e 'And R d represent the same meaning as described above.), R b O—CO—N (R e ) —R d — group (R b , R e and R d represent the same meaning as described above. ), R e R e 'N-CO-R d -group (R e , R e ' and R d represent the same meaning as described above), R e R e 'N-CO-NR e '. '-R d -groups (R e , R e ′ and R e ″ are the same or different, R e and R e ′ have the same meaning as described above, and R e ″ represents R e and Represents the same meaning, and R d is the same as above. ), R e R e ′ NC (═NR e ″) —NR e ″ ″ —R d — groups (R e , R e ′, R e ″ and R e ″). 'Is the same or different, R e , R e ′ and R e ″ represent the same meaning as described above, R e ′ ″ represents the same meaning as R e, and R d represents the above And R b —SO 2 —NR e —R d — group (R b , R e and R d represent the same meaning as described above), R e R e 'N— SO 2 —R d — group (R e , R e ′ and R d represent the same meaning as described above. ), A C2-C10 alkenyl group or a C2-C10 alkynyl group. ].
(2) Y 0 group: M b0 -R d -group [M b0 is M c0 -group {M c0 is M d0 -R d ' -group {M d0 is M a -group (M a is It represents the same meaning as described above) and may be substituted with a 6-10-membered aryl group which may be substituted or a M a -group (M a represents the same meaning as described above). 5-10 membered heteroaryl group, or M a -group (M a represents the same meaning as described above) 3-10 membered ring carbonization which may contain an unsaturated bond which may be substituted A hydrogen or heterocyclic group, or
(b 0 ) — group (in (b 0 ), G 0 represents a saturated or unsaturated, non-aromatic, 5- to 14-membered hydrocarbon ring or heterocyclic ring which may have a substituent. ),
A (c 0 ) -group (in (c 0 ), J 0 may contain a nitrogen atom and forms an aromatic 5- to 7-membered ring);
(D 0 ) -group {d 0 is substituted with a carbonyl group or a thiocarbonyl group, and further, an oxy group, a thio group, a —NR 1 -group {R 1 is a hydrogen atom or a C1-C10 alkyl group, Or a halogen atom or an R 2 —B 1 — group (R 2 represents a C 1 -C 10 alkyl group, a C 3 -C 10 alkenyl group or a C 3 -C 10 alkynyl group, and B 1 represents an oxy group, a thio group, a sulfinyl group or A C2-C10 alkyl group, a C3-C10 alkenyl group, or a C3-C10 alkynyl group substituted with a sulfonyl group. }, A 5- to 12-membered hydrocarbon ring which may be substituted with a sulfinyl group or a sulfonyl group. } Or
(E 0 ) -group {e 0 is a carbonyl group, a thiocarbonyl group, an oxy group, a thio group, a —NR 1 — group (R 1 is as defined above), a sulfinyl group or a sulfonyl group. It forms an optionally substituted 5-12 membered hydrocarbon ring. Represents}, R d 'are the same or different and R d, it represents the same meaning as R d. }. }, M c0 -B a - group (. M c0 and B a are representing the same meaning), M c0 -CO- group (. M c0 is representative of the same meaning as), M c0 -CO-O- group (M c0 represents the same meaning as described above), M c0 O-CO- group (M c0 represents the same meaning as described above), M c0 R e N- group (M c0 and R e represent the same meaning as described above), M c0 —CO—NR e — group (M c0 and R e represent the same meaning as described above), M c0 O—CO —NR e — group (M c0 and R e represent the same meaning as described above), M c0 R e N—CO— group (M c0 and R e represent the same meaning as described above), M c0 R e N-CO- NR e '- group (M c0, R e and R e'. are representing the same meaning as), M c0 R e N- C (= N e ') -NR e' '- group (M c0, R e, R e' and R e '' represents the same meaning), M c0 -SO 2 -NR e -. group (M c0 And R e represent the same meaning as described above) or a M c0 R e N—SO 2 — group (M c0 and R e represent the same meaning as described above), and R d represents the above Represents the same meaning as ].
(3) Z 0 group: having halogen atom, C1-C10 alkoxy group, C3-C10 alkenyloxy group, C3-C10 alkynyloxy group, carbonyl group, thiocarbonyl group, oxy group, thio group, sulfinyl group or sulfonyl group It may be a 5- to 12-membered hydrocarbon ring or heterocyclic ring, which is an aromatic or non-aromatic monocyclic or condensed ring and a group condensed with the α ring.
II. β 'is
Formula (II'-1)
[Where:
(1) Qα represents an optionally substituted hydroxyl group or an optionally substituted amino group.
(2) W α represents an oxygen atom or a —NT α — group (T α represents a hydrogen atom or a substituent on a nitrogen atom).
(3) K α and L α are the same or different and represent a hydrogen atom or a substituent on a carbon atom, and K α and L α are a C3-C10 alkylene group which may have a substituent. Alternatively, it may form a C4-C10 alkenylene group which may have a substituent. ]
A group represented by
Formula (II'-2)
[Wherein, T α represents the same meaning as described above, and L β represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (II'-3)
[Wherein, T α represents the same meaning as described above, and L γ represents a C1-C10 alkyl group. ]
A group represented by
Formula (II-4)
[Wherein, T α represents the same meaning as described above. ]
A group represented by
Formula (II'-5)
[Wherein, T α represents the same meaning as described above, and K β represents a cyano group or a UOCO- group (U represents a hydrogen atom or a C1-C10 alkyl group). ]
A group represented by
Formula (II'-6)
[Wherein W α represents the same meaning as described above, and K γ and L δ represent a C3-C10 alkylene group which may have a substituent or a C4-C10 alkenylene which may have a substituent. Make a basis. ]
A group represented by
Formula (II'-7)
[Wherein Q α and W α represent the same meaning as described above, and K δ and L ε represent -V α = V α '-V α ″ = V α ''' -group (V α , V α ′, V α ″ and V α ″ ″ are the same or different and each represents an optionally substituted methine group or —N = group, and V α , V α ′, V α ″ And at least one of V α ′ ″ represents —N = group. ]
A group represented by
Formula (II'-8)
[Wherein, T α represents the same meaning as described above, and Q β represents a hydroxyl group which may be substituted. ]
Or a group represented by
Formula (II'-9)
[Wherein W α represents the same meaning as described above. ]
Represents a group represented by
However, when α is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
[式中、
I.aは、チオフェン環、フラン環、ピロール環又はテトラゾール環を表し、Xaは、シアノ基で置換されたC1-C10アルキル基、又は、テトラヒドロピラン−4−イリデン基で置換されたC1-C10アルキル基、又は、ハロゲン原子若しくはシアノ基で置換されたC2-C10アルケニル基、又は、C1-C10アルコキシカルボニル基で置換されたC2-C10アルケニル基、又は、ヒドロキシ基で置換されたC3-C10アルキニル基、又は、a0−r1−b−r1’−基{a0は、C1-C10アルキルチオ基で置換されたメチル基、C1-C10アルキルスルフィニル基で置換されたメチル基、C1-C10アルキルスルホニル基で置換されたメチル基、C2-C10アルケニル基、C2-C10アルキニル基、r2O−CO−基(r2は、C1-C10アルキル基又は水酸基で置換されたC2-C10アルキル基を表す。)、カルボキシ基、rr’N−CO−基(r及びr’は、同一又は相異なり、水素原子又はC1-C10アルキル基を表す。)、a1−NH−CO−基(a1は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、a1’−CO−基(a1’は、モルホリノ基を表す。)、rr’N−CH2−基(r及びr’は、前記と同一の意味を表す。)、r0−(O)l−CONH−CH2−基(r0は、C1-C10アルキル基を表し、lは0又は1を表す。)、r−OCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、シアノ基又はスルホメチル基を表し、r1は、C1-C10アルキレン基を表し、r1’は、単結合又はC1-C10アルキレン基を表し、bは、オキシ基、チオ基、スルフィニル基、スルホニル基又はイミノ基を表す。}、又は、a2−y−CO−NH−基(a2は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表し、yは、オキシ基又はイミノ基を表す。)、又は、rO−COCO−NH−基(rは、前記と同一の意味を表す。)、又は、a3−z−NH−基(a3は、C2-C10アルケニル基、又は、C1-C10アルコキシ基、C1-C10アルコキシカルボニル基、カルボキシ基若しくはシアノ基で置換されたC1-C10アルキル基を表し、zは、カルボニル基又はスルホニル基を表す。)、又は、a4−Nr’CO−基{a4は、C1-C10アルコキシ基、又は、C3-C10アルケニルオキシ基、又は、r0−SO2−基(r0は、前記と同一の意味を表す。)、又は、水酸基若しくはC1-C10アルコキシ基で置換されたC2-C10アルキル基、又は、r0r0’N−基(r0は、前記と同一の意味を表し、r0’は、r0と同一又は相異なり、r0と同一の意味を表す。)で置換されたC2-C10アルキル基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、シアノ基若しくはアミノカルボニル基で置換されたC1-C10アルキル基、又は、rO−CO−(rO−COCH2)CH−基(rは、前記と同一の意味を表す。)を表し、r’は、前記と同一の意味を表す。}、又は、a5−NHSO2−基(a5は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。)、又は、r0ON=CH−基(r0は、前記と同一の意味を表す。)、又は、r0NHCSNH−基(r0は、前記と同一の意味を表す。)、又は、r0NHC(−Sr0’)=N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、(rO)2P(=O)CH2−基(rは、前記と同一の意味を表す。)を表し、pは、0、1、2又は3を表し、pが2以上のとき、Xaは、同一又は相異なり、
Yaは、ハロゲン原子、又は、ハロゲン原子で置換されてもよいC1-C10アルキル基、又は、C1-C10アルコキシ基で置換されてもよいC1-C10アルキル基、又は、C2-C10アルケニル基、又は、C2-C10アルキニル基、又は、2−オキソ−オキサゾリジン−3−イル基、又は、[1,3]ジオキソラン−2−イル基、又は、モルホリノ基で置換されたC1-C10アルコキシ基、又は、a0’−b’−基(a0’は、ハロゲン原子で置換されてもよいC1-C10アルキル基を表し、b’は、オキシ基、チオ基、スルフィニル基又はスルホニル基を表す。)、又は、ニトロ基、又は、シアノ基、又は、rO−CO−基(rは、前記と同一の意味を表す。)、又は、r0r0’N−基(r0及びr0’は、前記と同一の意味を表す。)、又は、r0CO−NH−基(r0は、前記と同一の意味を表す。)、又は、r0r0’NCONH−基(r0及びr0’は、前記と同一の意味を表す。)、又は、rr’NCO−基(r及びr’は、前記と同一の意味を表す。)、又は、水酸基を表し、qは、0、1、2又は3を表し、qが2以上のとき、Yaは、同一又は相異なり、qが2以上のとき、隣接しているYaは、a環と縮環して2,3−ジヒドロ−ベンゾ[1,4]ジオキシン環をなしてもよい。
II.b'は、
式(V'-1)
[式中、Qaは、ra−O−基{raは、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、r0r0’N−CH2−基(r0及びr0’は、前記と同一の意味を表す。)、rOCH2−基(rは、前記と同一の意味を表す。)、r0−CO−基(r0は、前記と同一の意味を表す。)、C1-C10アルコキシカルボニル基、カルボキシ基、アミノカルボニル基若しくはシアノ基で置換されたC1-C10アルキル基、又は、r3−r1−基(r3は、フェニル基又はピリジル基を表し、r1は、前記と同一の意味を表す。)を表す。}、又は、ピペリジノ基、又は、モルホリノ基、又は、r4r4’N−基(r4及びr4’は、同一又は相異なり、水素原子、又は、C1-C10アルキル基、又は、C3-C10アルケニル基、又は、C3-C10アルキニル基、又は、C1-C10アルコキシ基で置換されたC2-C10アルキル基を表す。但し、同時に水素原子となることはない。)を表し、Waは、酸素原子又は−NTa−基[Taは、rb−基(rbは、raと同一又は相異なり、raと同一の意味を表す。)又はr3’−基(r3’は、r3と同一又は相異なり、r3と同一の意味を表す。)を表す。]を表し、Kaは、水素原子、ハロゲン原子又はC1-C10アルキル基を表し、Laは、水素原子又はC1-C10アルキル基を表し、KaとLaとは、C3-C10アルキレン基又は1,3−ブタジエニレン基をなすことがある。]
で示される基、
式(V'-2)
[式中、Taは、前記と同一の意味を表し、Lbは水酸基又はメチル基を表す。]
で示される基、
式(V'-3)
[式中、Taは、前記と同一の意味を表し、Lcは、C1-C10アルキル基を表す。]
で示される基、
式(V'-4)
[式中、Taは、前記と同一の意味を表す。]
で示される基、
式(V'-5)
[式中、Taは、前記と同一の意味を表し、Kbは、シアノ基又はUOCO−基(Uは、水素原子又はC1-C10アルキル基を表す。)を表す。]
で示される基、
式(V'-6)
[式中、Waは、前記と同一の意味を表し、KcとLdとは、C3-C10アルキレン基又はC4-C10アルケニレン基をなす。]
で示される基、
式(V'-7)
[式中、Qa及びWaは、前記と同一の意味を表し、KdとLeとは、−Va=Va’−Va’’=Va’’’−基(Va、Va’、Va’’及びVa’’’は、同一又は相異なり、メチン基、又は、−N=基を表し、Va、Va’、Va’’及びVa’’’のうち少なくとも一つは−N=基を表す。)をなす。]
で示される基、
式(V'-8)
[式中、Taは、前記と同一の意味を表し、Qbは、ra−O−基(raは、前記と同一の意味を表す。)を表す。]
で示される基、又は、
式(V-9')
[式中、Waは、前記と同一の意味を表す。]
で示される基を表す。
但し、aがフラン環又はチオフェン環のとき、p及びqが同時に0になることはない。
尚、複数の置換基の間での同一記号における「前記と同一の意味を表す」とは、当該複数の置換基が互いに独立しながら前記と同一の意味を表すことを示し、当該複数の置換基の間では、選ばれる置換基の選択肢の範囲が同一であるが、その範囲内で選ばれる限り当該選ばれる置換基は同じであっても、異なっていてもよいことを意味するものである。]
で示されるシンナモイル化合物。 Formula (V ')
[Where:
I. a is a thiophene ring, a furan ring, represents a pyrrole ring or a tetrazole ring, X a is C1-C10 alkyl group substituted with a cyano group, or, C1-C10 alkyl substituted with tetrahydropyran-4-ylidene group Group, a C2-C10 alkenyl group substituted with a halogen atom or a cyano group, a C2-C10 alkenyl group substituted with a C1-C10 alkoxycarbonyl group, or a C3-C10 alkynyl group substituted with a hydroxy group Or a 0 -r 1 -br 1 ′ -group {a 0 is a methyl group substituted with a C1-C10 alkylthio group, a methyl group substituted with a C1-C10 alkylsulfinyl group, or a C1-C10 alkyl A methyl group substituted with a sulfonyl group, a C2-C10 alkenyl group, a C2-C10 alkynyl group, an r 2 O—CO— group (r 2 is a C2-C10 alkyl group or a C2-C10 alkyl group substituted with a hydroxyl group) Express) Group, RR'N-CO- group (r and r 'are the same or different. Represents a hydrogen atom or a C1-C10 alkyl group), a 1 -NH-CO- group (a 1, the C1-C10 . representing a C2-C10 alkyl group substituted with an alkoxy group), a 1 '-CO- group (a 1' represents a morpholino group), rr'N-CH 2 -. group (r and r 'are , R 0- (O) 1 —CONH—CH 2 — group (r 0 represents a C 1 -C 10 alkyl group, and l represents 0 or 1), r— An OCH 2 — group (where r represents the same meaning as described above), an r 0 —CO— group (where r 0 represents the same meaning as described above), a cyano group or a sulfomethyl group, and r 1 represents represents a C1-C10 alkylene group, r 1 'represents a single bond or a C1-C10 alkylene group, b is oxy, thio, sulfinyl group, sulfonyl group or embryos Roh represents a group. }, Or, a 2 -y-CO-NH- group (a 2 represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group, y represents an oxy group or an imino group.), Or , rO-COCO-NH- group (r represents the same meaning as above.), or, a 3 -z-NH- group (a 3 is C2-C10 alkenyl group, or, C1-C10 alkoxy group Represents a C1-C10 alkyl group substituted with a C1-C10 alkoxycarbonyl group, a carboxy group or a cyano group, and z represents a carbonyl group or a sulfonyl group) or an a 4 -Nr′CO— group {a 4, C1-C10 alkoxy group, or a C3-C10 alkenyloxy group, or, r 0 -SO 2 - group (. r 0 represents the same meaning as), or a hydroxyl or C1-C10 alkoxy A C2-C10 alkyl group substituted with a group, or an r 0 r 0 'N- group (where r 0 is the same as defined above) Represents one meaning of, r 0 'is different from r 0 the same or different, C2-C10 alkyl group substituted with represents the same meaning as r 0.), Or, and rO-CO- group (r is Represents the same meaning as described above), a C1-C10 alkyl group substituted with a cyano group or an aminocarbonyl group, or an rO—CO— (rO—COCH 2 ) CH— group (r is as defined above). And r ′ represents the same meaning as described above. }, Or, a 5 -NHSO 2 - group (. A 5 represents a C2-C10 alkyl group substituted with C1-C10 alkoxy group), or, r 0 ON = CH- group (r 0, the Or r 0 NHCSNH- group (r 0 represents the same meaning as described above), or r 0 NHC (-Sr 0 ') = N- group (r 0 and r 0 ′ represents the same meaning as described above.) or (rO) 2 P (═O) CH 2 — group (r represents the same meaning as described above), and p represents 0. , 1, 2 or 3 and when p is 2 or more, X a is the same or different,
Y a is a halogen atom, a C1-C10 alkyl group that may be substituted with a halogen atom, a C1-C10 alkyl group that may be substituted with a C1-C10 alkoxy group, or a C2-C10 alkenyl group, Or a C2-C10 alkynyl group, a 2-oxo-oxazolidin-3-yl group, a [1,3] dioxolan-2-yl group, or a C1-C10 alkoxy group substituted with a morpholino group, or , A 0 '-b'- group (a 0 ' represents a C1-C10 alkyl group which may be substituted with a halogen atom, and b 'represents an oxy group, a thio group, a sulfinyl group or a sulfonyl group). Or a nitro group, a cyano group, or an rO—CO— group (where r represents the same meaning as described above), or an r 0 r 0 ′ N-group (r 0 and r 0 ′ are represents the same meaning as.), or, r 0 CO-NH- group (r 0, the same Meanings.), Or, r 0 r 0 'NCONH- group (r 0 and r 0', the. Represents the same meaning as), or, Rr'NCO- group (r and r 'are, Represents the same meaning as described above), or represents a hydroxyl group, q represents 0, 1, 2 or 3, and when q is 2 or more, Y a is the same or different and q is 2 or more. In some cases, adjacent Y a may be condensed with a ring to form a 2,3-dihydro-benzo [1,4] dioxin ring.
II. b '
Formula (V'-1)
Wherein, Q a is r a -O- group {r a is a hydrogen atom, or, C1-C10 alkyl group, or, C3-C10 alkenyl group, or, C3-C10 alkynyl group, or, r 0 r 0 'N-CH 2 - group (r 0 and r 0' represents the same meaning as.), Roch 2 - group (. r is representative of the same meaning as above), r 0 -CO - group (. r 0 is representative of the same meaning), C1-C10 alkoxycarbonyl group, a carboxy group, C1-C10 alkyl group substituted with aminocarbonyl group or a cyano group, or, r 3 -r 1 -Represents a group (wherein r 3 represents a phenyl group or a pyridyl group, and r 1 represents the same meaning as described above). }, Or piperidino group, morpholino group, or r 4 r 4 ′ N-group (where r 4 and r 4 ′ are the same or different, a hydrogen atom, a C1-C10 alkyl group, or C 3 -C10 alkenyl group, or C3-C10 alkynyl group, or a C2-C10 alkyl group substituted with C1-C10 alkoxy group. However, not hydrogen atoms at the same time.) represents, W a is , oxygen atom or -NT a - group [T a is r b - group (r b may be the same or different phases and r a, represents the same meaning as r a.) or r 3 '- group (r 3 'differs r 3 and same or different, represent a representative.) the same meaning as r 3. Represents], K a represents a hydrogen atom, a halogen atom or a C1-C10 alkyl group, a L a represents a hydrogen atom or a C1-C10 alkyl group, a and K a and L a, C3-C10 alkylene group Alternatively, it may form a 1,3-butadienylene group. ]
A group represented by
Formula (V'-2)
Wherein, T a represents the same meaning as above, L b represents a hydroxyl group or a methyl group. ]
A group represented by
Formula (V'-3)
Wherein, T a represents the same meaning as, L c represents a C1-C10 alkyl group. ]
A group represented by
Formula (V'-4)
Wherein, T a represents the same meaning as above. ]
A group represented by
Formula (V'-5)
Wherein, T a represents the same meaning as above, K b is cyano group or UOCO- group (U represents. A hydrogen atom or a C1-C10 alkyl group);. ]
A group represented by
Formula (V'-6)
[Wherein W a represents the same meaning as described above, and K c and L d form a C3-C10 alkylene group or a C4-C10 alkenylene group. ]
A group represented by
Formula (V'-7)
Wherein, Q a and W a represents the same meaning as, the K d and L e, -V a = V a '-V a''= V a''' - group (V a , V a ′, V a ″ and V a ″ are the same or different and represent a methine group or —N = group, and V a , V a ′, V a ″ and V a ″ At least one of-represents -N = group. ]
A group represented by
Formula (V'-8)
Wherein, T a represents the same meaning as, Q b is r a -O- group (r a represents. The same meanings as the above) represents a. ]
Or a group represented by
Formula (V-9 ')
[Wherein W a represents the same meaning as described above. ]
Represents a group represented by
However, when a is a furan ring or a thiophene ring, p and q are not 0 simultaneously.
In addition, “representing the same meaning as described above” in the same symbol among a plurality of substituents indicates that the plurality of substituents represent the same meaning as described above while being independent of each other. The range of choices of substituents selected among groups is the same, but as long as it is selected within the range, the selected substituents may be the same or different. . ]
A cinnamoyl compound represented by:
An effective amount of the cinnamoyl compound contained as an active ingredient in the composition according to claim 1 or 9, or the compound according to claims 2-6, 10 and 11 to a mammalian patient in need of hair restoration treatment. A hair-growth method characterized by administering.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006054781A JP2006273847A (en) | 2005-03-02 | 2006-03-01 | Cinnamoyl compound and its application |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005057363 | 2005-03-02 | ||
JP2006054781A JP2006273847A (en) | 2005-03-02 | 2006-03-01 | Cinnamoyl compound and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006273847A true JP2006273847A (en) | 2006-10-12 |
Family
ID=37208926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006054781A Pending JP2006273847A (en) | 2005-03-02 | 2006-03-01 | Cinnamoyl compound and its application |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006273847A (en) |
-
2006
- 2006-03-01 JP JP2006054781A patent/JP2006273847A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007308441A (en) | Heterocycle-containing compound and its application | |
JP6648137B2 (en) | Heterocyclic derivatives and uses thereof | |
CA2879053C (en) | Thiophene derivatives used in the treatment of diabetes | |
JP2002521408A (en) | Compounds and methods | |
AU5570299A (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
WO1999019303A1 (en) | Pyrazole derivatives | |
JP2007308402A (en) | Cinnamoyl compound and its application | |
WO2006093339A1 (en) | Use of cinnamoyl compound | |
WO2006100922A1 (en) | Cinnamoyl compound and use thereof | |
AU2004274328B2 (en) | Cinnamoyl compound and use of the same | |
US20020052396A1 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
CA2539165A1 (en) | Cinnamoyl compound and use of the same | |
EP1671950B1 (en) | Cinnamoyl derivatives and use thereof | |
JP2006273848A (en) | Application of cinnamoyl compound | |
JP2006273848A5 (en) | ||
JP2006273847A (en) | Cinnamoyl compound and its application | |
JP2007308401A (en) | Cinnamoyl compound and its application | |
JP4797351B2 (en) | Cinnamoyl compounds and uses thereof | |
JP2006104061A (en) | Cinnamoyl compound-containing type i collagen gene transcription inhibitory composition | |
JP2009161479A (en) | Heterocycle-containing compound and its application | |
WO2003080592A1 (en) | 2-pyrone compounds and use thereof | |
JP2004123621A (en) | 4-methoxy-1-benzopyran-2-one compound and its application | |
JP4815773B2 (en) | Cinnamoyl compounds and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20080131 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20080515 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120327 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120724 |